Item Name,CatalogNumber,CAS Number,Pathway,Target,Information,SMILES,mean viability,std viability
&alpha;-Estradiol,B7201,57-91-0,Endocrinology and Hormones,Estrogen/progestogen Receptor,Endogenous estrogen receptor ligand,O[C@H]1[C@]2(C)[C@@H](CC1)[C@H](CCC3=C4C=CC(O)=C3)[C@@H]4CC2,107.1,3.5
(+)-Catechin hydrate,N1692,225937-10-0,Natural Products,Others,1,1,97.1,6.7
(+)-Ketoconazole,B1240,142128-59-4,Metabolism,P450,Potent inhibitor of cytochrome P450c17,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,109.0,7.2
"(+,-)-Octopamine HCl",B1995,770-05-8,Neuroscience,Dopamine Receptor,adrenoceptor agonist,C1=CC(=CC=C1C(CN)O)O.Cl,96.4,2.9
(+/-)-Sulfinpyrazone,B6139,57-96-5,Neuroscience,COX,platelet COX inhibitor,O=C(N1C2=CC=CC=C2)C(C(N1C3=CC=CC=C3)=O)CCS(C4=CC=CC=C4)=O,132.9,30.1
(-)-Huperzine A,A1932,102518-79-6,Neuroscience,Alzheimer,NMDA receptor antagonist/AChE inhibitor,C/C=C1[C@@]2(N)C3=C(NC(C=C3)=O)C[C@]/1([H])C=C(C)C2,113.8,20.5
(-)-Lobeline hydrochloride,B6586,134-63-4,Neuroscience,Nicotinic Receptor,nicotinic receptor partial agonist,O[C@H](C1=CC=CC=C1)C[C@H]2N(C)[C@H](CC(C3=CC=CC=C3)=O)CCC2.Cl,101.0,2.3
(-)-Tetramisole,B1777,16595-80-5,Immunology/Inflammation,Parasite,Inhibitor of alkaline phosphatase,C1CSC2=NC(CN21)C3=CC=CC=C3.Cl,98.5,5.6
(-)-epicatechin,B4964,490-46-0,TGF-β / Smad Signaling,PKC,1,1,100.3,7.0
(-)-epicatechin gallate,B4965,1257-08-5,TGF-β / Smad Signaling,PKC,1,1,99.9,19.9
"(2S,3S)-2-Amino-3-methylpentanoic acid",C6111,73-32-5,Others,Others,1,1,104.6,7.0
(6-)ε-​Aminocaproic acid,B2076,60-32-2,Others,Others,antifibrinolytic agent,C(CCC(=O)O)CCN,102.1,4.9
"(R)-(+)-1,2-Dithiolane-3-pentanoic acid",C6326,1200-22-2,Others,Others,1,1,101.3,8.4
(R)-Crizotinib,A3020,877399-52-5,Tyrosine Kinase,c-MET,"C-MET/ALK inhibitor,potent and ATP-competitve",CC(C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N,12.2,14.7
(R)-baclofen,B1531,69308-37-8,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist,C1=CC(=CC=C1C(CC(=O)O)CN)Cl,98.8,0.8
"(R,S)-Atenolol",C5286,29122-68-7,GPCR/G protein,Adrenergic Receptor,β1-adrenergic receptor antagonist,NC(CC1=CC=C(OCC(O)CNC(C)C)C=C1)=O,100.7,8.3
(RS)-(&#177;)-Sulpiride,B6492,15676-16-1,Neuroscience,Dopamine Receptor,D2-like dopamine receptor antagonist,O=C(C(C=C1S(=O)(N)=O)=C(C=C1)OC)NC[C@@H]2N(CC)CCC2,106.1,5.2
(S)-10-Hydroxycamptothecin,B4745,19685-09-7,DNA Damage/DNA Repair,Topoisomerase,1,1,-5.0,0.9
(S)-Flurbiprofen,C5264,51543-39-6,Neuroscience,COX,inhibitors of COX-1 and COX-2,FC1=CC([C@@H](C(O)=O)C)=CC=C1C2=CC=CC=C2,94.4,5.1
(S)-Ketoprofen,C3334,22161-81-5,Neuroscience,COX,COX-1 and COX-2 inhibitor,O=C(C1=CC=CC([C@H](C)C(O)=O)=C1)C2=CC=CC=C2,93.6,12.0
(S)-Naproxen,C5755,22204-53-1,Neuroscience,COX,non-selective COX inhibitor,C[C@H](C(O)=O)C1=CC=C2C=C(OC)C=CC2=C1,99.1,7.6
(±)-Baclofen,C4051,1134-47-0,Neuroscience,GABA Receptor,1,1,98.2,2.6
"1,4-Benzoquinone",C6224,106-51-4,Others,Others,1,1,101.4,1.4
1-Hexadecanol,B1651,36653-82-4,Others,Others,Fatty alcohol,CCCCCCCCCCCCCCCCO,109.6,9.6
10-DAB (10-Deacetylbaccatin),A4395,32981-86-5,Cell Cycle/Checkpoint,Microtubule/Tubulin,Precursor of antitumor compound Palitaxel and Docetaxel,O[C@](C(C)(C)C1=C(C)[C@H]2O)(C2)[C@H]([C@@H]([C@@](C([C@H]1O)=O)(C)[C@@H]3O)[C@]4([C@@H](C3)OC4)OC(C)=O)OC(C5=CC=CC=C5)=O,131.1,27.1
10-Hydroxycamptothecin,N2591,64439-81-2,Natural Products,Topoisomerase,1,1,102.2,0.3
17-AAG (KOS953),A4054,75747-14-7,Proteases,HSP,Hsp90 inhibitor,CC1CC(C(C(C=C(C(C(C=CC=C(C(=O)NC2=CC(=O)C(=C(C1)C2=O)NCC=C)C)OC)OC(=O)N)C)C)O)OC,122.8,16.8
17-Hydroxyprogesterone,B6126,68-96-2,Endocrinology and Hormones,Estrogen/progestogen Receptor,endogenous progestogen as well as chemical intermediate in the biosynthesis of other steroid hormones,CC([C@@]1(O)CC[C@@]2([H])[C@]([C@]3([H])CC[C@@]21C)([H])CCC4=CC(CC[C@@]43C)=O)=O,96.8,5.4
2'-Deoxyguanosine,B4721,961-07-9,Others,Others,2'-Deoxyguanosine,1,118.8,11.6
2-Deoxy-D-glucose,B1027,154-17-6,Others,Hexokinase,1,1,98.2,7.1
2-Deoxyuridine,B7866,951-78-0,Others,kinase,"Rutin metabolite, antioxidant",OC[C@](O1)([H])[C@](O)([H])C[C@]1([H])N2C=CC(O)=NC2=O,96.9,2.5
2-Methoxyestradiol (2-MeOE2),A4188,362-07-2,Apoptosis,Apoptosis Inducers,"Apoptotic, antiproliferative and antiangiogenic agent",CC12CCC3C(C1CCC2O)CCC4=CC(=C(C=C34)OC)O,91.8,19.6
2-Naphthol,C6160,135-19-3,Others,Others,1,1,109.4,1.7
2-Thiouracil,B1872,141-90-2,Others,Others,antihyperthyroid agent,C1=CNC(=S)NC1=O,93.4,6.4
"3,4-Dihydroxybenzoic acid",N2466,99-50-3,Natural Products,Others,1,1,96.9,0.5
3-Hydroxy-2-methyl-4H-pyran-4-one,C6210,118-71-8,Others,Others,1,1,94.0,7.5
3-n-Butylphathlide,N2117,6066-49-5,Natural Products,Others,1,1,87.4,12.4
4-Aminobenzoic acid,B7869,150-13-0,Others,Others,1,1,89.5,1.9
4-Aminobutyric acid,P10002,56-12-2,Others,APIs,1,C(CC(=O)O)CN,113.9,6.1
4-Aminophenol,C6133,123-30-8,Others,Others,1,1,107.1,17.8
4-Aminopyridine,B3530,504-24-5,Membrane Transporter/Ion Channel,Potassium Channel,potassium channel-blocking agent,1,105.5,6.0
4-Aminosalicylic acid,C6187,65-49-6,Microbiology & Virology,Anti-infection,1,1,107.4,21.6
4-Hydroxybenzoic acid,B7870,99-96-7,Others,Others,1,1,100.7,11.1
4-Methylbenzylidene camphor,C3558,36861-47-9,Endocrinology and Hormones,Estrogen/progestogen Receptor,1,1,117.7,21.0
4-Methylumbelliferone (4-MU),B6001,90-33-5,Others,Others,1,1,93.4,4.2
4-Nitrophenol,C6223,100-02-7,Others,Others,1,1,115.1,26.7
5-Aminolevulinic acid HCl,B2070,5451-9-2,Others,Others,photosensitizing agent， antineoplastic agent,NCC(CCC(O)=O)=O.Cl,100.8,1.4
5-Azacytidine,A1907,320-67-2,Chromatin/Epigenetics,DNA Methyltransferase,DNA methyltransferase inhibitor.,C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N,51.1,7.1
5-Methoxypsoralen,N1304,484-20-8,Natural Products,DNA/RNA Synthesis,1,COC1=C2C=CC(=O)OC2=CC3=C1C=CO3,115.4,45.3
5-Methoxytryptamine,B7872,608-07-1,Neuroscience,5-HT Receptor,"Full agonist at the 5-HT1, 5-HT2, 5-HT4, 5-HT6, and 5-HT7 receptors but has no affinity for the 5-HT3 receptor",COC1=CC(C(CCN)=CN2)=C2C=C1,100.6,3.0
5-hydroxy-L-Tryptophan,C3999,4350-09-8,Others,Others,1,OC1=CC=C2C(C(C[C@H](N)C(O)=O)=CN2)=C1,110.0,15.7
5-hydroxymethyl-2-furaldehyde,N1335,67-47-0,Natural Products,Others,1,C1=C(OC(=C1)C=O)CO,109.7,9.9
"6,7-Dihydroxycoumarin",N1764,305-01-1,Natural Products,Lipoxygenase,1,1,110.0,4.9
8-Methoxypsoralen,N1305,298-81-7,Natural Products,P450 (e.g. CYP17),CYP inhibitor,COC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,119.2,11.3
ABT-199,A8194,1257044-40-8,Apoptosis,Bcl-2 Family,"Bcl-2 inhibitor,potent and selective",CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C,112.2,3.5
ABT-263 (Navitoclax),A3007,923564-51-6,Apoptosis,Bcl-2 Family,"Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w",CC(CC1)(C)CC(CN2CCN(C3=CC=C(C(NS(C4=CC=C(N[C@@H](CSC5=CC=CC=C5)CCN6CCOCC6)C(S(C(F)(F)F)(=O)=O)=C4)(=O)=O)=O)C=C3)CC2)=C1C7=CC=C(Cl)C=C7,20.9,19.0
ABT-888 (Veliparib),A3002,912444-00-9,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,CC1(CCCN1)C2=NC3=C(C=CC=C3N2)C(=O)N,108.6,3.8
ACP-196,B6185,1420477-60-6,Angiogenesis,BTK,irreversible BTK inhibitor,O=C(NC1=NC=CC=C1)C2=CC=C(C3=C4C(N)=NC=CN4C([C@H]5N(C(C#CC)=O)CCC5)=N3)C=C2,95.0,6.4
AG-120,B7805,1448347-49-6,Metabolism,Dehydrogenase,1,1,98.5,3.9
AG-221 (Enasidenib),B7804,1446502-11-9,Metabolism,Dehydrogenase,mutant isocitrate dehydrogenase 2 (IDH2) inhibitor,CC(O)(C)CNC1=NC(C2=NC(C(F)(F)F)=CC=C2)=NC(NC3=CC(C(F)(F)F)=NC=C3)=N1,104.3,6.9
AHU-377 hemicalcium salt,B3267,1369773-39-6,Metabolism,Neprilysin,1,1,99.8,4.6
AHU-377(Sacubitril),B1070,149709-62-6,GPCR/G protein,Angiotensin Receptor,1,1,102.8,4.9
AN-2690,A3177,174671-46-6,Microbiology & Virology,Antibiotic,Antifungal agent,B1(C2=C(CO1)C=C(C=C2)F)O,104.8,9.8
AN-2728,A3178,906673-24-3,Metabolism,PDE,"PDE4 inhibitor,anti-inflammatory compound",N#CC1=CC=C(OC2=CC=C3C(COB3O)=C2)C=C1,102.3,12.2
ARN-509,A8364,956104-40-8,Endocrinology and Hormones,Androgen Receptor,1,1,103.5,0.8
AT13387,A4056,912999-49-6,Proteases,HSP,Hsp90 inhibitor,CC(C)C1=C(C=C(C(=C1)C(=O)N2CC3=C(C2)C=C(C=C3)CN4CCN(CC4)C)O)O,117.0,33.2
ATP disodium salt,B3304,987-65-5,Others,Others,1,1,96.6,7.5
AXL1717,A3209,477-47-4,Tyrosine Kinase,IGF1R,1,1,8.1,17.6
AZD-9291,B1104,1421373-65-0,JAK/STAT Signaling,EGFR,Mutated forms EGFR inhibitor,CN1C=C(C2=NC(NC3=C(OC)C=C(N(CCN(C)C)C)C(NC(C=C)=O)=C3)=NC=C2)C4=C1C=CC=C4,105.3,2.1
AZD6244 (Selumetinib),A8207,606143-52-6,MAPK Signaling,MEK1/2,MEK inhibitor,CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO,24.5,16.8
AZD7545,B1286,252017-04-2,Others,PDHK,1,1,103.4,8.7
Abacavir,A3139,136470-78-5,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Inhibitor of HIV reverse transcriptase,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N,103.8,6.5
Abacavir sulfate,B2220,188062-50-2,Others,Others,Reverse transcriptase inhibitor,C1CC1NC2=NC(=NC3=C2N=CN3C4CC(C=C4)CO)N.OS(=O)(=O)O,95.6,6.0
Abiraterone,A4240,154229-19-3,Metabolism,P450,Potent CYP17 inhibitor,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O,109.8,9.4
Abiraterone acetate,A8202,154229-18-2,Metabolism,P450,Cytochrome p450 17a1 inhibitor,CC(=O)OC1CCC2(C3CCC4(C(C3CC=C2C1)CC=C4C5=CN=CC=C5)C)C,103.9,0.9
Abscisic Acid (Dormin),B4883,21293-29-8,Others,Others,1,1,90.6,6.4
Acamprosate calcium,A3142,77337-73-6,Membrane Transporter/Ion Channel,GABA Receptor,GABA receptor agonist and modulator of glutamatergic systems,CC(=O)NCCCS(=O)(=O)[O-].CC(=O)NCCCS(=O)(=O)[O-].[Ca+2],112.6,5.0
Acarbose,A2431,56180-94-0,Others,Others,Alpha-glucosidase inhibitor,CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(OC(C(C3O)O)O)CO)CO)O)O)NC4C=C(C(C(C4O)O)O)CO,112.1,6.2
Acebutolol HCl,B1330,34381-68-5,GPCR/G protein,Adrenergic Receptor,β-adrenergic receptors antagonist,CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C.Cl,105.8,7.6
Acemetacin,B1440,53164-05-9,Neuroscience,COX,COX inhibitor,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)OCC(=O)O,93.8,1.6
Acetaminophen,B3532,103-90-2,Neuroscience,COX,COX inhibitor,C/C(O)=N/C1=CC=C(O)C=C1,102.7,3.8
Acetanilide,B2071,103-84-4,Others,Others,aniline derivative,CC(=O)NC1=CC=CC=C1,98.5,0.9
Acetazolamide,B6125,59-66-5,Metabolism,Carbonic Anhydrase,carbonic anhydrase (CA) inhibitor,C/C(O)=N/C1=NN=C(S(N)(=O)=O)S1,106.9,14.1
Acetohydroxamic Acid,B8690,546-88-3,Microbiology & Virology,Anti-infection,"Irreversible inhibitor of urease, derivative of hydroxyurea",1,103.9,9.2
Acetylcholine Chloride,B1596,60-31-1,Neuroscience,AChR,Major transmitter at many nervous sites,CC(=O)OCC[N+](C)(C)C.[Cl-],111.9,0.9
Acetylcysteine,A8356,616-91-1,Neuroscience,AChR,Antioxidant;mucolytic agent,CC(=O)NC(CS)C(=O)O,96.6,14.3
Acipimox,B2072,51037-30-0,Others,Others,Antilipolytic agent,CC1=CN=C(C=[N+]1[O-])C(=O)O,95.1,3.8
Acitretin,A2415,55079-83-9,Others,RAR/RXR,Metabolite of etretinate,CC1=CC(=C(C(=C1C=CC(=CC=CC(=CC(=O)O)C)C)C)C)OC,117.5,32.0
Aclidinium Bromide,B1609,320345-99-1,Neuroscience,Muscarinic Receptor,LAMAs antagonist,C1C[N+]2(CCC1C(C2)OC(=O)C(C3=CC=CS3)(C4=CC=CS4)O)CCCOC5=CC=CC=C5.[Br-],92.1,7.5
Actinomycin D,A4448,50-76-0,Apoptosis,Apoptosis Inducers,1,1,-15.4,13.0
Acyclovir,A8644,59277-89-3,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agent,C1=NC2=C(N1COCCO)NC(=NC2=O)N,102.5,2.3
Adapalene,A1267,106685-40-9,Others,Others,RARβ and RARγ agonist,COC1=C(C=C(C=C1)C2=CC3=C(C=C2)C=C(C=C3)C(=O)O)C45CC6CC(C4)CC(C6)C5,32.3,5.4
Adapalene sodium salt,B1277,911110-93-5,Others,Others,Retinoic acid receptor agonist,COC1=C(C23C[C@@]4([H])C[C@](C2)([H])C[C@](C3)([H])C4)C=C(C5=CC=C6C=C(C([O-])=O)C=CC6=C5)C=C1.[Na+],102.1,0.8
Adefovir Dipivoxil,B2222,142340-99-6,Microbiology & Virology,CMV,Reverse transcriptase inhibitor,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C1N=CN=C2N)OCOC(=O)C(C)(C)C,-5.2,2.5
Ademetionine,B3513,29908-03-0,Others,Others,"S-adenosylmethionine, PDE4B inhibitor",C[S+](C[C@](O1)([H])[C@](O)([H])[C@](O)([H])[C@]1([H])N2C=NC(C2=NC=N3)=C3N)CC[C@@](N)([H])C([O-])=O,99.3,5.5
Adenine,B1468,73-24-5,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,High affinity adenine receptor agonist,C1=NC2=C(N1)C(=NC=N2)N,104.5,7.7
Adenine HCl,B1471,2922-28-3,DNA Damage/DNA Repair,DNA Synthesis,Adenine receptor agonist,C1=NC2=C(N1)C(=NC=N2)N.Cl,109.3,3.6
Adenine sulfate,B1469,321-30-2,DNA Damage/DNA Repair,DNA Synthesis,1,1,97.7,8.4
Adenosine,B1877,58-61-7,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,nucleoside,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,103.7,7.2
Adenosine 5-triphosphate,B7876,34369-07-8,Others,Others,Purinergic P2 receptor agonist,NC1=C(N=CN2[C@@]3([H])[C@@](O)([H])[C@@](O)([H])[C@@](O3)([H])COP(O)(OP(O)(OP(O)(O)=O)=O)=O)C2=NC=N1,97.5,0.8
Adenosine-5'-diphosphate,C4341,58-64-0,Metabolism,Others,"central component of energy storage, metabolism, and signal transduction in vivo;agonist of purinergic receptors",O[C@H]1[C@H](N2C=NC3=C2N=CN=C3N)O[C@H](COP(OP(O)(O)=O)(O)=O)[C@H]1O,102.0,10.0
Adiphenine HCl,B1878,50-42-0,Neuroscience,AChR,nicotinic receptor inhibitor,CCN(CC)CCOC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2.Cl,105.1,5.0
Adrenalone HCl,B1331,62-13-5,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,CNCC(=O)C1=CC(=C(C=C1)O)O.Cl,80.5,4.5
Afatinib (BIBW2992),A8247,439081-18-2,JAK/STAT Signaling,EGFR,Irreversible EGFR/HER2 inhibitor,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4,33.1,4.7
Afatinib dimaleate,A3145,850140-73-7,Tyrosine Kinase,HER2,EGFR inhibitor,CN(C)CC=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OC4CCOC4.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,42.3,7.6
Afuresertib,B4811,1047644-62-1,PI3K/Akt/mTOR Signaling,PKB,pan-AKT inhibitor,CN1C(=C(C=N1)Cl)C2=C(SC(=C2)C(=O)NC(CC3=CC(=CC=C3)F)CN)Cl,43.3,3.6
Agomelatine,B2262,138112-76-2,Neuroscience,5-HT Receptor,MT1/MT2 / 5-HT2C agonist,CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC,97.1,5.9
Alarelin Acetate,A3151,79561-22-1,Endocrinology and Hormones,GnRH,1,1,101.8,8.1
Albendazole,A8358,54965-21-8,Microbiology & Virology,Antibiotic,treatment of a variety of parasitic worm infestations,CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC,106.9,1.9
Albendazole Oxide,B1880,54029-12-8,Cell Cycle/Checkpoint,Microtubule Associated,Microtubule associated inhibitor,CCCS(=O)C1=CC2=C(C=C1)N=C(N2)NC(=O)OC,95.1,10.0
Alcaftadine,B3518,147084-10-4,Neuroscience,Histamine Receptor,H1 histamine receptor antagonist,CN1CC/C(CC1)=C2C3=CC=CC=C3CCN4C(C=O)=CN=C/24,91.1,2.3
Alendronate,B2073,121268-17-5,Others,Farnesyl Diphosphate Synthase,Bone resorption inhibitor,[O-]P(O[H])(C(O[H])(C([H])([H])C([H])([H])C([H])([H])N([H])[H])P(O[H])(O[H])=O)=O.[H]O[H].[H]O[H].[H]O[H].[Na+],120.7,23.5
Alendronate sodium,A8359,129318-43-0,Others,Others,Osteoclast-mediated bone resorption inhibitor,C(CC(O)(P(=O)(O)O)P(=O)(O)[O-])CN.[Na+],52.8,4.4
Alfacalcidol,B2153,41294-56-8,Vitamin D Related,VD/VDR,Bone resorption inhibitor,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,81.1,10.8
Alfuzosin HCl,A5173,81403-68-1,GPCR/G protein,Adrenergic Receptor,"α1 adrenoceptor antagonist,functionally uro-selective",CN(CCCNC(=O)C1CCCO1)C2=NC3=CC(=C(C=C3C(=N2)N)OC)OC.Cl,93.6,2.6
Alibendol,B1881,26750-81-2,Others,Others,"antispasmodic,choleretic,cholekinetic",COC1=C(C(=CC(=C1)CC=C)C(=O)NCCO)O,102.7,4.7
Aliskiren,A3153,173334-57-1,Others,Renin,Direct renin inhibitor,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N,111.0,19.5
Aliskiren Hemifumarate,B2215,173334-58-2,Others,Renin,renin inhibitor,CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.CC(C)C(CC1=CC(=C(C=C1)OC)OCCCOC)CC(C(CC(C(C)C)C(=O)NCC(C)(C)C(=O)N)O)N.C(=CC(=O)O)C(=O)O,101.2,6.5
Allantoin,N2301,97-59-6,Natural Products,Others,1,C1(C(=O)NC(=O)N1)NC(=O)N,106.8,1.2
Allopregnanolone,B7456,516-54-1,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptor positive allosteric modulator,O[C@H]1C[C@H]2[C@@](CC1)(C)[C@@H]3[C@@H](CC2)[C@H]4[C@]([C@@H](C(C)=O)CC4)(C)CC3,99.1,1.6
Allopurinol,A8360,315-30-0,Others,XAO,Xanthine oxidase inhibitor,C1=C2C(=NC=NC2=O)NN1,102.4,0.5
Allylthiourea,B1882,109-57-9,Others,Others,Selective inhibitor of ammonia oxidation,C=CCNC(=S)N,108.6,10.4
Almotriptan Malate,B2243,181183-52-8,Neuroscience,5-HT Receptor,5-HT1B/1D-receptor agonist,CN(C)CCC1=CNC2=C1C=C(C=C2)CS(=O)(=O)N3CCCC3.C(C(C(=O)O)O)C(=O)O,100.0,1.9
Alogliptin (SYR-322),A4038,850649-61-5,Proteases,DPP-4,"DPP-4 inhibitor,potent and highly selective",CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N,108.8,0.9
Alogliptin Benzoate,A3156,850649-62-6,Proteases,DPP-4,"DPP-4 inhibitor,selective and potent,antidiabetic drug",CN1C(=O)C=C(N(C1=O)CC2=CC=CC=C2C#N)N3CCCC(C3)N.C1=CC=C(C=C1)C(=O)O,99.2,9.3
Alosetron Hydrochloride,A3159,122852-69-1,Neuroscience,5-HT Receptor,"5-HT3 receptor antagonist,potent and highly selective",CC1=C(N=CN1)CN2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,109.1,3.2
Alprostadil,B2154,745-65-3,GPCR/G protein,Prostaglandin Receptor,vasodilator,CCCCCC(C=CC1C(CC(=O)C1CCCCCCC(=O)O)O)O,73.7,7.3
Altrenogest,B1503,850-52-2,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist,CC12C=CC3=C4CCC(=O)C=C4CCC3C1CCC2(CC=C)O,96.7,18.2
Altretamine,A2559,645-05-6,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic agent,CN(C)C1=NC(=NC(=N1)N(C)C)N(C)C,101.1,23.7
Alvelestat,B1037,848141-11-7,Proteases,Elastase,NE inhibitor,CC(N1C2=CC=CC(C(F)(F)F)=C2)=C(C3=CC=NN3C)C=C(C1=O)C(NCC4=NC=C(S(C)(=O)=O)C=C4)=O,106.4,11.2
Alverine Citrate,B1655,5560-59-8,GPCR/G protein,OX Receptor,Drug used for functional gastrointestinal disorders,CCN(CCCC1=CC=CC=C1)CCCC2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,106.1,3.0
Alvimopan,A3162,156053-89-3,Endocrinology and Hormones,Opioid Receptor,Mu-opioid receptors antagonist,C[C@@]1([H])CN(C[C@](/C(O)=N/CC(O)=O)([H])CC2=CC=CC=C2)CC[C@]1(C3=CC(O)=CC=C3)C,102.1,5.6
Amantadine,C6299,768-94-5,Microbiology & Virology,Anti-infection,1,1,103.1,3.0
Amantadine HCl,B1486,665-66-7,Neuroscience,Dopamine Receptor,Dopamine receptor agonist,C1C2CC3CC1CC(C2)(C3)N.Cl,107.4,5.2
Ambrisentan,B2075,177036-94-1,Neuroscience,Dopamine Receptor,ETA-receptor antagonist,CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C,113.6,3.8
Ambroxol HCl,B2267,23828-92-4,Membrane Transporter/Ion Channel,Sodium Channel,TTX-resistant Na+ currents inhibitor,C1CC(CCC1NCC2=CC(=CC(=C2N)Br)Br)O.Cl,102.6,9.2
Amfenac Sodium Monohydrate,B1656,61618-27-7,Neuroscience,COX,COX inhibitor,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)[O-])N.O.[Na+],105.6,0.8
Amidopyrine,B1883,58-15-1,1,1,analgesic，antipyretic,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C,104.0,5.3
Amifostine,B3474,20537-88-6,Others,Others,cytoprotective adjuvant,NCCCNCCSP(O)(O)=O,106.9,2.9
Amikacin,B3431,37517-28-5,Microbiology & Virology,Antibiotic,aminoglycoside antibiotic,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N,100.0,10.1
Amikacin disulfate,B1658,39831-55-5,Microbiology & Virology,Anti-infection,Semisynthetic aminoglycoside antibiotic,C1C(C(C(C(C1NC(=O)C(CCN)O)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(C(C(C(O3)CN)O)O)O)N.OS(=O)(=O)O.OS(=O)(=O)O,101.9,6.6
Amiloride HCl,B1884,2016-88-8,Membrane Transporter/Ion Channel,"Sodium Channel, Calcium Channel","epithelial sodium channel (ENaC) inhibitor, selective",C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.Cl,83.0,11.0
Amiloride HCl dihydrate,B2268,17440-83-4,Membrane Transporter/Ion Channel,Sodium Channel,potent epithelial sodium channel (ENaC) blocker,C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N.O.O.Cl,90.9,4.6
Aminoglutethimide,B1380,125-84-8,Endocrinology and Hormones,Aromatase,Aromatase inhibitor,CCC1(CCC(=O)NC1=O)C2=CC=C(C=C2)N,106.9,4.1
Aminoguanidine hydrochloride,B6452,1937-19-5,Others,iNOS,iNOS inhibitor,N/C(N)=N\N.Cl,92.4,4.9
Aminophylline,A4346,317-34-0,Metabolism,PDE,Pan-PDE inhibitor,CN1C2=C(C(=O)N(C1=O)C)NC=N2.CN1C2=C(C(=O)N(C1=O)C)NC=N2.C(CN)N,106.9,4.8
Aminothiazole,B1659,96-50-4,Microbiology & Virology,Anti-infection,Thyroid inhibitor,C1=CSC(=N1)N,99.2,7.6
Amiodarone HCl,B1389,19774-82-4,Membrane Transporter/Ion Channel,Potassium Channel,Anti-arrhythmic drug,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCN(CC)CC)I.Cl,114.0,9.1
Amisulpride,B1479,71675-85-9,Neuroscience,Dopamine Receptor,Dopamine D2/D3 receptor antagonist,CCN1CCCC1CNC(=O)C2=CC(=C(C=C2OC)N)S(=O)(=O)CC,100.3,2.3
Amitriptyline HCl,B2231,549-18-8,Neuroscience,5-HT Receptor,Serotonin /norepinephrine receptor/5-HT4/5-HT2 inhibitor,CN(C)CCC=C1C2=CC=CC=C2CCC3=CC=CC=C31.Cl,103.7,5.8
Amlexanox,C5108,68302-57-8,Immunology/Inflammation,1,1,CC(C1=CC=C2C(C(C3=C(O2)N=C(N)C(C(O)=O)=C3)=O)=C1)C,95.2,3.4
Amlodipine,B1410,88150-42-9,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN,94.0,4.9
Amlodipine Besylate,B1411,111470-99-6,Membrane Transporter/Ion Channel,Calcium Channel,Block of L-type calcium channel,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2Cl)C(=O)OC)C)COCCN.C1=CC=C(C=C1)S(=O)(=O)O,99.3,11.1
Amodiaquine dihydrochloride dihydrate,B6134,6398-98-7,Metabolism,Transferase,histamine N-methyl transferase inhibitor,CCN(CC1=CC(NC2=C3C=CC(Cl)=CC3=NC=C2)=CC=C1O)CC.Cl.Cl.O.O,104.5,0.2
Amonafide,A2782,69408-81-7,DNA Damage/DNA Repair,Topoisomerase,"DNA intercalator,Topo II inhibitor",CN(C)CCN1C(=O)C2=CC=CC3=CC(=CC(=C32)C1=O)N,126.5,33.7
Amorolfine HCl,B2077,78613-38-4,Microbiology & Virology,Antibiotic,antifungal reagent,CCC(C)(C)C1=CC=C(C=C1)CC(C)CN2CC(OC(C2)C)C.Cl,98.0,9.9
Amoxapine,B1660,14028-44-5,Neuroscience,GlyT,GLYT2a transport activity inhibitor,C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl,99.3,4.6
Amoxicillin,B1661,26787-78-0,Microbiology & Virology,Anti-infection,"Moderate-spectrum, bacteriolytic, β-lactam antibiotic",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C,100.4,13.6
Amoxicillin trihydrate,B3361,61336-70-7,Microbiology & Virology,Anti-infection,Broad spectrum antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=C(C=C3)O)N)C(=O)O)C.O.O.O,89.7,1.1
Amphotericin B,B1885,1397-89-3,Microbiology & Virology,Antibiotic,amphipathic polyene antibiotic,CC1C=CC=CC=CC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(CC(C(CCC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,123.2,16.9
Ampicillin,A2510,69-52-3,Microbiology & Virology,Antibiotic,β-lactam antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)[O-])C.[Na+],94.4,2.0
Ampicillin Trihydrate,B1662,7177-48-2,Microbiology & Virology,Anti-infection,β-lactam antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)C.O.O.O,106.1,0.8
Amprenavir (agenerase),A8201,161814-49-9,Proteases,HIV Protease,HIV-1 protease inhibitor,CC(C)CN(CC(C(CC1=CC=CC=C1)NC(=O)OC2CCOC2)O)S(=O)(=O)C3=CC=C(C=C3)N,118.4,16.7
Amprolium HCl,B1663,137-88-2,Metabolism,Vitamin,Thiamin antagonist/coccidiostat,CCCC1=NC=C(C(=N1)N)C[N+]2=CC=CC=C2C.Cl.[Cl-],101.8,2.7
Amsacrine,B1302,51264-14-3,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 2 inhibitor,COC1=C(C=CC(=C1)NS(=O)(=O)C)NC2=C3C=CC=CC3=NC4=CC=CC=C42,94.5,5.1
Amsacrine hydrochloride,B1303,54301-15-4,DNA Damage/DNA Repair,Topoisomerase,1,1,8.8,6.0
"Amuvatinib (MP-470, HPK 56)",A4237,850879-09-3,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,C1CN(CCN1C2=NC=NC3=C2OC4=CC=CC=C43)C(=S)NCC5=CC6=C(C=C5)OCO6,62.9,2.9
Amygdalin,N1837,29883-15-6,Natural Products,Others,1,1,95.9,0.3
Anagrelide HCl,A4352,58579-51-4,Metabolism,PDE,Thrombocytopenic agent,C1C2=C(C=CC(=C2Cl)Cl)NC3=NC(=O)CN31.Cl,126.8,35.4
Anastrozole,B1382,120511-73-1,Endocrinology and Hormones,Aromatase,Aromatase inhibitor,CC(C)(C#N)C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C#N,97.9,8.1
Andrographolide,N1855,5508-58-7,Immunology/Inflammation,IκB/IKK,1,1,104.1,5.5
Androsterone,C4201,53-41-8,Endocrinology and Hormones,Androgen Receptor,1,O=C1CC[C@@]2([H])[C@]3([H])CC[C@@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C,101.6,13.0
Angiotensin II,A1042,4474-91-3,Cardiovascular,Angiotensin Receptor,1,1,43.7,51.0
Anidulafungin,B1224,166663-25-8,Microbiology & Virology,Antibiotic,Antifungal drug,O[C@H]1[C@H](C)CN(C([C@H]([C@H](C)O)NC([C@H]([C@@H]([C@@H](C(C=C2)=CC=C2O)O)O)NC([C@H](C3)N(C([C@H]([C@H](C)O)NC4=O)=O)C[C@@H]3O)=O)=O)=O)[C@@H]1C(N[C@H]([C@@H](C[C@@H]4NC(C5=CC=C(C6=CC=C(C(C=C7)=CC=C7OCCCCC)C=C6)C=C5)=O)O)O)=O,103.7,0.5
Aniracetam,B1210,72432-10-1,Membrane Transporter/Ion Channel,AMPAR,Nootropic drug for senile dementia,COC1=CC=C(C=C1)C(=O)N2CCCC2=O,107.0,5.7
Anisodamine,C5580,55869-99-3,GPCR/G protein,Adrenergic Receptor,weak antagonist of α1-adrenoceptors,O=C([C@H](CO)C1=CC=CC=C1)O[C@@H]2C[C@@H](N3C)[C@@H](O)C[C@@H]3C2,106.3,11.7
Anisole Methoxybenzene,A7048,100-66-3,Others,Others,"Flavouring agent; precursor to perfumes, insect pheromones, and pharmaceuticals",1,108.9,17.1
Antazoline HCl,B1664,2508-72-7,Neuroscience,Histamine Receptor,Histamine receptor inhibitor,C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3.Cl,103.1,9.3
Antipyrine,B1886,60-80-0,Others,Others,analgesic and antipyretic agent,CC1=CC(=O)N(N1C)C2=CC=CC=C2,103.6,1.0
Apatinib,B2303,811803-05-1,Tyrosine Kinase,VEGFR,"VEGFR2 inhibitor, orally bioavailable, selective",CS(=O)(=O)O.C1CCC(C1)(C#N)C2=CC=C(C=C2)NC(=O)C3=C(N=CC=C3)NCC4=CC=NC=C4,102.9,0.3
Apigenin,N1828,520-36-5,Natural Products,P450 (e.g. CYP17),1,1,83.0,0.3
Apixaban,A4341,503612-47-3,Proteases,Thrombin,Factor Xa inhibitor,COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N,108.5,5.2
Apramycin Sulfate,B1665,65710-07-8,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,CNC1C(C2C(CC(C(O2)OC3C(CC(C(C3O)O)N)N)N)OC1OC4C(C(C(C(O4)CO)N)O)O)O.OS(=O)(=O)O,104.3,5.7
Apremilast (CC-10004),A4317,608141-41-9,Metabolism,PDE,PDE4 inhibitor,CCOC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC,107.4,0.7
Aprepitant,A1684,170729-80-3,Neuroscience,Substance P/NK1 Receptor,Substance P (SP) inhibitor,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F,109.1,6.1
Aprotinin,A2574,9087-70-1,Proteases,Serine Protease,Inhibitor of bovine pancreatic trypsin,CC(O)=O.CC.CC.CCccC.[R].[P].[2H].[L].[E].[P].[P].[Y].[3H].[G].[KH].[R].[R].[Y].F.[Y].[*].[L].F.[V].[Y].[G].[G].[R].[KH].[R].N.N.F.[KH].S.[*].[2H].[R].[G].[G].[*].[KH].[*].[3H].C.[*].F.[P].[*].I.I.N.[Q].[3H].[M],99.5,3.2
Arbidol HCl,A8362,131707-23-8,Microbiology & Virology,Influenza A virus,Antiviral chemical agent,CCOC(=O)C1=C(N(C2=CC(=C(C(=C21)CN(C)C)O)Br)C)CSC3=CC=CC=C3.Cl,103.8,6.9
Arbutin,N1714,497-76-7,Natural Products,Tyrosinase,1,C1=CC(=CC=C1O)OC2C(C(C(C(O2)CO)O)O)O,100.2,9.3
Arecoline hydrobromide,B3370,300-08-3,Neuroscience,AChR,muscarinic acetylcholine receptor agonist,CN1CCC=C(C1)C(=O)OC.Br,139.0,38.6
Argatroban,A8363,74863-84-6,Proteases,Thrombin,Thrombin mediated fibrinogen cleavage inhibitor,O=C([C@H](CCC/N=C(N)/N)NS(=O)(C1=C2NC[C@H](C)CC2=CC=C1)=O)N3[C@@H](C(O)=O)C[C@H](C)CC3,55.3,1.4
Aripiprazole,B2232,129722-12-9,Neuroscience,Dopamine Receptor,5-HT receptor partial agonist,C1CC(=O)NC2=C1C=CC(=C2)OCCCCN3CCN(CC3)C4=C(C(=CC=C4)Cl)Cl,86.7,6.0
Aristolochic Acid A,N2032,313-67-7,Natural Products,1,1,1,87.1,9.8
Arsonic acid,A8355,97-44-9,Others,Others,An organoarsenic compound,CC(=O)NC1=C(C=CC(=C1)[As](=O)(O)O)O,99.0,10.5
Artemether,N1742,71963-77-4,Natural Products,Anti-infection,1,[H][C@@]1(C([H])([H])C2([H])[H])[C@]3([C@@]([C@@]4([H])C([H])([H])[H])([H])C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])[H])OOC2(C([H])([H])[H])O[C@@]3([H])O[C@]4([H])OC([H])([H])[H],48.3,6.1
Artemether (SM-224),A4014,71963-77-4,Ubiquitination/Proteasome,Proteasome,1,1,67.8,31.6
Artemisinine,N1827,63968-64-9,Natural Products,Anti-infection,1,O=C1O[C@]2([H])OC3(C([H])([H])[H])OO[C@]42[C@](C([H])([H])C3([H])[H])([H])[C@@](C([H])([H])[H])([H])C([H])([H])C([H])([H])[C@@]4([H])[C@@]1([H])C([H])([H])[H],99.9,2.9
Artesunate,B3662,88495-63-0,Others,Others,derivative of the natural product artemisinin,O=C(CCC(O)=O)O[C@H]1O[C@@H]2O[C@@]3(C)OO[C@]42[C@@H](CC3)[C@H](C)CC[C@H]4[C@H]1C,97.7,15.1
Articaine HCl,B1887,23964-57-0,Others,Others,dental local anesthetic,CCCNC(C)C(=O)NC1=C(SC=C1C)C(=O)OC.Cl,102.9,4.5
Ascomycin(FK 520),A3191,104987-12-4,Microbiology & Virology,Antibiotic,1,1,115.3,6.6
Asenapine,A5010,85650-56-2,Neuroscience,5-HT Receptor,Inhibits adrenergic receptor/5-HT receptor,[H][C@@]1(C(C=C(Cl)C=C2)=C2OC3=C4C=CC=C3)[C@]4([H])CN(C)C1.OC(/C=C/C(O)=O)=O,94.1,5.5
Asiaticoside,N1357,16830-15-2,Natural Products,ROS,1,1,88.9,3.1
Aspartame,B1888,22839-47-0,Others,Others,non-saccharide sweetener,COC(=O)C(CC1=CC=CC=C1)NC(=O)C(CC(=O)O)N,95.6,1.2
Aspirin (Acetylsalicylic acid),A4013,50-78-2,Neuroscience,COX,Cyclooxygenase (COX) inhibitor,CC(=O)OC1=CC=CC=C1C(=O)O,16.3,29.0
Asunaprevir (BMS-650032),A3195,630420-16-5,Proteases,HCV Protease,NS3 protease inhibitor,CC(C)(C)C(C(=O)N1CC(CC1C(=O)NC2(CC2C=C)C(=O)NS(=O)(=O)C3CC3)OC4=NC=C(C5=C4C=C(C=C5)Cl)OC)NC(=O)OC(C)(C)C,101.9,5.9
Atazanavir,A8205,198904-31-3,Proteases,HIV Protease,"HIV protease inhibitor,highly potent",CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC,101.1,2.9
Atazanavir sulfate (BMS-232632-05),A4040,229975-97-7,Proteases,HIV Protease,Protease inhibitor,CC(C)(C)C(C(=O)NC(CC1=CC=CC=C1)C(CN(CC2=CC=C(C=C2)C3=CC=CC=N3)NC(=O)C(C(C)(C)C)NC(=O)OC)O)NC(=O)OC.OS(=O)(=O)O,110.3,15.0
Atipamezole hydrochloride,B7226,104075-48-1,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor antagonist,CCC1(C2=CN=CN2)CC3=CC=CC=C3C1.Cl,115.0,10.7
Atomoxetine HCl,B2244,82248-59-7,Neuroscience,5-HT Receptor,Noradrenalin re-uptake inhibitor,CC1=CC=CC=C1OC(CCNC)C2=CC=CC=C2.Cl,92.6,4.6
Atorvastatin Calcium,A4367,134523-03-8,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.CC(C)C1=C(C(=C(N1CCC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4.[Ca+2],66.6,22.9
Atovaquone,B2078,95233-18-4,Microbiology & Virology,Anti-infection,unique naphthoquinone with broad-spectrum antiprotozoal activity,ClC1=C([H])C([H])=C(C([H])=C1[H])C2([H])C([H])([H])C([H])([H])C(C(C3=O)=C(C4=C([H])C([H])=C([H])C([H])=C4C3=O)O[H])([H])C([H])([H])C2([H])[H],90.6,3.0
Atracurium Besylate,B1666,64228-81-5,Neuroscience,AChR,Neuromuscular blocking agent,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],95.4,8.3
Atropine,A8369,5908-99-6,Neuroscience,AChR,MAChRs antagonist,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3.O.OS(=O)(=O)O,106.4,3.5
Atropine,B8694,51-55-8,Neuroscience,mAChR,"Non-selective, competitive antagonist of the muscarinic acetylcholine receptor",1,98.9,6.8
Aucubin,N2758,479-98-1,Natural Products,1,1,1,110.0,1.3
Auranofin,B7687,34031-32-8,Others,Reductases,thioredoxin reductase (TrxR) inhibitor,[S-][C@@H]1O[C@H](COC(C)=O)[C@@H]([C@@H]([C@H]1OC(C)=O)OC(C)=O)OC(C)=O.CCP(CC)CC.[Au+],97.3,1.3
Avanafil,A4334,330784-47-9,Metabolism,PDE,PDE5 inhibitor,O=C(C1=CN=C(N2[C@H](CO)CCC2)N=C1NCC3=CC=C(OC)C(Cl)=C3)NCC4=NC=CC=N4,99.6,2.2
Avibactam sodium,B8227,1192491-61-4,Microbiology & Virology,Anti-infection,β-lactamase inhibitor,O=S(ON1[C@@]2(CC[C@H]([N@](C1=O)C2)C(N)=O)[H])([O-])=O.[Na+],101.6,1.0
Avobenzone,B2079,70356-09-1,Others,Others,"topical, broad range UV protector",CC(C)(C)C1=CC=C(C=C1)C(=O)CC(=O)C2=CC=C(C=C2)OC,91.5,12.9
Axitinib (AG 013736),A8370,319460-85-0,Tyrosine Kinase,VEGFR,VEGFR1/ c-Kit inhibitor,CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)C=CC4=CC=CC=N4,56.4,2.3
Azacyclonol,B1891,115-46-8,Neuroscience,5-HT Receptor,tranquilizer，antipsychotic,C1CNCCC1C(C2=CC=CC=C2)(C3=CC=CC=C3)O,106.6,7.1
Azaguanine-8,B1667,134-58-7,Others,Others,Purine analogs,C12=NNNC1=NC(=NC2=O)N,113.3,3.2
Azaperone,B1668,1649-18-9,Neuroscience,Dopamine Receptor,Dopamine antagonist,C1CN(CCN1CCCC(=O)C2=CC=C(C=C2)F)C3=CC=CC=N3,101.7,6.9
Azathioprine,B1892,446-86-6,DNA Damage/DNA Repair,DNA Synthesis,purine synthesis and GTP-binding protein Rac1 activation inhibitor,CN1C=NC(=C1SC2=NC=NC3=C2NC=N3)[N+](=O)[O-],93.5,6.6
Azelaic Acid,M1301,123-99-9,Microbiology & Virology,Anti-infection,1,O=C(O)CCCCCCCC(O)=O,108.6,7.0
Azelastine HCl,B1568,79307-93-0,Neuroscience,Histamine Receptor,"Potent, second-generation, selective, histamine receptor antagonist",CN1CCCC(CC1)N2C(=O)C3=CC=CC=C3C(=N2)CC4=CC=C(C=C4)Cl.Cl,106.6,2.1
Azelnidipine,B1414,123524-52-7,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker;antihypertensive,CC1=C(C(C(=C(N1)N)C(=O)OC2CN(C2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC(C)C,109.9,4.8
Azilsartan,B2210,147403-03-0,GPCR/G protein,Angiotensin Receptor,Potent angiotensin II type 1 (AT1) receptor inverse agonist,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)O,114.0,2.5
Azilsartan Medoxomil,B2218,863031-21-4,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor type 1 antagonist,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NC(=O)ON5)C(=O)OCC6=C(OC(=O)O6)C,102.6,5.6
Azithromycin,B1398,83905-01-5,Microbiology & Virology,Antibiotic,Antibiotic by inhibiting protein synthesis,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O,103.1,7.7
Azithromycin Dihydrate,B1669,117772-70-0,Microbiology & Virology,Anti-infection,Macrolide antibiotic,CCC1C(C(C(N(CC(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)C)O)(C)O.O.O,102.8,1.1
Azlocillin sodium salt,B1893,37091-65-9,Microbiology & Virology,Anti-infection,semisynthetic penicillin and β-lactam antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCNC4=O)C(=O)[O-])C.[Na+],105.4,4.1
Aztreonam,A5931,78110-38-0,Microbiology & Virology,Antibiotic,"Monobactam antibiotic,selectively active against Gram-negative aerobic bacteria",CC1C(C(=O)N1S(=O)(=O)O)NC(=O)C(=NOC(C)(C)C(=O)O)C2=CSC(=N2)N,123.2,0.2
BAF312 (Siponimod),B3225,1230487-00-9,GPCR/G protein,S1P receptor,"S1P agonist,potent and selective",CCC1=C(C=CC(=C1)C(=NOCC2=CC(=C(C=C2)C3CCCCC3)C(F)(F)F)C)CN4CC(C4)C(=O)O,91.1,3.4
BHT,C5273,128-37-0,Others,Others,1,CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1,101.3,8.1
BI6727 (Volasertib),A8558,755038-65-4,Cell Cycle/Checkpoint,PLK,"Plk inhibitor,highly potent",CCC1C(=O)N(C2=CN=C(N=C2N1C(C)C)NC3=C(C=C(C=C3)C(=O)NC4CCC(CC4)N5CCN(CC5)CC6CC6)OC)C,112.8,10.5
BIBR-1048,A8381,211915-06-9,Proteases,Thrombin,Thrombin inhibitor,CCCCCCOC(=O)N=C(C1=CC=C(C=C1)NCC2=NC3=C(N2C)C=CC(=C3)C(=O)N(CCC(=O)OCC)C4=CC=CC=N4)N,100.7,7.8
BIRB 796 (Doramapimod),A5639,285983-48-4,MAPK Signaling,p38,"P38 MAPK inhibitor,cell permeable and highly selective",CC1=CC=C(C=C1)N2C(=CC(=N2)C(C)(C)C)NC(=O)NC3=CC=C(C4=CC=CC=C43)OCCN5CCOCC5,115.5,6.3
BMN 673,A4153,1207456-01-6,DNA Damage/DNA Repair,PARP,1,1,107.4,1.1
BMS-708163 (Avagacestat),A4022,1146699-66-2,Proteases,Gamma Secretase,γ-secretase inhibitor,C1=CC(=CC=C1S(=O)(=O)N(CC2=C(C=C(C=C2)C3=NOC=N3)F)C(CCC(F)(F)F)C(=O)N)Cl,99.6,9.0
BYL-719,A8346,1217486-61-7,PI3K/Akt/mTOR Signaling,PI3K,Selective PI3Kα inhibitor,CC1=C(SC(=N1)NC(=O)N2CCCC2C(=O)N)C3=CC(=NC=C3)C(C)(C)C(F)(F)F,94.8,2.7
Bacitracin,B1670,1405-87-4,Microbiology & Virology,Anti-infection,Peptide antibiotic,CCC(C)C1C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)NCCCCC(C(=O)NC(C(=O)N1)CCCN)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)NC(=O)C(CC(C)C)NC(=O)C2CSC(=N2)C(C(C)CC)N)CC(=O)N)CC(=O)O)CC3=CN=CN3)CC4=CC=CC=C4,95.0,1.4
Bacitracin Zinc,B1671,1405-89-6,Microbiology & Virology,Antibiotic,1,1,99.4,12.3
Baicalein,N1858,491-67-8,Natural Products,P450 (e.g. CYP17),1,1,98.3,4.7
Baicalin,N1778,21967-41-9,Natural Products,GABA Receptor,1,1,111.2,14.4
Balsalazide,B3460,80573-04-2,Ubiquitination/Proteasome,Interleukin Related; STAT,anti-inflammatory drug,OC1=C(C(O)=O)C=C(/N=N/C2=CC=C(C(NCCC(O)=O)=O)C=C2)C=C1,84.6,3.0
Bambuterol (hydrochloride),B8668,81732-46-9,GPCR/G protein,Adrenergic Receptor,"Prodrug for terbutaline, long-acting β-adrenoceptor agonist",1,99.1,1.4
Barasertib (AZD1152-HQPA),A4112,722544-51-6,Chromatin/Epigenetics,Aurora Kinase,"Aurora Kinase B inhibitor, Potent and selective",CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCO,123.5,33.6
Bardoxolone methyl,A3221,218600-53-4,Chromatin/Epigenetics,JAK,"IKK inhibitor, potent antioxidant inflammation modulator",CC1(CCC2(CCC3(C(C2C1)C(=O)C=C4C3(CCC5C4(C=C(C(=O)C5(C)C)C#N)C)C)C)C(=O)OC)C,29.2,21.2
"Baricitinib (LY3009104, INCB028050)",A4141,1187594-09-7,Chromatin/Epigenetics,JAK,"JAK1/JAK2 inhibitor,selective orally bioavailable",CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,23.6,8.6
Baricitinib phosphate,A3222,1187595-84-1,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor,CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OP(=O)(O)O,31.3,11.4
Batimastat (BB-94),A2577,130370-60-4,Proteases,MMP,MMP inhibitor,CNC([C@@H](NC([C@@H]([C@H](CSC1=CC=CS1)C(NO)=O)CC(C)C)=O)CC2=CC=CC=C2)=O,45.1,40.7
Bazedoxifene acetate,A3233,198481-33-3,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor modulator,CC1=C(N(C2=C1C=C(C=C2)O)CC3=CC=C(C=C3)OCCN4CCCCCC4)C5=CC=C(C=C5)O.CC(=O)O,97.5,4.3
Beclomethasone dipropionate,B1248,5534-09-8,GPCR/G protein,Glucocorticoid Receptor,Corticosteroid used for asthma and rhinitis,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC,107.2,8.8
Bedaquiline,B3492,843663-66-1,Microbiology & Virology,Antibiotic,anti-tuberculosis drug,CN(C)CC[C@@]([C@H](C1=CC=CC=C1)C2=CC3=CC(Br)=CC=C3N=C2)(O)C4=CC=CC5=C4C=CC=C5,97.1,9.3
Bedaquiline fumarate,B3491,845533-86-0,Microbiology & Virology,Antibiotic,anti-tuberculosis drug,CN(CC[C@@]([C@](C1=CC2=CC(Br)=CC=C2N=C1OC)([H])C3=CC=CC=C3)(O)C4=CC=CC5=CC=CC=C54)C.O=C(O)/C([H])=C([H])/C(O)=O,95.1,0.5
Belinostat (PXD101),A4096,414864-00-9,DNA Damage/DNA Repair,HDAC,Hydroxamate-type HDAC inhibitor,C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO,108.8,8.1
Bemegride,B1672,64-65-3,Neuroscience,GABA Receptor,GABA receptor antagonist,CCC1(CC(=O)NC(=O)C1)C,102.8,0.3
Benazepril HCl,B2216,86541-74-4,Others,Others,angiotensin-converting enzyme (ACE) inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC2CCC3=CC=CC=C3N(C2=O)CC(=O)O.Cl,97.4,5.2
Bendamustine HCl,A1984,3543-75-7,Apoptosis,Apoptosis Inducers,Cytostatic agent for non-Hodgkin lymphomas,CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCC(=O)O.Cl,92.6,10.8
Benidipine HCl,B1409,91599-74-5,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,CC1=C(C(C(=C(N1)C)C(=O)OC2CCCN(C2)CC3=CC=CC=C3)C4=CC(=CC=C4)[N+](=O)[O-])C(=O)OC.Cl,108.9,4.7
Benserazide HCl,B1489,14919-77-8,Metabolism,Decarboxylase,Decarboxylase inhibitor,C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl,101.4,3.8
Benzbromarone,B1673,3562-84-3,Metabolism,P450,TMEM16A/B calcium-activated chloride channel (CaCC) blocker,CCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)Br)O)Br,103.9,2.5
Benzethonium Chloride,B1674,121-54-0,Neuroscience,AChR,Potent inhibitor of nAChRs,CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCC[N+](C)(C)CC2=CC=CC=C2.[Cl-],99.7,3.6
Benzocaine,B1675,1994-9-7,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,CCOC(=O)C1=CC=C(C=C1)N,106.8,1.1
Benzoic Acid,B1676,65-85-0,Others,Others,Organic aromatic monocarboxylic acid,C1=CC=C(C=C1)C(=O)O,105.8,15.0
Benztropine mesylate,B1554,132-17-2,Neuroscience,Histamine Receptor,Dopamine transporter (DAT) inhibitor,CN1C2CCC1CC(C2)OC(C3=CC=CC=C3)C4=CC=CC=C4.CS(=O)(=O)O,101.0,1.0
Benzydamine HCl,B1677,132-69-4,Immunology/Inflammation,PGE synthase,Topical nonsteroidal anti-inflammatory drug (NSAID),CN(C)CCCOC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3.Cl,98.5,7.8
Benzyl alcohol,C6118,100-51-6,Others,Others,1,1,105.0,0.2
Benzyl benzoate,C6180,120-51-4,Others,Others,1,1,105.6,11.1
Bephenium Hydroxynaphthoate,A8376,3818-50-6,Others,Others,Anthelmintic agent,C[N+](C)(CCOC1=CC=CC=C1)CC2=CC=CC=C2.C1=CC=C2C=C(C(=CC2=C1)C(=O)O)[O-],103.9,4.5
Bepotastine Besilate,B1569,190786-44-8,Neuroscience,Histamine Receptor,"Non-sedating, selective antagonist of histamine 1 (H1) receptor",C1CN(CCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O.C1=CC=C(C=C1)S(=O)(=O)O,97.8,2.7
Berbamine hydrochloride,N2471,6078-17-7,Natural Products,Bcr-Abl,1,1,107.8,18.9
Berberine,N1368,2086-83-1,Natural Products,Others,1,1,108.5,13.3
Berberine Sulfate,N2076,633-66-9,Natural Products,Anti-infection,1,1,135.8,9.5
Berberine hydrochloride,N1699,633-65-8,Natural Products,Anti-infection,1,1,97.6,5.8
Bergenin,N1369,477-90-7,Natural Products,Others,1,1,95.5,11.5
Besifloxacin HCl,B1895,405165-61-9,Microbiology & Virology,Antibiotic,fourth-generation fluoroquinolone antibiotic,C1CCN(CC(C1)N)C2=C(C=C3C(=C2Cl)N(C=C(C3=O)C(=O)O)C4CC4)F.Cl,96.5,1.5
Bestatin,A2575,58970-76-6,Proteases,Aminopeptidase,Aminopeptidase inhibitor,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=CC=C1)N)O,115.7,15.1
Betacarotene,A8377,7235-40-7,Others,Others,1,1,101.2,2.6
Betahistine 2HCl,B1555,5579-84-0,Neuroscience,Histamine Receptor,Histamine H3 receptor inhibitor,CNCCC1=CC=CC=N1.Cl.Cl,100.8,12.1
Betaine,N1709,107-43-7,Natural Products,Others,PCR Reagent,C[N+](C)(C)CC(=O)[O-],109.5,8.4
Betaine hydrochloride,N1700,590-46-5,Natural Products,Others,1,C[N+](C)(C)CC(=O)O.[Cl-],108.2,5.5
Betamethasone,B1896,378-44-9,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C,111.1,0.2
Betamethasone Dipropionate,A8378,5593-20-4,Others,Others,Glucocorticoid receptor agonist,CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)OC(=O)CC,101.2,2.3
Betamethasone Valerate,A8379,2152-44-5,Others,Others,anti-inflammatory corticosteroid,CCCCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CO,100.4,3.4
Betamipron,B1679,3440-28-6,Microbiology & Virology,Anti-infection,Parenteral carbapenem antibiotic,C1=CC=C(C=C1)C(=O)NCCC(=O)O,101.4,5.4
Betaxolol,B1352,63659-18-7,GPCR/G protein,Adrenergic Receptor,βadrenergic receptor blocker,CC(NCC(O)COC1=CC=C(CCOCC2CC2)C=C1)C,101.4,2.1
Betaxolol HCl,B1353,63659-19-8,GPCR/G protein,Adrenergic Receptor,β1 adrenergic receptor blocker,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,108.7,1.1
Bethanechol chloride,B1599,590-63-6,Neuroscience,AChR,Muscarinic receptor agonist,CC(C[N+](C)(C)C)OC(=O)N.[Cl-],106.9,9.7
Betrixaban,B3234,330942-05-7,Metabolism,Factor Xa,1,1,112.3,2.1
Bexarotene,A8380,153559-49-0,Others,Retinoid X Receptors,Retinoid Receptor agonist,CC1=CC2=C(C=C1C(=C)C3=CC=C(C=C3)C(=O)O)C(CCC2(C)C)(C)C,102.2,3.0
Bezafibrate,B1680,41859-67-0,Metabolism,PPAR,Lipid-lowering agent,CC(C)(C(=O)O)OC1=CC=C(C=C1)CCNC(=O)C2=CC=C(C=C2)Cl,102.7,9.7
Biapenem,A1373,120410-24-4,Microbiology & Virology,Antibiotic,Highly broad spectrum antibiotic agent,CC1C2C(C(=O)N2C(=C1SC3CN4C=NC=[N+]4C3)C(=O)[O-])C(C)O,109.9,9.9
Bicalutamide,A5065,90357-06-5,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,CC(CS(=O)(=O)C1=CC=C(C=C1)F)(C(=O)NC2=CC(=C(C=C2)C#N)C(F)(F)F)O,98.5,3.3
Bifonazole,B1897,60628-96-8,Microbiology & Virology,Anti-infection,imidazole antifungal drug,C1=CC=C(C=C1)C2=CC=C(C=C2)C(C3=CC=CC=C3)N4C=CN=C4,75.5,9.8
Bimatoprost,B2139,155206-00-1,GPCR/G protein,Prostaglandin Receptor,prostaglandin analog,CCNC(=O)CCCC=CCC1C(CC(C1C=CC(CCC2=CC=CC=C2)O)O)O,127.1,29.7
Bindarit,B2156,130641-38-2,Immunology/Inflammation,CCR,"CCL2, CCL7 and CCL8 inhibitor",CC(C)(C(=O)O)OCC1=NN(C2=CC=CC=C21)CC3=CC=CC=C3,97.9,4.1
Biotin,A8010,58-85-5,Labels and tags,Biotinylation Reagents,Lysine probe coupled to mass spectrometry detection,C1C2C(C(S1)CCCCC(=O)O)NC(=O)N2,97.8,8.7
Biperiden HCl,B1598,1235-82-1,Neuroscience,Muscarinic Receptor,1,1,117.3,26.8
Birinapant (TL32711),A4219,1260251-31-7,Apoptosis,IAP,Potent XIAP/cIAP1 antagonist,CCC(C(=O)N1CC(CC1CC2=C(NC3=C2C=CC(=C3)F)C4=C(C5=C(N4)C=C(C=C5)F)CC6CC(CN6C(=O)C(CC)NC(=O)C(C)NC)O)O)NC(=O)C(C)NC,87.3,0.9
Bisacodyl,B1898,603-50-9,Others,Others,stimulant laxative drug,CC(=O)OC1=CC=C(C=C1)C(C2=CC=C(C=C2)OC(=O)C)C3=CC=CC=N3,115.8,13.2
Bisoprolol fumarate,B1354,104344-23-2,GPCR/G protein,Adrenergic Receptor,Selective α-adrenergic blocker,CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O.C(=CC(=O)O)C(=O)O,107.1,7.1
Bisphenol A,C6285,80-05-7,Others,Others,1,1,99.3,5.2
Bivalirudin Trifluoroacetate,A3244,128270-60-0,Proteases,Thrombin,Reversible thrombin inhibitor,CC[C@]([C@@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/[C@](/N=C(O)/C/N=C(O)/[C@](/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/C/N=C(O)/[C@]1([H])CCCN1C([C@](/N=C(O)/[C@]2([H])CCCN2C([C@@](N)([H])CC3=CC=CC=C3)=O)([H])CCCNC(N)=N)=O)([H])CC(O)=N)([H])CC(O)=O)([H,114.6,7.2
Bleomycin Sulfate,A8331,9041-93-4,DNA Damage/DNA Repair,DNA Synthesis,"Chemotherapy agent, induces DNA strand break",CC1=C(N=C(N=C1N)C(CC(=O)N)NCC(C(=O)N)N)C(=O)NC(C(C2=CN=CN2)OC3C(C(C(C(O3)CO)O)O)OC4C(C(C(C(O4)CO)O)OC4C(C(C(C(O4)CO)O)OC(=O)N)O)C(=O)NC(C)C(C(C)C(=O)NC(C(C)O)C(=O)NCCC5=NC(=CS5)C6=NC(=CS6)C(=O)NCCC[S+](C)C)O.OS(=O)(=O)[O-],93.4,3.1
Blonanserin,A8384,132810-10-7,Neuroscience,5-HT Receptor,1,1,122.6,7.5
Boceprevir,A3261,394730-60-0,Proteases,HCV Protease,"HCV protease inhibitor,potent and selective",CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C,107.4,0.7
Bortezomib (PS-341),A2614,179324-69-7,Ubiquitination/Proteasome,Proteasome,1,1,-9.0,3.5
Bosentan,B1682,147536-97-8,GPCR/G protein,Endothelin Receptor,Endothelin receptor antagonist,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,98.6,1.2
Bosentan Hydrate,B1521,157212-55-0,GPCR/G protein,Endothelin Receptor,endothelin receptor antagonist,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC.O,114.6,6.1
Bosutinib (SKI-606),A2149,380843-75-4,TGF-β / Smad Signaling,Bcr-Abl,Potent Abl/Src kinases,CN1CCN(CC1)CCCOC2=C(C=C3C(=C2)N=CC(=C3NC4=CC(=C(C=C4Cl)Cl)OC)C#N)OC,31.7,25.4
Brexpiprazole,B1102,913611-97-9,Neuroscience,Dopamine Receptor,"5-HT2A, α1B-, and α2C-adrenergic receptors antagonist",C1CN(CCN1CCCCOC2=CC3=C(C=C2)C=CC(=O)N3)C4=C5C=CSC5=CC=C4,108.0,5.2
Brimonidine Tartrate,B1683,70359-46-5,GPCR/G protein,Adrenergic Receptor,Highly selective α-adrenergic receptor agonist,C1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br.C(C(C(=O)O)O)(C(=O)O)O,98.5,2.1
Brinzolamide,A4359,138890-62-7,Metabolism,Carbonic Anhydrase,CA II inhibitor,CCNC1CN(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)CCCOC,105.2,5.5
Brivaracetam,B4806,357336-20-0,1,1,High-affinity ligand for synaptic vesicle glycoprotein 2A (SV2A),1,110.0,17.3
Bromfenac Sodium,B1684,91714-93-1,Neuroscience,COX,COX inhibitor,C1=CC(=C(C(=C1)CC(=O)[O-])N)C(=O)C2=CC=C(C=C2)Br.[Na+],94.4,3.3
Bromhexine HCl,B1899,611-75-6,Others,Others,bronchial mucolytic agent,CN(CC1=CC(=CC(=C1N)Br)Br)C2CCCCC2.Cl,103.9,10.3
Bromocriptine mesylate,B6298,22260-51-1,Neuroscience,Dopamine Receptor,D2-like dopamine receptor agonist,BrC(NC1=CC=CC2=C31)=C3C[C@H](C2=C4)N(C)C[C@@H]4C(N[C@]5(C(C)C)O[C@@]6(N(C5=O)[C@@H](CC(C)C)C(N7[C@H]6CCC7)=O)O)=O.OS(=O)(C)=O,105.0,6.7
Brompheniramine hydrogen maleate,B1545,980-71-2,Neuroscience,Histamine Receptor,Histamine H1 receptors antagonist,CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,109.0,6.4
Broxyquinoline,B1685,521-74-4,Microbiology & Virology,Anti-infection,Antiprotozoal agent,C1=CC2=C(C(=C(C=C2Br)Br)O)N=C1,107.8,11.4
Brucine,N1490,357-57-3,Natural Products,Others,1,COC1=C(C=C2C(=C1)C34CCN5C3CC6C7C4N2C(=O)CC7OCC=C6C5)OC,106.3,1.4
Budesonide,B1900,51333-22-3,GPCR/G protein,Glucocorticoid Receptor,Anti-inflammatory corticosteroid,O=C(C([H])([H])O[H])[C@@]12OC(C([H])([H])C([H])([H])C([H])([H])[H])([H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H],60.4,2.7
Bufexamac,B1443,2438-72-4,Neuroscience,COX,COX inhibitor,CCCCOC1=CC=C(C=C1)CC(=O)NO,110.3,5.4
Buflomedil HCl,B1889,35543-24-9,GPCR/G protein,Adrenergic Receptor,vasodilator,COC1=CC(=C(C(=C1)OC)C(=O)CCCN2CCCC2)OC.Cl,101.5,13.0
Bumetanide,A1855,28395-03-1,Membrane Transporter/Ion Channel,NKCC,NKCC cotransporter inhibitor,CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2,115.7,13.6
Bupivacaine HCl,B1420,18010-40-7,Membrane Transporter/Ion Channel,Sodium Channel,Anaesthetic drug,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,109.1,11.9
Bupropion hydrochloride,B3326,31677-93-7,Neuroscience,"AChR,Dopamine Receptor",Dopamine/norepinephrine inhibitor,CC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Cl,111.9,2.8
Buspirone HCl,B1687,33386-08-2,Neuroscience,5-HT Receptor,Classic 5-HT1A partial agonist,C1CCC2(C1)CC(=O)N(C(=O)C2)CCCCN3CCN(CC3)C4=NC=CC=N4.Cl,99.1,4.2
Busulfan,A8386,55-98-1,DNA Damage/DNA Repair,DNA Alkylating,DNA alkylating agent,CS(=O)(=O)OCCCCOS(=O)(=O)C,129.2,24.2
Butane diacid,N1941,110-15-6,Natural Products,Others,1,1,106.6,0.5
Butenafine HCl,B1901,101827-46-7,Microbiology & Virology,Antibiotic,synthetic benzylamine antifungal,CC(C)(C)C1=CC=C(C=C1)CN(C)CC2=CC=CC3=CC=CC=C32.Cl,94.5,5.8
Butoconazole nitrate,B1902,64872-77-1,Microbiology & Virology,Anti-infection,Antifungal agent,C1=CC(=C(C(=C1)Cl)SC(CCC2=CC=C(C=C2)Cl)CN3C=CN=C3)Cl.[N+](=O)(O)[O-],73.0,13.5
Butylparaben,C6178,94-26-8,Microbiology & Virology,Anti-infection,1,1,94.7,5.1
"CAL-101 (Idelalisib, GS-1101)",A3005,870281-82-6,PI3K/Akt/mTOR Signaling,PI3K,PI3K inhibitor,CCC(C1=NC2=C(C(=CC=C2)F)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,70.3,14.0
CB-5083,B6032,1542705-92-9,Ubiquitination/Proteasome,p97,1,1,105.6,0.3
CEP-18770,A4009,847499-27-8,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor,B(C(CC(C)C)NC(=O)C(C(C)O)NC(=O)C1=CC=CC(=N1)C2=CC=CC=C2)(O)O,-5.1,19.4
CH5424802,A8393,1256580-46-7,Tyrosine Kinase,ALK,"ALK inhibitor,potent and ATP-competitive",CCC1=C(C=C2C(=C1)C(=O)C3=C(C2(C)C)NC4=C3C=CC(=C4)C#N)N5CCC(CC5)N6CCOCC6,132.5,40.6
CO-1686 (AVL-301),A3320,1374640-70-6,JAK/STAT Signaling,EGFR,EGFR inhibitor,CC(=O)N1CCN(CC1)C2=CC(=C(C=C2)NC3=NC=C(C(=N3)NC4=CC(=CC=C4)NC(=O)C=C)C(F)(F)F)OC,95.0,7.0
CP-945598 HCl,A1435,686347-12-6,GPCR/G protein,Cannabinoid Receptor,"CB1 antagonist,selective and high affinity",CCNC1(CCN(CC1)C2=NC=NC3=C2N=C(N3C4=CC=C(C=C4)Cl)C5=CC=CC=C5Cl)C(=O)N.Cl,110.7,8.3
CP21R7,C4009,125314-13-8,PI3K/Akt/mTOR Signaling,GSK-3,1,NC1=CC=CC(C(C(N2)=O)=C(C3=CN(C)C4=C3C=CC=C4)C2=O)=C1,86.2,8.7
CUDC-101,A4092,1012054-59-9,DNA Damage/DNA Repair,HDAC,Multitargeted HDAC inhibitor,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCCCCC(=O)NO,112.8,4.3
CX-4945 (Silmitasertib),A8330,1009820-21-6,PI3K/Akt/mTOR Signaling,CK2,CK2 inhibitor,C1=CC(=CC(=C1)Cl)NC2=C3C=CN=CC3=C4C=CC(=CC4=N2)C(=O)O,96.4,7.1
Cabazitaxel,B2157,183133-96-2,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule associated inhibitor,CO[C@H]1C[C@]2([H])[C@](CO2)(OC(C)=O)[C@]3([H])[C@]1(C)C([C@H](OC)C4=C(C)[C@@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(OC(C)(C)C)=O)=O)C[C@]([C@H]3OC(C6=CC=CC=C6)=O)(O)C4(C)C)=O,91.9,4.9
"Cabozantinib (XL184, BMS-907351)",A2977,849217-68-1,Tyrosine Kinase,c-MET,VEGFR2/Met/Ret/Kit/FLT//AXL inhibitor,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F,118.6,12.0
Cabozantinib malate (XL184),B1401,1140909-48-3,Tyrosine Kinase,c-MET,MET andVEGF receptor2 inhibitor,COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F.C(C(C(=O)O)O)C(=O)O,48.2,3.7
Caffeic acid,N1735,331-39-5,Natural Products,Others,1,C1=CC(=C(C=C1C=CC(=O)O)O)O,97.4,4.3
Calcifediol,B2140,19356-17-3,Vitamin D Related,VD/VDR,Major circulating form of vitamin D3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,85.2,13.5
Calcipotriol,A3271,112965-21-6,Vitamin D Related,VD/VDR,"Vitamin D3 analog,regulates cell differentiation and proliferation",CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C,85.3,8.8
Calcitriol,B2141,32222-06-3,Vitamin D Related,VD/VDR,Active metabolite of vitamin D3,CC(CCCC(C)(C)O)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,76.0,4.2
Calcium D-Panthotenate,B5995,137-08-6,Metabolism,Vitamin,"water-soluble vitamin, precursor in the biosynthesis of coenzyme A",CC(CO)([C@](O)([H])/C([O-])=N/CCC([O-])=O)C.CC(CO)([C@](O)([H])/C(O)=N/CCC(O)=O)C.[Ca+2],104.0,10.5
Calcium Gluceptate,A8387,17140-60-2,Others,Others,Calcium supplement,C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2],116.4,3.3
Camostat Mesilate,B2082,59721-29-8,Membrane Transporter/Ion Channel,Sodium Channel,Trypsin-like protease inhibitor,CN(C)C(=O)COC(=O)CC1=CC=C(C=C1)OC(=O)C2=CC=C(C=C2)N=C(N)N.CS(=O)(=O)O,100.2,3.0
Camptothecin,A2877,7689-03-4,DNA Damage/DNA Repair,Topoisomerase,1,1,106.0,7.3
Canagliflozin,A8333,842133-18-0,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective",CC1=C(C=C(C=C1)C2C(C(C(C(O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F,107.1,2.3
Candesartan,A5932,139481-59-7,Endocrinology and Hormones,RAAS,Angiotensin II receptor 1 (AT1) antagonist,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)O,105.4,6.0
Candesartan Cilexetil,B2203,145040-37-5,Endocrinology and Hormones,RAAS,Prodrug of the angiotensin II receptor 1 (AT1) antagonist candesartan,CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)C(=O)OC(C)OC(=O)OC6CCCCC6,101.4,8.1
Canrenone,B7341,976-71-6,Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonist,O=C1O[C@]2(CC1)[C@]3(C)[C@@H](CC2)[C@H](C=C4)[C@@H]([C@](CC5)(C)C4=CC5=O)CC3,90.4,11.9
Capecitabine,A8647,154361-50-9,DNA Damage/DNA Repair,DNA Synthesis,"DNA, RNA and protein synthesis inhibitor",CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2C(C(C(O2)C)O)O,107.6,11.3
Capreomycin Sulfate,B1689,1405-37-4,Microbiology & Virology,Anti-infection,Cyclic peptide antibiotic,O=C([C@]([H])(C)NC([C@](N)([H])CNC1=O)=O)N[C@@]([H])(CNC(CC(CCCN)N)=O)C(NC(C(N[C@@]1([H])[C@@H]2CCNC(N)=N2)=O)=CNC(N)=O)=O.[xH2SO4],106.3,11.9
Capsaicin,A3278,404-86-4,Apoptosis,Apoptosis Inducers,TRPV1 receptor agonist,CC(C)C=CCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,108.8,10.5
Captopril,A4078,62571-86-2,Endocrinology and Hormones,RAAS,1,1,88.7,22.8
Carbadox,A8388,6804-7-5,Others,Others,antibiotic,COC(=O)N=NC=C1C=[N+](C2=CC=CC=C2N1O)[O-],94.4,1.9
Carbamazepine,B1390,298-46-4,Membrane Transporter/Ion Channel,Sodium Channel,Inhibitor of neuronal voltage-gated Na+ channels,C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N,96.6,6.7
Carbamoylcholine chloride,B7196,51-83-2,Neuroscience,Nicotinic Receptor,Cholinergic receptor agonist,O=C(N)OCC[N+](C)(C)C.[Cl-],96.1,10.9
Carbazochrome sodium sulfonate (AC-17),B1903,51460-26-5,Others,Others,antihemorrhagic agent,CN1C(CC2=CC(=NNC(=O)N)C(=O)C=C21)S(=O)(=O)[O-].[Na+],103.4,5.9
"Carbenicillin, Disodium Salt",A2511,4800-94-6,Microbiology & Virology,Antibiotic,"Inhibits the cell-wall synthesis,antibiotic",CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],116.1,5.3
Carbenoxolone disodium,A8389,7421-40-1,Neuroscience,Gap Junction,11β-HSD inhibitor,CC1(C2CCC3(C(C2(CCC1OC(=O)CCC(=O)[O-])C)C(=O)C=C4C3(CCC5(C4CC(CC5)(C)C(=O)[O-])C)C)C)C.[Na+].[Na+],100.4,6.0
Carbetocin,B5736,37025-55-1,Others,Others,oxytocin receptor agonist,1,104.8,3.8
Carbidopa,B1904,28860-95-9,Metabolism,Decarboxylase,Decarboxylase inhibitor,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)NN,69.8,24.4
Carbimazole,B1905,22232-54-8,Others,Others,imidazole antithyroid agent,CCOC(=O)N1C=CN(C1=S)C,99.0,2.4
Carboplatin,A2171,41575-94-4,DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent that forms platinum-DNA adducts.,C1CC(C1)(C(=O)[O-])C(=O)[O-].N.N.[Pt+2],20.5,2.3
Carfilzomib (PR-171),A1933,868540-17-4,Ubiquitination/Proteasome,Proteasome,"Proteasome inhibitor,epoxomicin analog",CC(C)CC(C(=O)C1(CO1)C)NC(=O)C(CC2=CC=CC=C2)NC(=O)C(CC(C)C)NC(=O)C(CCC3=CC=CC=C3)NC(=O)CN4CCOCC4,-12.5,3.1
Cariprazine,A3282,839712-12-8,Neuroscience,Dopamine Receptor,"D2/D3 partial agonist,antipsychotic drug",CN(C)C(=O)NC1CCC(CC1)CCN2CCN(CC2)C3=C(C(=CC=C3)Cl)Cl,114.4,3.5
Carmofur,A2548,61422-45-5,DNA Damage/DNA Repair,DNA Synthesis,"Cytostatic derivative of fluorouracilm,antineoplatic agent",CCCCCCNC(=O)N1C=C(C(=O)NC1=O)F,117.4,11.1
Carmustine,B3489,154-93-8,DNA Damage/DNA Repair,DNA Alkylating,cell-cycle phase nonspecific alkylating antineoplastic agent,ClCC/N=C(O)/N(N=O)CCCl,100.4,3.6
Carprofen,B1690,53716-49-7,Neuroscience,COX,COX inhibitor,CC(C1=CC2=C(C=C1)C3=C(N2)C=CC(=C3)Cl)C(=O)O,95.0,1.2
Carteolol HCl,B5944,51781-21-6,GPCR/G protein,Adrenergic Receptor,Non-selective beta-adrenoceptor antagonist,CC(C)(NCC(O)COC1=CC=CC2=C1CCC(O)=N2)C.Cl,106.4,6.6
Carvacrol,C6244,499-75-2,Others,Others,1,1,84.4,9.1
Carvedilol,B1332,72956-09-3,GPCR/G protein,Adrenergic Receptor,Potent β-adrenoceptor and α1-adrenoceptor antagonist,COC1=CC=CC=C1OCCNCC(COC2=CC=CC3=C2C4=CC=CC=C4N3)O,109.7,10.0
Casanthranol,A8390,8024-48-4,Others,Others,1,1,108.7,72.3
Caspofungin,B4972,162808-62-0,Microbiology & Virology,Anti-infection,lipopeptide antifungal drug,O=C([C@@H]1C[C@@H](O)CN1C([C@@H](NC(C2CC(CCCCCCCCC(C)CC(CC)C)=O)=O)[C@@H](C)O)=O)N[C@@H]([C@H](O)[C@@H](O)C3=CC=C(O)C=C3)C(N[C@@H]([C@H](O)CCN)C(N4CC[C@H](O)[C@H]4C(N[C@@H](NCCN)[C@H](O)C2)=O)=O)=O,108.1,4.4
Caspofungin Acetate,B2083,179463-17-3,Others,"β(1,3)-D-Glucan Synthase",lipopeptide antifungal drug,CCC(C)CC(C)CCCCCCCCC(=O)NC1CC(C(NC(=O)C2C(CCN2C(=O)C(NC(=O)C(NC(=O)C3CC(CN3C(=O)C(NC1=O)C(C)O)O)C(C(C4=CC=C(C=C4)O)O)O)C(CCN)O)O)NCCN)O.CC(=O)O.CC(=O)O,105.0,8.9
Catharanthine,N1382,2468-21-5,Natural Products,AChR,1,O=C([C@@]1(C(N([H])C2=C([H])C([H])=C([H])C([H])=C32)=C3C([H])([H])C4([H])[H])[C@](C(C([H])([H])C([H])([H])[H])=C5[H])([H])N4C([H])([H])[C@@]5([H])C1([H])[H])OC([H])([H])[H],102.5,6.0
Cediranib (AZD217),A1882,288383-20-0,Tyrosine Kinase,VEGFR,"VEGFR inhibitor receptor,highly potent",CC1=CC2=C(N1)C=CC(=C2F)OC3=NC=NC4=CC(=C(C=C43)OC)OCCCN5CCCC5,75.1,10.5
Cefaclor,A5559,53994-73-3,Microbiology & Virology,Antibiotic,Cephalosporin antibiotic inhibiting cell wall synthesis.,C1C(=C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)N)C(=O)O)Cl,111.2,4.3
Cefadroxil (hydrate),C3991,66592-87-8,Microbiology & Virology,Antibiotic,broad-spectrum antibiotic,OC1=CC=C([C@@H](N)C(N[C@@H]2C(N3[C@]2([H])SCC(C)=C3C(O)=O)=O)=O)C=C1.O,107.8,2.1
Cefazolin (sodium salt),C4183,27164-46-1,Microbiology & Virology,Antibiotic,"broad-spectrum, first-generation cephalosporin antibiotic",O=C(CN1N=NN=C1)N[C@H](C2=O)[C@]3([H])N2C(C([O-])=O)=C(CSC4=NN=C(C)S4)CS3.[Na+],108.8,7.4
Cefdinir,A8391,91832-40-5,Microbiology & Virology,Antibiotic,Third generation cephalosporin antibiotic,C=CC1=C(N2C(C(C2=O)NC(=O)C(=NO)C3=CSC(=N3)N)SC1)C(=O)O,105.0,10.2
Cefditoren Pivoxil,B2086,117467-28-4,Microbiology & Virology,Antibiotic,1,1,111.4,3.3
Cefepime Dihydrochloride Monohydrate,B3519,123171-59-5,Microbiology & Virology,Antibiotic,broad-spectrum cephalosporin,NC1=NC(/C(C(N[C@H]2[C@]3([H])C(C(C([O-])=O)=C(C[N+]4(C)CCCC4)CS3)C2=O)=O)=N/OC)=CS1.Cl.Cl.O,100.7,2.4
Cefixime,C5378,79350-37-1,Microbiology & Virology,Antibiotic,third generation cephalosporin antibiotic,[H][C@@]1([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OCC(O)=O)=O)N(C(C(O)=O)=C(C=C)CS1)C2=O,92.2,9.2
Cefonicid (sodium salt),C3812,61270-78-8,Microbiology & Virology,Antibiotic,second-generation cephalosporin antibiotic,O=C(N[C@H]1[C@](SCC(CSC2=NN=NN2CS([O-])(=O)=O)=C3C([O-])=O)([H])N3C1=O)[C@H](O)C4=CC=CC=C4.[Na+].[Na+],95.7,6.7
Cefoperazone,A8392,62893-19-0,Microbiology & Virology,Antibiotic,Third-generation cephalosporin antibiotic,CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=C(C=C2)O)C(=O)NC3C4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,94.9,0.1
Cefoselis Sulfate,B1906,122841-12-7,Microbiology & Virology,Antibiotic,beta-lactam antibiotic,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CN4C=CC(=N)N4CCO)C(=O)O.OS(=O)(=O)O,104.1,2.7
Cefotaxime (sodium salt),C4588,64485-93-4,Microbiology & Virology,Antibiotic,cephalosporin antibiotic,[H][C@@]1([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N(C(C([O-])=O)=C(COC(C)=O)CS1)C2=O.[Na+],99.8,3.4
Cefoxitin (sodium salt),C4849,33564-30-6,Microbiology & Virology,Antibiotic,second generation cephalosporin antibiotic,O=C1[C@](NC(CC2=CC=CS2)=O)(OC)[C@]3([H])N1C(C([O-])=O)=C(COC(N)=O)CS3.[Na+],87.7,18.1
Cefpodoxime Proxetil,B4973,87239-81-4,Microbiology & Virology,Anti-infection,cephalosporin antibiotic,CC(C)OC(OC(C)OC(C1=C(COC)CS[C@]([H])([C@@H]2NC(/C(C3=CSC(N)=N3)=N\OC)=O)N1C2=O)=O)=O,86.4,8.9
Cefprozil,B4974,92665-29-7,Microbiology & Virology,Bacterial,antibiotic,OC1=CC=C([C@@H](N)C(N[C@@H]2C(N3[C@@]2([H])SCC(/C=C/C)=C3C(O)=O)=O)=O)C=C1,102.3,3.3
Cefprozil hydrate,B2142,121123-17-9,Microbiology & Virology,Bacterial,1,1,98.0,3.2
Cefsulodin (sodium salt),C5593,52152-93-9,Microbiology & Virology,Antibiotic,β-lactam antibiotic,O=C(N[C@@H]1C(N2[C@]1([H])SCC(C[N+]3=CC=C(C(N)=O)C=C3)=C2C([O-])=O)=O)[C@H](S([O-])(=O)=O)C4=CC=CC=C4.[Na+],98.5,6.4
Ceftazidime,B3539,72558-82-8,Microbiology & Virology,Antibiotic,third-generation cephalosporin,CC(C([O-])=O)(O/N=C(\C(O)=N\[C@]([C@]1([H])N2C(C(O)=O)=C(CS1)C[N+]3=CC=CC=C3)([H])C2=O)C(N4)=CSC4=N)C,101.0,0.0
Ceftazidime,B8669,78439-06-2,Others,Others,Broad-spectrum β-lactam antibiotic used for parenteral administration,1,101.4,0.1
Ceftiofur HCl,B1907,103980-44-5,Microbiology & Virology,Anti-infection,cephalosporin antibiotic,CON=C(C1=CSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)CSC(=O)C4=CC=CO4)C(=O)O.Cl,101.3,3.4
Ceftriaxone Sodium Trihydrate,B1691,104376-79-6,Microbiology & Virology,Anti-infection,Third-generation cephalosporin antibiotic,O=C1N(C(C([O-])=O)=C2CSC(N(C)N=C3[O-])=NC3=O)[C@H](SC2)[C@@H]1NC(/C(C4=CSC(N)=N4)=N\OC)=O.[Na+].[Na+].[3.5H2O],104.1,4.6
Celecoxib,A1664,169590-42-5,Neuroscience,COX,Selective cyclooxygenase-2 (COX-2) inhibitor,CC1=CC=C(C=C1)C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F,99.3,6.2
Cellobiose,B7879,528-50-7,Others,Others,1,1,96.1,1.2
Cephalexin,B1692,15686-71-2,Microbiology & Virology,Antibiotic,Antibiotic,CC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)N)SC1)C(=O)O,104.7,2.6
Cepharanthine,N2771,481-49-2,Natural Products,TNF-α,antiperoxidant potency,CN1CCC2=CC3=C(C4=C2C1CC5=CC=C(C=C5)OC6=C(C=CC(=C6)CC7C8=CC(=C(C=C8CCN7C)OC)O4)OC)OCO3,112.7,3.0
Cesium chloride,A4468,7647-17-8,Apoptosis,Other Apoptosis,1,1,97.3,8.5
Cetirizine,A3298,83881-51-0,Neuroscience,Histamine Receptor,Antihistamine,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,119.1,9.5
Cetirizine DiHCl,B1547,83881-52-1,Neuroscience,Histamine Receptor,H1 receptor inverse agonist,C1CN(CCN1CCOCC(=O)O)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,101.2,6.1
Cetrimonium Bromide (CTAB),B1693,57-09-0,Microbiology & Virology,Anti-infection,Component of the broad-spectrum antiseptic cetrimide,CCCCCCCCCCCCCCCC[N+](C)(C)C.[Br-],96.8,6.3
Cetrorelix,B4975,120287-85-6,GPCR/G Protein,GNRH Receptor,gonadotropin-releasing hormone (GnRH) antagonist,1,115.0,4.9
Cetylpyridinium Chloride,B1694,123-03-5,Microbiology & Virology,Anti-infection,Cationic quaternary ammonium compound used as oropharyngeal antiseptic.,CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1.[Cl-],111.5,8.0
Chenodeoxycholic Acid,B1908,474-25-9,Others,FXR,nuclear receptors(FXR) activator,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,95.9,5.9
Chitosamine hydrochloride,N2702,66-84-2,Natural Products,Others,1,C(C(C(C(C(C=O)N)O)O)O)O.Cl,101.2,6.9
Chlorambucil,B3716,305-03-3,Others,Others,nitrogen mustard alkylating agent,ClCCN(CCCl)C(C=C1)=CC=C1CCCC(O)=O,101.4,7.0
Chloramphenicol,A2512,56-75-7,Microbiology & Virology,Antibiotic,Inhibits translation(blocking peptidyl transferase),C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)[N+](=O)[O-],96.9,9.8
Chlorcyclizine (hydrochloride),C3989,14362-31-3,Neuroscience,Histamine Receptor,1,1,103.1,6.1
Chlorhexidine HCl,B1695,3697-42-5,Microbiology & Virology,Anti-infection,Antiseptic,C1=CC(=CC=C1NC(=NC(=NCCCCCCN=C(N)N=C(N)NC2=CC=C(C=C2)Cl)N)N)Cl.Cl.Cl,106.3,3.6
Chlorhexidine digluconate,B3525,18472-51-0,Microbiology & Virology,Antibiotic,antiseptic,ClC1=CC=C(NC(NC(NCCCCCCNC(NC(NC2=CC=C(Cl)C=C2)=N)=N)=N)=N)C=C1.OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])C(O)=O.OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])C(O)=O,109.7,11.5
Chlormezanone,B1909,80-77-3,Others,Others,Anxiolytic and skeletal muscle relaxant,CN1C(S(=O)(=O)CCC1=O)C2=CC=C(C=C2)Cl,111.4,2.9
Chlorocresol,B1696,59-50-7,Membrane Transporter/Ion Channel,Calcium Channel,Activator of ryanodine receptor,CC1=C(C=CC(=C1)O)Cl,101.5,6.6
Chlorogenic acid,N1769,327-97-9,Natural Products,Others,1,C1C(C(C(CC1(C(=O)O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,98.9,2.2
Chloroquine diphosphate,A8628,50-63-5,Ubiquitination/Proteasome,Autophagy,"Antimalarial drug,TLR7 TLR9 inhibitor",CCN(CC)CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl.OP(=O)(O)O.OP(=O)(O)O,73.5,35.3
Chlorothiazide,A8397,58-94-6,Others,Others,Carbonic anhydrase inhibitor,ClC1=C(C=C2S(=O)(NC=NC2=C1)=O)S(=O)(N)=O,96.3,5.2
Chlorotrianisene,B5912,569-57-3,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen agonist,COC1=CC=C(/C(C2=CC=C(OC)C=C2)=C(Cl)/C3=CC=C(OC)C=C3)C=C1,107.4,2.6
Chloroxine,B1910,773-76-2,Microbiology & Virology,Anti-infection,synthetic antibacterial compound,C1=CC2=C(C(=C(C=C2Cl)Cl)O)N=C1,65.3,0.2
Chlorpheniramine Maleate,B1556,113-92-8,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,CN(C)CCC(C1=CC=C(C=C1)Cl)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,100.4,7.9
Chlorpromazine HCl,B1480,69-09-0,Neuroscience,Dopamine Receptor,dopamine receptor antagonist,CN(C)CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,97.9,10.1
Chlorpropamide,B1697,94-20-2,Others,Others,Oral antihyperglycemic agent,CCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)Cl,97.7,1.1
Chlorprothixene,A8398,113-59-7,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,109.4,4.3
Chlorprothixene (hydrochloride),C3509,6469-93-8,Neuroscience,Dopamine Receptor,1,1,113.0,28.3
Chlorquinaldol,B1698,72-80-0,Microbiology & Virology,Anti-infection,Antifungal and antibacterial,CC1=NC2=C(C=C1)C(=CC(=C2O)Cl)Cl,22.8,4.3
Chlortalidone,B8671,77-36-1,Others,Others,Diuretic drug used to treat hypertension,1,102.0,14.5
Chlortetracycline HCl,B1699,64-72-2,Microbiology & Virology,Anti-infection,Tetracycline antibiotic,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C(C=CC(=C41)Cl)O)O)O)O)C(=O)N)N(C)C)O.Cl,103.3,2.5
Chlorzoxazone,B1701,95-25-0,Metabolism,P450,Muscle-relaxing drug,C1=CC2=C(C=C1Cl)NC(=O)O2,102.2,3.1
Cholic acid,N1680,81-25-4,Natural Products,Others,1,CC(CCC(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C,108.7,0.8
Choline Chloride,B1703,67-48-1,Neuroscience,AChR,Quaternary ammonium salt,C[N+](C)(C)CCO.[Cl-],96.7,0.3
Choline Fenofibrate,A3308,856676-23-8,Immunology/Inflammation,IκB/IKK,Choline salt of fenofibric acid,CC(C([O-])=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C.C[N+](C)(CCO)C,157.3,60.2
Chondroitin sulfate,N2730,9007-28-7,Natural Products,Others,1,1,105.4,9.6
Chromocarb,B1704,4940-39-0,Others,Others,Vasoprotectant,C1=CC=C2C(=C1)C(=O)C=C(O2)C(=O)O,101.7,0.0
Ciclesonide,B3477,126544-47-6,GPCR/G protein,Glucocorticoid Receptor,glucocorticoid,CC(C(OCC([C@@]12[C@@](O[C@@](O2)([H])C3CCCCC3)([H])C[C@@]4([H])[C@]([C@]5([H])[C@](O)([H])C[C@@]41C)([H])CCC6=CC(C=C[C@@]65C)=O)=O)=O)C,92.8,7.3
Ciclopirox,B2087,29342-05-0,Membrane Transporter/Ion Channel,"ATPase,Anti-infection",broad-spectrum antifungal agent,CC1=CC(=O)N(C(=C1)C2CCCCC2)O,98.6,5.1
Ciclopirox ethanolamine,B1384,41621-49-2,Membrane Transporter/Ion Channel,ATPase,"iron chelator, broad-spectrum antifungal agent",CC1=CC(=O)N(C(=C1)C2CCCCC2)O.C(CO)N,102.9,7.4
Cidofovir,A5790,113852-37-2,Microbiology & Virology,CMV,Anti-CMV drug;inhibitor of viral DNA syntheis,C1=CN(C(=O)N=C1N)CC(CO)OCP(=O)(O)O,97.4,4.6
Cilastatin,B8667,82009-34-5,Others,Others,Renal dehydropeptidase-I and leukotriene D4 dipeptidase inhibitor,1,109.7,9.9
Cilengitide,A8660,188968-51-6,Angiogenesis,Integrin,Integrin inhibitor for αvβ3 and αvβ5,CC(C)C1C(=O)NC(C(=O)NCC(=O)NC(C(=O)NC(C(=O)N1C)CC2=CC=CC=C2)CC(=O)O)CCCN=C(N)N,106.2,24.0
Cilnidipine,A1447,132203-70-4,Membrane Transporter/Ion Channel,Calcium Channel,Blocker of Dual L- and N-type calcium channel,CC1=C(C(C(=C(N1)C)C(=O)OCC=CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OCCOC,119.7,15.6
Cilomilast,A4329,153259-65-5,Metabolism,PDE,Potent PDE4 inhibitor,COC1=C(C=C(C=C1)C2(CCC(CC2)C(=O)O)C#N)OC3CCCC3,104.4,5.8
Cilostazol,A4337,73963-72-1,Metabolism,PDE,PDE3 inhibitor,C1CCC(CC1)N2C(=NN=N2)CCCCOC3=CC4=C(C=C3)NC(=O)CC4,113.4,14.3
Cimetidine,B1557,51481-61-9,Neuroscience,Histamine Receptor,H2 receptor antagonist,CC1=C(N=CN1)CSCCNC(=NC)NC#N,99.3,9.8
Cinacalcet,A3313,226256-56-0,GPCR/G protein,Calcimimetic Agent,"Calcimimetic agent,orally active",CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F,104.4,11.2
Cinacalcet HCl,B1423,364782-34-3,GPCR/G protein,Calcimimetic Agent,Calcium-sensing receptor (CaR) agonist,CC(C1=CC=CC2=CC=CC=C21)NCCCC3=CC(=CC=C3)C(F)(F)F.Cl,100.5,10.4
Cinchonidine,B3664,485-71-2,Others,Others,alkaloid,O[C@H](C1=CC=NC2=CC=CC=C12)[C@H]3[N@@]4C[C@@H](C=C)[C@@H](CC4)C3,113.3,6.3
Cinchophen,B1705,132-60-5,Others,Others,Analgesic drug,C1=CC=C(C=C1)C2=NC3=CC=CC=C3C(=C2)C(=O)O,106.5,5.0
Cinepazide maleate,B1911,26328-04-1,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCN(CC2)CC(=O)N3CCCC3.C(=CC(=O)O)C(=O)O,104.1,2.8
Cinnamic acid,N1877,140-10-3,Natural Products,Others,Unsaturated carboxylic acid,C1=CC=C(C=C1)C=CC(=O)O,103.8,9.1
Cinnarizine,B6156,298-57-7,Neuroscience,Histamine Receptor,antihistamine and calcium channel blocker,C1(/C=C/CN2CCN(C(C3=CC=CC=C3)C4=CC=CC=C4)CC2)=CC=CC=C1,94.3,4.4
Ciprofibrate,A4306,52214-84-3,Metabolism,PPAR,PPARα agonist,CC(C(O)=O)(OC1=CC=C(C2CC2(Cl)Cl)C=C1)C,106.2,9.1
Ciprofloxacin (hydrochloride),C5539,93107-08-5,Microbiology & Virology,Antibiotic,1,1,108.9,16.6
Cisapride,B1198,81098-60-4,Neuroscience,5-HT Receptor,5-HT4 receptor agonist,COC1CN(CCC1NC(=O)C2=CC(=C(C=C2OC)N)Cl)CCCOC3=CC=C(C=C3)F,95.8,9.1
Cisatracurium Besylate,B1355,96946-42-8,GPCR/G protein,Adrenergic Receptor,Neuromuscular-blocking drug,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-],88.9,5.8
Cisplatin,A8321,15663-27-1,Apoptosis,Caspase,"Inhibits DNA synthesis,chemotherapy drug",N.N.Cl[Pt+2]Cl,112.5,20.3
Citalopram hydrobromide,B6736,59729-32-7,Neuroscience,5-HT Receptor,5-HT uptake inhibitor,FC1=CC=C(C=C1)[C@@]2(CCCN(C)C)OCC3=CC(C#N)=CC=C23.Br,115.4,13.7
Citicoline (sodium salt),C5242,33818-15-4,Others,Others,1,O=P([O-])(OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)N2C(N=C(C=C2)N)=O)OP(OCC[N+](C)(C)C)([O-])=O.[Na+],104.0,2.2
Citric acid,B7297,77-92-9,Others,Reagents,Commonly used laboratory reagent,OC(CC(O)=O)(C(O)=O)CC(O)=O,96.2,0.4
Cladribine,A2187,4291-63-8,DNA Damage/DNA Repair,DNA Synthesis,Apoptosis inducer in CLL cells,C1C(C(OC1N2C=NC3=C2N=C(N=C3N)Cl)CO)O,-10.0,5.3
Clarithromycin,A4322,81103-11-9,Metabolism,CYP3A/CYP450,"CYP3A inhibitor, potent",CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)O,103.5,2.3
Clemastine Fumarate,B1558,14976-57-9,Neuroscience,Histamine Receptor,Selective histamine H1 receptor antagonist,CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCC3CCCN3C.C(=CC(=O)O)C(=O)O,92.9,7.7
Clemizole hydrochloride,A3316,1163-36-6,Neuroscience,HCV; HCV Protease; Histamine Receptor,H1 histamine receptor antagonist,C1CCN(C1)CC2=NC3=CC=CC=C3N2CC4=CC=C(C=C4)Cl.Cl,107.4,8.5
Clenbuterol (hydrochloride),C3119,21898-19-1,GPCR/G protein,Adrenergic Receptor,sympathomimetic β2-adrenoceptor agonist used as a bronchodilator in the treatment of pulmonary diseases,ClC1=CC(C(O)CNC(C)(C)C)=CC(Cl)=C1N.Cl,91.9,2.3
Clevidipine Butyrate,B1415,167221-71-8,Membrane Transporter/Ion Channel,Calcium Channel,Dihydropyridine calcium channel blocker,CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,98.4,4.9
Climbazole,B1706,38083-17-9,Microbiology & Virology,Anti-infection,Broad-spectrum imidazole antifungal agent,CC(C)(C)C(=O)C(N1C=CN=C1)OC2=CC=C(C=C2)Cl,104.1,0.5
Clindamycin,B1707,18323-44-9,Others,Others,Antibiotic,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl,91.9,3.0
Clindamycin HCl,B1913,21462-39-5,Microbiology & Virology,Anti-infection,Lincosamide antibiotic,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)Cl.Cl,97.1,3.1
Clindamycin Phosphate,B1708,24729-96-2,Microbiology & Virology,Anti-infection,Lincosamide antibiotic,CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)OP(=O)(O)O)O)O)C(C)Cl,111.9,1.4
Clobetasol propionate,B1915,25122-46-7,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,CCC(=O)OC1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)C(=O)CCl,48.7,3.1
Clodronate Disodium,B1709,22560-50-5,Others,Others,1,1,110.3,4.0
Clofarabine,A1412,123318-82-1,DNA Damage/DNA Repair,DNA Synthesis,"Antimetabolite,inhibit DNA polymerase and ribonucleotide reductase",C1=NC2=C(N1C3C(C(C(O3)CO)O)F)N=C(N=C2N)Cl,-5.2,8.9
Clofazimine,B1710,2030-63-9,Metabolism,Phospholipase,Tuberculosis drug,CC(C)N=C1C=C2C(=NC3=CC=CC=C3N2C4=CC=C(C=C4)Cl)C=C1NC5=CC=C(C=C5)Cl,102.9,8.0
Clofibrate,B3610,637-07-0,Metabolism,PPAR,PPAR agonist,ClC1=CC=C(C=C1)OC(C)(C)C(OCC)=O,103.8,4.2
Clofibric Acid,B1711,882-09-7,Metabolism,PPAR,PPAR agonist,CC(C)(C(=O)O)OC1=CC=C(C=C1)Cl,97.1,1.5
Clomiphene citrate,B1504,50-41-9,Endocrinology and Hormones,Estrogen/progestogen Receptor,Selective estrogen receptor modulator,CCN(CC)CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Cl)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,38.7,0.7
Clomipramine HCl,B2234,17321-77-6,Neuroscience,5-HT Receptor,SERT/NET dopamine transporter (DAT) blocker,CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl.Cl,107.7,8.4
Clonidine HCl,B1333,4205-91-8,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,C1CN=C(N1)NC2=C(C=CC=C2Cl)Cl.Cl,108.6,2.6
Clopidogrel,A5183,120202-66-6,Neuroscience,P2 Receptor,P2Y12 receptor antagonist,COC(=O)C(C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O,99.9,24.4
Clorgyline (hydrochloride),C4137,17780-75-5,Metabolism,MAO,1,1,104.9,2.9
Clorprenaline HCL,B1713,6933-90-0,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,CC(C)NCC(C1=CC=CC=C1Cl)O.Cl,102.4,2.8
Clorsulon,B1917,60200-06-8,Microbiology & Virology,Anti-infection,Anthelmintic agent,C1=C(C(=CC(=C1N)S(=O)(=O)N)S(=O)(=O)N)C(=C(Cl)Cl)Cl,105.4,0.5
Closantel,B1714,57808-65-8,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2O)I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl,107.0,6.4
Closantel Sodium,B1715,61438-64-0,Microbiology & Virology,Anti-infection,Gram positive antibacterial activity inhibitor,CC1=CC(=C(C=C1NC(=O)C2=CC(=CC(=C2[O-])I)I)Cl)C(C#N)C3=CC=C(C=C3)Cl.[Na+],85.9,6.5
Clotrimazole,A8401,23593-75-1,Microbiology & Virology,Antibiotic,antifungal compound,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3Cl)N4C=CN=C4,101.0,23.5
Cloxacillin Sodium,B1918,7081-44-9,Microbiology & Virology,Anti-infection,semisynthetic beta-lactamase resistant penicillin antibiotic,CC1=C(C(=NO1)C2=CC=CC=C2Cl)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],112.3,25.5
Clozapine,B2235,5786-21-0,Neuroscience,Dopamine Receptor,5-HT receptor antagonist,CN1CCN(CC1)C2=C3C=CC=CC3=NC4=C(N2)C=C(C=C4)Cl,96.5,7.0
Cobicistat (GS-9350),A4313,1004316-88-4,Metabolism,CYP3A/CYP450,Selective CYP3A inhibitor,CC(C1=NC(CN(C(NC(C(NC(CC2=CC=CC=C2)CCC(NC(OCC3=CN=CS3)=O)CC4=CC=CC=C4)=O)CCN5CCOCC5)=O)C)=CS1)C,106.4,3.6
Cobimetinib,A3321,934660-93-2,MAPK Signaling,MEK1/2,Selective MEK inhibitor,C1CCNC(C1)C2(CN(C2)C(=O)C3=C(C(=C(C=C3)F)F)NC4=C(C=C(C=C4)I)F)O,18.5,5.7
Coenzyme Q10,N1796,303-98-0,Natural Products,Endogenous Metabolite; Reactive Oxygen Species,1,1,100.4,2.4
Colchicine,A3324,64-86-8,Cell Cycle/Checkpoint,Microtubule/Tubulin,Tubulin Inhibitor,CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,-5.8,13.8
Colistin Sulfate,B1716,1264-72-8,Microbiology & Virology,Anti-infection,Cationic polypeptide antibiotic,1,98.4,6.4
Conivaptan HCl,A8402,168626-94-6,GPCR/G protein,Vasopressin Receptor,Vasopressin receptor antagonist,CC1=NC2=C(N1)CCN(C3=CC=CC=C32)C(=O)C4=CC=C(C=C4)NC(=O)C5=CC=CC=C5C6=CC=CC=C6.Cl,123.1,15.8
Corticosterone,B7469,50-22-6,GPCR/G protein,Glucocorticoid Receptor,1,1,98.7,4.3
Cortisone acetate,B1919,1950-4-4,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,CC(=O)OCC(=O)C1(CCC2C1(CC(=O)C3C2CCC4=CC(=O)CCC34C)C)O,99.9,3.3
Costundide,N2333,553-21-9,DNA Damage/DNA Repair,Telomerase,1,1,96.2,4.8
Costunolide,A3327,553-21-9,DNA Damage/DNA Repair,Telomerase,1,1,107.5,18.8
Coumarin,N1707,91-64-5,Natural Products,Immunology & Inflammation related,Precursor in chemical reaction,C1=CC=C2C(=C1)C=CC(=O)O2,103.6,6.6
Creatinine,B1717,60-27-5,Others,Others,1,1,116.8,7.1
Crenolanib (CP-868596),A8307,670220-88-9,Tyrosine Kinase,PDGFR,"PDGFR-β inhibitor,potent and selective",CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4,99.8,6.9
Crizotinib hydrochloride,B3608,1415560-69-8,Tyrosine Kinase,ALK,inhibitor of the c-Met kinase and the NPM-ALK,C[C@](OC(C=C(C(C=N1)=CN1C2CCNCC2)C=N3)=C3N)([H])C4=C(Cl)C=CC(F)=C4Cl.Cl,8.8,0.2
Cromolyn sodium,B3300,15826-37-6,Membrane Transporter/Ion Channel,Calcium Channel,Mast cell membrane stabilizer,C1=CC2=C(C(=C1)OCC(COC3=CC=CC4=C3C(=O)C=C(O4)C(=O)[O-])O)C(=O)C=C(O2)C(=O)[O-].[Na+].[Na+],105.1,0.1
Crotaline,N1470,315-22-0,Natural Products,Others,1,O=C([C@@](C([H])([H])[H])([H])[C@@]([C@@]1(C([H])([H])[H])O[H])(C([H])([H])[H])O[H])O[C@@]2([H])[C@](C(C([H])([H])OC1=O)=C([H])C3([H])[H])([H])N3C([H])([H])C2([H])[H],88.8,4.5
Crotamiton,B8697,483-63-6,Microbiology & Virology,Parasite,Scabicidal and antipruritic agent,1,103.2,6.5
Crystal Violet,B1920,548-62-9,Others,Others,triarylmethane dye,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-],-7.7,2.4
Curculigoside,N2324,85643-19-2,Natural Products,Immunology & Inflammation related,1,1,116.5,14.8
Curcumin,A3335,458-37-7,Immunology/Inflammation,KEAP1-Nrf2,Tyrosinase inhibitor,COC1=C(C=CC(=C1)C=CC(=O)CC(=O)C=CC2=CC(=C(C=C2)O)OC)O,101.3,11.5
Cyclamic acid,B1921,100-88-9,Others,Others,artificial sweetening agent,C1CCC(CC1)NS(=O)(=O)O,107.9,8.4
Cyclandelate,B1718,456-59-7,Others,Others,Inhibitor of rat hepatic acycloenzyme A,CC1CC(CC(C1)(C)C)OC(=O)C(C2=CC=CC=C2)O,105.2,20.8
Cyclo(RGDyK),B6015,250612-42-1,Angiogenesis,Integrin,αVβ3 integrin inhibitor,NCCCC[C@@]1([H])/C(O)=N/[C@@](/C(O)=N/C/C(O)=N/[C@@](/C(O)=N/[C@](/C(O)=N/1)([H])CC2=CC=C(O)C=C2)([H])CC(O)=O)([H])CCCNC(N)=N.FC(F)(F)C(O)=O.FC(F)(F)C(O)=O,107.4,0.5
Cyclobenzaprine HCl,B5994,6202-23-9,GPCR/G protein,5-HT Receptor,5-HT2 receptor antagonist,CN(CC/C=C1C2=CC=CC=C2C=CC3=CC=CC=C3\1)C.Cl,109.4,5.3
Cyclophosphamide,A2343,50-18-0,DNA Damage/DNA Repair,DNA Synthesis,Nitrogen mustard alkylating agent and prodrug.,C1CNP(=O)(OC1)N(CCCl)CCCl,96.1,0.0
Cyclophosphamide monohydrate,A4232,6055-19-2,Others,Others,"alkylating, cytotoxic agent,antitumor activity",C1CNP(=O)(OC1)N(CCCl)CCCl.O,102.3,5.9
Cyclosporin A,B1922,59865-13-3,Immunology/Inflammation,1,Immunosuppressive agent,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,101.7,12.0
Cyclosporine,A5938,79217-60-0,Others,Others,Immunosuppressant drug,CCC1C(=O)N(CC(=O)N(C(C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)NC(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N(C(C(=O)N1)C(C(C)CC=CC)O)C)C(C)C)C)CC(C)C)C)CC(C)C)C)C)C)CC(C)C)C)C(C)C)CC(C)C)C)C,118.1,21.3
Cyproheptadine hydrochloride,B3309,969-33-5,Neuroscience,Histamine Receptor,serotonin and histamine antagonist as well as antimuscarinic reagent,CN1CCC(=C2C3=CC=CC=C3C=CC4=CC=CC=C42)CC1.Cl,102.9,11.1
Cyproterone Acetate,A8404,427-51-0,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,ClC1=C([H])C(C(C([H])([H])C2([H])[H])([H])C(C2(C(C([H])([H])[H])=O)OC(C([H])([H])[H])=O)(C([H])([H])[H])C([H])([H])C3([H])[H])([H])C3([H])C(C1=C([H])C4=O)(C([H])([H])[H])C5([H])C4([H])C5([H])[H],98.5,1.1
Cyromazine,B3681,66215-27-8,Others,Others,"insecticide, acaricide",NC1=NC(NC2CC2)=NC(N)=N1,96.6,7.1
Cysteamine HCl,B1719,156-57-0,Others,Others,Drug used to treat cystinosis,C(CS)N.Cl,110.2,22.1
Cytarabine,A8405,147-94-4,DNA Damage/DNA Repair,DNA Synthesis,"cytotoxic agent, blocks DNA synthesis",C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,-17.9,3.0
Cytarabine hydrochloride,B1100,69-74-9,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O.Cl,100.7,4.2
Cytidine,B1923,65-46-3,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,pyrimidine nucleoside,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O,109.5,12.1
Cytisine,N1738,485-35-8,Natural Products,AChR,1,O=C1N(C2=C([H])C([H])=C1[H])C([H])([H])[C@@]3([H])C([H])([H])[C@]2([H])C([H])([H])N([H])C3([H])[H],93.1,4.1
D-(+)-Raffinose (hydrate),C3436,17629-30-0,Others,Others,1,O[C@@H]1[C@@H](O)[C@@H](OC[C@@H]2[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@]3(CO)O[C@H](CO)[C@@H](O)[C@@H]3O)O2)O[C@H](CO)[C@@H]1O.O.O.O.O.O,116.5,15.6
D-(-)-Salicin,N1880,138-52-3,Natural Products,COX,1,1,102.3,0.3
D-(−)-Fructose,M1482,57-48-7,Others,Others,1,OC[C@](O)([H])[C@](O)([H])[C@@](O)([H])C(CO)=O,112.0,17.3
D-Cycloserine,B1721,68-41-7,Microbiology & Virology,Anti-infection,NMDA receptor (NMDAR) partial agonist,C1C(C(=O)NO1)N,99.5,6.2
D-Glutamine,C6322,5959-95-5,Neuroscience,GluR,1,1,103.3,0.1
D-Mannitol,B2090,69-65-8,Others,Others,osmotic diuretic agent，weak renal vasodilator.,C(C(C(C(C(CO)O)O)O)O)O,106.0,6.4
DAPT (GSI-IX),A8200,208255-80-5,Neuroscience,Amyloid β,"γ-secretase inhibitor,potent and specific",CC(C(=O)NC(C1=CC=CC=C1)C(=O)OC(C)(C)C)NC(=O)CC2=CC(=CC(=C2)F)F,100.7,2.9
DCA,B7174,2156-56-1,Others,Others,1,1,107.1,6.0
DL-Carnitine HCl,B1934,461-05-2,Others,Others,quaternary ammonium compound,C[N+](C)(C)CC(CC(=O)O)O.[Cl-],89.3,6.6
DL-Serine,C6137,302-84-1,Metabolism,PKM,1,1,80.4,12.2
DL-α-Difluoromethylornithine (hydrochloride hydrate),C3328,96020-91-6,Metabolism,ornithine decarboxylase,"ornithine decarboxylase inhibitor, irreversible",FC(F)C(C(O)=O)(N)CCCN.Cl.O,110.3,7.9
DL-α-Lipoic Acid,C3789,1077-28-7,Others,Others,1,OC(=O)CCCCC1SSCC1,98.2,4.8
DL-α-Tocopherol,C6328,10191-41-0,Metabolism,Vitamin,1,1,101.0,10.0
Dabigatran etexilate mesylate,A3345,872728-81-9,Proteases,Thrombin,"Direct thrombin inhibitor,anticoagulant,prodrug of dabigatran",CCCCCCOC(NC(C1=CC=C(NCC2=NC3=C(C=CC(C(N(C4=CC=CC=N4)CCC(OCC)=O)=O)=C3)N2C)C=C1)=N)=O.CS(=O)(O)=O,103.7,11.6
Dabrafenib (GSK2118436),B1407,1195765-45-7,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F,86.3,3.4
Dabrafenib Mesylate (GSK-2118436),A3347,1195768-06-9,MAPK Signaling,Raf,Inhibitor of BRAF(V600) mutants,CC(C)(C)C1=NC(=C(S1)C2=NC(=NC=C2)N)C3=C(C(=CC=C3)NS(=O)(=O)C4=C(C=CC=C4F)F)F.CS(=O)(=O)O,103.2,8.6
Dacarbazine,A2197,4342-03-4,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic( malignant melanoma and sarcomas),CN(C)NN=C1C(=NC=N1)C(=O)N,51.4,0.4
Daclatasvir (BMS-790052),A5618,1214735-16-6,Proteases,HCV Protease,HCV NS5A inhibitor,CC(C)C(C(=O)N1CCCC1C2=NC=C(N2)C3=CC=C(C=C3)C4=CC=C(C=C4)C5=CN=C(N5)C6CCCN6C(=O)C(C(C)C)NC(=O)OC)NC(=O)OC,100.6,1.8
"Dacomitinib (PF299804, PF299)",A8319,1110813-31-4,JAK/STAT Signaling,EGFR,HER inhibitor,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)NC(=O)C=CCN4CCCCC4,102.8,7.3
Daidzein,N1862,486-66-8,Natural Products,Others,Anti-cancer reagent,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O)O,93.2,7.9
Daminozide,A3348,1596-84-5,DNA Damage/DNA Repair,HDAC,1,1,105.9,3.9
Danazol,C3644,17230-88-5,Endocrinology and Hormones,Androgen Receptor,weak androgenic effects,O[C@@]1(C#C)CC[C@@]2([H])[C@]3([H])CCC4=CC5=C(C=NO5)C[C@]4(C)[C@@]3([H])CC[C@@]21C,111.5,3.8
Danoprevir (RG7227),A4024,850876-88-9,Proteases,HCV Protease,1,1,105.0,22.8
"Dantrolene, sodium salt",B6329,14663-23-1,Membrane Transporter/Ion Channel,Calcium Channel,ryanodine receptor (RYR) channels inhibitor,O=C1N=C(N(C1)/N=C/C2=CC=C(C(C=C3)=CC=C3[N+]([O-])=O)O2)[O-].[Na+],102.0,2.6
Dapagliflozin,A5854,461432-26-8,Metabolism,SGLT,"SGLT2 inhibitor,potent and selective",CCOC1=CC=C(C=C1)CC2=C(C=CC(=C2)C3C(C(C(C(O3)CO)O)O)O)Cl,62.7,0.3
Dapoxetine HCl,B2264,129938-20-1,Neuroscience,5-HT Receptor,Selective serotonin reuptake inhibitor,CN(C)C(CCOC1=CC=CC2=CC=CC=C21)C3=CC=CC=C3.Cl,101.8,0.4
Dapsone,B3448,80-08-0,Microbiology & Virology,Antibiotic,sulfone antibiotic,NC1=CC=C(S(C2=CC=C(N)C=C2)(=O)=O)C=C1,109.0,18.1
Daptomycin,A1206,103060-53-3,DNA Damage/DNA Repair,DNA Synthesis,Calcium-dependent antibiotic,CCCCCCCCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CC(=O)N)C(=O)NC(CC(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC3=O)CCCN)CC(=O)O)C)CC(=O)O)CO)C(C)CC(=O)O)CC(=O)C4=CC=CC=C4N)C,116.0,5.2
Darifenacin HBr,B1600,133099-07-7,Neuroscience,Muscarinic Receptor,Selective M3 muscarinic receptor antagonist,C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5.Br,96.3,7.7
Darunavir,A8206,206361-99-1,Proteases,HIV Protease,HIV-1 protease inhibitor,CC(CN(S(C1=CC=C(N)C=C1)(=O)=O)C[C@](O)([H])[C@](/N=C(O[C@@]2([H])CO[C@]3([H])[C@@]2([H])CCO3)\O)([H])CC4=CC=CC=C4)C,101.0,2.6
Darunavir Ethanolate,B4950,635728-49-3,Proteases,HIV Protease,1,1,110.0,6.3
Dasatinib (BMS-354825),A3017,302962-49-8,TGF-β / Smad Signaling,Bcr-Abl,Src and BCR-Abl inhibitor,CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=NC(=NC(=C3)N4CCN(CC4)CCO)C,95.3,0.1
Dasatinib Monohydrate,B5954,863127-77-9,TGF-β / Smad Signaling,Bcr-Abl,1,1,78.2,15.6
Daunorubicin HCl,B2285,23541-50-6,Microbiology & Virology,Antibiotic,DNA topoisomerase II inhibitor,Cl[H].O=C(C([H])([H])[H])[C@@](C([H])([H])[C@]1([H])O[C@](C([H])([H])[C@]2([H])N([H])[H])([H])O[C@](C([H])([H])[H])([H])[C@@]2([H])O[H])(C([H])([H])C3=C1C(O[H])=C(C(C4=C5C([H])=C([H])C([H])=C4OC([H])([H])[H])=O)C(C5=O)=C3O[H])O[H],-12.5,7.1
Decamethonium Bromide,B1601,541-22-0,Neuroscience,AChR,Nicotinic AChR partial agonist,C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C.[Br-].[Br-],101.7,3.1
"Decitabine (NSC127716, 5AZA-CdR)",A1906,2353-33-5,Chromatin/Epigenetics,DNA Methyltransferase,Deoxycytidine analog and cellular diifferentiation inducer,C1C(C(OC1N2C=NC(=NC2=O)N)CO)O,29.9,20.1
Defactinib,B4800,1073154-85-4,Tyrosine Kinase,FAK,FAK phosphorylation inhibitor,CNC(=O)C1=CC=C(C=C1)NC2=NC=C(C(=N2)NCC3=NC=CN=C3N(C)S(=O)(=O)C)C(F)(F)F,99.3,4.4
Deferasirox,A8639,201530-41-8,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Oral iron chelator,C1=CC(=C2NC(=C3C=CC=CC3=O)N(N2)C4=CC=C(C=C4)C(=O)O)C(=O)C=C1,94.8,6.5
Deferiprone,B1723,30652-11-0,Others,Others,Chelating agent,CC1=C(C(=O)C=CN1C)O,98.5,7.7
Deferoxamine mesylate,B6068,138-14-7,Others,Others,iron-chelating agent,CC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCC/N=C(O)/CCC(N(O)CCCCCN)=O)=O)=O.CS(O)(=O)=O,91.5,3.5
Deflazacort,B1924,14484-47-0,GPCR/G protein,Glucocorticoid Receptor,anti-inflammatory and immunosuppressant,O=C(C([H])([H])OC(C([H])([H])[H])=O)[C@@]12N=C(C([H])([H])[H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H],70.2,3.1
Dehydroandrographolide,N1390,134418-28-3,Natural Products,Chloride Channel,1,1,104.7,13.7
Dehydrocostus Lactone,N2334,477-43-0,Natural Products,IκB/IKK,1,1,95.2,0.6
Dehydroepiandrosterone (DHEA),B1375,53-43-0,Membrane Transporter/Ion Channel,Calcium Channel,Endogenous steroid hormone,CC12CCC3C(C1CCC2=O)CC=C4C3(CCC(C4)O)C,98.5,1.0
Deoxyarbutin,B1925,53936-56-4,Proteases,Tyrosinase,Tyrosinase inhibitor,C1CCOC(C1)OC2=CC=C(C=C2)O,89.9,6.9
Deoxycholic acid,N1669,83-44-3,Natural Products,Others,Bile Acid;proinflammatory agent,CC(CCC(=O)O)C1CCC2C1(C(CC3C2CCC4C3(CCC(C4)O)C)O)C,97.0,0.0
Deoxycorticosterone acetate,B1724,56-47-3,GPCR/G protein,Adrenergic Receptor,Steroid hormone,CC(=O)OCC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,98.0,11.4
Desipramine hydrochloride,B7261,58-28-6,GPCR/G protein,Adrenergic Transporters,noradrenalin transporters inhibitor,CNCCCN1C2=CC=CC=C2CCC3=CC=CC=C13.Cl,133.6,50.2
Desloratadine,B1571,100643-71-8,Neuroscience,Histamine Receptor,High affinity histamine H1 receptor antagonist,C1CC2=C(C=CC(=C2)Cl)C(=C3CCNCC3)C4=C1C=CC=N4,103.5,8.4
Desmopressin,A3359,16679-58-6,GPCR/G protein,Vasopressin Receptor,Hemostatic and anti-diuretic,O=C(C1CSSCCC(NC(CC2=CC=C(O)C=C2)C(NC(CC3=CC=CC=C3)C(NC(CCC(N)=O)C(NC(CC(N)=O)C(N1)=O)=O)=O)=O)=O)N4C(C(NC(C(NCC(N)=O)=O)CCC/N=C(N)\N)=O)CCC4,108.8,4.3
Desogestrel,B4976,54024-22-5,Endocrinology and Hormones,Estrogen/progestogen Receptor,progestin used in hormonal contraceptives,[H][C@@]12C(CC[C@]([C@@](CC[C@]3(C#C)O)([H])[C@]3(CC)C4)([H])[C@]2([H])C4=C)=CCCC1,100.8,0.5
Desonide,B2158,638-94-8,GPCR/G protein,Glucocorticoid Receptor,nonfluorinated corticosteroid anti-inflammatory agent,O=C(C([H])([H])O[H])[C@@]12OC(C([H])([H])[H])(C([H])([H])[H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[H])(C([H])=C5[H])C3=C([H])C5=O)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H],114.5,17.9
Desvenlafaxine,B2236,93413-62-8,Neuroscience,5-HT Receptor,serotonin (5-HT) and norepinephrine (NE) reuptake inhibitor,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O,97.5,4.5
Desvenlafaxine Succinate,B2246,386750-22-7,Neuroscience,5-HT Receptor,serotonin (5-HT) transporter and norepinephrine (NE) transporter reuptake inhibitor,CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O.C(CC(=O)O)C(=O)O.O,95.2,4.0
Detomidine HCl,B1356,90038-01-0,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,CC1=C(C(=CC=C1)CC2=CN=CN2)C.Cl,96.6,5.8
Dexamethasone (DHAP),A2324,50-02-2,Ubiquitination/Proteasome,Autophagy,Glucocorticoidan;anti-inflammatory,O=C1C=C[C@@]2(C)C(CC[C@@]3([H])[C@]2(F)[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@@H](C)[C@@]4(C(CO)=O)O)=C1,55.6,3.7
Dexamethasone acetate,B1926,1177-87-3,GPCR/G protein,Glucocorticoid Receptor,IL Receptor modulator,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)COC(=O)C)O)C)O)F)C,49.3,14.1
Dexlansoprazole,B1725,138530-94-6,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,102.8,2.5
Dexmedetomidine,B1334,113775-47-6,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C,112.0,4.5
Dexmedetomidine HCl,B1357,145108-58-3,GPCR/G protein,Adrenergic Receptor,Highly selective and potent alpha-2 adrenoceptor agonist,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,119.4,13.5
Dexpanthenol,C6234,81-13-0,Metabolism,Vitamin,1,1,102.9,0.5
Dexrazoxane,B3407,24584-09-6,Others,Others,cardioprotective agent,CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2,78.9,7.3
"Dexrazoxane HCl (ICRF-187, ADR-529)",A1602,149003-01-0,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor,intracellular ion chelator,cardioprotective agent",CC(CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2.Cl,78.4,1.3
Dextrose (D-glucose),A8406,50-99-7,Others,Others,Simple sugar (monosaccharide),C(C1C(C(C(C(O1)O)O)O)O)O,96.6,5.1
Diacerein,B1726,13739-02-1,Others,IL Receptor,IL receptor inhibitor,CC(=O)OC1=CC=CC2=C1C(=O)C3=C(C=C(C=C3C2=O)C(=O)O)OC(=O)C,101.9,1.5
Diazoxide,B6526,364-98-7,Membrane Transporter/Ion Channel,AMPAR,positive allosteric modulator of the AMPA and kainate receptors,ClC1=CC=C2NC(C)=NS(=O)(C2=C1)=O,98.1,16.5
Dibenzothiophene,B1727,132-65-0,Others,Others,Intermediate of organic synthesis,C1=CC=C2C(=C1)C3=CC=CC=C3S2,98.3,4.1
Dibucaine,B3373,85-79-0,Others,Others,Local anesthetic,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC,100.7,21.0
Dibucaine (Cinchocaine) HCl,A8407,61-12-1,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC.Cl,95.6,8.6
"Dibutyryl-cAMP, sodium salt",B9001,16980-89-5,MAPK Signaling,cAMP,Cell-permeable cAMP analog that activates cAMP-dependent protein kinases,CCC/C([O-])=N/C1=C(N=CN2[C@@]3([H])[C@@](OC(CCC)=O)([H])[C@@](O4)([H])[C@@](O3)([H])COP4(O)=O)C2=NC=N1.[Na+],107.0,18.1
Dichlorphenamide,A8408,120-97-8,Metabolism,Carbonic Anhydrase,1,1,-9.0,3.5
Diclazuril,B1927,101831-37-2,Microbiology & Virology,Anti-infection,anti-coccidial drug,C1=CC(=CC=C1C(C#N)C2=C(C=C(C=C2Cl)N3C(=O)NC(=O)C=N3)Cl)Cl,109.3,2.9
Diclofenac,B3505,15307-86-5,Neuroscience,COX,non-selective COX inhibitor,ClC1=C(NC2=CC=CC=C2CC(O)=O)C(Cl)=CC=C1,100.0,12.9
Diclofenac Diethylamine,B1928,78213-16-8,Neuroscience,COX,non-selective COX inhibitor,CCNCC.C1=CC=C(C(=C1)CC(=O)O)NC2=C(C=CC=C2Cl)Cl,105.6,3.9
Diclofenac Potassium,B1929,15307-81-0,Immunology/Inflammation,1,nonsteroidal anti-inflammatory drug,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[K+],96.0,0.1
Diclofenac Sodium,B1457,15307-79-6,Neuroscience,COX,COX inhibitor,C1=CC=C(C(=C1)CC(=O)[O-])NC2=C(C=CC=C2Cl)Cl.[Na+],104.7,0.2
Dicyclomine HCl,A8409,67-92-5,Others,Others,Anticholinergic drug,CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2.Cl,92.9,9.2
Didanosine,A8410,69655-05-6,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,C1CC(OC1CO)N2C=NC3=C2NC=NC3=O,109.2,10.4
Dienogest,B1516,65928-58-7,Endocrinology and Hormones,Estrogen/progestogen Receptor,Orally active synthetic progesterone,CC12CCC3=C4CCC(=O)C=C4CCC3C1CCC2(CC#N)O,107.9,9.2
Diethylstilbestrol,B2088,56-53-1,Endocrinology and Hormones,Estrogen/progestogen Receptor,synthetic nonsteroidal estrogen,CCC(=C(CC)C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,108.1,2.4
Difloxacin HCl,A8411,98106-17-3,Others,Others,quinolone antimicrobial antibiotic,CN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4=CC=C(C=C4)F)F,105.3,10.9
Diflunisal,B6137,22494-42-4,Neuroscience,COX,"COX inhibitor, nonsteroidal anti-inflammatory drug (NSAID)",FC1=CC(F)=C(C2=CC(C(O)=O)=C(O)C=C2)C=C1,106.9,10.2
Difluprednate,B1728,23674-86-4,Others,Others,Corticosteroid,CCCC(=O)OC1(CCC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C(=O)COC(=O)C,99.9,3.9
Digoxin,B7684,20830-75-5,Membrane Transporter/Ion Channel,ATPase,Na+/K+ ATPase pump inhibitor,O[C@]1([C@]([C@@H](C2=CC(OC2)=O)CC1)(C)[C@@H]3O)[C@H]4[C@H](C3)[C@](CC[C@@H]5O[C@@H](C[C@@H]6O)O[C@H](C)[C@H]6O[C@@H](C[C@@H]7O)O[C@H](C)[C@H]7O[C@@H](C[C@@H]8O)O[C@H](C)[C@H]8O)(C)[C@@H](C5)CC4,96.1,10.2
Dihydroartemisinin,N1713,71939-50-9,Microbiology & Virology,Antimalaria,1,[H][C@@]1(C([H])([H])C2([H])[H])[C@]3([C@@]([C@@]4([H])C([H])([H])[H])([H])C([H])([H])C([H])([H])[C@@]1([H])C([H])([H])[H])OO[C@@]2(C([H])([H])[H])O[C@@]3([H])O[C@@]4([H])O[H],107.4,8.7
Dihydrotestosterone(DHT),B8214,521-18-6,Endocrinology and Hormones,Androgen Receptor,1,1,99.0,10.5
Diltiazem HCl,B2089,33286-22-5,Membrane Transporter/Ion Channel,Calcium Channel,inhibitor of L-type Ca2+ channels,CC(=O)OC1C(SC2=CC=CC=C2N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC.Cl,99.9,1.1
Dimesna,A1652,16208-51-8,Others,Others,Uroprotective agent,C(CS(=O)(=O)[O-])SSCCS(=O)(=O)[O-].[Na+].[Na+],95.6,10.0
Dimethyl Fumarate,B1931,624-49-7,Immunology/Inflammation,KEAP1-Nrf2,nuclear factor (erythroid-derived)-like 2 (Nrf2) pathway activator,COC(=O)C=CC(=O)OC,105.2,6.7
Diminazene Aceturate,B1729,908-54-3,Others,Others,1,1,94.4,1.5
Dinaciclib (SCH727965),A8412,779353-01-4,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,Potent CDK inhibitor,CCC1=C2N=C(C=C(N2N=C1)NCC3=C[N+](=CC=C3)[O-])N4CCCCC4CCO,116.8,11.6
Diosimin,N2535,520-27-4,Natural Products,Others,1,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=C3)OC(=CC4=O)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,107.3,17.6
Diosmetin,B5990,520-34-3,Metabolism,CYP3A/CYP450,CYP1A1 inhibitor,COC1=C(O)C=C(C2=CC(C3=C(O)C=C(O)C=C3O2)=O)C=C1,101.7,6.7
Diperodon HCl,A8413,537-12-2,Others,Others,Local anaesthetics,O=C(NC1=CC=CC=C1)OC(COC(NC2=CC=CC=C2)=O)CN3CCCCC3.Cl,87.2,3.9
Diphemanil Methylsulfate,A8414,62-97-5,Neuroscience,AChR,AChR antagonist,C[N+]1(CCC(=C(C2=CC=CC=C2)C3=CC=CC=C3)CC1)C.COS(=O)(=O)[O-],104.0,7.5
Diphenhydramine HCl,B1932,147-24-0,Neuroscience,Histamine Receptor,H1 receptor antagonist,CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2.Cl,105.1,5.2
Diphenidol HCl,B4783,3254-89-5,Neuroscience,AChR,antagonist of muscarinic M2 and M3 receptor,OC(C1=CC=CC=C1)(C2=CC=CC=C2)CCCN3CCCCC3.Cl,101.6,4.4
Diphenylpyraline HCl,A8415,132-18-3,Others,Others,Histamine receptor antagonist,CN1CCC(CC1)OC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,100.7,0.7
Dipyridamole,B1933,58-32-2,Metabolism,PDE,PDE inhibitor,C1CCN(CC1)C2=NC(=NC3=C2N=C(N=C3N4CCCCC4)N(CCO)CCO)N(CCO)CCO,98.2,4.0
Dirithromycin,B1731,62013-04-1,Microbiology & Virology,Anti-infection,Macrolide glycopeptide antibiotic,CCC1C(C2C(C(C(CC(C(C(C(C(C(=O)O1)C)OC3CC(C(C(O3)C)O)(C)OC)C)OC4C(C(CC(O4)C)N(C)C)O)(C)O)C)NC(O2)COCCOC)C)(C)O,102.3,16.4
Disulfiram,A4015,97-77-8,Metabolism,Dopamine β-hydroxylase,Dopamine β-hydroxylase inhibitor,CCN(CC)C(=S)SSC(=S)N(CC)CC,106.7,6.6
Divalproex Sodium,B1391,76584-70-8,Ubiquitination/Proteasome,Autophagy,Epilepsy/migraines/bipolar disorder medicine,CCCC(CCC)C(=O)O.CCCC(CCC)C(=O)[O-].[Na+],101.4,6.9
Docetaxel,A4394,114977-28-5,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubulin disassembly inhibitor,O=C(N[C@H]([C@H](C(O[C@H]1C[C@]2(O)C(C)(C)C([C@@H](O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@@]4([H])C[C@@H]3O)([H])[C@@H]2OC(C5=CC=CC=C5)=O)=O)=C1C)=O)O)C6=CC=CC=C6)OC(C)(C)C,8.4,7.6
Docetaxel Trihydrate,A3370,148408-66-6,Cell Cycle/Checkpoint,Microtubule/Tubulin,Depolymerisation of microtubules inhibitor,CC([C@](OC([C@@](O)([H])[C@](NC(OC(C)(C)C)=O)([H])C1=CC=CC=C1)=O)([H])C[C@@]2(O)[C@](OC(C3=CC=CC=C3)=O)([H])[C@@]4([H])[C@@]([C@](O)([H])C[C@]5([H])[C@@]4(OC(C)=O)CO5)6C)=C(C(C)2C)[C@](O)([H])C6=O.O.O.O,135.5,22.4
Docosahexaenoic Acid,C4188,6217-54-5,Others,Others,1,CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O,99.5,9.1
Docosanol (Abreua),A8416,661-19-8,Others,Others,Saturated fatty alcohol,CCCCCCCCCCCCCCCCCCCCCCO,104.0,3.1
Dofetilide,A8417,115256-11-6,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,CN(CCC1=CC=C(C=C1)NS(=O)(=O)C)CCOC2=CC=C(C=C2)NS(=O)(=O)C,108.1,7.6
Dolasetron,B8718,115956-12-2,GPCR/G Protein,5-HT3,Potent antagonist of the serotonin (5-HT) receptor subtype 5-HT3,1,100.1,8.9
Domiphen Bromide,B1733,538-71-6,Others,Others,Quaternary ammonium antiseptic,CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1.[Br-],61.7,12.9
Domperidone,B1481,57808-66-9,Neuroscience,Dopamine Receptor,Drug for gastroparesis,C1CN(CCC1N2C3=C(C=C(C=C3)Cl)NC2=O)CCCN4C5=CC=CC=C5NC4=O,113.5,28.8
Donepezil HCl,B1602,120011-70-3,Chromatin/Epigenetics,Histone Acetyltransferases,AChE inhibitor,COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl,107.3,0.9
Dopamine HCl,B1482,62-31-7,Neuroscience,Dopamine Receptor,Dopamine D1-5 receptors agonist,C1=CC(=C(C=C1CCN)O)O.Cl,108.8,2.8
Doramectin,A3371,117704-25-3,Microbiology & Virology,Antibiotic,1,1,30.1,1.2
Doripenem,B1076,148016-81-3,Microbiology & Virology,Antibiotic,Ultra-broad spectrum injectable antibiotic,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O,108.0,7.3
Doripenem Hydrate,A2036,364622-82-2,Microbiology & Virology,Antibiotic,"Injectable antibiotic,ultra-broad spectrum",CC1C2C(C(=O)N2C(=C1SC3CC(NC3)CNS(=O)(=O)N)C(=O)O)C(C)O.O,110.3,10.4
Dorzolamide HCl,A4357,130693-82-2,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor,CCNC1CC(S(=O)(=O)C2=C1C=C(S2)S(=O)(=O)N)C.Cl,73.4,8.1
"Dovitinib (TKI-258, CHIR-258)",A2168,405169-16-6,Tyrosine Kinase,FGFR,Multitargeted RTK inhibitor,CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,6.0,10.6
Dovitinib (TKI258) Lactate,B5953,915769-50-5,Tyrosine Kinase,VEGFR,"Oral tyrosine kinase inhibitor (TKI) against FGFR1–3, VEGFR1–3, and platelet-derived growth factor receptor (PDGFR).",FC1=C(C(N)=C(C2=O)C3=NC4=C(N3)C=C(N5CCN(C)CC5)C=C4)C(N2)=CC=C1.CC(O)C(O)=O.O,109.5,6.7
Dovitinib Dilactic acid,A8418,852433-84-2,Tyrosine Kinase,VEGFR,FLT3 inhibitor,CC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)NC(=C4C(=C5C(=NC4=O)C=CC=C5F)N)N3,105.0,2.8
Doxapram HCl,A8419,7081-53-0,Others,Others,Potassium channel inhibitor,CCN1CC(CCN2CCOCC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)C1=O.O.Cl,108.7,20.7
Doxazosin Mesylate,A2884,77883-43-3,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor antagonist,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4COC5=CC=CC=C5O4)N)OC.CS(=O)(=O)O,103.7,5.0
Doxepin (hydrochloride),C4153,1229-29-4,Neuroscience,Histamine Receptor,"histamine, serotonin, adrenergic, and muscarinic receptors antagonist",CN(C)CC/C=C1C2=C(C=CC=C2)COC3=C/1C=CC=C3.Cl,105.0,15.1
Doxercalciferol,B2091,54573-75-0,Vitamin D Related,VD/VDR,Vitamin D receptor activator,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CC(C3=C)O)O)C,72.5,6.0
Doxifluridine,B2092,3094-9-5,Apoptosis,Thymidylate Synthase,oral prodrug of the antineoplastic agent 5-fluorouracil (5-FU),CC1C(C(C(O1)N2C=C(C(=O)NC2=O)F)O)O,106.2,5.9
Doxofylline,B1734,69975-86-6,Metabolism,PDE,PDE inhibitor,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC3OCCO3,97.2,2.2
Doxorubicin,A3966,23214-92-8,DNA Damage/DNA Repair,Topoisomerase,"Topo II inhibitor,immunosuppresive antineoplastic antibiotic",CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O,-19.0,3.1
Doxorubicin (Adriamycin) HCl,A1832,25316-40-9,DNA Damage/DNA Repair,Topoisomerase,"Antitumour antibiotic,inhibits TOPO II.",CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,-10.8,10.2
Doxycycline HCl,A8420,10592-13-9,Proteases,MMP,Tetracycline antibiotic;MMP inhibitor;cell selection reagent,CC1C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,102.3,0.2
Doxycycline hyclate,A4052,24390-14-5,Others,Others,MMP inhibitor,O=C(C1=C(O)[C@]2(O)[C@]([C@@H](O)[C@@]3([H])C(C2=O)=C(O)C4=C(O)C=CC=C4[C@@H]3C)([H])[C@H](N(C)C)C1=O)N.Cl,88.6,13.8
Doxylamine Succinate,B1735,562-10-7,Neuroscience,Histamine Receptor,Histamine receptor inhibitor,CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O,92.9,2.1
Dronedarone,A3374,141626-36-0,Metabolism,CYP3A/CYP450,"CYP3A4 and 2D6 inhibitor,moderate",CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC,100.1,12.4
Dronedarone HCl,B1935,141625-93-6,Membrane Transporter/Ion Channel,Potassium Channel,Antiarrhythmic drugs,CCCCC1=C(C2=C(O1)C=CC(=C2)NS(=O)(=O)C)C(=O)C3=CC=C(C=C3)OCCCN(CCCC)CCCC.Cl,106.7,8.0
Droperidol,B1736,548-73-2,Neuroscience,Dopamine Receptor,Dopamine-2 receptor antagonist,C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F,98.0,6.4
Dropropizine,B1737,17692-31-8,Others,Others,Racemic non-opiate antitussive agent,C1CN(CCN1CC(CO)O)C2=CC=CC=C2,112.5,7.6
Drospirenone,B1520,67392-87-4,Endocrinology and Hormones,Estrogen/progestogen Receptor,Synthetic progestin,O=C1OC2(C([H])([H])C1([H])[H])C3([H])C(C3([H])[H])([H])C4([H])C2(C([H])([H])[H])C([H])([H])C([H])([H])C(C(C([H])([H])C5([H])[H])(C([H])([H])[H])C6=C([H])C5=O)([H])C4([H])C7([H])C6([H])C7([H])[H],94.8,15.0
Duloxetine HCl,A8421,136434-34-9,Neuroscience,5-HT Receptor,5-HT receptor inhibitor,CNCCC(C1=CC=CS1)OC2=CC=CC3=CC=CC=C32.Cl,111.4,20.3
Dutasteride,A1659,164656-23-9,Endocrinology and Hormones,5-alpha Reductase,5-alpha-reductase inhibitor,CC12CCC3C(C1CCC2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CCC5C3(C=CC(=O)N5)C,5.1,8.5
Dyclonine HCl,B1936,536-43-6,Membrane Transporter/Ion Channel,Sodium Channel,local anesthetic,CCCCOC1=CC=C(C=C1)C(=O)CCN2CCCCC2.Cl,104.7,10.1
Dydrogesterone,B1739,152-62-5,Others,Progesterone Receptor,"Potent, orally active progestogen",CC(=O)C1CCC2C1(CCC3C2C=CC4=CC(=O)CCC34C)C,95.7,10.7
Dyphylline,A4343,479-18-5,Metabolism,PDE,Pan-PDE inhibitor,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC(CO)O,110.8,12.1
E 64d,A1903,88321-09-9,Proteases,Cathepsin,Cysteine protease inhibitor,CCOC(=O)C1C(O1)C(=O)NC(CC(C)C)C(=O)NCCC(C)C,108.3,6.2
EMD-1214063,A3388,1100598-32-0,Tyrosine Kinase,c-MET,"C-Met inhibitor,potent and selective",CN1CCC(CC1)COC2=CN=C(N=C2)C3=CC(=CC=C3)CN4C(=O)C=CC(=N4)C5=CC=CC(=C5)C#N,101.7,19.8
EX 527 (SEN0014196),A4181,49843-98-3,Chromatin/Epigenetics,Sirtuin,SIRT1 inhibitor,C1CC(C2=C(C1)C3=C(N2)C=CC(=C3)Cl)C(=O)N,105.4,2.1
Ebastine,B1740,90729-43-4,Neuroscience,Histamine Receptor,Histamine receptor antagonist,CC(C)(C)C1=CC=C(C=C1)C(=O)CCCN2CCC(CC2)OC(C3=CC=CC=C3)C4=CC=CC=C4,117.0,13.8
Echinacoside,N1605,82854-37-3,Natural Products,Others,1,1,102.3,3.4
Econazole nitrate,B1937,24169-02-6,Membrane Transporter/Ion Channel,"Anti-infection,Calcium Channel",Calcium channel inhibitor,C1=CC(=CC=C1COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],85.5,4.3
Edaravone,A5059,89-25-8,Others,Others,A radical scavenger and antioxidant,CC1=NN(C(=O)C1)C2=CC=CC=C2,111.8,7.8
Edoxaban,A3381,480449-70-5,Proteases,Thrombin,1,1,91.5,6.3
Edoxaban tosylate monohydrate,A3383,1229194-11-9,Proteases,Thrombin,Oral factor Xa inhibitor,CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O,108.8,0.8
Edrophonium (chloride),C4140,116-38-1,Neuroscience,AChE,acetylcholinesterase (AChE) inhibitor,OC1=CC([N+](C)(C)CC)=CC=C1.[Cl-],93.5,5.9
Efaproxiral Sodium,B1741,170787-99-2,Others,Others,Synthetic allosteric modifier of hemoglobin,CC1=CC(=CC(=C1)NC(=O)CC2=CC=C(C=C2)OC(C)(C)C(=O)[O-])C.[Na+],104.8,4.0
Efavirenz,B1119,154598-52-4,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F,96.7,5.3
Efinaconazole,B4834,164650-44-6,Microbiology & Virology,Antifungal,novel triazole antifungal drug,CC(C(CN1C=NC=N1)(C2=C(C=C(C=C2)F)F)O)N3CCC(=C)CC3,112.7,14.1
Eicosapentaenoic Acid,B3464,10417-94-4,Immunology/Inflammation,Immunology & Inflamm,EPA，omega-3 fatty acid,CC/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\C/C([H])=C([H])\CCCC(O)=O,100.7,2.1
Elacridar,A3384,143664-11-3,Others,Others,BCRP inhibitor,COC1=CC=CC2=C1NC3=C(C2=O)C=CC=C3C(=O)NC4=CC=C(C=C4)CCN5CCC6=CC(=C(C=C6C5)OC)OC,100.7,1.9
Eletriptan HBr,B2237,177834-92-3,Neuroscience,5-HT Receptor,selective 5-HT1B and 5-HT1D receptor agonist,CN1CCCC1CC2=CNC3=C2C=C(C=C3)CCS(=O)(=O)C4=CC=CC=C4.Br,99.4,1.1
Ellagic acid,A2306,476-66-4,DNA Damage/DNA Repair,Topoisomerase,Casein kinase 2 (CK2) inhibitor,OC1=C(O)C2=C3C(C(OC4=C3C(C(O2)=O)=CC(O)=C4O)=O)=C1,118.2,7.7
Eltrombopag,B2159,496775-61-2,Others,Thrombopoietin Receptor,nonpeptide agonist of the thrombopoietin receptor,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C,102.0,5.3
Eltrombopag Olamine,A3387,496775-62-3,Others,Thrombopoietin Receptor,C-mpl agonist,CC1=C(C=C(C=C1)N2C(=O)C(=C(N2)C)NN=C3C=CC=C(C3=O)C4=CC(=CC=C4)C(=O)O)C.C(CO)N.C(CO)N,100.8,10.4
Elvitegravir (GS-9137),A4070,697761-98-1,Proteases,HIV Integrase,"HIV-1 integrase inhibitor,potent",CC(C)C(CO)N1C=C(C(=O)C2=CC(=C(C=C21)OC)CC3=C(C(=CC=C3)Cl)F)C(=O)O,107.6,18.3
Embelin,A8235,550-24-3,Apoptosis,IAP,"XIAP inhibitor,cell-permeable",CCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O,106.6,8.1
Emodin,A3392,518-82-1,Immunology/Inflammation,NF-κB,1,1,103.3,3.5
Empagliflozin (BI 10773),A4601,864070-44-0,Metabolism,SGLT,SGLT-2 inhibitor for oral treatment of type 2 diabetes,C1COCC1OC2=CC=C(C=C2)CC3=C(C=CC(=C3)C4C(C(C(C(O4)CO)O)O)O)Cl,98.5,6.4
Emtricitabine,A8422,143491-57-0,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,C1C(OC(S1)CO)N2C=C(C(=NC2=O)N)F,132.3,38.6
Enalapril Maleate,B2205,76095-16-4,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CCCC2C(=O)O.C(=CC(=O)O)C(=O)O,103.3,6.0
Enoxacin (Penetrex),A8423,74011-58-8,Microbiology & Virology,Antibiotic,Topoisomerase inhibitor,CCN1C=C(C(=O)C2=CC(=C(N=C21)N3CCNCC3)F)C(=O)O,108.1,3.4
Enoxolone,B5986,471-53-4,Others,Others,major component of licorice,CC([C@]1([H])CC[C@]23C)([C@](O)([H])CC[C@@]1([C@@]2([H])C(C=C4[C@]5([H])C[C@](CC[C@](CC[C@]43C)5C)(C(O)=O)C)=O)C)C,104.8,0.0
Enrofloxacin,B1742,93106-60-6,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic,CCN1CCN(CC1)C2=C(C=C3C(=C2)N(C=C(C3=O)C(=O)O)C4CC4)F,101.3,10.7
Entacapone,A4168,130929-57-6,Chromatin/Epigenetics,Histone Methyltransferase,COMT inhibitor,CCN(CC)C(=O)C(=CC1=CC(=C(C(=C1)O)O)[N+](=O)[O-])C#N,102.0,6.9
Entecavir Hydrate,A1767,209216-23-9,Microbiology & Virology,Reverse Transcriptase,Antiviral drug used in hepatitis B infection,C=C1C(CC(C1CO)O)N2C=NC3=C2NC(=NC3=O)N.O,86.5,5.4
"Entinostat (MS-275,SNDX-275)",A8171,209783-80-2,DNA Damage/DNA Repair,HDAC,HDAC1 and HDAC3 inhibitor,C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC(=O)OCC3=CN=CC=C3,99.7,0.8
Entrectinib,B5859,1108743-60-7,Tyrosine Kinase,ALK,Orally active inhibitor of ALK kinase,CN1CCN(C2=CC(NC3CCOCC3)=C(C(/N=C4C5=C(NN/4)C=CC(CC6=CC(F)=CC(F)=C6)=C5)=O)C=C2)CC1,103.3,2.5
Enzastaurin (LY317615),A1670,170364-57-5,TGF-β / Smad Signaling,PKC,"PKC beta inhibitor,potent and selective",CN1C=C(C2=CC=CC=C21)C3=C(C(=O)NC3=O)C4=CN(C5=CC=CC=C54)C6CCN(CC6)CC7=CC=CC=N7,113.2,9.6
Epalrestat,B1743,82159-09-9,Others,Others,aldose reductase inhibitor,CC(=CC1=CC=CC=C1)C=C2C(=O)N(C(=S)S2)CC(=O)O,108.7,11.6
Epiandrosterone,B1505,481-29-8,Endocrinology and Hormones,Androgen Receptor,1,1,101.2,6.6
Epinastine HCl,B1744,108929-04-0,Neuroscience,Histamine Receptor,Histamine receptor antagonist,Cl[H].[H]C1(C([H])([H])N=C2N([H])[H])N2C3=C([H])C([H])=C([H])C([H])=C3C([H])([H])C4=C([H])C([H])=C([H])C([H])=C14,98.0,1.0
Epinephrine Bitartrate,B1358,51-42-3,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,CNCC(C1=CC(=C(C=C1)O)O)O.C(C(C(=O)O)O)(C(=O)O)O,86.2,1.9
Epinephrine HCl,B1327,55-31-2,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,CNCC(C1=CC(=C(C=C1)O)O)O.Cl,95.7,0.4
Epirubicin HCl,A2451,56390-09-1,DNA Damage/DNA Repair,Topoisomerase,Antibiotic antitumor agent,CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=C(C4=O)C=CC=C5OC)O)(C(=O)CO)O)N)O.Cl,-12.8,3.9
Epleremone,A8424,107724-20-9,Others,Mineralocorticoid Receptor,Mineralocorticoid receptor antagonists,O=C(C(C1([H])[H])([H])C2([H])C3(C(C([H])([H])C4([H])[H])(C([H])([H])[H])C1=C([H])C4=O)OC3([H])C([H])([H])C5(C([H])([H])[H])C2([H])C([H])([H])C([H])([H])[C@@]5(C([H])([H])C6([H])[H])OC6=O)OC([H])([H])[H],81.1,3.6
"Epothilone B (EPO906, Patupilone)",A1630,152044-54-7,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule stabilizing macrolide,CC1CCCC2(C(O2)CC(OC(=O)CC(C(C(=O)C(C1O)C)(C)C)O)C(=CC3=CSC(=N3)C)C)C,7.0,8.0
Eprazinone 2HCl,B1745,10402-53-6,Others,Others,Aucolytic,CCOC(CN1CCN(CC1)CC(C)C(=O)C2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl,107.8,3.4
Eprosartan Mesylate,B1746,144143-96-4,GPCR/G protein,Angiotensin Receptor,Angiotensin AT1 receptor antagonists,CCCCC1=NC=C(N1CC2=CC=C(C=C2)C(=O)O)C=C(CC3=CC=CS3)C(=O)O.CS(=O)(=O)O,100.2,1.3
Eptifibatide,B3490,188627-80-7,Angiogenesis,Integrin,Glycoprotein (GP) IIb/IIIa inhibitor,O=C([C@@](C([H])([H])C1=C([H])N([H])C2=C([H])C([H])=C([H])C([H])=C12)([H])N([H])C([C@@](C([H])([H])C(O[H])=O)([H])N([H])C(C([H])([H])N([H])C3=O)=O)=O)N4[C@@](C(N([H])[C@@](C(N([H])[H])=O)([H])C([H])([H])SSC([H])([H])C([H])([H])C(N([H])[C@@]3([H])C([H])([H,105.7,0.6
Equol,B1514,531-95-3,Endocrinology and Hormones,Estrogen/progestogen Receptor,1,1,97.5,2.7
Erdosteine,B1938,84611-23-4,Others,Others,mucolytic,C1CSC(=O)C1NC(=O)CSCC(=O)O,107.6,4.6
Eriodictyol,N2309,552-58-9,Natural Products,Others,1,1,101.2,6.1
Erlotinib,A3397,183321-74-6,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC,99.5,11.7
Erlotinib Hydrochloride,A8234,183319-69-9,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor,COCCOC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC=CC(=C3)C#C)OCCOC.Cl,104.3,11.2
Erythritol,B1747,149-32-6,Others,Others,1,1,103.4,8.4
Erythromycin,B1939,114-07-8,Microbiology & Virology,Antibiotic,macrolide antibiotic,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,102.6,1.7
Erythromycin Ethylsuccinate,B1940,1264-62-6,Microbiology & Virology,Anti-infection,Macrolide antibiotic,CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)OC(=O)CCC(=O)OCC)(C)O)C)C)O)(C)O,109.1,4.8
Escitalopram Oxalate,B2238,219861-08-2,Neuroscience,SSRIs,Selective 5-HT reuptake inhibitor,CN(C)CCCC1(C2=C(CO1)C=C(C=C2)C#N)C3=CC=C(C=C3)F.C(=O)(C(=O)O)O,91.8,0.5
Eslicarbazepine acetate,B3487,236395-14-5,Others,Others,antiepileptic drug,CC(O[C@@]1([H])CC2=CC=CC=C2N(C(O)=N)C3=CC=CC=C31)=O,99.4,5.9
Esmolol HCl,B1748,81161-17-3,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl,97.2,1.3
Esomeprazole Magnesium,B2200,161973-10-0,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=CC(=C3)OC.[Mg+2],102.4,0.2
Esomeprazole Sodium,B1388,161796-78-7,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C([N-]2)C=C(C=C3)OC.[Na+],88.8,2.9
Estradiol,A8425,50-28-2,Endocrinology and Hormones,Estrogen/progestogen Receptor,Sex hormone,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O,116.8,2.1
Estradiol Benzoate,B1941,50-50-0,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen/progestogen receptor agonist,CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5,96.9,6.7
Estradiol Cypionate,B1501,313-06-4,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor inhibitor,CC12CCC3C(C1CCC2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)O,104.5,9.1
Estradiol valerate,B1506,979-32-8,Endocrinology and Hormones,Androgen Receptor,Estrogen receptor agonist,CCCCC(=O)OC1CCC2C1(CCC3C2CCC4=C3C=CC(=C4)O)C,106.4,2.8
Estriol,B1507,50-27-1,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor antagonist,CC12CCC3C(C1CC(C2O)O)CCC4=C3C=CC(=C4)O,95.0,9.9
Estrone,A8426,53-16-7,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogenic hormone,CC12CCC3C(C1CCC2=O)CCC4=C3C=CC(=C4)O,104.3,3.9
Estropipate,B7438,7280-37-7,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist,O=C1[C@@]2(C)[C@H](CC1)[C@H](CCC3=CC(OS(O)(=O)=O)=CC=C43)[C@H]4CC2.N5CCNCC5,96.1,1.0
Ethacridine lactate monohydrate,B1749,6402-23-9,Microbiology & Virology,Anti-infection,Antiseptic agent,CCOC1=CC2=C(C3=C(C=C(C=C3)N)N=C2C=C1)N.CC(C(=O)O)O.O,44.3,10.3
Ethacrynic Acid,C4125,58-54-8,Membrane Transporter/Ion Channel,NKCC,1,1,112.3,10.2
Ethambutol HCl,A8427,1070-11-7,Others,Others,Antitubercular agent,CCC(CO)NCCNC(CC)CO.Cl.Cl,101.0,5.2
Ethamsylate,B1750,2624-44-4,Immunology/Inflammation,Prostaglandin Receptor,Haemostatic drug,CCNCC.C1=CC(=C(C=C1O)S(=O)(=O)O)O,107.9,9.3
Ethinyl Estradiol,A8428,57-63-6,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral contraceptive,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)O,90.7,1.1
Ethionamide,A8429,536-33-4,Microbiology & Virology,Antibiotic,Anti-tuberculosis antibiotic,CCC1=NC=CC(=C1)C(=S)N,97.7,0.6
Ethyl gallate,C6276,831-61-8,Immunology/Inflammation,NF-κB,1,1,91.2,0.8
Ethynodiol diacetate,B1508,297-76-7,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen receptor agonist,CC(=O)OC1CCC2C3CCC4(C(C3CCC2=C1)CCC4(C#C)OC(=O)C)C,103.8,0.0
Etidronate,B1752,2809-21-4,Others,phosphatase,Protein tyrosine phosphatase inhibitor,CC(O)(P(=O)(O)O)P(=O)(O)O,105.3,1.2
Etodolac,B1444,41340-25-4,Neuroscience,COX,COX-2 inhibitor,CCC1=CC=CC2=C1NC3=C2CCOC3(CC)CC(=O)O,99.0,1.0
Etofenamate,A3403,30544-47-9,Others,Others,Non-steroidal anti-inflammatory drug,C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F,119.5,18.9
Etomidate,A1958,33125-97-2,Neuroscience,GABA Receptor,General anesthetic with GABA modulatory and GABA-mimetic actions,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2,100.1,9.7
Etomidate hydrochloride,B1246,53188-20-8,Membrane Transporter/Ion Channel,GABA Receptor,GABAA receptors agonist,CCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2.Cl,98.6,2.1
Etonogestrel,B3470,54048-10-1,Endocrinology and Hormones,Estrogen/progestogen Receptor,steroidal progestin,CC[C@@]1([C@@]([C@]2([H])CCC3=CC(CC[C@]3([H])[C@@]42[H])=O)([H])CC[C@@]1(O)C#C)CC4=C,97.3,4.1
Etoposide,A1971,33419-42-0,DNA Damage/DNA Repair,Topoisomerase,Topo II inhibitor,CC1OCC2C(O1)C(C(C(O2)OC3C4COC(=O)C4C(C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O,1.5,15.2
Etoricoxib,A3405,202409-33-4,Neuroscience,COX,Specific COX-2 inhibitor,CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl,141.7,34.1
Etravirine (TMC125),B2224,269055-15-4,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,CC1=CC(=CC(=C1OC2=NC(=NC(=C2Br)N)NC3=CC=C(C=C3)C#N)C)C#N,100.1,2.5
Etretinate,B6148,54350-48-0,Others,Retinoid X Receptors,retinoid receptor agonist,CCOC(/C=C(/C=C/C=C(/C=C/C1=C(C=C(OC)C(C)=C1C)C)C)C)=O,96.6,1.2
Eugenol,B6149,97-53-0,Others,Others,naturally occuring scent chemical,C=CCC1=CC(OC)=C(O)C=C1,114.0,26.9
Evacetrapib (LY2484595),A4377,1186486-62-3,Metabolism,CETP,"CETP inhibitor,potent and selective",CC1=CC(=C2C(=C1)C(CCCN2CC3CCC(CC3)C(=O)O)N(CC4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F)C5=NN(N=N5)C)C,104.0,6.7
Evans Blue tetrasodium salt,B6472,314-13-6,Membrane Transporter/Ion Channel,Glutamate (EAAT) Transporters,L-glutamate uptake inhibitor,O=C1C(C(C=C/C1=N/NC(C(C)=C2)=CC=C2C3=CC=C(C(C)=C3)N/N=C4C(C(C(C=C\4)=C5S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C5)N)=O)=C6S([O-])(=O)=O)=C(C(S([O-])(=O)=O)=C6)N.[Na+].[Na+].[Na+].[Na+],103.4,3.5
Everolimus (RAD001),A8169,159351-69-6,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor,OCCO[C@H]1[C@H](OC)C[C@H](C[C@H](C)[C@H](CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]2OC)=O)OC([C@@H]3CCCCN3C(C([C@@]4(O)[C@H](C)CC[C@@H](C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C2=O)O4)=O)=O)=O)CC1,54.5,14.2
Exemestane,A1296,107868-30-4,Endocrinology and Hormones,Aromatase,"Steroidal aromatase inhibitor,selective and irreversible",CC12CCC3C(C1CCC2=O)CC(=C)C4=CC(=O)C=CC34C,106.3,2.8
Ezetimibe,A8430,163222-33-1,Metabolism,Cholesterol absorption,Cholesterol transport inhibitor,C1=CC(=CC=C1C2C(C(=O)N2C3=CC=C(C=C3)F)CCC(C4=CC=C(C=C4)F)O)O,98.5,17.2
FG-4592 (ASP1517),A4187,808118-40-3,Angiogenesis,HIF,HIF prolyl-hydroxylase inhibitor,CC1=NC(=C(C2=C1C=C(C=C2)OC3=CC=CC=C3)O)C(=O)NCC(=O)O,114.5,22.7
FT-207 (NSC 148958),B1474,17902-23-7,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,DNA/RNA synthesis inhibitor,C1CC(OC1)N2C=C(C(=O)NC2=O)F,96.7,3.6
Famciclovir,B1942,104227-87-4,Microbiology & Virology,HSV,Anti-herpesvirus oral prodrug of penciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N=C21)N)COC(=O)C,115.6,11.9
Famotidine,B1560,76824-35-6,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N,103.8,0.3
Famprofazone,A8431,22881-35-2,Others,Others,Non-steroidal anti-inflammatory agent,CC(C)C1=C(N(N(C1=O)C2=CC=CC=C2)C)CN(C)C(C)CC3=CC=CC=C3,102.2,1.9
Fargesin,N2203,31008-19-2,Natural Products,Others,1,1,77.1,5.9
Fasudil (HA-1077) HCl,A5734,105628-07-7,TGF-β / Smad Signaling,ROCK,Protein kinase inhibitor,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CN=C3.Cl,101.5,5.9
Febuxostat,A5926,144060-53-7,Others,XAO,non-purine selective inhibitor of xanthine oxidase,CC1=C(SC(=N1)C2=CC(=C(C=C2)OCC(C)C)C#N)C(=O)O,98.7,4.7
Felbamate,B2093,25451-15-4,Membrane Transporter/Ion Channel,NMDA Receptor,antagonist at the NMDA-associated glycine binding site,C1=CC=C(C=C1)C(COC(=O)N)COC(=O)N,83.6,9.0
Felodipine,B1416,72509-76-3,Membrane Transporter/Ion Channel,Calcium Channel,Selective L-type Ca2+ channel blocker,CCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C,95.7,7.7
Fenbendazole,A2610,43210-67-9,Others,Others,For pinworm treatment in animals,COC(=O)NC1=NC2=C(N1)C=C(C=C2)SC3=CC=CC=C3,22.2,3.8
Fendiline (hydrochloride),C5675,13636-18-5,GPCR/G protein,Adrenergic Receptor,1,1,92.8,4.2
Fenofibrate,B1943,49562-28-9,Metabolism,PPAR,PPARα agonist,CC(C)OC(=O)C(C)(C)OC1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)Cl,109.3,5.9
Fenofibric acid,B6128,42017-89-0,Metabolism,PPAR,ppar inhibitor， lipid-lowering agent,CC(C(O)=O)(OC1=CC=C(C(C2=CC=C(Cl)C=C2)=O)C=C1)C,97.4,2.3
Fenoldopam,B1483,67227-56-9,Neuroscience,Dopamine Receptor,D1-like dopamine receptor partial agonist,C1CNCC(C2=CC(=C(C(=C21)Cl)O)O)C3=CC=C(C=C3)O,99.2,2.1
Fenoldopam (mesylate),B8681,67227-57-0,Neuroscience,Dopamine Receptor,Agonist of dopamine D1A (D1R) and D1B (D5R) receptors,1,93.3,4.7
Fenoprofen Calcium,B1944,34597-40-5,Immunology/Inflammation,1,"nonsteroidal, anti-inflammatory antiarthritic agent",CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].CC(C1=CC(=CC=C1)OC2=CC=CC=C2)C(=O)[O-].[Ca+2],117.5,16.1
Fenoprofen calcium hydrate,B1945,71720-56-4,Immunology/Inflammation,1,"nonsteroidal, anti-inflammatory antiarthritic agent",CC(C([O-])=O)C1=CC(OC2=CC=CC=C2)=CC=C1.CC(C([O-])=O)C3=CC(OC4=CC=CC=C4)=CC=C3.[Ca+2].O.O,102.0,9.1
Fenretinide,A3412,65646-68-6,Others,RAR/RXR,1,1,40.2,6.2
Fenspiride HCl,B1754,5053-08-7,Neuroscience,5-HT Receptor,α adrenergic and H1 histamine receptor antagonist,C1CN(CCC12CNC(=O)O2)CCC3=CC=CC=C3.Cl,115.5,2.1
Fenticonazole Nitrate,A8432,73151-29-8,Microbiology & Virology,Anti-infection,Antifungal drug,C1=CC=C(C=C1)SC2=CC=C(C=C2)COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],100.1,2.2
Fexofenadine HCl,B1573,153439-40-8,Neuroscience,Histamine Receptor,Histamine H1 receptor inhibitor,CC(C)(C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O)C(=O)O.Cl,100.3,7.1
Fidaxomicin,B1755,873857-62-6,DNA Damage/DNA Repair,DNA/RNA Synthesis,macrocyclic antibiotic,CCC1C=C(C(CC=CC=C(C(=O)OC(CC=C(C=C(C1OC2C(C(C(C(O2)(C)C)OC(=O)C(C)C)O)O)C)C)C(C)O)COC3C(C(C(C(O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)C,102.9,3.3
Finasteride,A5143,98319-26-7,Endocrinology and Hormones,5-alpha Reductase,Inhibitor of Type II 5α-reductase,CC12CCC3C(C1CCC2C(=O)NC(C)(C)C)CCC4C3(C=CC(=O)N4)C,108.4,0.3
Fingolimod (FTY720),A8548,162359-56-0,GPCR/G protein,S1P receptor,S1P receptors agonist,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,66.3,13.8
Flavin adenine dinucleotide disodium,B7936,84366-81-4,Metabolism,Endogenous Metabolite,"Redox cofactor (electron carrier), involved in several important enzymatic reactions in metabolism",CC1=CC(N=C(C([O-])=N2)C3=NC2=O)=C(N3C[C@@](O)([H])[C@@](O)([H])[C@@](O)([H])COP([O-])(OP(O)(OC[C@](O4)([H])[C@](O)([H])[C@](O)([H])[C@]4([H])N5C=NC(C5=NC=N6)=C6N)=O)=O)C=C1C.[Na+].[Na+],94.5,8.5
Flavoxate hydrochloride,B3433,3717-88-2,Neuroscience,AChR,muscarinic AChR antagonist,CC1=C(OC2=C(C1=O)C=CC=C2C(=O)OCCN3CCCCC3)C4=CC=CC=C4.Cl,115.1,18.1
Flecainide acetate,A3418,54143-56-5,Membrane Transporter/Ion Channel,Sodium Channel,Antiarrhythmic drug,CC(=O)O.C1CCNC(C1)CNC(=O)C2=C(C=CC(=C2)OCC(F)(F)F)OCC(F)(F)F,100.3,23.4
Florfenicol,B1758,73231-34-2,Microbiology & Virology,Anti-infection,Antibacterial agent,CS(=O)(=O)C1=CC=C(C=C1)C(C(CF)NC(=O)C(Cl)Cl)O,93.5,11.3
Floxuridine,A2402,50-91-9,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic antimetabolite,C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O,39.9,0.4
Flubendazole,B1759,31430-15-6,Ubiquitination/Proteasome,Autophagy,Autophagy activator,COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=C(C=C3)F,21.5,9.8
Fluconazole,B2094,86386-73-4,Microbiology & Virology,Antibiotic,Triazole antifungal agent,C1=CC(=C(C=C1F)F)C(CN2C=NC=N2)(CN3C=NC=N3)O,107.4,2.5
Fluconazole hydrate,B1226,155347-36-7,Microbiology & Virology,Antibiotic,Triazole antifungal drug,FC1=CC(F)=C(C(CN2C=NC=N2)(O)CN3C=NC=N3)C=C1.O,94.1,14.2
Flucytosine,A8433,2022-85-7,Microbiology & Virology,Antibiotic,Antifungal drug,C1=NC(=O)NC(=C1F)N,115.5,21.2
Fludarabine,A5424,21679-14-1,DNA Damage/DNA Repair,DNA Synthesis,DNA synthsis inhibitor,C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F,1.4,8.0
Fludarabine Phosphate (Fludara),A8317,75607-67-9,DNA Damage/DNA Repair,DNA Synthesis,Inhibits STAT1 activation and DNA synthesis,C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(N=C2N)F,102.1,1.2
Flufenamic acid,B1760,530-78-9,Immunology/Inflammation,AMPK; Calcium Channel; Chloride Channel; COX; Potassium Channel,TRPC activator,C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC(=C2)C(F)(F)F,100.0,0.9
Flumazenil,A2917,78755-81-4,Neuroscience,GABA Receptor,Benzodiazepine antagonist,CCOC(=O)C1=C2CN(C(=O)C3=C(N2C=N1)C=CC(=C3)F)C,116.3,14.4
Flumequine,B2292,42835-25-6,DNA Damage/DNA Repair,Topoisomerase,DNA topoisomerase II inhibitor，synthetic chemotherapeutic antibiotic,FC1=C([H])C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])C2([H])[H],111.8,8.7
Flumethasone,B1761,2135-17-3,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,CC1CC2C3CC(C4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CO)O)C)O)F)C)F,39.9,14.7
Flunarizine 2HCl,B1412,30484-77-6,Membrane Transporter/Ion Channel,Calcium Channel,Calcium entry blocker,C1CN(CCN1CC=CC2=CC=CC=C2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl,105.8,12.5
Flunisolide,B8702,3385-03-3,1,1,Fluorinated corticosteroid receptor agonist,1,86.0,11.7
Flunixin Meglumin,B1445,42461-84-7,Neuroscience,COX,potent cyclooxygenase inhibitor,CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F.CNCC(C(C(C(CO)O)O)O)O,84.9,1.6
Fluocinolone Acetonide,B2095,67-73-2,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])[C@]3([H])F)([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H],59.1,3.9
Fluocinonide,B2144,356-12-7,GPCR/G protein,Glucocorticoid Receptor,Glucocorticoid receptor agonist,F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])[C@]3([H])F)([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])OC(C([H])([H])[H])=O)=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H],102.5,5.7
Fluorescein,C6358,2321-07-5,Others,Fluorescent Dyes/Probes,Fluorescein is a synthetic fluorescent tracer,1,100.2,1.2
Fluorometholone,B8699,426-13-1,GPCR/G protein,Glucocorticoid Receptor,Synthetic glucocorticoid with anti-inflammatory and anti-allergic properties,1,99.5,9.9
Fluorouracil (Adrucil),A4071,51-21-8,Proteases,HIV Integrase,Antitumor agent;inhibitor of thymidylate synthase,C1=C(C(=O)NC(=O)N1)F,95.7,0.9
Fluoxetine HCl,A2436,56296-78-7,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective",CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F.Cl,89.3,5.0
Flupirtine maleate,B1475,75507-68-5,Membrane Transporter/Ion Channel,NMDA Receptor,NMDA receptor antagonist,CCOC(=O)NC1=C(N=C(C=C1)NCC2=CC=C(C=C2)F)N.C(=CC(=O)O)C(=O)O,108.2,8.4
Flurbiprofen,A8434,5104-49-4,Immunology/Inflammation,PGE synthase,Cyclooxygenase inhibitors,CC(C1=CC(=C(C=C1)C2=CC=CC=C2)F)C(=O)O,102.7,1.7
Flutamide,B1376,13311-84-7,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonists,CC(C)C(=O)NC1=CC(=C(C=C1)[N+](=O)[O-])C(F)(F)F,104.0,2.7
Fluticasone propionate,B2096,80474-14-2,GPCR/G protein,Glucocorticoid Receptor,"High affinity, selective glucocorticoid receptor agonist",CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)SCF,111.6,1.5
Fluvastatin,A3419,93957-54-1,Metabolism,HMG-CoA Reductase,HMGCR inhibitor,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)O)O)O)C3=CC=C(C=C3)F,100.6,9.2
Fluvastatin Sodium,A4363,93957-55-2,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,CC(C)N1C2=CC=CC=C2C(=C1C=CC(CC(CC(=O)[O-])O)O)C3=CC=C(C=C3)F.[Na+],60.1,8.6
Fluvoxamine maleate,A2553,61718-82-9,Neuroscience,5-HT Receptor,"Serotonin reuptake inhibitor,selective,antidepressant",COCCCCC(=NOCCN)C1=CC=C(C=C1)C(F)(F)F.C(=CC(=O)O)C(=O)O,77.3,30.4
Folic acid,N2075,59-30-3,Natural Products,Vitamin,1,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CN=C3C(=N2)C(=O)N=C(N3)N,120.5,8.0
Fomepizole,B6124,7554-65-6,Metabolism,Dehydrogenase,competitive inhibitor of the enzyme alcohol dehydrogenase,CC1=CNN=C1,95.1,10.5
Foretinib (GSK1363089),A2974,849217-64-7,Tyrosine Kinase,VEGFR,VEGF and HGF receptor inhibitor,COC1=CC2=C(C=CN=C2C=C1OCCCN3CCOCC3)OC4=C(C=C(C=C4)NC(=O)C5(CC5)C(=O)NC6=CC=C(C=C6)F)F,8.9,11.2
Formononetin,N1625,485-72-3,Natural Products,Others,O-methylated isoflavone,COC1=CC=C(C=C1)C2=COC3=C(C2=O)C=CC(=C3)O,102.1,0.5
Fosaprepitant dimeglumine salt,B2145,265121-04-8,Neuroscience,Substance P/NK1 Receptor,Neurokinin-1 antagonist,CC(C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)OC2C(N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNCC(C(C(C(CO)O)O)O)O.CNCC(C(C(C(CO)O)O)O)O,108.9,0.9
Fosbretabulin (Combretastatin A4 Phosphate (CA4P)) Disodium,B1634,168555-66-6,Cell Cycle/Checkpoint,Microtubule/Tubulin,"microtubule destabilizing drug, water-soluble",COC1=C(C=C(C=C1)C=CC2=CC(=C(C(=C2)OC)OC)OC)OP(=O)([O-])[O-].[Na+].[Na+],97.8,7.2
Foscarnet Sodium,B1946,63585-09-1,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,C(=O)([O-])P(=O)([O-])[O-].[Na+].[Na+].[Na+],98.5,0.1
Fostamatinib (R788),B2284,901119-35-5,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),Spleen tyrosine kinase (Syk) inhibitor,CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)(O)O)C,97.3,5.3
Fructose,N1503,7660-25-5,Natural Products,Others,1,1,103.0,1.9
Fruquintinib(HMPL-013),B5864,1194506-26-7,Tyrosine Kinase,VEGFR,1,1,65.1,8.8
Fudosteine,B1763,13189-98-5,Others,Others,MUC5AC mucin hypersecretion inhibitor,C(CO)CSCC(C(=O)O)N,97.6,1.4
Fulvestrant,A1428,129453-61-8,Endocrinology and Hormones,Estrogen/progestogen Receptor,"Estrogen receptor antagonist,high affinity",CC12CCC3C(C1CCC2O)C(CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,99.1,0.3
Fumagillin,A4407,23110-15-8,Proteases,Aminopeptidase,Antibiotic and antiangiogenic agent,CC(=CCC1C(O1)(C)C2C(C(CCC23CO3)OC(=O)C=CC=CC=CC=CC(=O)O)OC)C,100.7,4.5
Fumalic acid,N1878,1135-24-6,Natural Products,Others,1,1,90.7,13.5
Furaltadone HCl,B1764,3759-92-0,Microbiology & Virology,Anti-infection,Antibacterial agent,C1COCCN1CC2CN(C(=O)O2)N=CC3=CC=C(O3)[N+](=O)[O-].Cl,94.9,3.4
Furazolidone,C6305,67-45-8,Microbiology & Virology,Anti-infection,1,1,95.8,2.4
Furfural,C6293,98-01-1,Others,Others,1,1,101.2,23.4
Furosemide,A8435,54-31-9,Membrane Transporter/Ion Channel,NKCC,GABAA receptors antagonist,C1=COC(=C1)CNC2=CC(=C(C=C2C(=O)O)S(=O)(=O)N)Cl,68.1,11.9
Fusidic Acid (sodium salt),C5167,751-94-0,Microbiology & Virology,Antibiotic,steroidal antibiotic,O[C@@H]1CC[C@@]2(C)[C@](CC[C@@]3(C)[C@@]2([H])[C@H](O)C[C@]4([H])[C@]3(C)C[C@H](OC(C)=O)/C4=C(C([O-])=O)/CC/C=C(C)/C)([H])[C@@H]1C.[Na+],103.6,16.4
GDC-0449 (Vismodegib),A3021,879085-55-9,Stem Cell,Hedgehog,"Hedgehog antagonist,potent and selective",CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl,110.3,0.1
GDC-0941,A8210,957054-30-7,PI3K/Akt/mTOR Signaling,PI3K,"PI3K inhibitor,potent and selective",CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6,102.1,7.4
GLPG0634,B1130,1206161-97-8,JAK/STAT Signaling,JAK,JAK1 inhibitor,C1CC1C(=O)NC2=NN3C(=N2)C=CC=C3C4=CC=C(C=C4)CN5CCS(=O)(=O)CC5,51.0,10.1
GM 6001,A4050,142880-36-2,Proteases,MMP,Broad spectrum MMP inhibitor,CC(C)CC(CC(=O)NO)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC,116.3,33.9
GS-7340,B8021,379270-37-8,Microbiology & Virology,HIV,HIV reverse transcriptase inhibitor,O=[P@@](N[C@H](C(OC(C)C)=O)C)(CO[C@H](C)CN1C2=NC=NC(N)=C2N=C1)OC3=CC=CC=C3,60.3,7.7
GS-9973,B3553,1229208-44-9,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor, orally bioavailable and selective",C12=NC=CN1C=C(C3=CC=C(C=NN4)C4=C3)N=C2NC5=CC=C(N6CCOCC6)C=C5,97.8,4.5
GSK1349572 sodiuM salt,B5856,1051375-19-9,Proteases,HIV Integrase,Next-generation HIV integrase (IN) inhibitor,C[C@](N12)([H])CCO[C@@]1([H])CN(C(C2=O)=C3[O-])C=C(/C(O)=N/CC4=C(F)C=C(F)C=C4)C3=O.[Na+],98.5,2.2
GSK2126458,A8556,1086062-66-9,PI3K/Akt/mTOR Signaling,mTOR,PI3K/mTOR inhibitor,COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F,12.9,16.6
Gabapentin,A8436,60142-96-3,Neuroscience,GABA Receptor,GABA enhancer,C1CCC(CC1)(CC(=O)O)CN,15.9,0.1
Gabapentin HCl,B1529,60142-95-2,Membrane Transporter/Ion Channel,Calcium Channel,GABA analog,C1CCC(CC1)(CC(=O)O)CN.Cl,115.1,5.6
Gabexate mesylate,A4012,56974-61-9,Proteases,Serine Protease,Trypsin-like serine proteinases inhibitor,CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C(N)N.CS(=O)(=O)O,95.0,4.5
Gadodiamide,B1765,122795-43-1,Others,Others,Gadolinium-based MRI contrast agent,CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].O.[Gd+3],100.4,7.2
Galanthamine,A3423,357-70-0,Neuroscience,AChR,Acetylcholinesterase inhibitor,[H][C@@]([C@@]1(C([H])=C2[H])C3=C(C([H])=C4[H])C([H])([H])N(C([H])([H])[H])C([H])([H])C1([H])[H])(C([H])([H])[C@@]2([H])O[H])OC3=C4OC([H])([H])[H],90.3,14.3
Galanthamine HBr,A1745,1953-04-4,Neuroscience,AChR,Acetylcholinesterase inhibitor,COC1=CC=C2C3=C1O[C@]4([H])[C@]3(C=C[C@H](O)C4)CCN(C)C2.Br,106.9,1.9
Gallamine Triethiodide,B1610,65-29-2,Neuroscience,AChR,Cholinergic receptor blocker,CC[N+](CC)(CC)CCOC1=C(C(=CC=C1)OCC[N+](CC)(CC)CC)OCC[N+](CC)(CC)CC.[I-].[I-].[I-],108.2,13.6
Gallic acid,N1830,149-91-7,Natural Products,ROS,1,C1=C(C=C(C(=C1O)O)O)C(=O)O,106.8,9.4
Ganciclovir,B2097,82410-32-0,Microbiology & Virology,HSV,Antiviral drug for CMV infections,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N,102.3,3.3
Ganetespib (STA-9090),A4385,888216-25-9,Proteases,HSP,"Hsp90 inhibitor,non-geldanamycin",CC(C)C1=CC(=C2NNC(=O)N2C3=CC4=C(C=C3)N(C=C4)C)C(=O)C=C1O,-5.3,8.8
Gastrodin,N1710,62499-27-8,Natural Products,Immunology & Inflammation related,1,C1=CC(=CC=C1CO)OC2C(C(C(C(O2)CO)O)O)O,99.8,7.0
Gatifloxacin,A1313,112811-59-3,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolone antibiotic,inhibits bacterial TOPO II",CC1CN(CCN1)C2=C(C=C3C(=C2OC)N(C=C(C3=O)C(=O)O)C4CC4)F,112.2,20.1
Gefitinib (ZD1839),A8219,184475-35-2,JAK/STAT Signaling,EGFR,Selective EGFR inhibitor,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4,97.9,1.1
Gefitinib hydrochloride,A3433,184475-55-6,JAK/STAT Signaling,EGFR,Potent EGFR inhibitor,COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4.Cl,107.0,15.3
Gemcitabine,A8437,95058-81-4,DNA Damage/DNA Repair,DNA Synthesis,inhibitor of DNA synthesis,C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F,0.1,4.0
Gemcitabine HCl,A1402,122111-03-9,DNA Damage/DNA Repair,DNA Synthesis,"Inhibits DNA synthesis,deoxycytidine analog",C1=CN(C(=O)N=C1N)[C@H]2C([C@@H]([C@H](O2)CO)O)(F)F,2.0,2.0
Gemfibrozil,B1947,25812-30-0,Metabolism,PPAR,PPARα activator,CC1=CC(=C(C=C1)C)OCCCC(C)(C)C(=O)O,107.6,2.4
"Geneticin, G-418 Sulfate",A2513,108321-42-2,Microbiology & Virology,Antibiotic,Aminoglycosidic antibiotic,CC(C1C(C(C(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)O)O)O.OS(=O)(=O)O.OS(=O)(=O)O,107.9,3.1
Genipin,N2408,6902-77-8,Natural Products,Others,used to treat symptoms of type 2 diabetes,COC(=O)C1=COC(C2C1CC=C2CO)O,93.4,6.9
Geniposide,N1360,24512-63-8,Natural Products,Others,Iridoid glycoside with various bioactivities,COC(=O)C1=COC(C2C1CC=C2CO)OC3C(C(C(C(O3)CO)O)O)O,107.0,14.8
Geniposidic acid,N1272,27741-01-1,Natural Products,Immunology & Inflammation related,1,C1C=C(C2C1C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)O)CO,110.0,5.7
Genistein,A2198,446-72-0,DNA Damage/DNA Repair,Topoisomerase,ER agonist,C1=CC(=CC=C1C2=COC3=CC(=CC(=C3C2=O)O)O)O,110.2,11.9
Gentamycin Sulfate,A2514,1405-41-0,Microbiology & Virology,Antibiotic,Aminoglycoside antibiotic,C[C@]1(O)CO[C@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3O[C@@]([H])([C@@H](C)NC)CC[C@H]3N)[C@@H]2O)[C@H](O)[C@H]1NC.C[C@]4(O)CO[C@H](O[C@H]5[C@H](N)C[C@H](N)[C@@H](O[C@H]6O[C@H](CN)CC[C@H]6N)[C@@H]5O)[C@H](O)[C@H]4NC.C[C@]7(O)CO[C@H](O[C@H]8[C@H](N)C[C@H](,112.6,3.4
Geraniol,C6279,106-24-1,Others,Others,1,1,106.1,13.8
Germacrone,N1500,6902-91-6,Natural Products,Others,1,1,103.9,2.3
Gestodene,B1517,60282-87-3,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progestogen hormonal contraceptive,CCC12CCC3C(C1C=CC2(C#C)O)CCC4=CC(=O)CCC34,106.6,2.9
Gimeracil,A4342,103766-25-2,Metabolism,Dehydrogenase,Dihydropyrimidine dehydrogenase inhibitor,C1=C(C(=CNC1=O)Cl)O,100.0,0.9
Ginkgolide A,N1900,15291-75-5,Natural Products,GABA Receptor,1,O[C@@]1([C@]2(O[C@H]3OC4=O)[C@]5([C@]3([C@H](C[C@H]5OC2=O)C(C)(C)C)[C@H]4O)C[C@H]1OC6=O)[C@H]6C,104.9,3.0
Ginkgolide C,N1908,15291-76-6,Natural Products,Others,1,1,82.8,12.5
Ginsenoside Rb1,N1620,41753-43-9,Natural Products,Others,1,1,101.1,13.8
Ginsenoside Re,N1615,52286-59-6,Natural Products,Others,1,1,105.8,11.3
Ginsenoside Rg1,N1613,22427-39-0,Natural Products,Others,1,1,95.4,3.6
Glibenclamide,B1296,10238-21-8,Metabolism,Saccharometabolism,Insulin production modulator,COC1=C(C=C(C=C1)Cl)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,118.8,15.9
Gliclazide,B2195,21187-98-4,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2,96.1,4.0
Glimepiride,A4033,93479-97-1,Proteases,DPP-4,Sulfonylurea compound,CCC1=C(CN(C1=O)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCC(CC3)C)C,104.8,1.9
Glipizide,A8438,29094-61-9,Membrane Transporter/Ion Channel,Potassium Channel,Oral anti-diabetic medication,CC1=NC=C(N=C1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,102.1,3.0
Gliquidone,B2196,33342-05-1,Membrane Transporter/Ion Channel,Potassium Channel,ATP-sensitive K+ channel antagonist,CC1(C2=C(C=C(C=C2)OC)C(=O)N(C1=O)CCC3=CC=C(C=C3)S(=O)(=O)NC(=O)NC4CCCCC4)C,100.6,6.5
Glycine,C6100,56-40-6,Others,Others,1,1,93.8,0.5
Glycocholic Acid,C3945,475-31-0,Others,Others,1,C[C@H](CCC(NCC(O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])C[C@H](O)[C@@]21C,111.6,17.3
Glycopyrrolate,B1266,596-51-0,Neuroscience,AChR,Muscarinic competitive antagonist,C[N+]1(CCC(C1)OC(=O)C(C2CCCC2)(C3=CC=CC=C3)O)C.[Br-],95.0,16.2
Glycylglycine,C6278,556-50-3,Others,Others,1,1,106.8,9.5
Glycyrrhizic acid,N1792,1405-86-3,Natural Products,"Dehydrogenase,MAO,High-mobility Group",1,1,103.2,5.6
Gramine,N2337,87-52-5,Natural Products,Others,1,1,99.6,10.4
Granisetron HCl,A1295,107007-99-8,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,CN1C2CCCC1CC(C2)NC(=O)C3=NN(C4=CC=CC=C43)C.Cl,83.2,35.2
Griseofulvin,B3680,126-07-8,Cell Cycle/Checkpoint,Microtubule/Tubulin,Microtubule associated inhibitor,ClC(C(O[C@]1(C(OC)=C2)[C@H](C)CC2=O)=C(C(OC)=C3)C1=O)=C3OC,97.6,2.6
Guaiacol,C4360,90-05-1,Others,Others,1,COC1=C(O)C=CC=C1,100.0,8.3
Guaifensin,A8442,93-14-1,Others,Others,Expectorant agent,COC1=CC=CC=C1OCC(CO)O,103.8,6.6
Guanabenz Acetate,B1335,23256-50-0,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl,104.8,3.2
Guanethidine (sulfate),B8683,645-43-2,Others,Others,Antihypertensive agent,1,102.4,3.4
Guanethidine Sulfate,A8443,60-02-6,Others,Others,1,1,60.8,52.1
Guanfacine hydrochloride,A3451,29110-48-3,GPCR/G protein,Adrenergic Receptor,α2A-adrenoceptor agonist,C1=CC(=C(C(=C1)Cl)CC(=O)N=C(N)N)Cl.Cl,102.4,29.1
Guanidine HCl,B1949,1950-1-1,Others,Others,Protein denaturant,C(=N)(N)N.Cl,105.6,8.1
H-Cit-OH,A7486,372-75-8,Amino Acids & Building Blocks,Unusual Amino Acids,1,1,99.1,0.9
H-Cys-OH,A7132,52-90-4,Amino Acids & Building Blocks,Amino Acids and Derivatives,1,C(C(C(=O)O)N)S,98.5,1.9
H-D-Ser-OH,A6743,312-84-5,Others,Others,Endogenous ligand for the glycine site of the N-methyl D-aspartate receptor (NMDAR),C(C(C(=O)O)N)O,104.7,0.4
H-Ser-OH,A7291,56-45-1,Amino Acids & Building Blocks,Amino Acids and Derivatives,1,C(C(C(=O)O)N)O,93.0,3.2
Halcinonide,B1766,3093-35-4,Immunology/Inflammation,Smo,Anti-inflammatory agent,ClC([H])([H])C([C@@]12OC(C([H])([H])[H])(C([H])([H])[H])O[C@]1([H])C([H])([H])[C@]([C@@](C([H])([H])C3([H])[H])([H])[C@]4([C@](C([H])([H])C5([H])[H])(C([H])([H])[H])C3=C([H])C5=O)F)([H])[C@]2(C([H])([H])[H])C([H])([H])[C@]4([H])O[H])=O,53.1,3.1
Halobetasol Propionate,B1767,66852-54-8,Metabolism,Phospholipase,Phospholipase (e.g. PLA) inhibitor,CCC(=O)OC1(C(CC2C1(CC(C3(C2CC(C4=CC(=O)C=CC43C)F)F)O)C)C)C(=O)CCl,53.2,11.3
Haloperidol,B2099,52-86-8,Neuroscience,Dopamine Receptor,Antipsychotic drug,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F,101.4,7.0
Haloperidol hydrochloride,B1242,1511-16-6,Neuroscience,Dopamine Receptor,Antipsychotic drug,C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CCCC(=O)C3=CC=C(C=C3)F.Cl,99.4,2.2
Harmine,B8316,442-51-3,Metabolism,"PPAR,MAO","Potent and selective inhibitor of DYRK1A, 5-HT antagonist and MAO inhibitor",CC1=NC=CC2=C1NC3=C2C=CC(OC)=C3,74.1,4.8
Harmine hydrochloride,N2182,343-27-1,Natural Products,DYRK,1,1,90.2,1.8
Harpagoside,N1461,19210-12-9,Natural Products,"GMNN - geminin, DNA replication inhibitor (human)",1,1,110.0,10.4
Helicid,N1582,80154-34-3,Natural Products,Others,1,1,102.9,17.3
Heparin sodium,A5066,9041-08-1,Proteases,Thrombin,Antithrombin III activator,O[C@@H]1C(OS([O-])(=O)=O)[C@H](OC2[C@@H](COS([O-])(=O)=O)OC(O)C(NS([O-])(=O)=O)[C@H]2O)OC(C([O-])=O)C1O.[Na+].[Na+].[Na+].[Na+],100.3,23.6
Hesperidin,N1809,520-26-3,Natural Products,Others,Flavonoids from citrus species,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=C4C(=O)CC(OC4=C3)C5=CC(=C(C=C5)OC)O)O)O)O)O)O)O)O,100.5,4.6
Hexachlorophene,B6140,70-30-4,Membrane Transporter/Ion Channel,Potassium Channel,KCNQ1/KCNE1 potassium channel activator,ClC1=CC(Cl)=C(Cl)C(CC2=C(Cl)C(Cl)=CC(Cl)=C2O)=C1O,121.4,34.9
Hexamethonium Bromide,B1592,55-97-0,Neuroscience,AChR,Selective antagonist of neuronal-type nicotinic AChR,C[N+](C)(C)CCCCCC[N+](C)(C)C.[Br-].[Br-],105.6,3.1
Hexestrol,B1509,84-16-2,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor agonist,CCC(C1=CC=C(C=C1)O)C(CC)C2=CC=C(C=C2)O,95.5,6.6
Histamine 2HCl,B1561,56-92-8,Neuroscience,Histamine Receptor,Histamine receptor agonist,C1=C(NC=N1)CCN.Cl.Cl,106.2,8.6
Histamine Phosphate,B1770,51-74-1,Neuroscience,Histamine Receptor,Histamine receptor agonist,C1=C(NC=N1)CCN.OP(=O)(O)O.OP(=O)(O)O,110.0,16.1
Homatropine Bromide,B1603,51-56-9,Neuroscience,AChR,Muscarinic AChR antagonist,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Br,90.5,0.1
Homatropine Methylbromide,B1604,80-49-9,Neuroscience,AChR,Muscarinic AChR antagonist,C[N+]1(C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O)C.[Br-],112.4,12.0
Homoharringtonine,N1504,26833-87-4,Natural Products,STAT,Cytotoxic alkaloid,1,104.3,10.7
Honokiol,N1672,35354-74-6,Immunology/Inflammation,IκB/IKK,1,1,106.9,0.9
Hydralazine HCl,B2101,304-20-1,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel activator,C1=CC=C2C(=C1)C=NN=C2NN.Cl,95.9,5.4
Hydrochlorothiazide,B1950,58-93-5,Others,Others,diuretic drug of the thiazide class,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl,100.8,2.2
Hydrocortisone,B1951,50-23-7,GPCR/G protein,Glucocorticoid Receptor,steroid hormone or glucocorticoid,CC12CCC(=O)C=C1CCC3C2C(CC4(C3CCC4(C(=O)CO)O)C)O,75.8,8.9
Hydroquinone,C6129,123-31-9,Immunology/Inflammation,ROS,1,1,92.7,13.4
Hydroxychloroquine Sulfate,B4874,747-36-4,Others,Others,Autophagy inhibitor,CCN(CCCC(C)NC1=C2C=CC(=CC2=NC=C1)Cl)CCO.OS(=O)(=O)O,112.4,23.5
Hydroxyfasudil hydrochloride,A3479,155558-32-0,TGF-β / Smad Signaling,ROCK,Rho-kinase inhibitor and vasodilator,C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CNC3=O.Cl,105.0,8.8
Hydroxyurea,B2102,127-07-1,DNA Damage/DNA Repair,DNA/RNA Synthesis,DNA synthesis inhibitor,C(=O)(N)NO,99.9,7.5
Hydroxyzine 2HCl,B1549,2192-20-3,Neuroscience,Histamine Receptor,Histamine H1-receptor antagonist,C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,90.3,8.1
Hygromycin B,A2515,31282-04-9,Microbiology & Virology,Antibiotic,Suitable for mammalian cell selection,CNC1CC(C(C(C1O)OC2C3C(C(C(O2)CO)O)OC4(O3)C(C(C(C(O4)C(CO)N)O)O)O)O)N,110.5,27.8
Hyodeoxycholic acid,N1644,83-49-8,Natural Products,Others,1,CC(CCC(=O)O)C1CCC2C1(CCC3C2CC(C4C3(CCC(C4)O)C)O)C,110.8,2.8
Hyoscyamine,B1605,101-31-5,Neuroscience,AChR,AChR inhibitor,CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3,111.5,9.5
Hyperoside,N1838,482-36-0,Natural Products,Others,1,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O,95.8,0.1
Hypoxanthine,B3674,68-94-0,Others,Others,1,1,110.6,8.1
INCB-024360,B6036,1204669-58-8,Metabolism,IDO,potent and selective inhibitor of IDO1,BrC1=C(F)C=CC(/N=C(NO)\C2=NON=C2NCCNS(N)(=O)=O)=C1,100.8,13.2
IPI-145 (INK1197),A1720,1201438-56-3,PI3K/Akt/mTOR Signaling,PI3K,PI3K-δ/PI3K-γ inhibitor,CC(C1=CC2=C(C(=CC=C2)Cl)C(=O)N1C3=CC=CC=C3)NC4=NC=NC5=C4NC=N5,30.0,10.3
Ibandronate sodium,B1772,138926-19-9,Others,Others,Potent bisphosphonate drug,CCCCCN(C)CCC(O)(P(=O)(O)O)P(=O)(O)[O-].O.[Na+],98.3,7.5
Ibudilast,C5183,50847-11-5,Metabolism,PDE,inhibitor of PDE4,CC(C)C1=NN(C=CC=C2)C2=C1C(C(C)C)=O,96.9,4.3
Ibuprofen,A8446,15687-27-1,Neuroscience,COX,inhibitor of cyclooxygenase 1 and cyclooxygenase 2,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O,95.1,5.7
Ibuprofen Lysine,A5791,57469-77-9,Neuroscience,COX,COX inhibitor,CC(C)CC1=CC=C(C=C1)C(C)C(=O)O.C(CCN)CC(C(=O)O)N,109.3,0.1
Ibutilide Fumarate,B2278,122647-32-9,Membrane Transporter/Ion Channel,Sodium Channel,Class III antiarrhythmic agent,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,91.4,1.5
Icotinib,B1496,610798-31-7,JAK/STAT Signaling,EGFR,EGFR tyrosine kinase inhibitor,[H]C1=C2OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC([H])([H])C([H])([H])OC2=C([H])C3=NC([H])=NC(N([H])C4=C([H])C([H])=C([H])C(C#C[H])=C4[H])=C31,103.5,4.2
Idarubicin HCl,A2476,57852-57-0,DNA Damage/DNA Repair,Topoisomerase,"Anthracycline and daunorubicin analog,topoisomerase inhibitor",CC1C(C(CC(O1)OC2CC(CC3=C(C4=C(C(=C23)O)C(=O)C5=CC=CC=C5C4=O)O)(C(=O)C)O)N)O.Cl,-18.6,5.7
Idebenone,B2103,58186-27-9,Immunology/Inflammation,ROS,synthetic analog of coenzyme Q10 (CoQ10),CC1=C(C(=O)C(=C(C1=O)OC)OC)CCCCCCCCCCO,105.7,5.7
Idoxuridine,B1773,54-42-2,Microbiology & Virology,Anti-infection,Antiviral agent,C1C(C(OC1N2C=C(C(=O)NC2=O)I)CO)O,51.9,2.7
Ifenprodil Tartrate,B1623,23210-58-4,Neuroscience,GluR,NMDA receptor antagonist,CC(C(C1=CC=C(C=C1)O)O)N2CCC(CC2)CC3=CC=CC=C3.C(C(C(=O)O)O)(C(=O)O)O,78.2,6.4
Ifosfamide,A2097,3778-73-2,DNA Damage/DNA Repair,DNA Synthesis,Cytostatic agent,C1CN(P(=O)(OC1)NCCCl)CCCl,99.1,9.2
Iloperidone,A5399,133454-47-4,Neuroscience,5-HT Receptor,Dopamine (D2) and serotonin (5HT2) receptor antagonist,CC(=O)C1=CC(=C(C=C1)OCCCN2CCC(CC2)C3=NOC4=C3C=CC(=C4)F)OC,95.8,9.9
Imatinib (STI571),B2171,152459-95-5,Tyrosine Kinase,c-Kit,Protein-tyrosine kinase inhibitor,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5,63.9,3.8
Imatinib Mesylate (STI571),A1805,220127-57-1,TGF-β / Smad Signaling,Bcr-Abl,Abl/c-kit/PDGFR inhibitor,CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5.CS(=O)(=O)O,56.2,16.8
Imidapril HCl,A8447,89396-94-1,Endocrinology and Hormones,RAAS,RAAS inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C(CN(C2=O)C)C(=O)O.Cl,114.7,0.4
Imidazole,B7845,288-32-4,Metabolism,phosphatases,1,1,113.1,5.6
Imipenem (hydrate),B8674,74431-23-5,Microbiology & Virology,Anti-infection,Intravenous β-lactam antibiotic,1,95.2,17.2
Imipramine (hydrochloride),C4117,113-52-0,Neuroscience,5-HT Receptor,serotonin and norepinephrine transporters inhibitor,CN(C)CCCN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.Cl,98.5,2.9
Indacaterol,A3496,312753-06-3,GPCR/G protein,Adrenergic Receptor,1,1,133.8,33.3
Indacaterol Maleate,B1369,753498-25-8,GPCR/G protein,Adrenergic Receptor,Ultra-long-acting β-adrenoceptor agonist,CCC1=C(C=C2CC(CC2=C1)NCC(C3=C4C=CC(=O)NC4=C(C=C3)O)O)CC.C(=CC(=O)O)C(=O)O,95.4,9.8
Indapamide,B1953,26807-65-8,Membrane Transporter/Ion Channel,Potassium Channel,thiazide-like diuretic drug,CC1CC2=CC=CC=C2N1NC(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N,118.3,20.5
Indigo,N1630,482-89-3,Natural Products,Others,1,C1=CC=C2C(=C1)C(=O)C(=C3C(=O)C4=CC=CC=C4N3)N2,96.9,12.4
Indomethacin,A8449,53-86-1,Neuroscience,COX,Cox inhibitor,CC1=C(C2=C(N1C(=O)C3=CC=C(C=C3)Cl)C=CC(=C2)OC)CC(=O)O,99.9,10.2
Iniparib (BSI-201),A4157,160003-66-7,Chromatin/Epigenetics,PARP,"PARP1 inhibitor,intravenously adminsitered",C1=CC(=C(C=C1C(=O)N)[N+](=O)[O-])I,105.3,0.4
Inosine,B3677,58-63-9,Others,Others,endogenous purine nucleoside,O[C@H]1[C@H](N2C(NC=NC3=O)=C3N=C2)O[C@H](CO)[C@H]1O,109.6,4.4
Inulin,B1954,9005-80-5,Others,Others,starchy substance,1,91.9,0.2
Iohexol,B3538,66108-95-0,Ubiquitination/Proteasome,Autophagy; Mitophagy,contrast agent,CC(N(C1=C(I)C(/C(O)=N/CC(O)CO)=C(I)C(/C(O)=N/CC(O)CO)=C1I)CC(O)CO)=O,105.7,3.7
Iopromide,C4185,73334-07-3,Others,Others,1,O=C(N(CC(O)CO)C)C1=C(I)C(C(NCC(O)CO)=O)=C(I)C(NC(COC)=O)=C1I,96.5,0.5
Ipratropium Bromide,A8451,22254-24-6,Neuroscience,AChR,AChR antagonist,CC(C)[N+]1(C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3)C.[Br-],117.7,29.4
Irbesartan,A5970,138402-11-6,GPCR/G protein,Angiotensin Receptor,Angiotensin II inhibitor,CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5,112.2,10.8
Irinotecan,A5133,97682-44-5,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase I inhibitor,O=C(OC1)C(O)(CC)C2=C1C(N(CC3=C4N=C5C(C=C(OC(N6CCC(N7CCCCC7)CC6)=O)C=C5)=C3CC)C4=C2)=O,21.9,2.0
Irinotecan HCl Trihydrate,B2293,136572-09-3,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor,O=C(N1CCC(CC1)N2CCCCC2)OC3=CC4=C(CC)C5=C(C(N6C5)=CC(C7(CC)O)=C(COC7=O)C6=O)N=C4C=C3.Cl.O.O.O,16.4,5.0
Irinotecan hydrochloride,B8623,100286-90-6,DNA Damage/DNA Repair,Autophagy; Topoisomerase,DNA topoisomerase I inhibitor,1,97.5,1.4
Irisflorentin,N1426,41743-73-1,Natural Products,Others,1,1,103.3,20.7
Irsogladine,B1593,57381-26-7,Metabolism,PDE,PDE4 inhibitor,C1=CC(=C(C=C1Cl)C2=NC(=NC(=N2)N)N)Cl,100.6,5.5
Isatin,B6153,91-56-5,Metabolism,MAO,endogenous monoamine oxidase inhibitor,O=C(C1=O)C2=C(N1)C=CC=C2,99.3,8.7
Isavuconazole,B4826,241479-67-4,Microbiology & Virology,Antifungal,triazole antifungal drug,CC(C1=NC(=CS1)C2=CC=C(C=C2)C#N)C(CN3C=NC=N3)(C4=C(C=CC(=C4)F)F)O,101.3,2.8
Isoconazole nitrate,B1956,24168-96-5,Microbiology & Virology,Anti-infection,azole antifungal reagent,C1=CC(=C(C(=C1)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],92.4,22.7
Isoniazid,B1957,54-85-3,Metabolism,Fatty Acid Synthase,antibiotic used for the treatment of tuberculosis,C1=CN=CC=C1C(=O)NN,103.3,8.6
Isonicotinic acid,C6135,55-22-1,Others,Others,1,1,110.8,0.2
Isoprenaline HCl,B1336,51-30-9,GPCR/G protein,Adrenergic Receptor,β-adrenergic receptor agonist,CC(C)NCC(C1=CC(=C(C=C1)O)O)O.Cl,93.7,0.8
Isorhamnetin,N1358,480-19-3,Natural Products,PXR,1,COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O,103.7,2.5
Isosorbide,B1774,652-67-5,Others,Others,Diuretic,C1[C@H]([C@@H]2[C@H](O1)[C@H](CO2)O)O,98.7,1.1
Isosorbide 5-mononitrate,C6315,16051-77-7,Others,Others,1,1,97.7,2.2
Isosorbide Dinitrate,B8664,87-33-2,Others,Others,Organic nitrate ester and nitric oxide (NO) donor,1,93.5,6.3
Isotretinoin,A4330,4759-48-2,Metabolism,Dopamine β-hydroxylase,Dopamine β-hydroxylase activator,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,97.1,17.4
Isovaleramide,B1775,541-46-8,Metabolism,Dehydrogenase,Dehydrogenase inhibitor,CC(C)CC(=O)N,105.9,2.6
Isoxsuprine (hydrochloride),C3347,579-56-6,GPCR/G protein,Adrenergic Receptor,1,1,98.9,9.0
Ispinesib (SB-715992),A5343,336113-53-2,Cell Cycle/Checkpoint,Ksp,Kinesin spindle protein (KSP)inhibitor,CC1=CC=C(C=C1)C(=O)N(CCCN)C(C2=NC3=C(C=CC(=C3)Cl)C(=O)N2CC4=CC=CC=C4)C(C)C,4.6,0.0
Isradipine (Dynacirc),A8453,75695-93-1,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC=CC3=NON=C32)C(=O)OC,98.6,4.9
Istradefylline (KW-6002),A8454,155270-99-8,GPCR/G protein,Adenosine Receptor,Selective A2A receptor antagonist,CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)C=CC3=CC(=C(C=C3)OC)OC)C,105.7,2.8
Itraconazole,B2104,84625-61-6,Microbiology & Virology,Antibiotic,antifungal agent,CCC(C)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,100.6,0.9
Ivabradine HCl,B1360,148849-67-6,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor inhibitor,CN(CCCN1CCC2=CC(=C(C=C2CC1=O)OC)OC)CC3CC4=CC(=C(C=C34)OC)OC.Cl,108.5,0.3
Ivacaftor (VX-770),A5047,873054-44-5,Membrane Transporter/Ion Channel,CFTR,Potent CFTR potentiator,CC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C,92.0,5.7
Ivermectin,A2813,70288-86-7,Membrane Transporter/Ion Channel,P2X purinergic receptor,NAChR/purinergic P2X4 receptor modulator,C/C([C@@H](O[C@H]1C[C@H](OC)[C@@H](O[C@H]2C[C@H](OC)[C@@H](O)[C@H](C)O2)[C@H](C)O1)[C@@H](C)/C=C/C=C(CO3)/[C@@]([C@@]3([H])[C@H](O)C(C)=C4)(O)[C@@H]4C5=O)=C\C[C@@H]6C[C@H](O5)C[C@@]7(O[C@@]([C@@H](C)CC)([H])[C@@H](C)CC7)O6,70.2,28.0
Ixabepilone,A3513,219989-84-1,Tyrosine Kinase,EGFR,1,1,119.2,36.7
K-115,B4809,887375-67-9,Cell Cycle/Checkpoint,Rho,Selective Rho kinase inhibitor,CC1CNCCCN1S(=O)(=O)C2=CC=CC3=CN=CC(=C32)F.O.O.Cl,127.3,23.2
KPT-330,B1464,1393477-72-9,Cell Cycle/Checkpoint,CRM1,"CRM1 inhibitor, orally bioavailable and selective",C1=CN=C(C=N1)NNC(=O)C=CN2C=NC(=N2)C3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F,118.0,37.1
Kaempferol,N1719,520-18-3,Apoptosis,Apoptosis Inducers,1,1,103.7,2.3
Kanamycin Sulfate,A2516,25389-94-0,Microbiology & Virology,Antibiotic,Water-soluble antibiotic,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N.OS(=O)(=O)O,43.0,74.5
Kasugamycin (hydrochloride),C5503,19408-46-9,Microbiology & Virology,Antibiotic,aminoglycosidic antibiotic,O[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2([H])O[C@H](C)[C@@H](NC(C(O)=O)=N)C[C@@H]2N)[C@@H]1O.Cl,106.0,12.0
Ketanserin,B2248,74050-98-9,Neuroscience,5-HT Receptor,specific 5-HT2A serotonin receptor antagonist,C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCN3C(=O)C4=CC=CC=C4NC3=O,102.8,0.8
Ketoconazole,A4316,65277-42-1,Metabolism,P450,Inhibitor of cyclosporine oxidase and testosterone 6 beta-hydroxylase,CC(=O)N1CCN(CC1)C2=CC=C(C=C2)OCC3COC(O3)(CN4C=CN=C4)C5=C(C=C(C=C5)Cl)Cl,104.2,0.5
Ketoprofen,B1446,22071-15-4,Neuroscience,COX,Dual COX1/2 inhibitor,CC(C1=CC=CC(=C1)C(=O)C2=CC=CC=C2)C(=O)O,101.6,3.3
Ketorolac tromethamine salt,B1447,74103-07-4,Neuroscience,COX,Non-selective COX inhibitor,C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O.C(C(CO)(CO)N)O,96.4,2.3
Ketotifen Fumarate,B1562,34580-14-8,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,CN1CCC(=C2C3=C(C(=O)CC4=CC=CC=C42)SC=C3)CC1.C(=CC(=O)O)C(=O)O,103.7,9.0
Kinetin,A3528,525-79-1,Others,Others,Plant growth hormones,C1=COC(=C1)CNC2=NC=NC3=C2NC=N3,82.4,50.0
L-(−)-Fucose,C3589,2438-80-4,Immunology/Inflammation,Immunology & Inflamm,1,C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C=O,104.6,0.2
L-Adrenaline,B1337,51-43-4,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,CNCC(C1=CC(=C(C=C1)O)O)O,105.2,3.3
L-Alanine,C6108,56-41-7,Others,Others,1,1,101.7,9.0
L-Arabinose,B7894,5328-37-0,Others,Others,"Aldopentose,component of biopolymers like hemicellulose and pectin",O[C@@]1([H])COC(O)([H])[C@@](O)([H])[C@@]1([H])O,103.8,4.0
L-Arginine (hydrochloride),B8604,1119-34-2,Immunology/Inflammation,NOS,Precursor of nitric oxide synthesis,1,90.4,4.1
L-Asparagine,C6177,70-47-3,Others,Others,1,1,93.4,1.6
L-Aspartic acid,C6106,56-84-8,Others,Others,1,1,99.8,0.5
L-Carnitine inner salt,N1935,541-15-1,Natural Products,Others,Quaternary amine found in mammalian tissue,C[N+](C)(C)CC(CC(=O)[O-])O,93.6,11.9
L-Cycloserine,B8632,339-72-0,Metabolism,Transferase,Potent inhibitor of serine palmitoyl transferase (SPT),1,100.4,3.0
L-Glutamine,A8461,56-85-9,GPCR/G protein,mGluR,Non-essential amino acid,C(CC(=O)N)C(C(=O)O)N,89.3,3.9
L-Glutathione Reduced,B7775,70-18-8,Others,Antioxidants,used to elute glutathione S-transferase (GST) from glutathione agarose.,SC[C@@H](C(NCC(O)=O)=O)NC(CC[C@@H](C(O)=O)N)=O,102.7,4.1
L-Hydroxyproline,C6112,51-35-4,Others,Others,1,1,106.5,6.3
L-Leucine,C6104,61-90-5,Others,Others,1,1,105.2,6.6
L-Lysine hydrochloride,C6134,657-27-2,Others,Others,1,1,98.4,5.6
L-Menthol,C6192,2216-51-5,Endocrinology and Hormones,Opioid Receptor,1,1,88.2,4.6
L-Methionine,C6113,63-68-3,Others,Others,1,1,76.0,2.6
L-Proline,C6101,147-85-3,Others,Others,1,1,103.2,5.6
L-Selenomethionine,C4042,3211-76-5,Immunology/Inflammation,ROS,1,OC([C@@H](N)CC[Se]C)=O,104.1,6.3
L-Theanine,N2085,3081-61-6,Natural Products,Others,1,1,115.6,22.6
L-Threonine,C6127,72-19-5,Others,Others,1,1,95.1,5.0
L-Thyroxine,B2107,51-48-9,Others,Others,Iodine containing hormone,C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N,105.7,14.7
L-Tryptophan,C6105,73-22-3,Others,Others,1,1,99.5,3.8
L-Valine,C6103,72-18-4,Others,Others,1,1,113.7,0.1
LCZ696,B4815,936623-90-4,GPCR/G protein,Angiotensin Receptor,A first in class ARNi (angiotensin receptor neprilysin inhibitor),CCCCC(N([C@@](C([O-])=O)([H])C(C)C)CC1=CC=C(C2=CC=CC=C2C3=N[N-]N=N3)C=C1)=O.CCOC([C@](C[C@@](/N=C([O-])/CCC([O-])=O)([H])CC4=CC=C(C5=CC=CC=C5)C=C4)([H])C)=O.[3Na+].[2.5H2O],100.9,4.5
"LDE225 (NVP-LDE225,Erismodegib)",B2266,956697-53-3,Stem Cell,Smoothened,"Smoothened inhibitor,potent and selective",CC1CN(CC(O1)C)C2=NC=C(C=C2)NC(=O)C3=CC=CC(=C3C)C4=CC=C(C=C4)OC(F)(F)F,93.7,15.9
LDE225 Diphosphate,A3543,1218778-77-8,Stem Cell,Smoothened,1,1,96.9,5.6
LDK378,A8328,1032900-25-6,Tyrosine Kinase,ALK,Potent ALK inhibitor,CC1=CC(=C(C=C1C2CCNCC2)OC(C)C)NC3=NC=C(C(=N3)NC4=CC=CC=C4S(=O)(=O)C(C)C)Cl,99.5,2.4
LEE011,A8641,1211441-98-3,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK4/6 inhibitor,CN(C)C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5,100.9,3.6
LOXO-101,B6176,1223405-08-0,Tyrosine Kinase,Trk,1,1,118.3,24.3
LY2157299,A8348,700874-72-2,TGF-β / Smad Signaling,TGF-βR1(ALK5),"TGF-βR1 inhibitor,potent and selective",CC1=CC=CC(=N1)C2=NN3CCCC3=C2C4=C5C=C(C=CC5=NC=C4)C(=O)N,103.5,5.5
LY2228820,A5566,862507-23-1,MAPK Signaling,p38,P38 MAP kinase inhibitor,CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N.CS(=O)(=O)O.CS(=O)(=O)O,98.5,9.0
LY2784544,A4147,1229236-86-5,Chromatin/Epigenetics,JAK,"JAK2 inhibitor,highly potent and selective",CC1=CC(=NN1)NC2=NN3C(=C(N=C3C(=C2)CN4CCOCC4)C)CC5=C(C=C(C=C5)Cl)F,105.9,2.6
LY2835219,A1794,1231930-82-7,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,potent and selective",CCN1CCN(CC1)CC2=CN=C(C=C2)NC3=NC=C(C(=N3)C4=CC5=C(C(=C4)F)N=C(N5C(C)C)C)F.CS(=O)(=O)O,18.8,4.9
LY2835219 free base,A3575,1231929-97-7,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,CDK inhibitor,CCN1CCN(CC2=CN=C(NC3=NC=C(F)C(C4=CC5=C(N=C(C)N5C(C)C)C(F)=C4)=N3)C=C2)CC1,99.8,9.0
LY2940680,A8651,1258861-20-9,Stem Cell,Hedgehog,"Hedgehog/SMO antagonist,inhibits Hh signaling",CN1C(=CC=N1)C2=NN=C(C3=CC=CC=C32)N4CCC(CC4)N(C)C(=O)C5=C(C=C(C=C5)F)C(F)(F)F,100.3,0.3
LY335979 (Zosuquidar 3HCL),A8549,167465-36-3,Membrane Transporter/Ion Channel,P-gp,Pgp (P-glycoprotein) inhibitor,FC1([C@H](C2=CC=CC=C23)[C@@H]1C4=CC=CC=C4[C@H]3N5CCN(C[C@H](COC6=C7C(N=CC=C7)=CC=C6)O)CC5)F.Cl.Cl.Cl,109.4,9.8
Labetalol HCl,B4795,32780-64-6,GPCR/G protein,Adrenergic Receptor,mixed alpha/beta adrenergic antagonist,CC(CCC1=CC=CC=C1)NCC(C2=CC(=C(C=C2)O)C(=O)N)O.Cl,111.7,13.2
Lacidipine,B1417,103890-78-4,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C=CC(=O)OC(C)(C)C)C(=O)OCC)C)C,88.2,5.7
Lactulose,B1776,4618-18-2,Others,Others,Stimulator of health-promoting bacterium growth,C(C1C(C(C(C(O1)OC2C(OC(C2O)(CO)O)CO)O)O)O)O,99.2,3.6
Lafutidine,B1575,118288-08-7,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,C1CCN(CC1)CC2=CC(=NC=C2)OCC=CCNC(=O)CS(=O)CC3=CC=CO3,102.2,9.8
Lamivudine,A8458,134678-17-4,Microbiology & Virology,Reverse Transcriptase,Nucleoside analog reverse transcriptase inhibitor,C1C(OC(S1)CO)N2C=CC(=NC2=O)N,103.4,0.8
Lamotrigine,B2249,84057-84-1,Membrane Transporter/Ion Channel,Sodium Channel,5-HT inhibitor， sodium channel blocker,C1=CC(=C(C(=C1)Cl)Cl)C2=C(N=C(N=N2)N)N,106.7,4.6
Lannaconitine,N2258,32854-75-4,Natural Products,Sodium Channel,1,1,120.7,32.5
Lansoprazole,A1229,103577-45-3,Membrane Transporter/Ion Channel,Proton Pump,"H+,K+-ATPase inhibitor",CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3N2)OCC(F)(F)F,74.9,4.5
Lansoprazole sodium,B1290,226904-00-3,Membrane Transporter/Ion Channel,Proton Pump,PPI/cytochrome P450 inhibitor,CC1=C(C=CN=C1CS(=O)C2=NC3=CC=CC=C3[N-]2)OCC(F)(F)F.[Na+],114.8,29.1
Lapatinib,A8218,231277-92-2,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent,selective and reversible",CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,103.9,3.6
Lapatinib Ditosylate,A3967,388082-78-8,JAK/STAT Signaling,EGFR,"EGFR/HER2 inhibitor,potent and selective",CC1=CC=C(C=C1)S(=O)(=O)O.CC1=CC=C(C=C1)S(=O)(=O)O.CS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl,90.8,3.7
Lapatinib ditosylate,C6283,388082-78-8,Others,Others,1,1,105.0,13.4
Laquinimod (ABR-215062),A8459,248281-84-7,Others,Others,"Immunomodulator,orally-available,quinolinone-based and broad spectrum",CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O,112.7,20.7
Latanoprost,B3411,130209-82-4,Others,Others,FP prostaglandin receptor agonist,CC(C)OC(=O)CCCC=CCC1C(CC(C1CCC(CCC2=CC=CC=C2)O)O)O,102.6,7.4
Lathyrol,N1486,34420-19-4,Natural Products,Others,1,1,131.9,18.9
Latrepirdine,B1572,97657-92-6,Neuroscience,GluR,Brain cell death inhibitor,CC1=CC2=C(C=C1)N(C3=C2CN(CC3)C)CCC4=CN=C(C=C4)C.Cl.Cl,104.1,10.3
Lauric Acid,B6155,143-07-7,Metabolism,Lipid Metabolism,saturated medium-chain fatty acid,CCCCCCCCCCCC(O)=O,102.7,2.3
Ledipasvir,A3546,1256388-51-8,Microbiology & Virology,HCV,HCV NS5A protein inhibitor,CC([C@@](/N=C(OC)\O)([H])C(N1CC2(C[C@@]1([H])C3=NC=C(N3)C4=CC5=C(C6=C(C5(F)F)C=C(C7=CC(N8)=C(N=C8[C@]9([H])[C@@]%1 ([H])CC[C@](N9C([C@](/N=C(OC)\O)([H])C(C)C)=O)([H])C%1 )C=C7)C=C6)C=C4)CC2)=O)C,122.2,10.8
Leflunomide,A2852,75706-12-6,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,"AHR agonist,immunosuppressive agent",CC1=C(C=NO1)C(=O)NC2=CC=C(C=C2)C(F)(F)F,112.5,16.6
Lenalidomide (CC-5013),A4211,191732-72-6,Apoptosis,TNF-α,"Antineoplastic agent,inhibits angiogenesis",C1CC(=O)NC(=O)C1N2CC3=C(C2=O)C=CC=C3N,104.8,12.1
Lenvatinib (E7080),A2174,417716-92-8,Tyrosine Kinase,VEGFR,VEGFR inhibitor,COC1=CC2=NC=CC(=C2C=C1C(=O)N)OC3=CC(=C(C=C3)NC(=O)NC4CC4)Cl,75.7,10.2
Lesinurad,A3549,878672-00-5,Membrane Transporter/Ion Channel,URAT1,URAT1 inhibitor,C1CC1C2=CC=C(C3=CC=CC=C23)N4C(=NN=C4Br)SCC(=O)O,100.7,8.4
Letrozole,A1307,112809-51-5,Endocrinology and Hormones,Aromatase,Non-steroidal aromatase inhibitor,C1=CC(=CC=C1C#N)C(C2=CC=C(C=C2)C#N)N3C=NC=N3,121.4,5.5
Leucovorin Calcium,A2489,6035-45-6,Metabolism,Folate Analogue,Derivative of folic acid,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)[O-])C(=O)[O-].O.O.O.O.O.[Ca+2],99.0,18.3
Leuprolide Acetate,A3551,74381-53-6,Endocrinology and Hormones,GnRH,Pituitary GnRH receptors agonist,CCNC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O,95.1,7.5
Levetiracetam,A1198,102767-28-2,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic drug,CCC(C(=O)N)N1CCCC1=O,120.0,3.6
Levobetaxolol HCl,B1778,116209-55-3,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,73.6,12.7
Levobupivacaine HCl,B1784,27262-48-2,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,CCCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,104.5,4.8
Levodopa,A8460,59-92-7,Neuroscience,Dopamine Receptor,1,1,99.4,4.3
Levofloxacin,B1959,100986-85-4,Microbiology & Virology,Antibiotic,synthetic fluoroquinolone antibiotic,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)[C@](C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],109.6,10.1
Levomefolate calcium,A3552,151533-22-1,Metabolism,Folate Analogue,Artificial form of folate,CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O.[Ca+2],104.9,1.6
Levonorgestrel,B1960,797-63-7,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen/progestogen receptor agonist,CCC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,107.7,0.4
Levosimendan,B1961,141505-33-1,Membrane Transporter/Ion Channel,Calcium Channel,calcium sensitiser,CC1CC(=O)NN=C1C2=CC=C(C=C2)NN=C(C#N)C#N,96.6,1.6
Levosulpiride,B1484,23672-07-3,Neuroscience,Dopamine Receptor,Antipsychotic drug,CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC,124.4,18.1
Levulinic acid,C6215,123-76-2,Others,Others,1,1,99.0,2.0
Licofelone,B1448,156897-06-2,Neuroscience,COX,"COX-1, COX-2 and 5-LOX inhibitor",CC1(CC2=C(C(=C(N2C1)CC(=O)O)C3=CC=C(C=C3)Cl)C4=CC=CC=C4)C,105.4,1.5
Lidocaine,A1450,137-58-6,Neuroscience,Histamine Receptor,Anasthetic and class Ib antiarrhythmic agent,CCN(CC)CC(=O)NC1=C(C=CC=C1C)C,101.5,2.0
Ligustrazine Hydrochloride,N1650,76494-51-4,Natural Products,Immunology & Inflammation related,1,1,93.1,1.5
Linagliptin (BI-1356),A4034,668270-12-0,Proteases,DPP-4,"DDP-4 inhibitor,highly potent and competitive",CC#CCN1C2=C(N=C1N3CCCC(C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C,99.2,17.7
Linalool,N2418,78-70-6,Natural Products,NMDAR,1,CC(=CCCC(C)(C=C)O)C,91.4,1.8
Linezolid,A5181,165800-03-3,Microbiology & Virology,Antibiotic,Antibacterial reagent,CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F,96.0,0.9
Linifanib (ABT-869),A2949,796967-16-3,Tyrosine Kinase,VEGFR,VEGFR/PDGFR inhibitor,CC1=CC(=C(C=C1)F)NC(=O)NC2=CC=C(C=C2)C3=C4C(=CC=C3)NN=C4N,28.9,13.4
Linoleic Acid,C3108,60-33-3,Others,Others,"Essential fatty acid, precursor of arachidonic acid (AA) and various prostaglandins",CCCCC/C=C\C/C=C\CCCCCCCC(=O)O,100.1,11.2
Linsitinib,A8334,867160-71-2,Tyrosine Kinase,Insulin Receptor,"IGF1R/IR inhibitor,potent and novel",CC1(CC(C1)C2=NC(=C3N2C=CN=C3N)C4=CC5=C(C=C4)C=CC(=N5)C6=CC=CC=C6)O,95.8,2.3
Liothyronine Sodium,B1779,55-06-1,Others,Others,Potent agonist of both thyroid hormone receptors TRα and TRβ,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(C(=O)[O-])N)I)I)O.[Na+],102.5,12.7
Lisinopril dihydrate,B3290,83915-83-7,Endocrinology and Hormones,RAAS,ACE inhibitor,C1CC(N(C1)C(=O)C(CCCCN)NC(CCC2=CC=CC=C2)C(=O)O)C(=O)O.O.O,107.2,1.4
Lithium Citrate,A8462,6080-58-6,Others,Others,Mood stabilizer,[Li+].[Li+].[Li+].C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.O.O.O.O,99.4,10.8
Lithium carbonate,B7705,554-13-2,Membrane Transporter/Ion Channel,ATPase,1,1,100.1,3.9
Lithocholic Acid,A8463,434-13-9,Others,Others,"Activator of vitamin D receptor,PXR and FXR",CC(CCC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)O)C)C,96.3,9.5
Loganin,N1327,18524-94-2,Natural Products,"BACE,AChR",Cox-1 inhibitor,CC1C(CC2C1C(OC=C2C(=O)OC)OC3C(C(C(C(O3)CO)O)O)O)O,106.0,7.1
Lomefloxacin HCl,B1781,98079-52-8,Microbiology & Virology,Anti-infection,Fluoroquinolone antibiotic,CCN1C=C(C(=O)C2=CC(=C(C(=C21)F)N3CCNC(C3)C)F)C(=O)O.Cl,93.7,0.2
Lomerizine HCl,B1782,101477-54-7,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,COC1=C(C(=C(C=C1)CN2CCN(CC2)C(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)OC)OC.Cl.Cl,60.5,3.5
Lomitapide,B4885,182431-12-5,Others,Others,"MTP inhibitor, orally active",C1CN(CCC1NC(=O)C2=CC=CC=C2C3=CC=C(C=C3)C(F)(F)F)CCCCC4(C5=CC=CC=C5C6=CC=CC=C64)C(=O)NCC(F)(F)F,111.9,11.5
Lomustine,B1963,13010-47-4,DNA Damage/DNA Repair,DNA Alkylating,Antineoplastic drug,C1CCC(CC1)NC(=O)N(CCCl)N=O,91.3,7.8
Lonafarnib,A4379,193275-84-2,Metabolism,Transferase,"Ftase inhibitor,potent and selective",C1CN(CCC1CC(=O)N2CCC(CC2)C3C4=C(C=C(C=C4CCC5=CC(=CN=C35)Br)Cl)Br)C(=O)N,40.5,4.6
Lonidamine,B1964,50264-69-2,Others,Others,hexokinase inactivator,C1=CC=C2C(=C1)C(=NN2CC3=C(C=C(C=C3)Cl)Cl)C(=O)O,105.1,11.3
Loperamide HCl,B1392,34552-83-5,Neuroscience,"Opioid Receptor,Autophagy","μ opioid receptors agonist, voltage-sensitive sodium channels blocker",1,96.4,5.4
Lopinavir,A8204,192725-17-0,Proteases,HIV Protease,"HIV protease inhibitor,highly potent",CC1=C(C(=CC=C1)C)OCC(=O)NC(CC2=CC=CC=C2)C(CC(CC3=CC=CC=C3)NC(=O)C(C(C)C)N4CCCNC4=O)O,104.9,8.2
Loratadine,A2960,79794-75-5,Neuroscience,Histamine Receptor,Peripheral HH1R antagonist,CCOC(=O)N1CCC(=C2C3=C(CCC4=C2N=CC=C4)C=C(C=C3)Cl)CC1,101.2,4.8
Lornoxicam,B1441,70374-39-9,Neuroscience,COX,COX-1/COX-2 inhibitor,CN1C(=C(C2=C(S1(=O)=O)C=C(S2)Cl)O)C(=O)NC3=CC=CC=N3,104.4,6.3
Losartan,B1072,114798-26-4,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CO)Cl,102.7,2.1
Losartan Potassium (DuP 753),A1425,124750-99-8,Endocrinology and Hormones,RAAS,Angiotensin AT1 receptor antagonist,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NN=N[N-]4)CO)Cl.[K+],117.2,23.7
Losmapimod,B4620,585543-15-3,MAPK Signaling,p38,"p38 MAPK inhibitor, orally active",FC1=C(C)C(C(C=C2)=NC=C2C(NCC(C)(C)C)=O)=CC(C(NC3CC3)=O)=C1,106.7,7.9
Loteprednol etabonate,B2106,82034-46-6,Microbiology & Virology,Antibiotic,potent glucocorticoid receptor agonist,CCOC(=O)OC1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)C(=O)OCCl,112.5,23.1
Lovastatin,A4365,75330-75-5,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,82.5,10.0
Loxapine Succinate,B1783,27833-64-3,Neuroscience,"5-HT Receptor, Dopamine Receptor",Dopamine receptor antagonist,CN1CCN(CC1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl.C(CC(=O)O)C(=O)O,95.4,12.9
Lubiprostone,B2108,136790-76-6,Membrane Transporter/Ion Channel,Chloride Channel,activator of ClC-2 chloride channels,CCCCC(C1(CCC2C(O1)CC(=O)C2CCCCCCC(=O)O)O)(F)F,86.6,3.9
Luliconazole,A3564,187164-19-8,Microbiology & Virology,Antibiotic,Azole antifungal agent(interdigital tinea pedis),C1C(SC(=C(C#N)N2C=CN=C2)S1)C3=C(C=C(C=C3)Cl)Cl,100.3,6.2
Lumefantrine,C3479,82186-77-4,Microbiology & Virology,Anti-infection,1,OC(CN(CCCC)CCCC)C1=C(C(C=CC(Cl)=C2)=C2/C3=C/C4=CC=C(Cl)C=C4)C3=CC(Cl)=C1,90.0,2.7
Lumiracoxib,B1458,220991-20-8,Neuroscience,COX,1,1,98.5,4.0
Lurasidone HCl,B1477,367514-88-3,Neuroscience,5-HT Receptor,1,1,93.2,2.9
Lutein,C5847,127-40-2,Others,Others,1,O[C@@H]1CC(C)([C@H](C(C)=C1)/C=C/C(C)=C/C=C/C(C)=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C2=C(C[C@H](CC2(C)C)O)C)C,98.9,3.3
MDV3100 (Enzalutamide),A3003,915087-33-1,Endocrinology and Hormones,Androgen Receptor,Androgen receptor antagonist,CC1(C(=O)N(C(=S)N1C2=CC(=C(C=C2)C(=O)NC)F)C3=CC(=C(C=C3)C#N)C(F)(F)F)C,108.7,1.0
"MEK162 (ARRY-162, ARRY-438162)",A1947,606143-89-9,MAPK Signaling,MEK1/2,"MEK1/2 inhibitor,potent and selective",CN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)F)C(=O)NOCCO,58.0,6.0
MK-2048,A4072,869901-69-9,Proteases,HIV Integrase,1,1,122.3,26.7
MK-4827,A3617,1038915-60-4,Chromatin/Epigenetics,PARP,"PARP-1/-2 inhibitor,potent and selective",C1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N,22.4,2.4
MK-5172,A3618,1350514-68-9,Proteases,NS3/4a protease,HCV NS3/4a protease inhibitor,COC1=CC2=C(N=C(CCCCC[C@@H]3C[C@H]3OC(N[C@@H](C(C)(C)C)C(N4[C@H](C(N[C@@]5(C(NS(=O)(C6CC6)=O)=O)[C@H](C5)C=C)=O)C[C@@H]7C4)=O)=O)C(O7)=N2)C=C1,109.1,9.4
MK3102,B5868,1226781-44-7,Proteases,DPP-4,Novel long-acting DPP-4 inhibitor,CS(N1C=C2CN([C@](CO3)([H])C[C@@](N)([H])[C@@]3([H])C4=C(F)C=CC(F)=C4)CC2=N1)(=O)=O,104.9,6.0
MLN2238,A4008,1072833-77-2,Ubiquitination/Proteasome,Proteasome,β5 site of the 20S proteasome inhibitor,B(C(CC(C)C)NC(=O)CNC(=O)C1=C(C=CC(=C1)Cl)Cl)(O)O,100.7,24.6
MLN8237 (Alisertib),A4110,1028486-01-2,Chromatin/Epigenetics,Aurora Kinase,"Aurora A Kinase inhibitor, Potent and selective",COC1=C(C(=CC=C1)F)C2=NCC3=CN=C(N=C3C4=C2C=C(C=C4)Cl)NC5=CC(=C(C=C5)C(=O)O)OC,99.8,1.2
MLN9708,A4007,1201902-80-8,Ubiquitination/Proteasome,Proteasome,Proteasome inhibitor,B1(OC(=O)CC(O1)(CC(=O)O)C(=O)O)C(CC(C)C)NC(=O)CNC(=O)C2=C(C=CC(=C2)Cl)Cl,-11.5,6.4
MPEP,B1628,96206-92-7,GPCR/G protein,mGluR,1,1,101.1,3.0
Macitentan,A1929,441798-33-0,GPCR/G protein,Endothelin Receptor,Endothelin (ET)(A) and ET(B) receptor antagonist,CCCNS(=O)(=O)NC1=C(C(=NC=N1)OCCOC2=NC=C(C=N2)Br)C3=CC=C(C=C3)Br,107.7,4.6
Madecassic acid,N2355,18449-41-7,Natural Products,Others,1,1,96.7,2.0
Madecassoside,N1663,34540-22-2,Natural Products,Others,1,1,108.5,9.1
Magnolol,N1359,528-43-8,Natural Products,NF-κB,1,1,101.8,3.5
Malic acid,C6203,6915-15-7,Others,Others,1,1,102.6,0.8
Malotilate,A2486,59937-28-9,Metabolism,5-Lipoxygenase,Stimulates hepatocyte regeneration,CC(C)OC(=O)C(=C1SC=CS1)C(=O)OC(C)C,5.4,5.7
Maltotriose,C4102,1109-28-0,Others,Others,1,OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O[C@@]([C@H](O)CO)([H])[C@H](O)[C@@H](O)C=O)O[C@@H]2CO)([H])O1,114.4,27.4
Manidipine,B1418,89226-50-6,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC,112.6,10.2
Manidipine 2HCl,B1419,89226-75-5,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,CC1=C(C(C(=C(N1)C)C(=O)OCCN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=CC=C4)C5=CC(=CC=C5)[N+](=O)[O-])C(=O)OC.Cl.Cl,119.8,13.2
Maprotiline HCl,B1338,10347-81-6,GPCR/G protein,Adrenergic Receptor,Selective noradrenalin re-uptake inhibitor,Cl[H].[H]C12C([H])([H])C([H])([H])C(C3=C([H])C([H])=C([H])C([H])=C23)(C([H])([H])C([H])([H])C([H])([H])N([H])C([H])([H])[H])C4=C([H])C([H])=C([H])C([H])=C14,97.4,0.6
Maraviroc,A8311,376348-65-1,Microbiology & Virology,HIV,"Selective CCR5 antagonist,antiretroviral agent",CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C,111.2,14.2
Marbofloxacin,A5346,115550-35-1,Microbiology & Virology,Antibiotic,Fluoroquinolone antibiotic for veterinary use,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)N(C([H])([H])[H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],106.0,4.4
Marimastat,A4049,154039-60-8,Proteases,MMP,"MMPs inhibitor,board spectrum",CC(C)CC(C(C(=O)NO)O)C(=O)NC(C(=O)NC)C(C)(C)C,85.8,6.7
Masitinib (AB1010),A2942,790299-79-5,Tyrosine Kinase,c-Kit,"Tyrosine kinase inhibitor, potent and selective",CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC(=CS4)C5=CN=CC=C5,61.1,5.5
Mebendazole,C4087,31431-39-7,Cell Cycle/Checkpoint,Microtubule/Tubulin,broad-spectrum anthelmintic that inhibits intestinal microtubule synthesis,O=C(C1=CC=C(NC(NC(OC)=O)=N2)C2=C1)C3=CC=CC=C3,25.6,8.8
Mecamylamine hydrochloride,B7205,826-39-1,Neuroscience,Nicotinic Receptor,nicotinic acetylcholine receptor antagonist,CC([C@@H]1C[C@H]2CC1)(C)[C@@]2(C)NC.Cl,104.2,2.8
Mecarbinate,B2109,15574-49-9,Others,Others,chemical intermediate of arbidol hydrochloride,CCOC(=O)C1=C(N(C2=C1C=C(C=C2)O)C)C,103.2,18.5
Mechlorethamine HCl,B1785,55-86-7,DNA Damage/DNA Repair,DNA/RNA Synthesis,DNA synthesis inhibitor,CN(CCCl)CCCl.Cl,25.5,4.1
Meclizine 2HCl,B1786,1104-22-9,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,CC1=CC(=CC=C1)CN2CCN(CC2)C(C3=CC=CC=C3)C4=CC=C(C=C4)Cl.Cl.Cl,98.6,9.7
Meclofenamate Sodium,B4796,6385-02-0,Neuroscience,COX,dual COX-1/COX-2 inhibitor,CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+],97.5,9.8
Medetomidine HCl,B1361,86347-15-1,GPCR/G protein,Adrenergic Receptor,Selective α2-adrenoceptor agonist,CC1=C(C(=CC=C1)C(C)C2=CN=CN2)C.Cl,114.9,8.0
Medroxyprogesterone,B3471,520-85-4,Endocrinology and Hormones,Estrogen/progestogen Receptor,potent progesterone receptor agonist,C[C@@](C1=CC(CC[C@]21C)=O)([H])C[C@]([C@]3([H])CC[C@]4(O)C(C)=O)([H])[C@]2([H])CC[C@@]34C,107.8,3.0
Medroxyprogesterone acetate,B1510,71-58-9,Endocrinology and Hormones,Estrogen/progestogen Receptor,Steroidal progestin,CC1CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,109.2,4.4
Mefenamic Acid,B1449,61-68-7,Neuroscience,COX,Anti-inflammatory agent,CC1=C(C(=CC=C1)NC2=CC=CC=C2C(=O)O)C,100.5,2.5
Mefloquine hydrochloride,A3593,51773-92-3,Microbiology & Virology,Antimalaria,"Quinoline methanol antimalarial agent,",C1CCNC(C1)C(C2=CC(=NC3=C2C=CC=C3C(F)(F)F)C(F)(F)F)O.Cl,89.6,2.2
Megestrol Acetate,B1377,595-33-5,Endocrinology and Hormones,Estrogen/progestogen Receptor,Anti-estrogen agent,CC1=CC2C(CCC3(C2CCC3(C(=O)C)OC(=O)C)C)C4(C1=CC(=O)CC4)C,97.9,11.4
Meglumine,B1965,6284-40-8,Others,Others,amino sugar,CNCC(C(C(C(CO)O)O)O)O,102.2,10.1
Melamine,C6225,108-78-1,Others,Others,1,1,103.4,3.7
Melatonin,A2842,73-31-4,Others,Others,Melatonin receptors agonist,CC(=O)NCCC1=CNC2=C1C=C(C=C2)OC,99.9,16.3
Melibiose,B7901,585-99-9,Others,Others,"Reducing disaccharide, carbon substrate",O=C[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O)([H])CO[C@]1([H])[C@@](O)([H])[C@](O)([H])[C@](O)([H])[C@@](O1)([H])CO,104.9,0.2
Meloxicam (Mobic),A8466,71125-38-7,Neuroscience,COX,Nonsteroidal anti-inflammatory drug,CC1=CN=C(S1)NC(=O)C2=C(C3=CC=CC=C3S(=O)(=O)N2C)O,107.5,32.6
Melphalan,A4473,148-82-3,Apoptosis,Other Apoptosis,DNA alkylating agent,C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl,22.4,3.5
Memantine hydrochloride,B3308,41100-52-1,Neuroscience,"P450, AMPA Receptor-kainate Receptor-NMDA Receptor",NMDA receptor antagonist,CC12CC3CC(C1)(CC(C3)(C2)N)C.Cl,104.5,5.2
Menadione,B1966,58-27-5,Others,"DNA/RNA Synthesis,phosphatase",precursor to vitamin K2,CC1=CC(=O)C2=CC=CC=C2C1=O,96.1,5.5
Menaquinone 4,C4195,863-61-6,Metabolism,Vitamin,1,O=C1C(C/C=C(C)/CC/C=C(C)/CC/C=C(C)/CC/C=C(C)/C)=C(C)C(C2=CC=CC=C21)=O,101.3,14.5
Mepenzolate Bromide,A8467,76-90-4,Others,Others,mAChR antagonist,C[N+]1(CCCC(C1)OC(=O)C(C2=CC=CC=C2)(C3=CC=CC=C3)O)C.[Br-],100.2,1.7
Mepiroxol,A8468,6968-72-5,Others,Others,Antihyperlipidemic drug,C1=CC(=C[N+](=C1)[O-])CO,99.3,7.5
Mepivacaine HCl,B1967,1722-62-9,Membrane Transporter/Ion Channel,Sodium Channel,local anesthetic,CC1=C(C(=CC=C1)C)NC(=O)C2CCCCN2C.Cl,98.7,3.8
Meptazinol HCl,B2110,59263-76-2,Endocrinology and Hormones,Opioid Receptor,Partial agonist at the μ1 opioid receptor,CCC1(CCCCN(C1)C)C2=CC(=CC=C2)O.Cl,103.3,2.1
Mepyramine maleate,B6396,59-33-6,Neuroscience,Histamine Receptor,inverse agonist for the H1 receptor,CN(C)CCN(C1=NC=CC=C1)CC(C=C2)=CC=C2OC.OC(/C=C\C(O)=O)=O,98.6,19.5
Mequinol,B1968,150-76-5,Others,Others,depigmentation agent,COC1=CC=C(C=C1)O,104.7,10.3
Mercaptopurine (6-MP),A2355,50-44-2,DNA Damage/DNA Repair,DNA Synthesis,Purine synthesis inhibitor,C1=NC2=C(N1)C(=S)N=CN2,17.7,7.0
Meropenem,A5124,96036-03-2,Microbiology & Virology,Antibiotic,β-lactam antibiotic of the carbapenem subclass,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O,91.4,5.0
Meropenem trihydrate,B1217,119478-56-7,Microbiology & Virology,Antibiotic,Broad-spectum β-lactam antibiotic,CC1C2C(C(=O)N2C(=C1SC3CC(NC3)C(=O)N(C)C)C(=O)O)C(C)O.O.O.O,92.3,3.5
Mesalamine,B1969,89-57-6,Immunology/Inflammation,PGE synthase,IKK inhibitor,C1=CC(=C(C=C1N)C(=O)O)O,102.1,3.8
Mesna,A8469,19767-45-4,Others,Others,Chemotherapy adjuvant;potential antioxidant,C(CS(=O)(=O)[O-])S.[Na+],107.9,1.5
Mesoridazine Besylate,A8701,32672-69-8,Others,Others,Phenothiazine dopamine receptor anatagonist,O=S(C)C1=CC=C2SC3=CC=CC=C3N(C2=C1)CC[C@H]4N(C)CCCC4.OS(=O)(C5=CC=CC=C5)=O,102.5,14.9
Mestranol,A8470,72-33-3,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen used in contraceptives,CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC,104.3,7.2
Metaxalone,B3455,1665-48-1,Others,Others,muscle relaxant,CC1=CC(C)=CC(OCC(O2)CN=C2O)=C1,113.5,27.8
Metformin HCl,B1970,1115-70-4,Others,Others,Anti-diabetic drug,CN(C)C(=N)N=C(N)N.Cl,103.1,5.1
Methacycline HCl,B1971,3963-95-9,Microbiology & Virology,Anti-infection,tetracycline antibiotic,CN(C)C1C2C(C3C(=C)C4=C(C(=CC=C4)O)C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O.Cl,101.3,0.1
Methazolamide,A4364,554-57-4,Metabolism,Carbonic Anhydrase,Carbonic anhydrase inhibitor,CC(=O)N=C1N(N=C(S1)S(=O)(=O)N)C,116.6,6.0
Methenamine,B1972,100-97-0,Microbiology & Virology,Anti-infection,antibiotic,[H]C1([H])N(C2([H])[H])C([H])([H])N3C([H])([H])N2C([H])([H])N1C3([H])[H],106.8,13.0
Methicillin (sodium salt),C3238,132-92-3,Microbiology & Virology,Antibiotic,semisynthetic penicillin antibiotic,O=C(N[C@@H]1C(N2[C@]1([H])SC(C)(C)[C@@H]2C([O-])=O)=O)C3=C(OC)C=CC=C3OC.[Na+],94.4,0.2
Methimazole,A8472,60-56-0,Others,Others,ICAM-1 inhibitor,CN1C=CNC1=S,94.9,0.7
Methotrexate,A4347,59-05-2,Metabolism,DHFR,"Folate antagonist,inhibits DFHR",CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,100.4,16.1
Methscopolamine,B1611,155-41-9,Neuroscience,AChR,Muscarinic acetylcholine receptor blocker,O=C(C(C1=C([H])C([H])=C([H])C([H])=C1[H])([H])C([H])([H])O[H])O[C@@]2([H])C([H])([H])[C@]3([H])[N+](C([H])([H])[H])(C([H])([H])[H])[C@@](C2([H])[H])([H])[C@@]4([H])O[C@@]34[H].[Br-],106.7,20.5
Methyl salicylate,C6190,119-36-8,Membrane Transporter/Ion Channel,TRPV,1,1,94.2,11.3
Methylcobalamin,B3404,13422-55-4,Others,Others,a form of vitamin B12,[CH3-].CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[Co+3],89.4,10.5
Methyldopa,B1787,555-30-6,GPCR/G protein,Adrenergic Receptor,alpha-2 adrenergic receptor agonist,CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N,102.6,2.7
Methylparaben,C6124,99-76-3,Others,Others,1,1,97.8,1.2
Methylprednisolone,A4233,83-43-2,GPCR/G protein,Glucocorticoid Receptor,"Apoptosis inducer,GR agonist",CC1CC2C3CCC(C3(CC(C2C4(C1=CC(=O)C=C4)C)O)C)(C(=O)CO)O,109.3,4.1
Methylprednisolone Sodium Succinate,B4953,2375-03-3,GPCR/G protein,Glucagon Receptor,glucocorticoid,O[C@@]1(C(COC(CCC([O-])=O)=O)=O)[C@](C2)(C)[C@@H](CC1)[C@H](C[C@@H]3C)[C@@H]([C@@](C)(C=C4)C3=CC4=O)[C@H]2O.[Na+],105.4,3.3
Methylthiouracil,B1974,1956-4-2,Others,Others,antithyroid preparation,CC1=CC(=O)NC(=S)N1,103.9,0.8
Methyocarbamol,A8473,532-03-6,Others,Others,Carbonic anhydrase inhibitor,COC1=CC=CC=C1OCC(COC(=O)N)O,98.8,0.5
Meticrane,A8471,1084-65-7,Others,Others,Peripheral-type benzodiazepine receptor (PBR) inhibitor,CC1=C(C=C2C(=C1)CCCS2(=O)=O)S(=O)(=O)N,96.0,5.5
Metoclopramide,A3599,364-62-5,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,CCN(CC)CCNC(=O)C1=CC(=C(C=C1OC)N)Cl,106.8,11.5
Metolazone,B1975,17560-51-9,Others,Others,thiazide-like diuretic,ClC1=C(C=C2C(NC(C)N(C3=CC=CC=C3C)C2=O)=C1)S(=O)(N)=O,103.9,6.0
Metoprolol Succinate,B6022,98418-47-4,GPCR/G protein,Adrenergic Receptor,beta-1 selective adrenergic receptor antagonist,OC(COC(C=C1)=CC=C1CCOC)CNC(C)C.OC(COC(C=C2)=CC=C2CCOC)CNC(C)C.OC(CCC(O)=O)=O,93.6,6.4
Metoprolol Tartrate,B1339,56392-17-7,GPCR/G protein,Adrenergic Receptor,β1-adrenergic blocking agent,CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.CC(C)NCC(COC1=CC=C(C=C1)CCOC)O.C(C(C(=O)O)O)(C(=O)O)O,103.2,1.8
Metronidazole,B1976,443-48-1,DNA Damage/DNA Repair,DNA/RNA Synthesis,nitroimidazole antibiotic,CC1=NC=C(N1CCO)[N+](=O)[O-],102.7,3.0
Metyrapone,B7347,54-36-4,Others,Hydroxylases,11-β hydroxylase (CYP11B1) inhibitor,O=C(C1=CC=CN=C1)C(C)(C)C2=CC=CN=C2,100.9,3.2
Mevastatin,B1788,73573-88-3,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,CCC(C)C(=O)OC1CCC=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O,53.0,2.4
Mexiletine HCl,B1789,5370-01-4,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,CC1=C(C(=CC=C1)C)OCC(C)N.Cl,98.0,1.2
Mezlocillin Sodium,B1790,42057-22-7,Microbiology & Virology,Anti-infection,Penicillin beta-lactam antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C.[Na],102.6,2.1
Mianserin HCl,A1796,21535-47-7,Neuroscience,Histamine Receptor,5-HT2 receptor antagonist,CN1CC2C3=C(C=CC=C3)CC4=C(C=CC=C4)N2CC1.Cl,113.1,8.2
Micafungin sodium,A3606,208538-73-2,Others,"β(1,3)-D-Glucan Synthase","Inhibitor of β-(1,3)-D-glucan synthesis;fungicide",CCCCCOC1=CC=C(C=C1)C2=CC(=NO2)C3=CC=C(C=C3)C(=O)NC4CC(C(NC(=O)C5C(C(CN5C(=O)C(NC(=O)C(NC(=O)C6CC(CN6C(=O)C(NC4=O)C(C)O)O)C(C(C7=CC(=C(C=C7)O)OS(=O)(=O)[O-])O)O)C(CC(=O)N)O)C)O)O)O.[Na+],112.5,1.2
Miconazole,B1977,22916-47-8,Microbiology & Virology,Anti-infection,imidazole antifungal agent,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl,61.9,8.4
Miconazole Nitrate,B1978,22832-87-7,Microbiology & Virology,Anti-infection,Antifungal agent,C1=CC(=C(C=C1Cl)Cl)COC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl.[N+](=O)(O)[O-],66.9,7.1
Midodrine (hydrochloride),C4493,43218-56-0,GPCR/G protein,Adrenergic Receptor,1,1,108.4,15.6
Midostaurin (PKC412),B3709,120685-11-2,TGF-β / Smad Signaling,PKC,PKC inhibitor,CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,8.4,2.9
Mifepristone,B1511,84371-65-3,GPCR/G protein,Glucocorticoid Receptor,Progesterone receptor antagonist,CC#CC1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)O,101.4,8.2
Miglitol,B2111,72432-03-2,Others,Others,Inhibitor of α-glucosidase,C1C(C(C(C(N1CCO)CO)O)O)O,101.4,15.0
Milnacipran HCl,B2112,101152-94-7,Neuroscience,SSRIs,Orally active 5-HT and noradrenalin re-uptake inhibitor,CCN(CC)C(=O)C1(CC1CN)C2=CC=CC=C2.Cl,95.1,3.4
Milrinone,B1386,78415-72-2,Metabolism,PDE,PDE-3 inhibitor,CC1=C(C=C(C(=O)N1)C#N)C2=CC=NC=C2,90.6,0.7
Miltefosine,B1371,58066-85-6,PI3K/Akt/mTOR Signaling,Akt,PI3K/Akt inhibitor,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,109.6,1.6
Minocycline HCl,B1791,13614-98-7,Microbiology & Virology,Antibiotic,Tetracycline antibiotic,CN(C)C1C2CC3CC4=C(C=CC(=C4C(=C3C(=O)C2(C(=C(C1=O)C(=O)N)O)O)O)O)N(C)C.Cl,97.4,0.6
Minoxidil,B1289,38304-91-5,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 channel (KATP) activator.,C1CCN(CC1)C2=NC(=N)N(C(=C2)N)O,95.3,7.8
Mirabegron (YM178),A8474,223673-61-8,GPCR/G protein,Adrenergic Receptor,Selective β3-adrenoceptor agonist,C1=CC=C(C=C1)C(CNCCC2=CC=C(C=C2)NC(=O)CC3=CSC(=N3)N)O,96.7,5.3
Mirtazapine,B2113,85650-52-8,Neuroscience,5-HT Receptor,"5-HT2, 5-HT3, histamine H1 receptor and  α2-adrenoceptor antagonist",[H]C1(C2=C([H])C([H])=C([H])C([H])=C2C([H])([H])C3=C4N=C([H])C([H])=C3[H])N4C([H])([H])C([H])([H])N(C([H])([H])[H])C1([H])[H],123.6,21.0
Misoprostol,B3484,59122-46-2,GPCR/G protein,Prostaglandin Receptor,synthetic prostaglandin E1 (PGE1) analog,1,89.2,6.2
Mitiglinide Calcium,B2193,145525-41-3,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel inhibitor,C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)[O-].C1CCC2CN(CC2C1)C(=O)CC(CC3=CC=CC=C3)C(=O)[O-].[Ca+2],111.1,1.4
Mitomycin C,A4452,50-07-7,Apoptosis,Apoptosis Inducers,"Inhibits DNA synthesis,antibiotic and antitumor agent",NC(C1=O)=C(C)C(C2=C1[C@@H](COC(N)=O)[C@]3(OC)N2C[C@H]4[C@@H]3N4)=O,3.3,1.2
Mitotane (Lsodren),A8475,53-19-0,Others,Others,Antineoplastic agents against adrenocortical carcinoma,C1=CC=C(C(=C1)C(C2=CC=C(C=C2)Cl)C(Cl)Cl)Cl,99.1,2.4
Mitoxantrone HCl,B2114,70476-82-3,DNA Damage/DNA Repair,Topoisomerase,"Topoisomerase II inhibitor, anti-neoplastic drug",C1=CC(=C2C(=C1NCCNCCO)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCNCCO.Cl.Cl,-8.8,5.6
Mizolastine,B1551,108612-45-9,Neuroscience,Histamine Receptor,1,1,106.7,4.6
Mizoribine,B1472,50924-49-7,Others,IMPDH,DNA/RNA synthesis inhibitor,C1=NC(=C(N1C2C(C(C(O2)CO)O)O)O)C(=O)N,104.6,4.5
"Mocetinostat (MGCD0103, MG0103)",A4089,726169-73-9,DNA Damage/DNA Repair,HDAC,"HDAC inhibitor,isotype-selective and potent",C1=CC=C(C(=C1)N)NC(=O)C2=CC=C(C=C2)CNC3=NC=CC(=N3)C4=CN=CC=C4,112.3,15.7
Moclobemide (Ro 111163),A4370,71320-77-9,Metabolism,MAO,Reversible inhibitor of MAO-A,C1COCCN1CCNC(=O)C2=CC=C(C=C2)Cl,91.0,5.6
Moguisteine,B2115,119637-67-1,Others,Others,novel peripheral non-narcotic antitussive drug,CCOC(=O)CC(=O)N1CCSC1COC2=CC=CC=C2OC,100.6,3.6
Molidustat (BAY85-3934),B5861,1154028-82-6,Chromatin/Epigenetics,HIF,Novel HIF-PH inhibitor,O=C1C(N2C=CN=N2)=CNN1C3=NC=NC(N4CCOCC4)=C3,94.6,13.3
Mometasone furoate,B1979,83919-23-7,GPCR/G protein,Glucocorticoid Receptor,glucocorticoid receptor agonist,CC1CC2C3CCC4=CC(=O)C=CC4(C3(C(CC2(C1(C(=O)CCl)OC(=O)C5=CC=CO5)C)O)Cl)C,98.9,0.1
Monobenzone,A8478,103-16-2,Others,Others,Skin depigmenting agent,C1=CC=C(C=C1)COC2=CC=C(C=C2)O,32.9,6.6
Monomethyl auristatin E,A3631,474645-27-7,Cell Cycle/Checkpoint,Microtubule/Tubulin,1,1,6.1,0.5
Montelukast Sodium,B1792,151767-02-1,GPCR/G protein,CysLT1 receptor,Leukotriene receptor antagonist,CC(C)(C1=CC=CC=C1CCC(C2=CC=CC(=C2)C=CC3=NC4=C(C=CC(=C4)Cl)C=C3)SCC5(CC5)CC(=O)[O-])O.[Na+],101.5,1.1
Morin,C5297,480-16-0,Others,Others,1,OC1=CC(O)=C2C(C(O)=C(OC2=C1)C3=C(C=C(C=C3)O)O)=O,102.7,3.7
Moroxydine HCl,B1980,3160-91-6,Microbiology & Virology,Anti-infection,synthetic antiviral compound,C1COCCN1C(=N)N=C(N)N.Cl,93.1,10.6
Mosapride Citrate,A1334,112885-42-4,Neuroscience,5-HT Receptor,5-HT receptor agonist,CCOC1=CC(=C(C=C1C(=O)NCC2CN(CCO2)CC3=CC=C(C=C3)F)Cl)N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,123.9,28.3
Motolimod (VTX-2337),B5996,926927-61-9,Immunology/Inflammation,TLR,TLR8 agonist,CCCN(C(C(CC1=N)=CC2=C(N1)C=C(C3=CC=C(C(N4CCCC4)=O)C=C3)C=C2)=O)CCC,95.3,1.3
Moxalactam (sodium salt),C4121,64953-12-4,Microbiology & Virology,Antibiotic,β-lactam antibiotic,OC1=CC=C([C@@H](C([O-])=O)C(N[C@@]2(OC)[C@](OCC(CSC3=NN=NN3C)=C4C([O-])=O)([H])N4C2=O)=O)C=C1.[Na+].[Na+],94.7,0.8
Moxidectin,B3611,113507-06-5,Microbiology & Virology,Antibiotic,anthelmintic drug,CC(/C([H])=C([C@](O1)([H])[C@@](/C(C[C@@]21C[C@](O3)([H])C[C@@](O2)([H])C/C([H])=C(C[C@@](/C([H])=C([H])/C([H])=C([C@@]45O)\CO[C@]5([H])[C@@](O)([H])C(C)=C[C@@]4([H])C3=O)([H])C)\C)=N\OC)([H])C)\C)C,114.1,21.3
Moxifloxacin HCl,A5323,186826-86-8,DNA Damage/DNA Repair,Topoisomerase,Fluoroquinolone antibiotic,COC1=C2C(=CC(=C1N3CC4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,103.7,19.5
Moxonidine,A4080,75438-57-2,Others,Imidazoline Receptors,I1R/α2AR agonist,CC1=NC(=C(C(=N1)Cl)NC2=NCCN2)OC,103.7,1.8
Mubritinib (TAK 165),B1543,366017-09-6,Tyrosine Kinase,HER2,Potent inhibitor of HER2/ErbB2,C1=CC(=CC=C1CCCCN2C=CN=N2)OCC3=COC(=N3)C=CC4=CC=C(C=C4)C(F)(F)F,48.5,3.1
Mupirocin,B4872,12650-69-0,DNA Damage/DNA Repair,DNA Synthesis,isoleucyl t-RNA synthetase inhibitor,CC(C1C(O1)CC2COC(C(C2O)O)CC(=CC(=O)OCCCCCCCCC(=O)O)C)C(C)O,90.5,5.9
Mycophenolate Mofetil,A4336,128794-94-5,Metabolism,Dehydrogenase,IMPDH inhibitor,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)OCCN3CCOCC3)OC,100.4,10.8
Mycophenolic acid,B1981,24280-93-1,Metabolism,Dehydrogenase,Dehydrogenase inhibitor,CC1=C(C(=C(C2=C1COC2=O)O)CC=C(C)CCC(=O)O)OC,16.8,2.0
N-Acetylneuraminic acid,B7905,131-48-6,Others,Others,1,1,96.7,8.5
N-Carbamyl-L-glutamic acid,B7907,1188-38-1,Others,Others,1,N=C(O)N[C@@](C(O)=O)([H])CCC(O)=O,100.0,1.3
N-acetyl-D-Glucosamine,C5679,7512-17-6,Others,Others,1,O=CC(C(C([C@@H](CO)O)O)O)NC(C)=O,96.3,8.7
NAD+,B1793,53-84-9,Others,Others,1,1,102.2,7.6
Nabumetone,B1450,42924-53-8,Neuroscience,COX,COX inhibitor,CC(=O)CCC1=CC2=C(C=C1)C=C(C=C2)OC,96.5,5.1
Nadifloxacin,B1982,124858-35-1,Microbiology & Virology,Anti-infection,topical fluoroquinolone antibiotic,FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])C2([H])[H])N(C([H])([H])C4([H])[H])C([H])([H])C([H])([H])C4([H])O[H],105.0,1.4
Nafamostat Mesylate(FUT-175),A2586,82956-11-4,Proteases,Serine Protease,Serine protease inhibitor,CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N,101.5,5.7
Nafcillin Sodium,B1983,7177-50-6,Microbiology & Virology,Anti-infection,"narrow-spectrum, beta-lactam antibiotic",CCOC1=C(C2=CC=CC=C2C=C1)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],103.0,5.2
Naftifine HCl,B1984,65473-14-5,Microbiology & Virology,Fungal,Allylamine antifungal agent,CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl,113.2,16.7
Naftopidil,B1362,57149-07-2,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor antagonist,COC1=CC=CC=C1N2CCN(CC2)CC(COC3=CC=CC4=CC=CC=C43)O,78.5,3.8
Nalidixic acid,B1985,389-08-2,DNA Damage/DNA Repair,Topoisomerase,synthetic quinolone antibiotic,CCN1C=C(C(=O)C2=C1N=C(C=C2)C)C(=O)O,104.7,4.9
Naloxone HCl,B1647,357-08-4,Endocrinology and Hormones,Opioid Receptor,μ opioid receptors antagonist,1,97.3,0.6
Naltrexone HCl,B1648,16676-29-2,Endocrinology and Hormones,Opioid Receptor,Opioid receptors antagonist,1,90.4,9.9
Napabucasin,B6029,83280-65-3,JAK/STAT Signaling,STAT,STAT3 inhibitor,CC(C(O1)=CC2=C1C(C3=CC=CC=C3C2=O)=O)=O,-4.7,4.0
Naphazoline HCl,B1340,550-99-2,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl,110.0,7.9
Naproxen Sodium,B5984,26159-34-2,Neuroscience,COX,cyclooxygenase inhibitor,C[C@@](C([O-])=O)([H])C1=CC2=CC=C(OC)C=C2C=C1.[Na+],98.8,12.3
Naratriptan,B2251,143388-64-1,Neuroscience,5-HT Receptor,selective 5-HT1 receptor subtype agonist,CNS(=O)(=O)CCC1=CC2=C(C=C1)NC=C2C3CCN(CC3)C.Cl,97.8,0.9
Natamycin,A5786,7681-93-8,Microbiology & Virology,Antibiotic,Antifungal macrolide polyene,O[C@](C1)(C[C@H](C[C@H]2O[C@@H]2/C=C\C(O[C@H](C)C/C=C\C=C/C=C\C=C/[C@@H]3O[C@@H]([C@H]([C@H]4N)O)O[C@H](C)[C@H]4O)=O)O)O[C@](C3)([H])[C@H](C(O)=O)[C@H]1O,101.9,9.9
Nateglinide,B2198,105816-04-4,Membrane Transporter/Ion Channel,Potassium Channel,Insulin secretagog agent,CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,103.3,2.1
Nebivolol,B1341,152520-56-4,GPCR/G protein,Adrenergic Receptor,Highly selective β1-adrenoceptor antagonist,C1CC2=C(C=CC(=C2)F)OC1C(CNCC(C3CCC4=C(O3)C=CC(=C4)F)O)O.Cl,101.2,2.3
Nedaplatin,B1986,95734-82-0,GPCR/G protein,Adrenergic Receptor,DNA synthesis inhibitor,C(C(=O)O)O.[NH2-].[NH2-].[Pt+2],42.4,0.3
Nefiracetam,B1532,77191-36-7,Neuroscience,GABA Receptor,GABA receptor activator,CC1=C(C(=CC=C1)C)NC(=O)CN2CCCC2=O,105.6,7.0
Nelarabine,A1379,121032-29-9,DNA Damage/DNA Repair,DNA Synthesis,Prodrug of ara-G for T-LBL/T-ALL,COC1=NC(=NC2=C1N=CN2C3C(C(C(O3)CO)O)O)N,61.1,12.0
Nelfinavir,B1122,159989-64-7,Proteases,HIV Integrase,HIV-1 protease inhibitor,CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O,104.6,5.6
Nelfinavir Mesylate,A3653,159989-65-8,Proteases,HIV Protease,"HIV protease inhibitor,antiretroviral drug for HIV treatment",CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O.CS(=O)(=O)O,110.2,14.6
Neomycin sulfate,B1795,1405-10-3,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,98.6,9.1
Neostigmine Bromide,B1594,114-80-7,Neuroscience,AChR,Cholinesterase inhibitor,CN(C)C(=O)OC1=CC=CC(=C1)[N+](C)(C)C.[Br-],95.5,3.8
Nepafenac,A2890,78281-72-8,Neuroscience,COX,COX-1 and COX-2 inhibitor,C1=CC=C(C=C1)C(=O)C2=C(C(=CC=C2)CC(=O)N)N,108.6,9.1
Neratinib (HKI-272),A8322,698387-09-6,JAK/STAT Signaling,EGFR,"HER2/EGFR inhibitor,potent and irreversible",CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)OCC4=CC=CC=N4)Cl)C#N)NC(=O)C=CCN(C)C,103.4,7.7
Netilmicin Sulfate,B1796,56391-57-2,Microbiology & Virology,Anti-infection,Active aminoglycoside antibiotic,CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.CCNC1CC(C(C(C1OC2C(C(C(CO2)(C)O)NC)O)O)OC3C(CC=C(O3)CN)N)N.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,96.3,9.2
Nevirapine,A8481,129618-40-2,Microbiology & Virology,Reverse Transcriptase,Non-nucleoside reverse transcriptase inhibitor,CC1=C2C(=NC=C1)N(C3=C(C=CC=N3)C(=O)N2)C4CC4,99.0,1.4
Nicaraven,B1797,79455-30-4,Others,Others,1,1,98.8,10.1
Nicardipine HCl,B1798,54527-84-3,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl,99.4,5.3
Nicergoline,B3440,27848-84-6,GPCR/G protein,Adenosine Receptor,vasodilator,CN1C=C2C[C@]3([H])[C@](C4=C2C1=CC=C4)(OC)C[C@](COC(C5=CC(Br)=CN=C5)=O)([H])CN3C,96.5,7.3
Niclosamide,B2283,50-65-7,JAK/STAT Signaling,STAT,Inhibitor of the STAT3 signaling pathway,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NC(=O)C2=C(C=CC(=C2)Cl)O,96.7,13.5
Nicorandil,B2197,65141-46-0,Membrane Transporter/Ion Channel,Potassium Channel,Potassium channel activator,C1=CC(=CN=C1)C(=O)NCCO[N+](=O)[O-],104.2,8.8
Nicotinamide,N1651,98-92-0,Natural Products,Sirtuin,PARP-1 inhibitor,C1=CC(=CN=C1)C(=O)N,92.3,0.7
Nicotine,N2703,54-11-5,Natural Products,Others,1,CN1CCCC1C2=CN=CC=C2,89.2,9.5
Nicotine Difartrate,A8482,65-31-6,Others,Others,Nicotinic acetylcholine receptor (nAChR) agonist,CN1CCCC1C2=CN=CC=C2.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,75.9,5.6
Nicotinic Acid,B1987,59-67-6,Others,Others,water-soluble vitamin belonging to the vitamin B family,C1=CC(=CN=C1)C(=O)O,91.4,4.7
Nifedipine,B1988,21829-25-4,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,106.5,4.8
Nifenazone,A8483,2139-47-1,Others,Others,Analgesic,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C3=CN=CC=C3,95.0,8.5
Niflumic acid,B1530,4394-00-7,Neuroscience,GABA Receptor,Ca2+-activated Cl- channel blocker,C1=CC(=CC(=C1)NC2=C(C=CC=N2)C(=O)O)C(F)(F)F,92.3,1.5
Nifuroxazide,B1799,965-52-6,JAK/STAT Signaling,STAT,STAT inhibitor,C1=CC(=CC=C1C(=O)NN=CC2=CC=C(O2)[N+](=O)[O-])O,80.3,6.7
Nilotinib monohydrochloride monohydrate,A3660,923288-90-8,TGF-β / Smad Signaling,Bcr-Abl,Bcr-Abl inhibitor,CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5.O.Cl,41.8,13.2
Nilotinib(AMN-107),A8232,641571-10-0,TGF-β / Smad Signaling,Bcr-Abl,"Bcr-Abl kinase inhibitor,selective",CC1=C(C=C(C=C1)C(=O)NC2=CC(=CC(=C2)N3C=C(N=C3)C)C(F)(F)F)NC4=NC=CC(=N4)C5=CN=CC=C5,96.6,0.3
Nilutamide,B8684,63612-50-0,Endocrinology and Hormones,Androgen Receptor,Antagonist of the androgen receptor,1,98.9,6.6
Nilvadipine,A8455,75530-68-6,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel inhibitor,CC1=C(C(C(=C(N1)C#N)C(=O)OC)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC(C)C,107.1,2.0
Nimesulide,B1452,51803-78-2,Neuroscience,COX,Non-steroidal anti-inflammatory drug,CS(=O)(=O)NC1=C(C=C(C=C1)[N+](=O)[O-])OC2=CC=CC=C2,96.7,0.2
Nimodipine,A8484,66085-59-4,Ubiquitination/Proteasome,Autophagy,Calcium Channel inhibitor & Autophagy activator,CC1=C(C(C(=C(N1)C)C(=O)OC(C)C)C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OCCOC,108.9,1.6
Nintedanib (BIBF 1120),A8252,656247-17-5,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor,CN1CCN(CC1)CC(=O)N(C)C2=CC=C(C=C2)NC(=C3C4=C(C=C(C=C4)C(=O)OC)NC3=O)C5=CC=CC=C5,101.6,0.2
Nisoldipine,B1989,63675-72-9,Membrane Transporter/Ion Channel,Calcium Channel,calcium channel blocker,CC1=C(C(C(=C(N1)C)C(=O)OCC(C)C)C2=CC=CC=C2[N+](=O)[O-])C(=O)OC,94.0,4.0
Nitazoxanide,A8485,55981-09-4,Others,Others,Antiprotozoal agent,CC(=O)OC1=CC=CC=C1C(=O)NC2=NC=C(S2)[N+](=O)[O-],94.1,2.0
Nithiamide,B1800,140-40-9,Microbiology & Virology,Anti-infection,Antibiotic used in veterinary,CC(=O)NC1=NC=C(S1)[N+](=O)[O-],96.6,1.9
Nitisinone,B3527,104206-65-7,Others,Others,inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase,FC(F)(F)C1=CC(N(=O)=O)=C(C(C2C(CCCC2=O)=O)=O)C=C1,94.9,8.2
Nitrendipine,B1393,39562-70-4,Membrane Transporter/Ion Channel,Calcium Channel,Calcium channel blocker,CCOC(=O)C1=C(NC(=C(C1C2=CC(=CC=C2)[N+](=O)[O-])C(=O)OC)C)C,102.2,5.1
Nitrofurantoin,B8682,67-20-9,Microbiology & Virology,Anti-infection,"Nitrofuran antibiotic, substrate of bacterial nitrofuran reductase",1,101.4,7.1
Nitrofurazone,A8486,59-87-0,Microbiology & Virology,Antibiotic,Antibiotic,C1=C(OC(=C1)[N+](=O)[O-])C=NNC(=O)N,95.9,6.8
Nitroxoline,B6135,4008-48-4,Microbiology & Virology,Antibiotic,antibacterial agent,OC1=C2C(C=CC=N2)=C(N(=O)=O)C=C1,97.7,7.4
Nizatidine,B1552,76963-41-2,Neuroscience,Histamine Receptor,Histamine H2 receptor antagonist,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C,103.0,1.5
Noradrenaline bitartrate monohydrate,B1990,108341-18-0,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,C1=CC(=C(C=C1C(CN)O)O)O.C(C(C(=O)O)O)(C(=O)O)O.O,104.7,6.5
Nordihydroguaiaretic acid,A3664,500-38-9,PI3K/Akt/mTOR Signaling,mTOR,1,1,114.8,27.0
Norethindrone,B1991,68-22-4,Others,Others,synthetic progestin,CC12CCC3C(C1CCC2(C#C)O)CCC4=CC(=O)CCC34,96.6,3.3
Nortriptyline (hydrochloride),C4077,894-71-3,Neuroscience,5-HT Receptor,norepinephrine and serotonin transporters blocker,CNCC/C=C1C2=C(C=CC=C2)CCC3=C/1C=CC=C3.Cl,103.1,2.5
Noscapine HCl,A8479,912-60-7,Others,Others,Multi-action opioid alkaloid,CN1CCC2=CC3=C(C(=C2C1C4C5=C(C(=C(C=C5)OC)OC)C(=O)O4)OC)OCO3.Cl,105.9,2.5
Novobiocin Sodium,B1992,1476-53-5,DNA Damage/DNA Repair,Topoisomerase,aminocoumarin antibiotic,CC1=C(C=CC2=C1OC(=O)C(=C2O)NC(=O)C3=CC(=C(C=C3)[O-])CC=C(C)C)OC4C(C(C(C(O4)(C)C)OC)OC(=O)N)O.[Na+],111.8,11.5
Nuciferine,N1578,475-83-2,Natural Products,Others,1,1,97.5,6.4
Nystatin (Fungicidin),B1993,1400-61-9,Microbiology & Virology,Antibiotic,antifungal antibiotic,CC1C=CC=CCCC=CC=CC=CC=CC(CC2C(C(CC(O2)(CC(C(CCC(CC(CC(CC(=O)OC(C(C1O)C)C)O)O)O)O)O)O)O)C(=O)O)OC3C(C(C(C(O3)C)O)N)O,102.1,1.9
ODM-201,A8452,1297538-32-9,Endocrinology and Hormones,Androgen Receptor,1,1,102.2,0.8
Obeticholic Acid,B4888,459789-99-2,Others,FXR,FXR agonist with anticholeretic activity,CCC1C2CC(CCC2(C3CCC4(C(C3C1O)CCC4C(C)CCC(=O)O)C)C)O,119.4,26.9
Octreotide acetate,B4979,83150-76-9,GPCR/G protein,Somatostatin Receptor,octapeptide congener of native somatostatin,CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O.CC(=O)O,110.5,14.6
Ofloxacin,A5511,82419-36-1,DNA Damage/DNA Repair,Topoisomerase,"Fluoroquinolones,antibiotics",FC1=C(C2=C(C3=C1[H])N(C([H])=C(C(O[H])=O)C3=O)C(C([H])([H])[H])([H])C([H])([H])O2)N4C([H])([H])C([H])([H])N(C([H])([H])[H])C([H])([H])C4([H])[H],83.2,2.9
Olanzapine,B2240,132539-06-1,Neuroscience,5-HT Receptor,Antagonist of 5-HT2A and dopamine D2 receptors,CC1=CC2=C(NC3=CC=CC=C3N=C2S1)N4CCN(CC4)C,103.2,0.7
"Olaparib (AZD2281, Ku-0059436)",A4154,763113-22-0,Chromatin/Epigenetics,PARP,Potent PARP1/PARP2 inhibitor,C1CC1C(=O)N2CCN(CC2)C(=O)C3=C(C=CC(=C3)CC4=NNC(=O)C5=CC=CC=C54)F,32.7,5.8
Oleanolic acid,N1826,508-02-1,Natural Products,Anti-infection,1,1,98.7,2.4
Oleic Acid,C4977,112-80-1,Others,Others,1,CCCCCCCC/C=C\CCCCCCCC(O)=O,105.0,10.9
Olmesartan,A3681,144689-24-7,GPCR/G protein,Angiotensin Receptor,Angiotensin II receptor antagonist,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)C(C)(C)O,111.1,10.7
Olmesartan medoxomil,A4082,144689-63-4,Proteases,ACE,AT1 receptor antagonist,CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O,99.6,20.5
Olopatadine HCl,B1576,140462-76-6,Neuroscience,Histamine Receptor,Histamine blocker,CN(C)CCC=C1C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O.Cl,110.0,14.9
Olprinone Hydrochloride,A3683,119615-63-3,Metabolism,PDE,"Phosphodiesterase 3 (PDE3) inhibitor, selective",CC1=C(C=C(C(=O)N1)C#N)C2=CN3C=CN=C3C=C2.Cl,103.0,2.6
Olsalazine Sodium,A8490,6054-98-4,Microbiology & Virology,Antibiotic,Anti-inflammatory prodrug,C1=CC(=C(C=C1NN=C2C=CC(=O)C(=C2)C(=O)O)C(=O)[O-])[O-].[Na+].[Na+],88.5,6.7
Oltipraz,B5958,64224-21-1,Immunology/Inflammation,Nrf2,Nrf2 activator;An antischistosomal agent,CC(C1=S)=C(SS1)C2=CN=CC=N2,99.9,11.0
Omeprazole,A2845,73590-58-6,Ubiquitination/Proteasome,Autophagy,"H+,K+-ATPase inhibitor",CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC,98.7,5.1
Ondansetron,B2241,99614-02-5,Neuroscience,5-HT Receptor,1,1,106.7,16.0
Ondansetron HCl,A5166,99614-01-4,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.Cl,104.9,11.1
Ondansetron hydrochloride dihydrate,B1204,103639-04-9,Neuroscience,5-HT Receptor,5-HT3 receptor antagonist,CC1=NC=CN1CC2CCC3=C(C2=O)C4=CC=CC=C4N3C.O.O.Cl,110.6,3.7
Orlistat,A8492,96829-58-2,Others,Others,Lipase inhibitor for obesity treatment,CCCCCCCCCCCC(CC1C(C(=O)O1)CCCCCC)OC(=O)C(CC(C)C)NC=O,91.5,13.5
Ornidazole,B1996,16773-42-5,Microbiology & Virology,Anti-infection,anti-bacterial and anti-protozoal drug,CC1=NC=C(N1CC(CCl)O)[N+](=O)[O-],100.6,5.5
Orotic acid,B1147,65-86-1,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Pyrimidinecarboxylic acid,C1=C(NC(=O)NC1=O)C(=O)O,99.0,15.3
Orphenadrine Citrate,B1606,4682-36-4,Neuroscience,AChR,Antiparkinsonian and analgesic drug,CC1=CC=CC=C1C(C2=CC=CC=C2)OCCN(C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,111.6,2.6
Oseltamivir,A3688,196618-13-0,Microbiology & Virology,1,inhibitor of influenza neuraminidase,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC,97.0,1.0
Oseltamivir acid,A3689,187227-45-8,Microbiology & Virology,1,Influenza neuraminidase inhibitor,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)O,98.5,2.5
Oseltamivir phosphate,B1803,204255-11-8,Microbiology & Virology,1,Potent and selective inhibitor of the neuraminidase,CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)OCC.OP(=O)(O)O,96.1,4.1
Ospemifene,B4871,128607-22-7,Endocrinology and Hormones,Estrogen/progestogen Receptor,non-hormonal selective estrogen receptor modulator (SERM),C1=CC=C(C=C1)C(=C(C2=CC=CC=C2)C3=CC=C(C=C3)OCCO)CCCl,93.5,9.5
Osthole,N1825,484-12-8,Natural Products,Others,1,1,101.0,0.0
Otilonium Bromide,B1607,26095-59-0,Neuroscience,AChR,AChR inhibitor,CCCCCCCCOC1=CC=CC=C1C(=O)NC2=CC=C(C=C2)C(=O)OCC[N+](C)(CC)CC.[Br-],107.2,19.0
Ouabain,B2270,630-60-4,Membrane Transporter/Ion Channel,Sodium Channel,selective Na+/K+-ATPase inhibitor,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,97.6,5.3
Ouabain Octahydrate,B3436,11018-89-6,Others,Others,selective Na+/K+-ATPase inhibitor,CC1C(C(C(C(O1)OC2CC(C3(C4C(CCC3(C2)O)C5(CCC(C5(CC4O)C)C6=CC(=O)OC6)O)CO)O)O)O)O,99.5,5.8
Oxacillin sodium monohydrate,B1997,7240-38-2,Microbiology & Virology,Anti-infection,an antibiotic used in resistant staphylococci infections,CC1=C(C(=NO1)C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].O.[Na+],105.6,5.1
Oxaliplatin,A8648,61825-94-3,DNA Damage/DNA Repair,DNA Synthesis,Antitumor agent,C1CCC(C(C1)N)N.C(=O)(C(=O)[O-])[O-].[Pt+2],104.7,4.6
Oxaprozin,B1804,21256-18-8,Neuroscience,COX,COX inhibitor,C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3,102.7,2.9
Oxcarbazepine,B2279,28721-07-5,Membrane Transporter/Ion Channel,Sodium Channel,BTX inhibitor,C1C2=CC=CC=C2N(C3=CC=CC=C3C1=O)C(=O)N,106.5,6.4
Oxeladin Citrate,A8493,52432-72-1,Others,Others,Cough suppressant,CCC(CC)(C1=CC=CC=C1)C(=O)OCCOCCN(CC)CC.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,103.3,8.1
Oxethazaine,A8494,126-27-2,Others,Others,Topical anesthetic,CC(C)(CC1=CC=CC=C1)N(C)C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC2=CC=CC=C2,98.0,8.8
Oxfendazole,B1998,53716-50-0,Microbiology & Virology,Anti-infection,broad spectrum benzimidazole anthelmintic,COC(=O)NC1=NC2=C(N1)C=C(C=C2)S(=O)C3=CC=CC=C3,98.8,6.2
Oxibendazole,B1999,20559-55-1,Microbiology & Virology,Anti-infection,1,1,22.2,17.7
Oxiconazole (nitrate),C3418,64211-46-7,Microbiology & Virology,Antibiotic,antifungal imidazole,ClC1=CC(Cl)=C(/C(CN2C=NC=C2)=N/OCC3=C(Cl)C=C(Cl)C=C3)C=C1.[O-][N+](O)=O,87.4,21.0
Oxiracetam,B4748,62613-82-5,Others,Others,cyclic derivative of gamma-aminobutyric acid (GABA),N=C(O)CN1CC(O)CC1=O,101.7,8.3
Oxybenzone,B4737,131-57-7,Others,Others,sunscreen agent,1,99.8,1.6
Oxybuprocaine HCl,B1805,5987-82-6,Membrane Transporter/Ion Channel,Sodium Channel,Local anesthetic,CCCCOC1=C(C=CC(=C1)C(=O)OCCN(CC)CC)N.Cl,92.8,7.9
Oxybutynin,A8495,5633-20-5,Neuroscience,AChR,AChR antagonist,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O,116.0,8.1
Oxybutynin chloride,B1134,1508-65-2,Neuroscience,AChR,Anticholinergic medication,CCN(CC)CC#CCOC(=O)C(C1CCCCC1)(C2=CC=CC=C2)O.Cl,99.9,3.0
Oxytetracycline (Terramycin),B2000,79-57-2,Microbiology & Virology,Antibiotic,broad-spectrum tetracycline antibiotic,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O,102.5,5.2
Oxytetracycline Dihydrate,B2001,6153-64-6,Microbiology & Virology,Anti-infection,prescription antibiotic,CC1(C2C(C3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O)O.O.O,111.8,9.8
Oxytocin,B4723,50-56-6,Others,Others,mammalian neurohypophysial hormone,1,96.8,8.6
Ozagrel,A4344,82571-53-7,Metabolism,Factor Xa,Thromboxane A2 synthetase inhibitor,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O,112.8,2.0
Ozagrel HCl,B2116,78712-43-3,Metabolism,P450 (e.g. CYP17),Potent and selective inhibitor of thromboxane (TXA2) synthetase,C1=CC(=CC=C1CN2C=CN=C2)C=CC(=O)O.Cl,100.3,17.9
Ozanimod (RPC1063),B6038,1306760-87-1,GPCR/G protein,S1P receptor,agonist of the sphingosine-1-phosphate receptor subtypes 1 and 5,CC(OC1=C(C#N)C=C(C2=NC(C3=CC=CC4=C3CC[C@]4([H])NCCO)=NO2)C=C1)C,104.3,0.7
PA-824,A1736,187235-37-6,Others,Others,1,1,92.3,4.0
PCI-24781 (CRA-024781),A4098,783355-60-2,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor,CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO,104.9,0.2
PCI-32765 (Ibrutinib),A3001,936563-96-1,Angiogenesis,BTK,Bruton's tyrosine kinase (BTK) inhibitor,C=CC(=O)N1CCCC(C1)N2C3=C(C(=N2)C4=CC=C(C=C4)OC5=CC=CC=C5)C(=NC=N3)N,85.3,12.0
PD 0332991 (Palbociclib) HCl,A8316,827022-32-2,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective",O=C1N(C2=NC(NC3=NC=C(C=C3)N4CCNCC4)=NC=C2C(C)=C1C(C)=O)C5CCCC5.Cl,104.4,1.1
PF-04449913,B3283,1095173-27-5,Stem Cell,Smoothened,1,1,101.7,2.0
PF-06463922,B4882,1454846-35-5,Tyrosine Kinase,ALK,1,1,137.3,16.0
PMSF,A2587,329-98-6,Proteases,Serine Protease,"Serine proteinases inhibitor, irreversible",C1=CC=C(C=C1)CS(=O)(=O)F,123.8,8.8
PSI-7977,A3738,1190307-88-0,DNA Damage/DNA Repair,DNA Synthesis,Antiviral agents for chronic HCV infection,CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3,101.0,20.4
PTC124 (Ataluren),A8553,775304-57-9,Membrane Transporter/Ion Channel,CFTR,CFTR-G542X nonsense allele inhibitor,C1=CC=C(C(=C1)C2=NC(=NO2)C3=CC(=CC=C3)C(=O)O)F,108.5,7.8
Paclitaxel (Taxol),A4393,33069-62-4,Cell Cycle/Checkpoint,Microtubule/Tubulin,Antineoplastic agent,O=C(N[C@H]([C@H](C(O[C@H]1C[C@]2(O)C(C)(C)C([C@@H](OC(C)=O)C([C@@]3(C)[C@]([C@@](CO4)(OC(C)=O)[C@H]4C[C@@H]3O)([H])[C@@H]2OC(C5=CC=CC=C5)=O)=O)=C1C)=O)O)C6=CC=CC=C6)C7=CC=CC=C7,9.2,4.9
Palbociclib (PD0332991) Isethionate,A8335,827022-33-3,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK4/6 inhibitor,highly selective",CC1=C(C(=O)N(C2=NC(=NC=C12)NC3=NC=C(C=C3)N4CCNCC4)C5CCCC5)C(=O)C.C(CS(=O)(=O)O)O,117.4,17.2
Paliperidone,A8496,144598-75-4,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,CC1=C(C(=O)N2CCCC(C2=N1)O)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,105.0,6.1
Palmitic Acid methyl ester,C5107,112-39-0,Others,Others,1,CCCCCCCCCCCCCCCC(OC)=O,92.2,0.9
Palmitic acid,N2456,57-10-3,Natural Products,Others,1,1,115.0,15.9
Palonosetron HCl,B2229,135729-62-3,Neuroscience,5-HT Receptor,5-HT receptor antagonist,C1CC2CN(C(=O)C3=C2C(=CC=C3)C1)C4CN5CCC4CC5.Cl,87.2,6.0
Pamidronate,B1807,40391-99-9,Stem Cell,Wnt/β-catenin,Supportive care drug in the category of bisphosphonates,C(CN)C(O)(P(=O)(O)O)P(=O)(O)O,103.8,7.5
Pamidronate Disodium,A2456,57248-88-1,Others,Others,Bisphosphonate antiresorptive agent & bone resorption inhibitor,C(CN)C(O)(P(=O)(O)[O-])P(=O)(O)[O-].[Na+].[Na+],119.1,5.4
Panaxtriol,N1949,32791-84-7,Natural Products,Others,1,1,123.5,35.6
Pancuronium dibromide,B1612,15500-66-0,Neuroscience,AChR,AChR antagonist,CC(=O)OC1CC2CCC3C(C2(CC1[N+]4(CCCCC4)C)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-].[Br-],93.5,7.8
Panobinostat (LBH589),A8178,404950-80-7,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO,97.7,5.4
Pantoprazole,B4720,102625-70-7,Membrane Transporter/Ion Channel,Proton Pump,H+/K+-ATPase inhibitor,1,114.4,3.3
Parecoxib Sodium,B1239,198470-85-8,Neuroscience,COX,COX-2 inhibitor,CCC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)C2=C(ON=C2C3=CC=CC=C3)C.[Na+],99.0,2.9
Pargyline (hydrochloride),C3106,306-07-0,Metabolism,MAO,MAO inhibitor,CN(CC#C)CC1=CC=CC=C1.Cl,99.6,6.5
Paromomycin Sulfate,B1808,1263-89-4,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)O)N)OC3C(C(C(O3)CO)OC4C(C(C(C(O4)CN)O)O)N)O)O)N.OS(=O)(=O)O,105.9,6.1
Paroxetine HCl,B2252,78246-49-8,Neuroscience,AChR,Antidepressant agents,C1CNCC(C1C2=CC=C(C=C2)F)COC3=CC4=C(C=C3)OCO4.Cl,102.0,14.1
Parthenolide,N1315,20554-84-1,DNA Damage/DNA Repair,HDAC,1,1,105.0,4.6
Pasiniazid,A8497,2066-89-9,Others,Others,Anti-TB and anti-leprosy drug,C1=CC(=C(C=C1N)O)C(=O)O.C1=CN=CC=C1C(=O)NN,86.1,13.8
Pazopanib (GW-786034),A3022,444731-52-6,Tyrosine Kinase,PDGFR,VEGFR/PDGFR/FGFR inhibitor,CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl,111.6,13.7
Pazopanib Hydrochloride,A8347,635702-64-6,Tyrosine Kinase,VEGFR,1,1,110.8,12.9
Pefloxacin Mesylate,B2003,70458-95-6,Microbiology & Virology,Antibiotic,synthetic chemotherapeutic agent， antibacterial agent,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O,107.0,12.1
Pefloxacin Mesylate Dihydrate,B2291,149676-40-4,Microbiology & Virology,Antibiotic,third generation of fluoroquinolone class of antibacterials,CCN1C=C(C(=O)C2=CC(=C(C=C21)N3CCN(CC3)C)F)C(=O)O.CS(=O)(=O)O.O.O,104.7,5.3
Pelitinib (EKB-569),A1835,257933-82-7,JAK/STAT Signaling,EGFR,"EGFR inhibitor,potent and irreversible",CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)C=CCN(C)C,45.0,10.6
Pemetrexed,A4390,150399-23-8,Metabolism,DHFR,"TS, DHFR,GARFT and AICARFT inhibitor",C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)[O-])C(=O)[O-].[Na+].[Na+],101.3,4.8
Pemetrexed disodium hemipenta hydrate,A3707,357166-30-4,Apoptosis,Thymidylate Synthase,Antifolate and antimetabolite agent,C1=CC(=CC=C1CCC2=CNC3=C2C(=O)N=C(N3)N)C(=O)NC(CCC(=O)O)C(=O)O.O.[Na+],55.8,2.8
Pemirolast potassium,B1563,100299-08-9,Neuroscience,Histamine Receptor,Histamine H1 receptor antagonist,CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+],110.6,4.7
Penciclovir,B1809,39809-25-1,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,HSV-1 DNA synthesis inhibitor,C1=NC2=C(N1CCC(CO)CO)NC(=NC2=O)N,105.0,8.1
Penfluridol,B1810,26864-56-2,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,C1CN(CCC1(C2=CC(=C(C=C2)Cl)C(F)(F)F)O)CCCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,99.3,4.2
Penicillamine,B8692,52-67-5,Others,Others,"Orally bioavailable copper chelator, antirheumatic",1,117.0,22.0
Penicillin G Sodium,B1678,69-57-8,Microbiology & Virology,Anti-infection,penicillin antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Na+],108.9,0.9
Pentadecanoic Acid,C4902,1002-84-2,Others,Others,1,OC(CCCCCCCCCCCCCC)=O,94.7,7.3
Pentamidine isethionate,B4980,140-64-7,Microbiology & Virology,Antibiotic,Drug to treat protozoal diseases,NC(C1=CC=C(OCCCCCOC2=CC=C(C(N)=N)C=C2)C=C1)=N.OCCS(O)(=O)=O.OCCS(O)(=O)=O,103.1,18.8
Pentostatin,A3708,53910-25-1,GPCR/G protein,Adenosine Receptor,Irreversible adenosine deaminase inhibitor,C1C(C(OC1N2C=NC3=C2NC=NCC3O)CO)O,92.8,7.7
Pentoxifylline,C3816,6493-05-6,Others,Others,1,CC(CCCCN1C(N(C)C(N=CN2C)=C2C1=O)=O)=O,108.1,4.7
Pentoxyverine Citrate,B1811,23142-01-0,Neuroscience,AChR,AChR antagonist,CCN(CC)CCOCCOC(=O)C1(CCCC1)C2=CC=CC=C2.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,93.8,9.9
Peramivir,A3709,330600-85-6,Microbiology & Virology,1,Aeuraminidase inhibitor;antiviral drug,CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C,105.8,1.8
Peramivir Trihydrate,B2147,1041434-82-5,Microbiology & Virology,1,"potent, specific influenza viral neuraminidase inhibitor",CCC(CC)C(C1C(CC(C1O)C(=O)O)N=C(N)N)NC(=O)C.O.O.O,103.0,4.5
Pergolide mesylate,B1485,66104-23-2,Neuroscience,Dopamine Receptor,Dopaminergic agonist,CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC.CS(=O)(=O)O,103.1,3.8
Perifosine,A8309,157716-52-4,PI3K/Akt/mTOR Signaling,Akt,1,1,113.3,14.4
Perindopril Erbumine,A8019,107133-36-8,Endocrinology and Hormones,RAAS,ACE inhibitor,CCCC(C(=O)OCC)NC(C)C(=O)N1C2CCCCC2CC1C(=O)O.CC(C)(C)N,98.1,0.7
Perphenazine,B6157,58-39-9,Neuroscience,Dopamine Receptor,dopamine antagonist,ClC1=CC(N(C2=CC=CC=C2S3)CCCN4CCN(CCO)CC4)=C3C=C1,101.4,2.5
Pexidartinib (PLX3397),B5854,1029044-16-3,Tyrosine Kinase,CSF-1R,CSF-1R inhibitor,ClC(C=N1)=CC2=C1NC=C2CC3=CN=C(NCC4=CN=C(C(F)(F)F)C=C4)C=C3,41.3,7.2
Pexmetinib (ARRY-614),B6012,945614-12-0,MAPK Signaling,p38,dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase,CC1=CC=C(N2C(NC(NCC3=CC(F)=CC=C3OC4=CC=C5C(C=NN5CCO)=C4)=O)=CC(C(C)(C)C)=N2)C=C1,97.4,0.9
Phenacetin,B1453,62-44-2,Neuroscience,COX,Non-opioid analgesic,CCOC1=CC=C(C=C1)NC(=O)C,105.2,6.4
Phenazopyridine HCl,B1812,136-40-3,Membrane Transporter/Ion Channel,Sodium Channel,Local analgesic,C1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,105.3,10.0
Phenformin HCl,B1373,834-28-6,Others,Others,biguanidine drug with anti-diabetic activity,C1=CC=C(C=C1)CCN=C(N)N=C(N)N.Cl,86.1,7.7
Phenindione,B1813,83-12-5,Metabolism,Vitamin,Anticoagulant,C1=CC=C(C=C1)C2C(=O)C3=CC=CC=C3C2=O,98.3,8.3
Pheniramine Maleate,B1814,132-20-7,Neuroscience,Histamine Receptor,Histamine receptor antagonist,CN(C)CCC(C1=CC=CC=C1)C2=CC=CC=N2.C(=CC(=O)O)C(=O)O,102.1,0.3
Phenoxybenzamine HCl,B1343,63-92-3,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,CC(COC1=CC=CC=C1)N(CCCl)CC2=CC=CC=C2.Cl,78.9,10.0
Phentolamine Mesylate,B1363,65-28-1,GPCR/G protein,Adrenergic Receptor,Alpha 1/2-blocking agent,CC1=CC=C(C=C1)N(CC2=NCCN2)C3=CC(=CC=C3)O.CS(=O)(=O)O,98.1,6.4
Phenylbutazone,B2004,50-33-9,Others,Others,non-steroidal anti-inflammatory agent,CCCCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3,95.6,4.8
Phenylephrine HCl,B1344,61-76-7,GPCR/G protein,Adrenergic Receptor,Selective α1-adrenergic receptor agonist,CNCC(C1=CC(=CC=C1)O)O.Cl,104.7,2.4
Phenylpiracetam,A3722,77472-70-9,Others,Others,Nootropic derivative of piracetam,O=C1N(CC(N)=O)CC(C2=CC=CC=C2)C1,114.6,20.3
Phenytoin,B2271,57-41-0,Membrane Transporter/Ion Channel,Sodium Channel,inactive voltage-gated sodium channel stabilizer,C1=CC=C(C=C1)C2(C(=O)NC(=O)N2)C3=CC=CC=C3,102.5,2.2
Phenytoin sodium,B2272,630-93-3,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel stabilizer,C1=CC=C(C=C1)C2(C(=O)NC(=N2)[O-])C3=CC=CC=C3.[Na+],102.7,11.4
Phloridzin,N1876,60-81-1,Natural Products,SGLT,1,C1=CC(=CC=C1CCC(=O)C2=C(C=C(C=C2OC3C(C(C(C(O3)CO)O)O)O)O)O)O,105.9,6.4
Phosphocreatine disodium salt,B7648,922-32-7,Others,Miscellaneous Compounds,used to regenerate ATP during skeletal muscle contraction,OC(CN(C)/C(N)=N/P([O-])([O-])=O)=O.[Na+].[Na+],96.8,0.6
Phthalic acid,C6308,88-99-3,Others,Others,1,1,114.4,20.1
Phytol,C5616,150-86-7,Others,RAR/RXR,activator of retinoid X receptors (RXRs),CC(CCC[C@@H](C)CCC[C@@H](C)CCC/C(C)=C/CO)C,96.3,1.8
Pidotimod,B2005,121808-62-6,Immunology/Inflammation,1,immunostimulant,C1CC(=O)NC1C(=O)N2CSCC2C(=O)O,113.9,16.6
Pilocarpine HCl,B1816,54-71-7,Neuroscience,AChR,Nonselective muscarinic acetylcholine receptor agonist,Cl[H].O=C1OC([H])([H])[C@@](C([H])([H])C2=C([H])N=C([H])N2C([H])([H])[H])([H])[C@]1([H])C([H])([H])C([H])([H])[H],96.7,5.9
Pimasertib (AS-703026),A5573,1236699-92-5,MAPK Signaling,MEK1/2,MEK1/2 inhibitor,C1=CC(=C(C=C1I)F)NC2=C(C=CN=C2)C(=O)NCC(CO)O,10.3,1.0
Pimavanserin,B8019,706779-91-1,GPCR/G protein,5-HT Receptor,5-HT2A inverse agonist,FC1=CC=C(C=C1)CN(C(NCC(C=C2)=CC=C2OCC(C)C)=O)C3CCN(C)CC3,97.9,4.3
Pimecrolimus,B1817,137071-32-0,Immunology/Inflammation,1,"inhibitor of inflammatory cytokines secretion, cell-selective",CO[C@@H]1C[C@H](/C=C(C)/[C@@H](OC([C@]2([H])CCCCN2C(C([C@]3(O)O[C@H]([C@@H](OC)C[C@H](C/C(C)=C/4)C)[C@@H](OC)C[C@H]3C)=O)=O)=O)[C@H](C)[C@H](CC([C@@H]4CC)=O)O)CC[C@@H]1Cl,85.6,10.7
Pimobendan,A4340,74150-27-9,Metabolism,PDE,Selective PDE3 inhibitor.Ca2+ channel sensitizer,CC1CC(=O)NN=C1C2=CC3=C(C=C2)N=C(N3)C4=CC=C(C=C4)OC,95.5,1.5
Pimozide,C3837,2062-78-4,Neuroscience,Dopamine Receptor,dopamine receptors inhibitor,FC1=CC=C(C(CCCN2CCC(N3C(NC4=C3C=CC=C4)=O)CC2)C5=CC=C(F)C=C5)C=C1,83.3,1.2
Pioglitazone,B2117,111025-46-8,Metabolism,PPAR,PPAR agonist,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3,100.0,5.5
Pioglitazone HCl,A4324,112529-15-4,Metabolism,PPAR,PPARγ agonist,CCC1=CN=C(C=C1)CCOC2=CC=C(C=C2)CC3C(=O)NC(=O)S3.Cl,100.9,1.5
Piperacillin Sodium,B1818,59703-84-3,Microbiology & Virology,Anti-infection,"Semisynthetic, broad-spectrum, ampicillin derived ureidopenicillin antibiotic",CCN1CCN(C(=O)C1=O)C(=O)NC(C2=CC=CC=C2)C(=O)NC3C4N(C3=O)C(C(S4)(C)C)C(=O)[O-].[Na+],100.5,2.6
Piperazine,C6183,110-85-0,Neuroscience,GABA Receptor,1,1,101.7,2.7
Piperine,N1674,94-62-2,Natural Products,P450 (e.g. CYP17),MAPK inhibitor,C1CCN(CC1)C(=O)C=CC=CC2=CC3=C(C=C2)OCO3,97.8,1.6
Pirarubicin,B2295,72496-41-4,DNA Damage/DNA Repair,Topoisomerase,1,1,100.1,0.2
Pirfenidone,B2288,53179-13-8,TGF-β / Smad Signaling,SMAD,TGF-β production inhibitor,CC1=CN(C(=O)C=C1)C2=CC=CC=C2,104.1,17.1
Piromidic Acid,A8502,19562-30-2,Others,Others,Quinolone antibiotic,CCN1C=C(C(=O)C2=CN=C(N=C21)N3CCCC3)C(=O)O,94.3,6.7
Piroxicam,A8503,36322-90-4,Neuroscience,COX,Prostaglandin synthesis/Coxinhibitor,CN1C(=C(C2=CC=CC=C2S1(=O)=O)O)C(=O)NC3=CC=CC=N3,99.2,15.4
Pitavastatin,B1124,147511-69-1,Metabolism,HMG-CoA Reductase,HMG-CoA reductase inhibitor,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)O)O)O)C4=CC=C(C=C4)F,102.3,3.2
Pitavastatin Calcium,A8504,147526-32-7,Metabolism,HMG-CoA Reductase,Enzyme HMGCR inhibitor,C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.C1CC1C2=NC3=CC=CC=C3C(=C2C=CC(CC(CC(=O)[O-])O)O)C4=CC=C(C=C4)F.[Ca+2],101.0,1.8
Pitolisant hydrochloride,A3727,903576-44-3,Neuroscience,Histamine Receptor,Nonimidazole inverse agonist,C1CCN(CC1)CCCOCCCC2=CC=C(C=C2)Cl.Cl,72.5,4.5
Pizotifen,B1206,15574-96-6,Neuroscience,5-HT Receptor,Highly selective 5-HT receptor blocking agent,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1,119.0,11.0
Pizotifen Malate,B2007,5189-11-7,Neuroscience,5-HT Receptor,5-HT receptor antagonist,CN1CCC(=C2C3=C(CCC4=CC=CC=C42)SC=C3)CC1.C(C(C(=O)O)O)C(=O)O,110.3,11.3
Plerixafor (AMD3100),A2025,110078-46-1,GPCR/G protein,CXCR,CXCR4 chemokine receptor antagonist,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3,99.8,7.2
Plerixafor 8HCl (AMD3100 8HCl),B1465,155148-31-5,GPCR/G protein,CXCR,CXCR4 antagonist,C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3.Cl.Cl.Cl.Cl.Cl.Cl.Cl.Cl,84.3,2.1
Podophyllotoxin,N1790,518-28-5,DNA Damage/DNA Repair,Topoisomerase,1,1,114.2,22.6
Polydatin,N1783,27208-80-6,Natural Products,Phospholipase (e.g. PLA),1,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)OC3C(C(C(C(O3)CO)O)O)O)O)O,102.2,5.2
Pomalidomide (CC-4047),A4212,19171-19-8,Apoptosis,TNF-α,"Immunomodulator,antumor/anti-angiogenic",C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)N,109.9,8.4
Ponatinib (AP24534),A5467,943319-70-8,TGF-β / Smad Signaling,Bcr-Abl,"pan-BCR-ABL inhibitor,multi-kinase inhibitor",CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5,100.1,9.9
Posaconazole,A1718,171228-49-2,Metabolism,C14ɑ demethylase,Sterol C14ɑ demethylase inhibitor,CCC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5CC(OC5)(CN6C=NC=N6)C7=C(C=C(C=C7)F)F,82.3,6.4
Potassium Canrenoate,A8506,2181-04-6,Others,Others,Aldosterone antagonist,CC12CCC(=O)C=C1C=CC3C2CCC4(C3CCC4(CCC(=O)[O-])O)C.[K+],101.2,3.7
Potassium Iodide,B2008,7681-11-0,Others,Others,metal halide with thyroid protecting and expectorant properties,[K+].[I-],94.9,1.6
Poziotinib,B5827,1092364-38-9,Tyrosine Kinase,HER2,irreversible pan-HER inhibitor,C=CC(N1CCC(OC2=C(OC)C=C3C(C(NC4=C(F)C(Cl)=C(Cl)C=C4)=NC=N3)=C2)CC1)=O,102.3,2.1
Pracinostat (SB939),A4095,929016-96-6,DNA Damage/DNA Repair,HDAC,Pan-HDAC inhibitor,CCCCC1=NC2=C(N1CCN(CC)CC)C=CC(=C2)C=CC(=O)NO,-14.8,1.9
Pralatrexate,A4350,146464-95-1,Metabolism,DHFR,"Antifolate,a folate analog",C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,108.2,0.1
Pramipexole,B1488,104632-26-0,Neuroscience,Dopamine Receptor,Dopamine agonist,CCCNC1CCC2=C(C1)SC(=N2)N,98.3,0.9
Pramipexole 2HCl Monohydrate,B1487,191217-81-9,Neuroscience,Dopamine Receptor,Novel non-ergoline dopamine receptor agonist,CCCNC1CCC2=C(C1)SC(=N2)N.O.Cl.Cl,98.6,7.2
Pramipexole dihydrochloride,A3733,104632-25-9,Neuroscience,Dopamine Receptor,Dopamine receptor agonist,CCCNC1CCC2=C(C1)SC(=N2)N.Cl.Cl,102.6,0.6
Pramiracetam,B2118,68497-62-1,Others,Others,nootropic drug,CC(C)N(CCNC(=O)CN1CCCC1=O)C(C)C,98.4,10.9
Pramoxine HCl,B1819,637-58-1,Others,Others,Local anesthetic,CCCCOC1=CC=C(C=C1)OCCCN2CCOCC2.Cl,94.3,3.4
Pranlukast,B2009,103177-37-3,Immunology/Inflammation,Leukotriene Receptor,"selective antagonist of the cysteinyl leukotrienes (LT) C(4), LTD(4) and LTE(4),",C1=CC=C(C=C1)CCCCOC2=CC=C(C=C2)C(=O)NC3=CC=CC4=C3OC(=CC4=O)C5=NNN=N5,98.7,2.2
Pranoprofen,B2010,52549-17-4,Neuroscience,COX,non-steroidal COX inhibitor,CC(C1=CC2=C(C=C1)OC3=C(C2)C=CC=N3)C(=O)O,102.0,5.2
Prasugrel,A1607,150322-43-3,Neuroscience,P2 Receptor,ADP receptor inhibitor,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4,107.9,2.0
Prasugrel hydrochloride,B1283,389574-19-0,GPCR/G protein,P2Y Receptor,P2 Receptor inhibitor,CC(=O)OC1=CC2=C(S1)CCN(C2)C(C3=CC=CC=C3F)C(=O)C4CC4.Cl,103.2,2.8
Pravastatin,B1125,81093-37-0,Metabolism,HMG-CoA Reductase,1,1,96.3,8.2
Pravastatin sodium,A4369,81131-70-6,Metabolism,HMG-CoA Reductase,"HMG-CoA reductase inhibitor,highly selective and competitive",CCC(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC(CC(CC(=O)[O-])O)O)O.[Na+],65.6,12.9
Praziquantel,B2011,55268-74-1,Microbiology & Virology,Antibiotic,anthelmintic,C1CCC(CC1)C(=O)N2CC3C4=CC=CC=C4CCN3C(=O)C2,98.5,4.3
Prazosin HCl,A5318,19237-84-4,GPCR/G protein,Adrenergic Receptor,α1 and α2B-adrenoceptor antagonist,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4=CC=CO4)N)OC.Cl,102.5,12.8
Prednisolone,B2012,50-24-8,GPCR/G protein,Glucocorticoid Receptor,synthetic glucocorticoid,CC12CC(C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C)O,60.8,6.4
Prednisolone Acetate,B2013,52-21-1,GPCR/G protein,Glucocorticoid Receptor,synthetic corticosteroid drug,CC(=O)OCC(=O)C1(CCC2C1(CC(C3C2CCC4=CC(=O)C=CC34C)O)C)O,61.9,0.7
Prednisone,B2148,1953-3-2,Others,Others,Glucocorticoid receptor agonist,CC12CC(=O)C3C(C1CCC2(C(=O)CO)O)CCC4=CC(=O)C=CC34C,98.3,4.2
Pregnenolone,B1512,145-13-1,Neuroscience,AChR,steroid hormone,CC(=O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C,97.2,7.4
Pridinol Methanesulfonate,A8507,6856-31-1,Others,Others,Anticholinergic / antiparkinsonian agent,CS(=O)(=O)O.C1CCN(CC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)O,104.7,1.6
Prilocaine,B2119,721-50-6,Others,Others,local anesthetic of the amino amide type,CCCNC(C)C(=O)NC1=CC=CC=C1C,107.2,5.5
Prilocaine hydrochloride,B1280,1786-81-8,Others,Others,Local anesthetic of the amino amide type,CCCNC(C)C(=O)NC1=CC=CC=C1C.Cl,107.2,1.3
Primaquine Diphosphate,B1820,63-45-6,Microbiology & Virology,Antimalaria,"antimalarial agent,blocks protein synthesis",CC(CCCN)NC1=C2C(=CC(=C1)OC)C=CC=N2.OP(=O)(O)O.OP(=O)(O)O,104.2,10.9
Primidone,B2120,125-33-7,Membrane Transporter/Ion Channel,Sodium Channel,anticonvulsant of the pyrimidinedione class,CCC1(C(=O)NCNC1=O)C2=CC=CC=C2,97.9,0.3
Probenecid,B2014,57-66-9,Membrane Transporter/Ion Channel,TRPV,"inhibitor of organic anion transport, MRP and pannexin-1 channel",CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(=O)O,98.0,6.2
Probucol,B2015,23288-49-5,Metabolism,LDL,"Antioxidant, anti-inflammatory and hypocholesterolemic agent",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)SC(C)(C)SC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,109.4,15.3
Procainamide HCl,B4798,614-39-1,Membrane Transporter/Ion Channel,Sodium Channel,sodium channel blocker,CCN(CC)CCNC(=O)C1=CC=C(C=C1)N.Cl,105.7,6.2
Procaine,B3435,59-46-1,Others,Others,Sodium channel inhibitor,CCN(CC)CCOC(=O)C1=CC=C(C=C1)N,99.2,2.1
Procarbazine HCl,B1470,366-70-1,DNA Damage/DNA Repair,DNA Synthesis,Antineoplastic chemotherapy drug,CC(C)NC(=O)C1=CC=C(C=C1)CNNC.Cl,96.5,1.7
Prochlorperazine,A8508,58-38-8,Others,Others,Dopamine (D2) receptor antagonist,CN(CC1)CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(Cl)C=C4,67.2,7.0
Proflavine Hemisulfate,B1821,1811-28-5,Microbiology & Virology,Anti-infection,Slow-acting disinfectant with bacteriostatic action,C1=CC(=CC2=NC3=C(C=CC(=C3)[NH3+])C=C21)N.C1=CC(=CC2=NC3=C(C=CC(=C3)[NH3+])C=C21)N.[O-]S(=O)(=O)[O-],99.0,11.6
Progesterone,A8509,57-83-0,Endocrinology and Hormones,Estrogen/progestogen Receptor,Progesterone,CC(=O)C1CCC2C1(CCC3C2CCC4=CC(=O)CCC34C)C,104.6,6.3
Promethazine HCl,B4784,58-33-3,Neuroscience,Histamine Receptor,histamine H1 receptor antagonist,CC(N(C)C)CN1C2=CC=CC=C2SC3=CC=CC=C31.Cl,101.2,0.9
Propafenone HCl,B2281,34183-22-7,Membrane Transporter/Ion Channel,Sodium Channel,classic anti-arrhythmic medication,CCCNCC(COC1=CC=CC=C1C(=O)CCC2=CC=CC=C2)O.Cl,103.5,5.7
Proparacaine HCl,B2274,5875-6-9,Membrane Transporter/Ion Channel,Sodium Channel,voltage-gated sodium channels antagonist,CCCOC1=C(C=C(C=C1)C(=O)OCCN(CC)CC)N.Cl,102.4,3.9
Propofol,C6265,2078-54-8,1,1,1,1,105.9,6.6
Propranolol HCl,B1346,318-98-9,GPCR/G protein,Adrenergic Receptor,Competitive non-selective beta-adrenergic receptors inhibitor,CC(C)NCC(COC1=CC=CC2=CC=CC=C21)O.Cl,107.6,8.4
Propylparaben,C6171,94-13-3,Others,others,1,1,103.5,12.4
Propylthiouracil,B2121,51-52-5,Others,Others,thyroperoxidase and 5'-deiodinase inhibitor,CCCC1=CC(=O)NC(=S)N1,98.5,2.2
Prostaglandin E2,B7005,363-24-6,GPCR/G protein,Prostanoid Receptors,1,1,121.2,31.9
Prostaglandin F2&#945;,B7617,38562-01-5,GPCR/G protein,Prostanoid Receptors,Prostaglandin E2 and F2α receptor agonist,O[C@@H](C1)[C@H](C/C=C\CCCC(O)=O)[C@@H](/C=C/[C@H](CCCCC)O)[C@@H]1O.OCC(CO)(CO)N,98.8,2.2
Protionamide,B2016,14222-60-7,Microbiology & Virology,Anti-infection,thioamide derivative with antitubercular activity,CCCC1=NC=CC(=C1)C(=S)N,96.0,2.1
Protopine,N2275,130-86-9,Natural Products,Calcium Channel,1,1,103.3,0.9
Protoporphyrin IX,B8225,553-12-8,Others,Others,1,O=C(CCC1=C2/C=C3C(CCC(O)=O)=C(C(/C=C(C(C)=C/4C=C)\NC4=C/C5=N/C(C(C=C)=C5C)=C\C(N2)=C1C)=N/3)C)O,102.0,18.4
Proxyphylline,C3278,603-00-9,GPCR/G protein,Adenosine Receptor,A1 adenosine receptor antagonist,CN(C(N1C)=O)C2=C(N(CC(O)C)C=N2)C1=O,116.3,28.9
Prucalopride,B2253,179474-81-8,Neuroscience,5-HT Receptor,5-HT4A and 5-HT4B receptor agonist,COCCCN1CCC(CC1)NC(=O)C2=CC(=C(C3=C2OCC3)N)Cl,108.4,18.1
Prulifloxacin (Pruvel),P10019,123447-62-1,Others,APIs,1,1,93.0,14.2
Psoralen,N1332,66-97-7,Natural Products,TGFβ1,1,1,97.1,8.8
Puromycin dihydrochloride,B7587,58-58-2,DNA Damage/DNA Repair,DNA Synthesis,allows selection for cells expressing the resistance gene puromycin N-acetyl-transferase (PAC) and successful Cas9-induced knock-in with puromycin resistance gene.,O[C@H]1[C@H]([C@@H](CO)O[C@H]1N2C3=NC=NC(N(C)C)=C3N=C2)NC([C@H](CC(C=C4)=CC=C4OC)N)=O.Cl.Cl,91.3,10.0
Pyrantel Pamoate,B2149,22204-24-6,Microbiology & Virology,Anti-infection,anthelmintic agent,CN1CCCN=C1C=CC2=CC=CS2.C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)O)O)O)C(=O)O,107.2,1.0
Pyrazinamide,B2122,98-96-4,Microbiology & Virology,Antibiotic,antitubercular agent,C1=CN=C(C=N1)C(=O)N,115.6,12.1
Pyridostigmine Bromide,B1613,101-26-8,Neuroscience,AChE,Reversible cholinesterase inhibitor,C[N+]1=CC=CC(=C1)OC(=O)N(C)C.[Br-],117.4,8.7
Pyridoxal 5 phosphate,B7910,54-47-7,Metabolism,Vitamin,1,1,97.5,1.0
Pyridoxine,B7912,65-23-6,Metabolism,Vitamin,1,CC1=C(O)C(CO)=C(CO)C=N1,94.5,12.9
Pyridoxine HCl,B2017,58-56-0,Metabolism,Vitamin,a form of vitamin B6,CC1=NC=C(C(=C1O)CO)CO.Cl,100.5,0.9
Pyrimethamine,A4353,58-14-0,Metabolism,DHFR,DHFR inhibitor,CCC1=C(C(=NC(=N1)N)N)C2=CC=C(C=C2)Cl,97.6,3.6
Pyrocatechol,C6271,120-80-9,Others,Others,1,1,92.4,5.7
Pyrogallol,C4157,87-66-1,Immunology/Inflammation,ROS,1,OC1=C(O)C(O)=CC=C1,104.3,4.3
Quercetin,N1841,117-39-5,PI3K/Akt/mTOR Signaling,PI3K,Antitumor agent,C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O,105.4,6.5
Quercetin dihydrate,A2552,6151-25-3,PI3K/Akt/mTOR Signaling,PI3K,1,1,87.8,15.7
Quercitrin,N1840,522-12-3,Natural Products,Immunology & Inflammation related,1,1,95.2,0.9
Quetiapine,A3744,111974-69-7,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42,114.1,23.8
Quetiapine Fumarate,B1490,111974-72-2,Neuroscience,Dopamine Receptor,Dopamine receptor antagonist,C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=CC(=O)O)C(=O)O,98.1,9.2
Quinacrine 2HCl,B1823,69-05-6,Metabolism,Phospholipase,1,1,101.3,7.9
Quinapril HCl,B2207,82586-55-8,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O.Cl,93.6,6.8
Quinestrol,C4274,152-43-2,Endocrinology and Hormones,Estrogen/progestogen Receptor,synthetic estrogen that is effective in hormone replacement therapy,C[C@@]12[C@@]([H])(CC[C@@]2(O)C#C)[C@]([C@]3([H])CC1)([H])CCC4=C3C=CC(OC5CCCC5)=C4,86.2,8.7
Quinidine,B7590,56-54-2,Membrane Transporter/Ion Channel,Other Channel Modulators,reduces both Na+ and K+ channel currents,O[C@H](C(C1=C2)=CC=NC1=CC=C2OC)[C@@H]3[N@@]4C[C@@H](C=C)[C@@H](CC4)C3,105.1,10.6
Quinine,B8714,130-95-0,Microbiology & Virology,Parasite; Potassium Channel,"Potassium channel blocker, orally active",1,108.4,7.1
Quinine HCl Dihydrate,B2123,6119-47-7,Membrane Transporter/Ion Channel,Potassium Channel,1,1,102.0,5.4
Quizartinib (AC220),A5793,950769-58-1,Tyrosine Kinase,FLT3,"FLT3 inhibitor,potent and selective",CC(C)(C)C1=CC(=NO1)NC(=O)NC2=CC=C(C=C2)C3=CN4C5=C(C=C(C=C5)OCCN6CCOCC6)SC4=N3,91.9,3.4
R-(−)-Mandelic Acid,B8606,611-71-2,Others,Others,Used as a building block to synthesize pharmaceutical drugs such as penicillin and cephalosporin,1,101.4,10.3
R788 disodium,A8332,1025687-58-4,Tyrosine Kinase,Spleen Tyrosine Kinase (Syk),"Syk inhibitor,ATP competitive and potent",CC1(C(=O)N(C2=C(O1)C=CC(=N2)NC3=NC(=NC=C3F)NC4=CC(=C(C(=C4)OC)OC)OC)COP(=O)([O-])[O-])C.[Na+].[Na+],94.5,2.9
RG7388,A3763,1229705-06-9,Apoptosis,p53,"MDM2 antagonist, oral, selective",CC(C)(C)CC1C(C(C(N1)C(=O)NC2=C(C=C(C=C2)C(=O)O)OC)C3=C(C(=CC=C3)Cl)F)(C#N)C4=C(C=C(C=C4)Cl)F,97.6,6.9
Rabeprazole,B3467,117976-89-3,Membrane Transporter/Ion Channel,Proton Pump,proton pump inhibitor,CC(C(OCCCOC)=CC=N1)=C1CS(C2=NC3=CC=CC=C3N2)=O,108.0,0.3
Rabeprazole sodium,B3466,117976-90-6,Membrane Transporter/Ion Channel,Proton Pump,proton pump inhibitor,CC(C(OCCCOC)=CC=N1)=C1CS(C2=NC3=CC=CC=C3[N-]2)=O.[Na+],96.1,2.5
Racecadotril,B1649,81110-73-8,Others,Endopeptidase,Potent enkephalinase inhibitor,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,101.5,3.8
Radotinib(IY-5511),B5846,926037-48-1,Apoptosis,Bcl-2 Family,Bcr-Abl tyrosine kinase inhibitor,CC1=C(NC2=NC=CC(C3=CN=CC=N3)=N2)C=C(/C(O)=N/C4=CC(N(C=N5)C=C5C)=CC(C(F)(F)F)=C4)C=C1,100.9,14.2
Raloxifene HCl,B1515,82640-04-8,Endocrinology and Hormones,Estrogen/progestogen Receptor,Estrogen receptor (ER),C1CCN(CC1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O.Cl,96.9,1.5
Raltegravir (MK-0518),A4073,518048-05-0,Proteases,HIV Integrase,HIV-1 integrase inhibitor,CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)F,109.8,23.6
Raltitrexed,B1476,112887-68-0,DNA Damage/DNA Repair,DNA Synthesis,Thymidylate synthase inhibitor,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)NC(CCC(=O)O)C(=O)O,56.9,5.9
Ramelteon,A1748,196597-26-9,GPCR/G protein,MT Receptor,"Agonist of melatonin receptor(M1-M2),highly selective",CCC(=O)NCCC1CCC2=C1C3=C(C=C2)OCC3,20.2,2.2
Ramipril,B2208,87333-19-5,Proteases,ACE,angiotensin-converting enzyme (ACE) inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2C3CCCC3CC2C(=O)O,97.5,0.6
Ranitidine,B1564,66357-59-3,Neuroscience,Histamine Receptor,Histamine H2-receptor antagonist,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(O1)CN(C)C.Cl,101.3,1.9
Ranolazine,A8510,95635-55-5,Others,Others,Anti-ischemic,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O,95.6,7.1
Ranolazine 2HCl,A5300,95635-56-6,Membrane Transporter/Ion Channel,Calcium Channel,Partial fatty acid oxidation inhibitor,CC1=C(C(=CC=C1)C)NC(=O)CN2CCN(CC2)CC(COC3=CC=CC=C3OC)O.Cl.Cl,105.8,3.2
Rapamycin (Sirolimus),A8167,53123-88-9,PI3K/Akt/mTOR Signaling,mTOR,Original antifungal antibiotic,O[C@H]1[C@H](OC)C[C@H](C[C@@H](C)[C@H](CC([C@H](C)/C=C(C)/[C@H]([C@@H](OC)C([C@@H](C[C@@H](/C=C/C=C/C=C(C)/[C@@H](OC)C[C@@H]2CC[C@@H](C)[C@@](C(C(N3[C@H]4CCCC3)=O)=O)(O)O2)C)C)=O)O)=O)OC4=O)CC1,61.6,7.6
Rasagiline,B8711,136236-51-6,Metabolism,MAO,Selective and irreversible propargylamine inhibitor of monoamine oxidase (MAO) B,1,101.7,6.7
Rasagiline Mesylate,A4366,161735-79-1,Metabolism,MAO,Irreversible MAO-B inhibitor,CS(=O)(=O)O.C#CCNC1CCC2=CC=CC=C12,31.0,6.7
Rebamipide,B2018,90098-04-7,Others,Others,cholecystokinin type 1 (CCK1) receptor inhibitor,C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl,102.4,0.7
Reboxetine mesylate,B2124,98769-84-7,Others,Others,Potent and selective inhibitor of noradrenalin uptake,CCOC1=CC=CC=C1OC(C2CNCCO2)C3=CC=CC=C3.CS(=O)(=O)O,88.6,3.6
Regadenoson,B5904,313348-27-5,GPCR/G protein,Adenosine Receptor,Highly selective and low affinity A2A adenosine agonist,C/N=C(O)/C(C=N1)=CN1C2=NC(N)=C(N=CN3[C@@]4([H])[C@@](O)([H])[C@@](O)([H])[C@@](O4)([H])CO)C3=N2,103.1,6.8
Regorafenib,A8236,755037-03-7,Tyrosine Kinase,c-RET,Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F,36.7,2.4
Regorafenib hydrochloride,A3750,835621-07-3,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.Cl,44.8,4.4
Regorafenib monohydrate,A3751,1019206-88-2,Tyrosine Kinase,c-RET,Tyrosine kinase inhibitor,CNC(=O)C1=NC=CC(=C1)OC2=CC(=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F)F.O,49.3,2.4
Repaglinide,A5316,135062-02-1,Membrane Transporter/Ion Channel,Potassium Channel,Kir6 (KATP) channel blocker,CCOC1=C(C=CC(=C1)CC(=O)NC(CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O,99.9,3.7
Reserpine,N1867,50-55-5,Natural Products,Others,1,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC,107.9,3.2
Reserpine hydrochloride,B1270,16994-56-2,Membrane Transporter/Ion Channel,Monoamine transporter,Blocker of VMAT,COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C6=CC(=C(C(=C6)OC)OC)OC.Cl,104.1,3.1
Resiquimod (R-848),B1054,144875-48-9,Immunology/Inflammation,TLR,1,1,106.4,8.6
Resorcinol,C6136,108-46-3,Microbiology & Virology,Anti-infection,1,1,95.7,12.2
Resveratrol,A4182,501-36-0,Chromatin/Epigenetics,Sirtuin,SIRT1 activator,C1=CC(=CC=C1C=CC2=CC(=CC(=C2)O)O)O,106.2,9.1
Retapamulin,B2019,224452-66-8,Microbiology & Virology,Antibiotic,"Pleuromutilin antibiotic,protein synthesis inhibitor",O[C@H]([C@](C)(C=C)C1)[C@H](C)[C@]2(CCC3=O)[C@]3([H])[C@@]([C@@H]1OC(CSC4C[C@](CC5)([H])N(C)[C@]5([H])C4)=O)(C)[C@H](C)CC2,103.0,1.1
Retigabine,B5888,150812-12-7,Membrane Transporter/Ion Channel,Potassium Channel,1,1,111.8,6.7
Retigabine dihydrochloride,A3758,150812-13-8,Membrane Transporter/Ion Channel,GABA Receptor,1,1,109.7,3.9
Retinyl (Vitamin A) Palmitate,B1869,79-81-2,Metabolism,Vitamin,ester of retinol (vitamin A) and palmitic acid,CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(CCCC1(C)C)C,95.2,13.7
Rhynchophylline,N1904,76-66-4,Natural Products,potassium voltage-gated channel subfamily H member 2,1,1,98.5,12.8
Ribavirin,B2125,36791-04-5,Microbiology & Virology,Anti-infection,Antiviral guanosine ribonucleoside analog,C1=NC(=NN1C2C(C(C(O2)CO)O)O)C(=O)N,83.0,3.8
Ribostamycin Sulfate,B1825,53797-35-6,Microbiology & Virology,Anti-infection,aminoglycoside antibiotic,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)N)OC3C(C(C(O3)CO)O)O)O)N.OS(=O)(=O)O,106.8,7.3
"Ridaforolimus (Deforolimus, MK-8669)",B1639,572924-54-0,PI3K/Akt/mTOR Signaling,mTOR,1,1,107.3,9.0
Rifabutin,B2126,72559-06-9,Microbiology & Virology,Antibiotic,anti-TB(tuberculosis) medicine,O[C@H]([C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C(C)\C(NC1=C2C3=NC4(CCN(CC(C)C)CC4)N2)=O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)/C=C/O[C@@]5(C)OC6=C(C5=O)C3=C(C(O)=C6C)C1=O,107.9,5.9
Rifampin,B2021,13292-46-1,Microbiology & Virology,Antibiotic,DNA-dependent RNA polymerase inhibitor,O[C@H]([C@H](C)[C@H]([C@H](/C=C/C=C(C)/C(NC1=C2O)=O)C)O)[C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@@]3(C)OC4=C(C)C(O)=C2C(C(/C1=C/NN5CCN(C)CC5)=O)=C4C3=O)OC)OC(C)=O,124.9,27.7
Rifapentine,B2127,61379-65-5,Microbiology & Virology,Antibiotic,antibiotic drug used in the treatment of tuberculosis,O[C@H]([C@H](C)[C@@H](O)[C@@H](C)/C=C/C=C1/C)[C@@H](C)[C@@](OC(C)=O)([H])[C@H](C)[C@@H](OC)/C=C/O[C@@]2(C)OC3=C(C2=O)C(C(O)=C4/C=N/N5CCN(C6CCCC6)CC5)=C(C(O)=C3C)C(O)=C4NC1=O,104.5,3.0
Rifaximin (Xifaxan),A8512,80621-81-4,DNA Damage/DNA Repair,DNA Synthesis,"RNA synthesis inhibitor, PXR activator",O[C@@H]([C@H](C)[C@H]([C@H](/C=C/C=C(C)\C(NC1=C2O)=O)C)O)[C@@H](C)[C@@H]([C@H](C)[C@H](/C=C/O[C@@](C3=O)(C)OC4=C3C(C5=C1N(C=CC(C)=C6)C6=N5)=C2C(O)=C4C)OC)OC(C)=O,101.7,3.5
"Rigosertib (ON-01910,Estybon)",A1404,1225497-78-8,Cell Cycle/Checkpoint,PLK,Plk1 inhibitor,COC1=C(C=C(C=C1)CS(=O)(=O)C=CC2=C(C=C(C=C2OC)OC)OC)NCC(=O)[O-].[Na+],6.8,3.4
Rilmenidine Phosphate,B4968,85409-38-7,Others,Imidazoline Receptors,1,1,123.6,34.3
Rilpivirine,A3765,500287-72-9,Microbiology & Virology,HIV,Inhibitor of next-generation nonnucleoside reverse transcriptase,CC1=CC(=CC(=C1NC2=NC(=NC=C2)NC3=CC=C(C=C3)C#N)C)C=CC#N,95.3,1.9
Riluzole,A8513,1744-22-5,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel protein inhibitor,C1=CC2=C(C=C1OC(F)(F)F)SC(=N2)N,102.3,5.8
Riluzole (hydrochloride),C5521,850608-87-6,Neuroscience,GABA Receptor; Sodium Channel,1,NC1=NC2=C(C=C(C=C2)OC(F)(F)F)S1.Cl,101.2,1.3
Rimantadine,B2128,13392-28-4,Microbiology & Virology,Anti-infection,anti-influenza virus drug,CC(C12CC3CC(C1)CC(C3)C2)N,106.5,2.2
Rimantadine Hydrochloride,B7849,1501-84-4,Microbiology & Virology,Influenza A virus,anti-influenza virus drug,CC(C12CC3CC(C1)CC(C3)C2)N,102.9,7.2
Rimonabant,B1429,168273-06-1,GPCR/G protein,Cannabinoid Receptor,CB1 receptor antagonist,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,97.7,2.0
Riociguat,A3767,625115-55-1,Others,Guanylate Cyclase,Soluble guanylate cyclase (sGC) stimulator,CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC,112.3,2.7
Risedronate Sodium,A5293,115436-72-1,Others,Others,FPP synthase inhibitor,C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+],101.5,8.8
Risperidone,A8514,106266-06-2,Neuroscience,5-HT Receptor,SR-2A inhibitor,CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F,86.9,18.9
Ritodrine HCl,B1347,23239-51-2,GPCR/G protein,Adrenergic Receptor,β-2 adrenergic receptor agonist,CC(C(C1=CC=C(C=C1)O)O)NCCC2=CC=C(C=C2)O.Cl,99.8,4.7
Ritonavir,A8203,155213-67-5,Proteases,HIV Protease,HIV protease inhibitor,CC(C)C1=NC(=CS1)CN(C)C(=O)NC(C(C)C)C(=O)NC(CC2=CC=CC=C2)CC(C(CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O,79.9,5.3
Rivaroxaban,A4338,366789-02-8,Metabolism,Factor Xa,Factor Xa inhibitor,C1COCC(=O)N1C2=CC=C(C=C2)N3CC(OC3=O)CNC(=O)C4=CC=C(S4)Cl,113.8,7.8
Rivastigmine,A3768,123441-03-2,Neuroscience,AChR,Cholinesterase inhibitor,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C,111.5,4.9
Rivastigmine Tartrate,A8515,129101-54-8,Neuroscience,AChR,AChR inhibitor,CCN(C)C(=O)OC1=CC=CC(=C1)C(C)N(C)C.C(C(C(=O)O)O)(C(=O)O)O,100.5,6.2
Rizatriptan Benzoate,A8516,145202-66-0,Neuroscience,5-HT Receptor,5-HT Receptor agonist,CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3.C1=CC=C(C=C1)C(=O)O,99.5,7.3
Rocilinostat (ACY-1215),A4083,1316214-52-4,DNA Damage/DNA Repair,HDAC,Selective HDAC6 inhibitor,C1=CC=C(C=C1)N(C2=CC=CC=C2)C3=NC=C(C=N3)C(=O)NCCCCCCC(=O)NO,98.8,4.5
Rocuronium Bromide,A1366,119302-91-9,Neuroscience,AChR,TGF-βR I kinase inhibitor,CC(=O)OC1C(CC2C1(CCC3C2CCC4C3(CC(C(C4)O)N5CCOCC5)C)C)[N+]6(CCCC6)CC=C.[Br-],87.7,2.0
Rofecoxib,B1454,162011-90-7,Neuroscience,COX,COX-2 inhibitor,CS(=O)(=O)C1=CC=C(C=C1)C2=C(C(=O)OC2)C3=CC=CC=C3,96.3,4.2
Roflumilast,A4319,162401-32-3,Metabolism,PDE,PDE-4 inhibitor,C1CC1COC2=C(C=CC(=C2)C(=O)NC3=C(C=NC=C3Cl)Cl)OC(F)F,105.2,7.3
Rolipram,A4328,61413-54-5,Metabolism,PDE,PDE4-inhibitor and an anti-inflammatory agent,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,114.5,15.1
"Romidepsin (FK228, depsipeptide)",A8173,128517-07-7,DNA Damage/DNA Repair,HDAC,"HDAC1/HDAC2 inhibitor,potent and selective",CC=C1C(=O)NC(C(=O)OC2CC(=O)NC(C(=O)NC(CSSCCC=C2)C(=O)N1)C(C)C)C(C)C,-0.7,2.3
Ronidazole,B2022,7681-76-7,Microbiology & Virology,Anti-infection,antiprotozoal agent,CN1C(=CN=C1COC(=O)N)[N+](=O)[O-],104.8,1.4
Ropinirole HCl,B2129,91374-20-8,Neuroscience,Dopamine Receptor,selective dopamine D2-receptor agonist,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1.Cl,88.3,6.2
Ropivacaine HCl,B2023,98717-15-8,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.Cl,121.6,24.7
Ropivacaine hydrochloride monohydrate,B3377,132112-35-7,Membrane Transporter/Ion Channel,Sodium Channel,"anaesthetic, long-acting and local",CCCN1CCCCC1C(=O)NC2=C(C=CC=C2C)C.O.Cl,81.8,25.4
"Roscovitine (Seliciclib,CYC202)",A1723,186692-46-6,Cell Cycle/Checkpoint,Cyclin-Dependent Kinases,"CDK inhibitor,potent and selective",CCC(CO)NC1=NC2=C(C(=N1)NCC3=CC=CC=C3)N=CN2C(C)C,84.5,5.0
Rosiglitazone,A4304,122320-73-4,Metabolism,PPAR,Potent PPARγ agonist,CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3,103.9,7.4
Rosiglitazone HCl,A4310,302543-62-0,Metabolism,PPAR,PPARγ agonist,CN(C1=CC=CC=N1)CCOC2=CC=C(CC3C(NC(S3)=O)=O)C=C2.Cl,107.3,8.6
Rosiglitazone maleate,A4302,155141-29-0,Metabolism,PPAR,"PPARγ agonist,high-affinity and selective,potent insulin sensitizer",CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=CC(=O)O)C(=O)O,92.5,22.9
Rosmarinic acid,N1768,20283-92-5,Natural Products,IκB/IKK,Anti-inflammatory and antimicrobial reagent,C1=CC(=C(C=C1CC(C(=O)O)OC(=O)C=CC2=CC(=C(C=C2)O)O)O)O,104.5,12.3
Rosuvastatin,B1123,287714-41-4,Metabolism,HMG-CoA Reductase,Competitive inhibitor of HMG-CoA reductase,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)O)O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C,108.1,10.0
Rosuvastatin Calcium,A8518,147098-20-2,Endocrinology and Hormones,RAAS,HMG-CoA reductase inhibitor,CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.CC(C)C1=NC(=NC(=C1C=CC(CC(CC(=O)[O-])O)O)C2=CC=C(C=C2)F)N(C)S(=O)(=O)C.[Ca+2],113.4,6.5
Rotundine,B3676,483-14-7,Neuroscience,Dopamine Receptor,"Dopamine D1 receptor antagonist,potent and selective",COC1=C(C2=C(CC3C4=CC(=C(C=C4CCN3C2)OC)OC)C=C1)OC,98.1,4.0
Roxatidine Acetate HCl,B1565,93793-83-0,Neuroscience,Histamine Receptor,Specific and competitive histamin H2-receptor antagonist,CC(=O)OCC(=O)NCCCOC1=CC=CC(=C1)CN2CCCCC2.Cl,102.4,4.6
Roxithromycin,B2024,80214-83-1,Microbiology & Virology,Anti-infection,semi-synthetic macrolide antibiotic,CCC1C(C(C(C(=NOCOCCOC)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O,102.1,6.9
"Rucaparib (AG-014699,PF-01367338)",A4156,459868-92-9,Chromatin/Epigenetics,PARP,Potent PARP inhibitor,OP(O)(O)=O.FC1=CC2=C3C(CCNC2=O)=C(C4=CC=C(CNC)C=C4)NC3=C1,93.7,1.7
Rufinamide,B2280,106308-44-5,Membrane Transporter/Ion Channel,GABA Receptor,voltage-gated sodium channel blocker,C1=CC(=C(C(=C1)F)CN2C=C(N=N2)C(=O)N)F,106.9,14.1
Rupatadine Fumarate,B1566,182349-12-8,Neuroscience,Histamine Receptor,Inhibitor of PAF and histamine (H1) receptor,CC1=CC(=CN=C1)CN2CCC(=C3C4=C(CCC5=C3N=CC=C5)C=C(C=C4)Cl)CC2.C(=CC(=O)O)C(=O)O,92.3,2.8
Rutin,N1833,153-18-4,Natural Products,Immunology & Inflammation related,1,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,108.0,5.8
Ruxolitinib (INCB018424),A3012,941678-49-5,Chromatin/Epigenetics,JAK,JAK inhibitor,C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3,123.0,8.2
Ruxolitinib phosphate,A3781,1092939-17-7,Chromatin/Epigenetics,JAK,JAK1/JAK2 inhibitor,[HH].C1CCC(C1)C(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3.OOP(=O)=O,26.2,5.2
S- (+)-Rolipram,A4349,85416-73-5,Metabolism,PDE,CAMP-specific PDE4 inhibitor,COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3,107.3,16.0
S/GSK1349572,A4074,1051375-16-6,Proteases,HIV Integrase,"HIV integrase inhibitor, novel and potent",CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O,99.8,7.0
SAR245409 (XL765),A5634,1349796-36-6,PI3K/Akt/mTOR Signaling,PI3K,mTOR/PI3K inhibitor,CC1=C(C=C(C=C1)C(=O)NC2=CC=C(C=C2)S(=O)(=O)NC3=NC4=CC=CC=C4N=C3NC5=CC(=CC(=C5)OC)OC)OC,104.5,21.7
SKF 525A (hydrochloride),C3560,62-68-0,Metabolism,P450,cytochrome P (CYP)450 inhibitor,O=C(OCCN(CC)CC)C(C1=CC=CC=C1)(CCC)C2=CC=CC=C2.Cl,131.0,25.7
Safinamide Mesylate,A4368,202825-46-5,Metabolism,MAO,"MAO-B inhibitor,potent,selective and reversible",CC(C(=O)N)NCC1=CC=C(C=C1)OCC2=CC(=CC=C2)F.CS(=O)(=O)O,105.5,2.1
Saikosaponin A,N1885,20736-09-8,Natural Products,NF-κB,1,1,118.6,10.5
Salbutamol Sulfate,B1348,51022-70-9,GPCR/G protein,Adrenergic Receptor,β-2 adrenergic receptor agonist,CC(C)(C)NCC(C1=CC(=C(C=C1)O)CO)O.OS(=O)(=O)O,89.2,0.8
Salicylamide,C6199,65-45-2,Immunology/Inflammation,Immunology & Inflamm,1,1,106.4,9.0
Salicylanilide,B1827,87-17-2,Microbiology & Virology,"Reverse Transcriptase, Integrase, Anti-infection","Antiviral,antibacterial,antifungal reagent",C1=CC=C(C=C1)NC(=O)C2=CC=CC=C2O,102.5,6.1
Salicylic acid,B1092,69-72-7,Neuroscience,COX,COX inhibitor,C1=CC=C(C(=C1)C(=O)O)O,104.1,8.9
Salidroside,N1789,10338-51-9,Natural Products,Others,1,1,102.0,9.5
Salinomycin,A3785,53003-10-4,Stem Cell,Wnt/β-catenin,Polyether ionophore antibiotic;anti-cancer,CCC(C1CCC(C(O1)C(C)C(C(C)C(=O)C(CC)C2C(CC(C3(O2)C=CC(C4(O3)CCC(O4)(C)C5CCC(C(O5)C)(CC)O)O)C)C)O)C)C(=O)O,110.5,5.2
Salirasib,A3787,162520-00-5,MAPK Signaling,RasGAP (Ras- P21),Inhibitor of active Ras protein,CC(=CCCC(=CCCC(=CCSC1=CC=CC=C1C(=O)O)C)C)C,106.1,3.8
Salmeterol xinafoate,A3789,94749-08-3,GPCR/G protein,Adrenergic Receptor,β2-adrenergic receptor agonist,C1=CC=C(C=C1)CCCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O.C1=CC=C2C(=C1)C=CC(=C2O)C(=O)O,103.5,11.9
Sanguinarine,N1338,2447-54-3,Natural Products,Antioxidant,1,C[N+]1=CC2=C3OCOC3=CC=C2C(C=C4)=C1C(C4=C5)=CC6=C5OCO6,87.1,0.3
Sanguinarine chloride,B5970,5578-73-4,Chromatin/Epigenetics,Protein Ser/Thr Phosphatases,Inhibitor of PP2C and MKP-1,C[N+]1=C2C(C=CC3=CC(OCO4)=C4C=C32)=C5C=CC(OCO6)=C6C5=C1.[Cl-],104.1,12.1
Saquinavir mesylate,A3791,149845-06-7,Proteases,HIV Protease,HIV Protease Inhibitor,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(C(CC3=CC=CC=C3)NC(=O)C(CC(=O)N)NC(=O)C4=NC5=CC=CC=C5C=C4)O.CS(=O)(=O)O,111.6,6.7
Saracatinib (AZD0530),A2133,379231-04-6,TGF-β / Smad Signaling,Bcr-Abl,"Src/Abl inhibitor,potent and selective",CN1CCN(CC1)CCOC2=CC(=C3C(=C2)N=CN=C3NC4=C(C=CC5=C4OCO5)Cl)OC6CCOCC6,102.7,8.5
Sarpogrelate hydrochloride,B3494,135159-51-2,GPCR/G protein,5-HT Receptor,5-HT2A receptor inhibitor,O=C(OC(COC1=CC=CC=C1CCC2=CC(OC)=CC=C2)CN(C)C)CCC(O)=O.Cl,97.3,3.4
Sasapyrine,B1829,552-94-3,Immunology/Inflammation,Reactive Oxygen Species,Nonsteroidal oral anti-inflammatory agent,C1=CC=C(C(=C1)C(=O)OC2=CC=CC=C2C(=O)O)O,100.6,2.1
Saxagliptin,A8650,361442-04-8,Proteases,DPP-4,Selective DPP4 inhibitor,C1C2CC2N(C1C#N)C(=O)C(C34CC5CC(C3)CC(C5)(C4)O)N,87.4,8.8
Sclareol,N2558,515-03-7,Natural Products,Others,1,CC1(CCCC2(C1CCC(C2CCC(C)(C=C)O)(C)O)C)C,109.4,11.5
Scopine,B1364,498-45-3,GPCR/G protein,Adrenergic Receptor,α1-adrenergic receptor agonist,[H][C@]12O[C@@]1([H])[C@@](C3([H])[H])([H])N(C([H])([H])[H])[C@]2([H])C([H])([H])[C@@]3([H])O[H],108.1,17.8
Scopolamine butylbromide,N2505,149-64-4,Natural Products,Others,1,O=C([C@H](C1=CC=CC=C1)CO)O[C@H]2C[C@@H]3[N@@+](CCCC)(C)[C@H](C2)[C@H]4O[C@@H]34.[Br-],109.1,10.7
Scopolamine hydrobromide,N2570,114-49-8,Natural Products,AChR,1,CN1C2CC(CC1C3C2O3)OC(=O)C(CO)C4=CC=CC=C4.Br,110.8,0.6
Scopoletin,C4449,92-61-5,Immunology/Inflammation,AChE,1,O=C1C=CC2=CC(OC)=C(C=C2O1)O,97.6,3.0
Scutellarin,N1753,27740-01-8,Natural Products,Others,1,1,96.8,8.6
Secnidazole,B2162,3366-95-8,Microbiology & Virology,Anti-infection,nitroimidazole anti-infective,CC1=NC=C(N1CC(C)O)[N+](=O)[O-],101.8,6.0
Semagacestat (LY450139),A8190,425386-60-3,Neuroscience,Amyloid β,γ-secretase inhibitor,CC(C)C(C(=O)NC(C)C(=O)NC1C2=CC=CC=C2CCN(C1=O)C)O,90.6,1.0
Sennoside A,N1678,81-27-6,Natural Products,MAO,1,1,107.4,2.9
Sennoside B,N1677,128-57-4,Natural Products,PDGFR,1,1,105.3,8.3
Serotonin HCl,B1830,153-98-0,Neuroscience,5-HT Receptor,Endogenous 5-HT receptor agonist,C1=CC2=C(C=C1O)C(=CN2)CCN.Cl,101.7,2.8
Sertaconazole nitrate,B1831,99592-39-9,Microbiology & Virology,Anti-infection,Broad-spectrum antifungal,C1=CC2=C(C(=C1)Cl)SC=C2COC(CN3C=CN=C3)C4=C(C=C(C=C4)Cl)Cl.[N+](=O)(O)[O-],86.0,11.4
Sertraline HCl,B2257,79559-97-0,Neuroscience,SSRIs,selective serotonin re-uptake inhibitor (SSRI),CNC1CCC(C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl.Cl,91.4,4.8
Sildenafil,A3817,139755-83-2,Metabolism,PDE,"PDE5 inhibitor, selective",CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C,99.1,8.8
Sildenafil Citrate,A4321,171599-83-0,Metabolism,PDE,Treat erectile dysfunction and PAH,CCCC1=NN(C2=C1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)C)OCC)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,107.1,8.3
Sildenafil mesylate,B6073,1308285-21-3,Metabolism,PDE,1,1,95.9,1.9
Silodosin,A8521,160970-54-7,GPCR/G protein,Adrenergic Receptor,α1-adrenoceptor antagonist,CC(CC1=CC2=C(C(=C1)C(=O)N)N(CC2)CCCO)NCCOC3=CC=CC=C3OCC(F)(F)F,100.4,6.3
Silymarin,N1711,22888-70-6,Natural Products,Others,1,COC1=C(C=CC(=C1)C2C(OC3=C(O2)C=C(C=C3)C4C(C(=O)C5=C(C=C(C=C5O4)O)O)O)CO)O,145.8,51.9
Simeprevir,A3820,923604-59-5,Proteases,HCV Protease,Inhibitor of HCV NS3/4A protease,COC1=CC=C(C(O[C@H]2CC(C(N(C)CCCC/C=C\[C@H]3C[C@@]3(C(NS(=O)(C4CC4)=O)=O)NC5=O)=O)[C@H]5C2)=CC(C6=NC(C(C)C)=CS6)=N7)C7=C1C,123.9,2.9
Simvastatin (Zocor),A8522,79902-63-9,Metabolism,HMG-CoA Reductase,HMGCR (HMG-CoA reductase) inhibitor,CCC(C)(C)C(=O)OC1CC(C=C2C1C(C(C=C2)C)CCC3CC(CC(=O)O3)O)C,102.6,8.4
Sinomenine,N1722,115-53-7,Natural Products,Others,1,1,103.1,1.3
Sinomenine Hydrochloride,N2189,6080-33-7,Natural Products,"Immunology & Inflammation related,Autophagy",1,1,106.0,28.2
Sitafloxacin Hydrate,B2150,163253-35-8,Microbiology & Virology,Anti-infection,"new-generation, broad-spectrum oral fluoroquinolone antibiotic",C1CC12CN(CC2N)C3=C(C=C4C(=C3Cl)N(C=C(C4=O)C(=O)O)C5CC5F)F.O,100.4,4.1
Sitagliptin,C6249,486460-32-6,Proteases,DPP-4,1,1,106.1,3.4
Sitagliptin phosphate monohydrate,A4036,654671-77-9,Proteases,DPP-4,Potent DPP-4 inhibitor,[HH].C1CN2C(=NN=C2C(F)(F)F)CN1C(=O)CC(CC3=CC(=C(C=C3F)F)F)N.O.OOP(=O)=O,129.4,9.6
Sivelestat (ONO-5046),B6189,127373-66-4,Proteases,Elastase,neutrophil elastase inhibitor,O=C(O)CNC(C1=CC=CC=C1NS(=O)(C2=CC=C(OC(C(C)(C)C)=O)C=C2)=O)=O,119.8,1.1
Sodium 4-Aminosalicylate,B1643,6018-19-5,Immunology/Inflammation,NF-κB,NF-κB inhibitor,C1=CC(=C(C=C1N)O)C(=O)[O-].O.O.[Na+],102.8,1.0
Sodium 4-amiropparaty Hyalrate,A8523,94-16-6,Others,Others,Sodium 4-amiropparaty Hyalrate,C1=CC(=CC=C1C(=O)NCC(=O)[O-])N.[Na+],91.8,8.6
Sodium Aescinate,N1729,20977-05-3,Natural Products,Others,1,1,109.5,4.2
Sodium Danshensu,N1804,67920-52-9,Natural Products,P450 (e.g. CYP17),1,C1=CC(=C(C=C1CC(C(=O)[O-])O)O)O.[Na+],100.0,2.9
Sodium Monensin,B3668,22373-78-0,Others,Others,naturally polyether ionophore antibiotic,O[C@H]1C[C@]2(O[C@H]([C@H](C)[C@@H]([C@@H](C([O-])=O)C)OC)[C@@H]1C)O[C@@](CC2)(C)[C@@H]3O[C@](CC3)(CC)[C@H]4O[C@H]([C@H]([C@@H](C)C[C@H]5C)O[C@]5(CO)O)C[C@H]4C.[Na+],95.9,10.7
Sodium Monofluorophosphate,B1837,10163-15-2,Others,phosphatase,Pyruvate kinase/alkaline phosphatase inhibitor,[O-]P(=O)([O-])F.[Na+].[Na+],100.2,6.7
Sodium Nitrite,B1838,7632-00-0,Immunology/Inflammation,ROS,myeloperoxidase inhibitor,N(=O)[O-].[Na+],109.9,3.7
Sodium Nitroprusside,B2026,14402-89-2,Others,Others,nitric oxide (NO) donor,1,87.5,7.5
Sodium Phenylbutyrate,A4107,1716-12-7,DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor,C1=CC=C(C=C1)CCCC(=O)[O-].[Na+],91.5,4.0
Sodium Picosulfate,B2027,10040-45-6,Others,Others,laxative,C1=CC=NC(=C1)C(C2=CC=C(C=C2)OS(=O)(=O)[O-])C3=CC=C(C=C3)OS(=O)(=O)[O-].[Na+].[Na+],98.0,2.2
Sodium Tauroursodeoxycholate (TUDC),B6019,35807-85-3,Others,Others,water soluble bile salt,C[C@]([C@@]1([H])CC[C@@]2([H])[C@@]([C@](O)([H])C[C@]3([H])C[C@@](O)([H])CC[C@@]34C)([H])[C@]4([H])CC[C@]12C)([H])CC/C([O-])=N/CCS(O)(=O)=O.[Na+],101.9,1.3
Sodium ascorbate,B1834,134-03-2,Metabolism,Vitamin,mineral salts of ascorbic acid,O=C1C(O)=C([O-])[C@@H]([C@@H](O)CO)O1.[Na+],101.4,4.4
Sodium benzoate,C6115,532-32-1,Others,Others,1,1,106.4,5.9
Sodium butyrate,B1835,156-54-7,DNA Damage/DNA Repair,HDAC,Histone deacetylase inhibitor,CCCC(=O)[O-].[Na+],107.3,3.5
Sodium dodecyl sulfate,C6142,151-21-3,Others,Others,1,1,108.9,16.0
Sodium phosphate dibasic,B7293,7558-79-4,Others,Reagents,Commonly used in biological assay buffers,OP([O-])([O-])=O.[Na+].[Na+],114.8,28.6
Sodium salicylate,B2028,54-21-7,Immunology/Inflammation,NF-κB,NF-κB inhibitor,C1=CC=C(C(=C1)C(=O)[O-])O.[Na+],107.9,5.8
Solifenacin succinate,B1614,242478-38-2,Neuroscience,Muscarinic Receptor,Muscarinic receptor antagonist,C1CN2CCC1C(C2)OC(=O)N3CCC4=CC=CC=C4C3C5=CC=CC=C5.C(CC(=O)O)C(=O)O,90.3,10.6
Sorafenib,A3009,284461-73-0,MAPK Signaling,Raf,Raf kinases and tyrosine kinases inhibitor,CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,101.7,11.9
Sorafenib Tosylate,A8245,475207-59-1,Tyrosine Kinase,PDGFR,1,CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F,97.3,15.1
Sorbitol,B2029,50-70-4,Others,Others,sugar alcohol,C(C(C(C(C(CO)O)O)O)O)O,93.1,10.5
Sotalol,B1367,959-24-0,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor antagonist,CC(C)NCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.Cl,101.6,4.9
Sotalol hydrochloride,B3341,959-24-0,GPCR/G protein,Adrenergic Receptor,1,1,93.1,4.2
Sotrastaurin (AEB071),A8525,425637-18-9,TGF-β / Smad Signaling,PKC,PKC inhibitor,CN1CCN(CC1)C2=NC3=CC=CC=C3C(=N2)C4=C(C(=O)NC4=O)C5=CNC6=CC=CC=C65,109.1,11.8
Spectinomycin (hydrochloride hydrate),C5621,22189-32-8,Microbiology & Virology,Antibiotic,aminocyclitol antibiotic,[H][C@@]12[C@@](C(C[C@@H](C)O2)=O)(O)O[C@]3([H])[C@@H](NC)[C@@H](O)[C@@H](NC)[C@H](O)[C@@]3([H])O1.Cl.Cl.O.O.O.O.O,100.6,6.4
Spectinomycin dihydrochloride,B3342,21736-83-4,Microbiology & Virology,Anti-infection,new parenteral antibiotic,Cl[H].Cl[H].O=C1[C@]2(O[H])O[C@@]([C@@]([C@@]3([H])O[H])([H])N([H])C([H])([H])[H])([H])[C@]([C@@]([C@]3([H])N([H])C([H])([H])[H])([H])O[H])([H])O[C@]2([H])O[C@@](C([H])([H])[H])([H])C1([H])[H],114.4,6.5
Spermine,C4910,71-44-3,Neuroscience,NMDA,Mixed NMDA glutamate receptor agonist/antagonist at the polyamine site,NCCCNCCCCNCCCN,103.2,8.8
Spermine tetrahydrochloride,B6522,306-67-2,Membrane Transporter/Ion Channel,NMDA Receptor,1,1,93.6,10.8
Spiramycin,B1839,8025-81-8,Microbiology & Virology,Anti-infection,16-membered ring macrolide (antibiotic),CC1CC=CC=CC(C(CC(C(C(C(CC(=O)O1)O)OC)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)OC4CCC(C(O4)C)N(C)C,94.8,6.6
Spironolactone,B1378,52-01-7,Endocrinology and Hormones,Androgen Receptor,Competitive mineralocorticoid (aldosterone) receptor antagonist,CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C,102.3,2.4
Stavudine (d4T),B2225,3056-17-5,Microbiology & Virology,HIV,Reverse transcriptase inhibitor,CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO,99.8,8.1
Stearic Acid,C4607,57-11-4,Others,NF-kB,1,CCCCCCCCCCCCCCCCCC(O)=O,105.7,0.2
Stearic Acid methyl ester,C3969,112-61-8,Others,Others,1,CCCCCCCCCCCCCCCCCC(OC)=O,112.4,5.3
Stevioside,N1708,57817-89-7,Natural Products,Others,1,1,91.3,2.7
Stiripentol,A8704,49763-96-4,Metabolism,Dehydrogenase,1,1,96.3,5.2
Streptomycin sulfate,B2034,3810-74-0,Microbiology & Virology,Anti-infection,aminoglycoside antibiotic,CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.CC1C(C(C(O1)OC2C(C(C(C(C2O)O)N=C(N)N)O)N=C(N)N)OC3C(C(C(C(O3)CO)O)O)NC)(C=O)O.OS(=O)(=O)O.OS(=O)(=O)O.OS(=O)(=O)O,109.7,2.6
Streptozocin,A4457,18883-66-4,Apoptosis,Apoptosis Inducers,Antibiotic and antitumor agent,CN(C(=O)NC1C(C(C(OC1O)CO)O)O)N=O,104.1,8.1
Succinylcholine Chloride Dihydrate,B1595,6101-15-1,Neuroscience,AChR,Nicotinic AChR agonist,C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.O.O.[Cl-].[Cl-],106.2,1.1
Sucralose,B1840,56038-13-2,Others,Others,artificial sweetener and sugar substitute,C(C1C(C(C(C(O1)OC2(C(C(C(O2)CCl)O)O)CCl)O)O)Cl)O,81.4,1.9
Sulbactam,B2131,68373-14-8,Microbiology & Virology,Anti-infection,irreversible β-lactamase inhibitor,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)O)C,101.7,6.4
Sulbactam sodium,B2035,69388-84-7,Microbiology & Virology,Anti-infection,irreversible β-lactamase inhibitor,CC1(C(N2C(S1(=O)=O)CC2=O)C(=O)[O-])C.[Na+],103.6,22.2
Sulconazole Nitrate,B2036,61318-91-0,Microbiology & Virology,Anti-infection,imidazole derivative with broad-spectrum antifungal activity,C1=CC(=CC=C1CSC(CN2C=CN=C2)C3=C(C=C(C=C3)Cl)Cl)Cl.[N+](=O)(O)[O-],109.6,2.2
Sulfacetamide Sodium,B1395,127-56-0,Ubiquitination/Proteasome,Autophagy,Sulfonamide antibiotic,CC(=O)[N-]S(=O)(=O)C1=CC=C(C=C1)N.[Na+],100.6,1.8
Sulfadiazine,A8527,68-35-9,Microbiology & Virology,Antibiotic,Sulfonamide antibiotic,C1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,111.7,20.5
Sulfadimethoxine,B3301,122-11-2,Microbiology & Virology,Anti-infection,Antimicrobial agent,COC1=NC(=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N)OC,106.8,7.0
Sulfadoxin,B1841,2447-57-6,Microbiology & Virology,Anti-infection,synthetic analog of para-aminobenzoic acid (PABA),COC1=C(N=CN=C1OC)NS(=O)(=O)C2=CC=C(C=C2)N,94.6,6.4
Sulfaguanidine,B1842,57-67-0,Microbiology & Virology,Anti-infection,sulfonamide antibiotic,C1=CC(=CC=C1N)S(=O)(=O)N=C(N)N,113.1,5.3
Sulfamerazine,B2037,127-79-7,Microbiology & Virology,Anti-infection,sulfonamide antibacterial,CC1=NC(=NC=C1)NS(=O)(=O)C2=CC=C(C=C2)N,101.4,1.1
Sulfameter,B2038,651-06-9,Microbiology & Virology,Antibiotic,long-acting sulfonamide antibacterial,COC1=CN=C(N=C1)NS(=O)(=O)C2=CC=C(C=C2)N,113.0,7.2
Sulfamethazine,B2132,57-68-1,Microbiology & Virology,Anti-infection,sulfonamide antibacterial,CC1=CC(=NC(=N1)NS(=O)(=O)C2=CC=C(C=C2)N)C,98.9,4.0
Sulfamethizole,B2039,144-82-1,Microbiology & Virology,Anti-infection,sulfathiazole antibacterial agent,CC1=NN=C(S1)NS(=O)(=O)C2=CC=C(C=C2)N,102.2,3.3
Sulfamethoxazole,B2040,723-46-6,Microbiology & Virology,Anti-infection,sulfonamide bacteriostatic antibiotic,CC1=CC(=NO1)NS(=O)(=O)C2=CC=C(C=C2)N,95.6,3.7
Sulfanilamide,B2041,63-74-1,Microbiology & Virology,Antibiotic,competitive inhibitor for bacterial enzyme dihydropteroate synthetase,C1=CC(=CC=C1N)S(=O)(=O)N,92.0,3.4
Sulfaphenazole,C4131,526-08-9,Metabolism,P450,CYP2C9 inhibitor,NC1=CC=C(S(NC2=CC=NN2C3=CC=CC=C3)(=O)=O)C=C1,107.1,5.5
Sulfapyridine,B1844,144-83-2,Microbiology & Virology,Antibiotic,short-acting sulfonamide antibiotic,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N,106.0,8.8
Sulfasalazine,A5770,599-79-1,Others,Others,NF-κB activation inhibitor,C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)NN=C3C=CC(=O)C(=C3)C(=O)O,81.8,39.0
Sulfathiazole,B2042,72-14-0,Microbiology & Virology,Anti-infection,short-acting sulfa drug,C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2,102.6,2.5
Sulfisoxazole,B2043,127-69-5,Microbiology & Virology,Anti-infection,selective ETA endothelin receptor antagonist,CC1=C(ON=C1C)NS(=O)(=O)C2=CC=C(C=C2)N,95.9,5.6
Sulfisoxazole Acetyl,B4954,80-74-0,Microbiology & Virology,Bacterial; Endothelin Receptor,sulfonamide antibacterial,O=S(C1=CC=C(N([H])[H])C=C1)(N(C(C)=O)C2=C(C)C(C)=NO2)=O,82.3,24.6
Sulindac,B2044,38194-50-2,Neuroscience,COX,Anti-inflammatory agent;COX inhibitor,CC1=C(C2=C(C1=CC3=CC=C(C=C3)S(=O)C)C=CC(=C2)F)CC(=O)O,100.3,4.0
Sumatriptan,B4981,103628-46-2,Neuroscience,5-HT Receptor,5-HT1 receptor agonist,CNS(CC1=CC(C(CCN(C)C)=CN2)=C2C=C1)(=O)=O,104.5,4.9
Sumatriptan Succinate,A5294,103628-48-4,Neuroscience,5-HT Receptor,5-HT1 receptor agonist,CNS(=O)(=O)CC1=CC2=C(C=C1)NC=C2CCN(C)C.C(CC(=O)O)C(=O)O,90.8,6.8
Sunitinib,B1045,557795-19-4,Tyrosine Kinase,PDGFR,RTK inhibitor,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C,98.9,1.8
Sunitinib malate,A8255,341031-54-7,Tyrosine Kinase,VEGFR,VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor,CCN(CC)CCNC(=O)C1=C(NC(=C1C)C=C2C3=C(C=CC(=C3)F)NC2=O)C.C(C(C(=O)O)O)C(=O)O,98.8,0.9
Suprofen,B2133,40828-46-4,Immunology/Inflammation,TLR,dual COX-1/COX-2 inhibitor,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)O,98.6,0.4
Suramin hexasodium salt,B6752,129-46-4,Membrane Transporter/Ion Channel,P2X purinergic receptor,1,1,83.1,2.4
Synephrine,N2706,94-07-5,Natural Products,Adrenergic Receptor,1,1,101.0,10.0
T 705,B1114,259793-96-9,Microbiology & Virology,HCV,Potent and selective RNA-dependent RNA polymerase inhibitor,C1=C(N=C(C(=O)N1)C(=O)N)F,103.3,3.2
TAK-438,A2308,1260141-27-2,Membrane Transporter/Ion Channel,ATPase,Blocker of potassium-competitive acid,CNCC1=CN(C(=C1)C2=CC=CC=C2F)S(=O)(=O)C3=CN=CC=C3.C(=CC(=O)O)C(=O)O,112.8,5.0
TAK-700 (Orteronel),A4326,426219-18-3,Endocrinology and Hormones,Androgen Receptor,"Human 17,20-lyase inhibitor",CNC(=O)C1=CC2=C(C=C1)C=C(C=C2)C3(CCN4C3=CN=C4)O,101.5,0.4
TG101348 (SAR302503),A4136,936091-26-8,Chromatin/Epigenetics,JAK,"JAK-2 inhibitor,potent and selective",CC1=CN=C(N=C1NC2=CC(=CC=C2)S(=O)(=O)NC(C)(C)C)NC3=CC=C(C=C3)OCCN4CCCC4,101.4,0.3
TH-302,A3872,918633-87-1,DNA Damage/DNA Repair,Topoisomerase,"Hypoxia-activated prodrug,inhibits H460/HT29 cell growth",CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr,-6.1,9.6
TOK-001,A8623,851983-85-2,Endocrinology and Hormones,Androgen Receptor,CYP17 inhibitor and androgen receptor (AR) antagonist,CC12CCC(CC1=CCC3C2CCC4(C3CC=C4N5C=NC6=CC=CC=C65)C)O,100.7,25.7
"TSU-68 (SU6668,Orantinib)",A5331,252916-29-3,Tyrosine Kinase,VEGFR,"PDGFR/Flk-1/FGFR1 inhibitor,potent and competitive",CC1=C(NC(=C1CCC(=O)O)C)C=C2C3=CC=CC=C3NC2=O,94.7,9.2
Tacrine hydrochloride,B6527,1684-40-8,Neuroscience,AChE,cholinesterase inhibitor,NC1=C2CCCCC2=NC3=CC=CC=C13.Cl,94.5,10.4
Tacrolimus (FK506),B2143,104987-11-3,Microbiology & Virology,Antibiotic,"Macrolide calcineurin inhibitor,immunosuppressant",CO[C@@H]1C[C@H](/C=C(C)/[C@@H](OC([C@]2([H])CCCCN2C(C([C@]3(O)O[C@H]([C@@H](OC)C[C@H](C/C(C)=C/4)C)[C@@H](OC)C[C@H]3C)=O)=O)=O)[C@H](C)[C@H](CC([C@@H]4CC=C)=O)O)CC[C@H]1O,83.0,4.3
Tadalafil,A4327,171596-29-5,Metabolism,PDE,PDE5 inhibitor,O=C1N(C)CC(N([C@@H]2C(C=C3)=CC4=C3OCO4)[C@]1([H])CC5=C2NC6=CC=CC=C56)=O,110.2,2.2
Tamibarotene,A3856,94497-51-5,Others,RARs,RARα agonist,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,90.2,4.2
Tamoxifen,B5965,10540-29-1,TGF-β / Smad Signaling,Autophagy; Estrogen Receptor/ERR; HSP,TGF-β modulatory and PKC inhibitory effects,CC/C(C1=CC=CC=C1)=C(C2=CC=C(OCCN(C)C)C=C2)\C3=CC=CC=C3,103.4,1.3
Tamoxifen Citrate,B1394,54965-24-1,Endocrinology and Hormones,Estrogen/progestogen Receptor,Antiestrogen drug,CCC(=C(C1=CC=CC=C1)C2=CC=C(C=C2)OCCN(C)C)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,91.6,3.7
Tandospirone,B1199,87760-53-0,Neuroscience,5-HT Receptor,1,1,100.9,0.5
Tanshinone I,N1845,568-73-0,Natural Products,Phospholipase (e.g. PLA),1,1,102.6,2.1
Tanshinone IIA,N1846,568-72-9,Immunology/Inflammation,IκB/IKK,1,1,102.0,0.6
Tanshinone IIA---sulfonic sodium,N1940,69659-80-9,Natural Products,CaMK,1,1,105.4,19.1
Tasisulam,B1422,519055-62-0,Apoptosis,Caspase,antitumor agent,C1=CC(=C(C=C1Cl)Cl)C(=O)NS(=O)(=O)C2=CC=C(S2)Br,98.3,0.6
Taurine,B1846,107-35-7,Others,Others,Glycine receptor agonist,C(CS(=O)(=O)O)N,105.6,6.5
Tauroursodeoxycholic Acid,C3233,14605-22-2,Others,Others,1,C[C@H](CCC(NCCS(O)(=O)=O)=O)[C@@]1([H])CC[C@@]2([H])[C@]3([H])[C@@H](O)C[C@]4([H])C[C@H](O)CC[C@]4(C)[C@@]3([H])CC[C@@]21C,103.5,6.1
Taxifolin,N1842,480-18-2,Natural Products,VEGFR,1,1,102.6,5.9
Tazarotene,A5710,118292-40-3,Others,RARs,Topical retinoid;antiproliferative;inducer of TIG3 tumor suppressor,CCOC(=O)C1=CN=C(C=C1)C#CC2=CC3=C(C=C2)SCCC3(C)C,85.7,0.2
Tebipenempivoxil,A8529,161715-24-8,Microbiology & Virology,Anti-infection,Carbapenem antibiotic,CC1C2C(C(=O)N2C(=C1SC3CN(C3)C4=NCCS4)C(=O)OCOC(=O)C(C)(C)C)C(C)O,106.6,2.2
Tedizolid,A3863,856866-72-3,Microbiology & Virology,Antibiotic,Oxazolidinone for gram-positive infections,CN1N=C(N=N1)C2=NC=C(C=C2)C3=C(C=C(C=C3)N4CC(OC4=O)CO)F,79.1,5.4
Telaprevir (VX-950),A4031,402957-28-2,Proteases,HCV Protease,HCV NS3-4A protease inhibitor,CCCC(C(=O)C(=O)NC1CC1)NC(=O)C2C3CCCC3CN2C(=O)C(C(C)(C)C)NC(=O)C(C4CCCCC4)NC(=O)C5=NC=CN=C5,96.9,2.1
Telbivudine,A8530,3424-98-4,Microbiology & Virology,HBV,Reverse Transcriptase inhibitor,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O,102.9,3.7
Telmisattan,A8531,144701-48-4,Endocrinology and Hormones,RAAS,Angiotensin II receptor antagonist,CCCC1=NC2=C(C=C(C=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C(=O)O)C5=NC6=CC=CC=C6N5C)C,108.1,12.1
Temocapril HCl,B2213,110221-44-8,Endocrinology and Hormones,RAAS,angiotensin-converting enzyme (ACE) inhibitor,CCOC(=O)C(CCC1=CC=CC=C1)NC2CSC(CN(C2=O)CC(=O)O)C3=CC=CS3.Cl,103.7,0.1
Temozolomide,B1399,85622-93-1,DNA Damage/DNA Repair,DNA Alkylating,"DNA methylating, chemotherapeutic agent",CN1C(=O)N2C=NC(=C2N=N1)C(=O)N,92.3,3.0
Temsirolimus,A8314,162635-04-3,PI3K/Akt/mTOR Signaling,mTOR,MTOR inhibitor,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H](OC([C@]2([H])CCCCN2C(C([C@]3(O)O[C@@](C[C@H](OC)/C(C)=C/C=C/C=C/[C@H](C[C@@H](C)C4=O)C)([H])CC[C@H]3C)=O)=O)=O)CC([C@H](C)/C=C(C)/[C@@H](O)[C@H]4OC)=O)CC[C@H]1OC(C(CO)(C)CO)=O,102.0,7.5
Teneligliptin hydrobromide,A3865,906093-29-6,Proteases,DPP-4,Dipeptidyl peptidase-4 inhibitor,CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.CC1=NN(C(=C1)N2CCN(CC2)C3CC(NC3)C(=O)N4CCSC4)C5=CC=CC=C5.Br.Br.Br.Br.Br,106.3,5.7
Teniposide,A8532,29767-20-2,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase inhibitor,COC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,111.4,7.0
Tenofovir,A5275,147127-20-6,Microbiology & Virology,Reverse Transcriptase,HIV reverse transcriptase inhibitor,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,113.8,13.7
Tenofovir Disoproxil Fumarate,A1755,202138-50-9,Microbiology & Virology,Reverse Transcriptase,Antiretroviral agent( HIV-1 RT inhibitor),CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O,85.3,14.4
Tenoxicam,B1849,59804-37-4,Immunology/Inflammation,1,antiinflammatory agent,CN1C(=C(C2=C(S1(=O)=O)C=CS2)O)C(=O)NC3=CC=CC=N3,95.3,2.8
Terazosin HCl,B1365,70024-40-7,GPCR/G protein,Adrenergic Receptor,Selective α1-adrenoceptor antagonist,COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.O.O.Cl,110.7,17.2
Terbinafine,A8533,91161-71-6,Microbiology & Virology,Antibiotic,Allylamine antifungal agent,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21,106.9,4.5
Terbinafine HCl,B2047,78628-80-5,Others,Squalene epoxidase,Potent non-competitive inhibitor of squalene epoxidase,CC(C)(C)C#CC=CCN(C)CC1=CC=CC2=CC=CC=C21.Cl,103.8,3.5
Terbutaline Sulfate,B1328,23031-32-5,GPCR/G protein,Adrenergic Receptor,Selective β2-adrenergic receptor agonist,CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.CC(C)(C)NCC(C1=CC(=CC(=C1)O)O)O.OS(=O)(=O)O,111.6,14.9
Terconazole,B8679,67915-31-5,Microbiology & Virology,Anti-infection,Orally bioavailable broad-spectrum triazole antifungal agent,1,83.3,11.4
Terephthalic acid,C6298,100-21-0,Others,Others,1,1,92.8,5.1
Terfenadine,A8534,50679-08-8,Others,Others,Histamine H1-receptor antagonist,CC(C)(C)C1=CC=C(C=C1)C(CCCN2CCC(CC2)C(C3=CC=CC=C3)(C4=CC=CC=C4)O)O,97.1,13.4
Teriflunomide,B1850,108605-62-5,Others,DHODH,Inhibitor of dihydroorotate dehydrogenase,CC(=C(C#N)C(=O)NC1=CC=C(C=C1)C(F)(F)F)O,105.6,7.4
Tetrabenazine,B3542,58-46-8,Neuroscience,Dopamine Receptor,VMAT-inhibitor,CC(CC1CN2CCC3=CC(OC)=C(OC)C=C3C2CC1=O)C,98.2,7.9
Tetracaine HCl,B1413,136-47-0,Membrane Transporter/Ion Channel,Calcium Channel,Anaesthetic and allosteric inhibitor,CCCCNC1=CC=C(C=C1)C(=O)OCCN(C)C.Cl,114.0,13.9
Tetracycline Hydrochloride,A2517,64-75-5,Microbiology & Virology,Antibiotic,Bacteriostatic antibiotics,CC1(C2CC3C(C(=O)C(=C(C3(C(=O)C2=C(C4=C1C=CC=C4O)O)O)O)C(=O)N)N(C)C)O.Cl,99.6,8.5
Tetrahydrozoline HCl,B1349,522-48-5,GPCR/G protein,Adrenergic Receptor,Adrenergic receptor agonist,C1CC(C2=CC=CC=C2C1)C3=NCCN3.Cl,110.5,8.5
Tetrandrine,N1798,518-34-3,Natural Products,Calcium Channel,1,1,121.7,26.7
Thalidomide,A4216,50-35-1,Apoptosis,TNF-α,"Immunomodulatory agent,sedative drug,angiogenesis inhibitor",C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O,105.3,3.2
Theophylline,N1442,58-55-9,Natural Products,Adenosine Receptor; Autophagy; Endogenous Metabolite; Phosphodiesterase (PDE),1,CN1C2=C(C(=O)N(C1=O)C)NC=N2,106.6,6.9
Thiabendazole,A8536,148-79-8,Others,Others,Fungicide,C1=CC=C2C(=C1)NC(=N2)C3=CSC=N3,94.0,11.1
Thiamine HCl (Vitamin B1),B1852,67-03-8,Metabolism,Vitamin,hydrochloride salt form of thiamine,CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.Cl.[Cl-],104.1,12.2
Thiamphenicol,B1853,15318-45-3,Microbiology & Virology,Anti-infection,antimicrobial antibiotic,CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)NC(=O)C(Cl)Cl)O,102.4,5.1
Thio-TEPA,B3742,52-24-4,DNA Damage/DNA Repair,DNA Alkylating,alkylating agent used to treat cancer,S=P(N1CC1)(N2CC2)N3CC3,130.1,49.0
Thioguanine,A4176,154-42-7,DNA Damage/DNA Repair,DNA Methyltransferase,Purine antimetabolite,C1=NC2=C(N1)C(=S)N=C(N2)N,107.9,4.1
Thioridazine HCl,A8537,130-61-0,Others,Others,Calcium channel protein inhibitor,CN1CCCCC1CCN2C3=CC=CC=C3SC4=C2C=C(C=C4)SC.Cl,61.0,14.1
Thiostrepton,B7336,1393-48-2,DNA Damage/DNA Repair,DNA Synthesis,1,1,120.1,7.5
Thonzonium Bromide,B4962,553-08-2,Microbiology & Virology,Bacterial,surface active agent and inhibitor of V-ATPase proton transport,C[N+](CCN(C1=NC=CC=N1)CC(C=C2)=CC=C2OC)(C)CCCCCCCCCCCCCCCC.[Br-],90.7,6.3
Thymidine,C3486,50-89-5,DNA,DNA Synthesis,1,1,100.1,2.2
Thymol,C6149,89-83-8,Immunology/Inflammation,1,1,1,97.6,0.3
Tiagabine,B3488,115103-54-3,Neuroscience,GABA Receptor,selective gamma-aminobutyric acid (GABA) reuptake inhibitor,CC(C=CS1)=C1/C(C2=C(C=CS2)C)=C/CCN3CCC[C@](C(O)=O)([H])C3,87.8,5.9
Tiagabine hydrochloride,B3443,145821-59-6,Neuroscience,GABA Receptor,GABA uptake inhibitor,CC(C=CS1)=C1/C(C2=C(C=CS2)C)=C/CCN3CCC[C@](C(O)=O)([H])C3.Cl,106.4,19.6
Tianeptine sodium,A5322,30123-17-2,Neuroscience,5-HT Receptor,"5-HT uptake facilitator,selective,antidepressant",CN1C2=CC=CC=C2C(C3=C(S1(=O)=O)C=C(C=C3)Cl)NCCCCCCC(=O)[O-].[Na+],104.8,8.3
Ticagrelor,B2166,274693-27-5,GPCR/G protein,P2Y Receptor,P2Y12 receptor antagonist,CCCSC1=NC2=C(C(=N1)NC3CC3C4=CC(=C(C=C4)F)F)N=NN2C5CC(C(C5O)O)OCCO,101.7,2.0
Ticarcillin sodium,B1854,29457-07-6,Microbiology & Virology,Anti-infection,semisynthetic antibiotic,CC1(C(N2C(S1)C(C2=O)NC(=O)C(C3=CSC=C3)C(=O)[O-])C(=O)[O-])C.[Na+].[Na+],101.9,9.4
Ticlopidine HCl,B2164,53885-35-1,GPCR/G protein,Adenosine Receptor,Purinergic (P2Y) receptor antagonist,C1CN(CC2=C1SC=C2)CC3=CC=CC=C3Cl.Cl,94.3,9.8
Tideglusib,B1539,865854-05-3,PI3K/Akt/mTOR Signaling,GSK-3,non-ATP-competitive GSK-3β inhibitor,C1=CC=C(C=C1)CN2C(=O)N(SC2=O)C3=CC=CC4=CC=CC=C43,100.2,5.4
Tigecycline,A5226,220620-09-7,Microbiology & Virology,Antibiotic,Glycylcycline antibiotic,CC(C)(C)NCC(=O)NC1=C(C2=C(CC3CC4C(C(=O)C(=C(C4(C(=O)C3=C2O)O)O)C(=O)N)N(C)C)C(=C1)N(C)C)O,103.6,12.3
Tilmicosin,B2049,108050-54-0,Microbiology & Virology,Anti-infection,macrolide antibiotic,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)O)N(C)C)O)CCN3CC(CC(C3)C)C)C)C)COC4C(C(C(C(O4)C)O)OC)OC,119.5,14.8
Timolol Maleate,B1350,26921-17-5,GPCR/G protein,Adrenergic Receptor,"Non-selective, beta-adrenergic receptor antagonist",CC(C)(C)NCC(COC1=NSN=C1N2CCOCC2)O.C(=CC(=O)O)C(=O)O,102.3,11.5
Tinidazole,B2050,19387-91-8,Microbiology & Virology,Antibiotic,anti-parasitic drug,CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C,100.3,3.6
Tioconazole,B2051,65899-73-2,Microbiology & Virology,Anti-infection,antifungal medication,C1=CC(=C(C=C1Cl)Cl)C(CN2C=CN=C2)OCC3=C(SC=C3)Cl,61.2,1.0
Tiopronin (Thiola),A8538,1953-02-2,Others,Others,Drug for cystinuria treatment,CC(C(=O)NCC(=O)O)S,87.0,1.1
Tiotropium Bromide,A3874,136310-93-5,Neuroscience,AChR,MAChR M antagonist,O=C(C(C1=C([H])C([H])=C([H])S1)(C2=C([H])C([H])=C([H])S2)O[H])O[C@@]3([H])C([H])([H])[C@]4([H])[N+](C([H])([H])[H])(C([H])([H])[H])[C@@](C3([H])[H])([H])[C@@]5([H])O[C@@]45[H].[Br-],101.0,3.0
Tioxolone,A4362,4991-65-5,Metabolism,Carbonic Anhydrase,CAI inhibitor,OC1=CC(OC(S2)=O)=C2C=C1,111.3,1.6
Tipifarnib (Zarnestra),A4227,192185-72-1,Metabolism,Transferase,1,1,91.7,12.2
Tipiracil hydrochloride,A3875,183204-72-0,Others,Thymidine phosphorylase,Thymidine phosphorylase inhibitor,C1CC(=N)N(C1)CC2=C(C(=O)NC(=O)N2)Cl.Cl,112.3,9.3
Tiratricol,B1855,51-24-1,Others,Others,thyroid hormone analogue,C1=CC(=C(C=C1OC2=C(C=C(C=C2I)CC(=O)O)I)I)O,96.9,2.1
Tirofiban hydrochloride monohydrate,A3877,150915-40-5,Others,Glycoprotein,Glycoprotein IIb/IIIa inhibitor,O=C(O)[C@@H](NS(=O)(CCCC)=O)CC1=CC=C(OCCCCC2CCNCC2)C=C1.Cl.O,100.8,2.8
Tivantinib (ARQ 197),A8325,905854-02-6,Tyrosine Kinase,c-MET,"C-Met inhibitor,non-ATP-competitive",O=C([C@H](C(C1=CC=C2)=CN3C1=C2CCC3)[C@@H]4C5=CNC6=CC=CC=C56)NC4=O,99.6,0.7
Tivozanib (AV-951),A2251,475108-18-0,Tyrosine Kinase,VEGFR,"VEGFR inhibitor,potent and selective",CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl,93.5,6.7
Tizanidine,B1063,51322-75-9,GPCR/G protein,Adrenergic Receptor,α2 adrenergic agonist,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl,97.9,10.3
Tizanidine HCl,B1368,64461-82-1,GPCR/G protein,Adrenergic Receptor,α2-adrenergic receptor agonist,C1CN=C(N1)NC2=C(C=CC3=NSN=C32)Cl.Cl,92.8,3.8
Tobramycin,B1856,32986-56-4,Microbiology & Virology,Anti-infection,Aminoglycoside antibiotic,C1C(C(C(C(C1N)OC2C(C(C(C(O2)CO)O)N)O)O)OC3C(CC(C(O3)CN)O)N)N,81.8,4.2
Tofacitinib (CP-690550) Citrate,A4135,540737-29-9,Chromatin/Epigenetics,JAK,Potent JAK inhibitor,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,110.0,6.2
"Tofacitinib (CP-690550,Tasocitinib)",A4138,477600-75-2,Chromatin/Epigenetics,JAK,Janus kinase inhibitor,CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N,107.8,6.9
Tolazamide,B8719,1156-19-0,Others,Others,Sulfonylurea receptor 1 (SUR1) inhibitor,1,99.8,7.8
Tolazoline HCl,B1329,59-97-2,GPCR/G protein,Adrenergic Receptor,non-selective competitive α-adrenergic receptor antagonist,C1CN=C(N1)CC2=CC=CC=C2.Cl,89.9,7.1
Tolbutamide,B2194,64-77-7,Membrane Transporter/Ion Channel,Potassium Channel,first generation potassium channel blocker,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C=C1)C,106.6,11.0
Tolcapone,A4383,134308-13-7,Metabolism,Transferase,COMT inhibitor,CC1=CC=C(C=C1)C(=O)C2=CC(=C(C(=C2)O)O)[N+](=O)[O-],101.4,9.1
Tolfenamic Acid,B1455,13710-19-5,Neuroscience,COX,Non-steroidal anti-inflammatory drug,CC1=C(C=CC=C1Cl)NC2=CC=CC=C2C(=O)O,113.5,8.2
Tolnaftate,B2053,2398-96-1,Microbiology & Virology,Anti-infection,anti-fungal agent,CC1=CC(=CC=C1)N(C)C(=S)OC2=CC3=CC=CC=C3C=C2,115.5,3.4
Tolperisone HCl,B1857,3644-61-9,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,CC1=CC=C(C=C1)C(=O)C(C)CN2CCCCC2.Cl,94.5,4.7
Tolterodine tartrate,B1620,124937-52-6,Neuroscience,Muscarinic Receptor,Competitive muscarinic receptor antagonist,CC1=CC(=C(C=C1)O)C(CCN(C(C)C)C(C)C)C2=CC=CC=C2.C(C(C(=O)O)O)(C(=O)O)O,106.2,13.6
Toltrazuril,B2054,69004-03-1,Microbiology & Virology,Antibiotic,antiprotozoal agent,CC1=C(C=CC(=C1)N2C(=O)NC(=O)N(C2=O)C)OC3=CC=C(C=C3)SC(F)(F)F,97.0,3.7
Tolvaptan,B2300,150683-30-0,GPCR/G protein,Vasopressin Receptor,AVP V2-receptor antagonist,CC1=CC=CC=C1C(=O)NC2=CC(=C(C=C2)C(=O)N3CCCC(C4=C3C=CC(=C4)Cl)O)C,101.2,9.6
Topiramate,A4360,97240-79-4,Metabolism,Carbonic Anhydrase,"GluR5 receptor antagonist,anticonvulsant",CC1(OC2COC3(C(C2O1)OC(O3)(C)C)COS(=O)(=O)N)C,128.3,10.1
Topiroxostat,B1192,577778-58-6,Others,XAO,Xanthine oxidoreductase (XOR) inhibitor,C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N,98.5,9.3
Topotecan,B4982,123948-87-8,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor,CC[C@]1(O)C(C=C2C3=NC4=CC=C(O)C(CN(C)C)=C4C=C3CN2C5=O)=C5COC1=O,-3.7,6.4
Topotecan HCl,B2296,119413-54-6,DNA Damage/DNA Repair,Topoisomerase,Topoisomerase 1 inhibitor,Cl[H].O=C1N(C([H])([H])C2=C([H])C(C(C([H])([H])N(C([H])([H])[H])C([H])([H])[H])=C3O[H])=C(C([H])=C3[H])N=C42)C4=C([H])C([C@@](C([H])([H])C([H])([H])[H])5O[H])=C1C([H])([H])OC5=O,99.5,7.1
Torcetrapib,A4378,262352-17-0,Metabolism,CETP,CETP inhibitor,CCC1CC(C2=C(N1C(=O)OCC)C=CC(=C2)C(F)(F)F)N(CC3=CC(=CC(=C3)C(F)(F)F)C(F)(F)F)C(=O)OC,97.9,5.1
Toremifene Citrate,B1513,89778-27-8,Endocrinology and Hormones,Estrogen/progestogen Receptor,Oral selective estrogen receptor modulator (SERM),CN(C)CCOC1=CC=C(C=C1)C(=C(CCCl)C2=CC=CC=C2)C3=CC=CC=C3.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,100.6,2.2
Torsemide,B2055,56211-40-6,Others,Others,pyridine-sulfonyl urea type loop diuretic,CC1=CC(=CC=C1)NC2=C(C=NC=C2)S(=O)(=O)NC(=O)NC(C)C,102.7,1.5
Trametinib (GSK1120212),A3018,871700-17-3,MAPK Signaling,MEK1/2,"MEK1 and MEK2 inhibitor, potent and selective",CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5,117.5,19.7
Trametinib DMSO solvate,A3887,1187431-43-1,MAPK Signaling,MEK1/2,Allosteric MEK1/MEK2 kinase inhibitor,CC1=C2C(=C(N(C1=O)C)NC3=C(C=C(C=C3)I)F)C(=O)N(C(=O)N2C4=CC(=CC=C4)NC(=O)C)C5CC5.CS(=O)C,14.6,0.4
Tramiprosate,B7446,3687-18-1,Neuroscience,Amyloid β,1,1,107.3,0.9
Trandolapril,B3540,87679-37-6,Proteases,ACE,angiotensin-converting enzyme (ACE) inhibitor,O=C([C@@H](N[C@H](C(OCC)=O)CCC1=CC=CC=C1)C)N2[C@H](C(O)=O)C[C@@]3([H])CCCC[C@@]32[H],96.0,1.9
Tranexamic Acid,B1858,1197-18-8,Others,Others,competitive inhibitor of plasminogen activation,C1CC(CCC1CN)C(=O)O,105.2,1.6
Tranilast,A5375,53902-12-8,GPCR/G protein,Angiotensin Receptor,Angiogenesis inhibitor,COC1=C(C=C(C=C1)C=CC(=O)NC2=CC=CC=C2C(=O)O)OC,100.6,2.1
Tranylcypromine hydrochloride,B7514,1986-47-6,Chromatin/Epigenetics,Histone Demethylases,LSD1/BHC110 and monoamine oxidase (MAO) inhibitor,N[C@H]1[C@H](C2=CC=CC=C2)C1.Cl,83.6,3.5
Trazodone HCl,B2230,25332-39-2,Neuroscience,5-HT Receptor,5-HT receptor antagonist,C1CN(CCN1CCCN2C(=O)N3C=CC=CC3=N2)C4=CC(=CC=C4)Cl.Cl,103.9,2.1
Trelagliptin,A3888,865759-25-7,Proteases,DPP-4,"DPP-4 inhibitor,long-acting and selective",CN1C(=O)C=C(N(C1=O)CC2=C(C=CC(=C2)F)C#N)N3CCCC(C3)N,88.6,6.0
Tretinoin (Aberela),A8539,302-79-4,Others,RARs,"retinoic acid, treats acne vulgaris and keratosis pilaris",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,91.0,22.3
Triamcinolone,B1859,124-94-7,GPCR/G protein,Glucocorticoid Receptor,synthetic glucocorticoid agonist,CC12CC(C3(C(C1CC(C2(C(=O)CO)O)O)CCC4=CC(=O)C=CC43C)F)O,67.7,2.3
Triamcinolone Acetonide,A8540,76-25-5,Others,Others,Antiinflammatory steroid,F[C@@]1([C@@](C([H])([H])[H])(C([H])=C2[H])C3=C([H])C2=O)[C@](C([H])([H])C3([H])[H])([H])[C@@]4([H])[C@@](C([H])([H])[C@]1([H])O[H])(C([H])([H])[H])[C@]5(C(C([H])([H])O[H])=O)OC(C([H])([H])[H])(C([H])([H])[H])O[C@]5([H])C4([H])[H],104.4,1.9
Triamterene,B2275,396-01-0,Membrane Transporter/Ion Channel,Sodium Channel,Sodium channel inhibitor,C1=CC=C(C=C1)C2=NC3=C(N=C2N)N=C(N=C3N)N,95.4,3.8
Trichlormethiazide,B2056,133-67-5,Others,Others,thiazide diuretic,C1=C2C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)NC(N2)C(Cl)Cl,112.7,36.3
Triciribine,A8541,35943-35-2,PI3K/Akt/mTOR Signaling,Akt,"Akt inhibitor,highly selective",[H][C@](N1C(N=C([H])N=C2N(C([H])([H])[H])N=C3N([H])[H])=C2C3=C1[H])([C@]4([H])O[H])O[C@@](C([H])([H])O[H])([H])[C@@]4([H])O[H],106.1,0.2
Triclabendazole,B1860,68786-66-3,Cell Cycle/Checkpoint,Microtubule Associated,Microtubule associated inhibitor,CSC1=NC2=CC(=C(C=C2N1)Cl)OC3=C(C(=CC=C3)Cl)Cl,101.7,1.5
Triclosan,C4035,3380-34-5,Microbiology & Virology,Antibiotic,broad-spectrum antibacterial agent,ClC1=C(OC2=CC=C(Cl)C=C2O)C=CC(Cl)=C1,99.4,4.8
Trifluoperazine 2HCl,B1397,440-17-5,Ubiquitination/Proteasome,Autophagy,Dopamine D2 receptor inhibitor,CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F.Cl.Cl,72.7,11.9
Triflurdine (Viroptic),A8542,70-00-8,Apoptosis,Thymidylate Synthase,Anti-herpesvirus antiviral drug,C1C(C(OC1N2C=C(C(=O)NC2=O)C(F)(F)F)CO)O,112.6,13.7
Triflusal,B1461,322-79-2,Neuroscience,COX,COX inhibitor,CC(=O)OC1=C(C=CC(=C1)C(F)(F)F)C(=O)O,99.8,2.4
Trigonelline Hydrochloride,N2577,6138-41-6,Natural Products,Others,1,1,102.7,2.5
Trilostane,A4348,13647-35-3,Metabolism,Dehydrogenase,3β-HSD inhibitor,N#CC1=C([C@@]2([H])O[C@@]2(C([H])([H])C3([H])[H])[C@@](C1([H])[H])(C([H])([H])[H])[C@]4([H])[C@]3([H])[C@@](C([H])([H])C([H])([H])[C@]5([H])O[H])([H])[C@]5(C([H])([H])[H])C([H])([H])C4([H])[H])O[H],105.5,3.4
Trimebutine,B1650,39133-31-8,Endocrinology and Hormones,Opioid Receptor,Antimuscarinic,CCC(COC(=O)C1=CC(=C(C(=C1)OC)OC)OC)(C2=CC=CC=C2)N(C)C,96.5,10.8
Trimethoprim,B2057,738-70-5,Microbiology & Virology,Anti-infection,bacteriostatic antibiotic,COC1=CC(=CC(=C1OC)OC)CC2=CN=C(N=C2N)N,99.7,6.2
Trimipramine (maleate),C5734,521-78-8,Neuroscience,Histamine Receptor,potent antagonist of histamine H1 receptor,CN(C)CC(C)CN1C2=C(C=CC=C2)CCC3=C1C=CC=C3.OC(/C=C\C(O)=O)=O,124.4,26.0
Tripelennamine HCl,B1553,154-69-8,Neuroscience,Histamine Receptor,H1-receptor antagonist,CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2.Cl,104.9,7.5
Triptolide,A3891,38748-32-2,Immunology/Inflammation,NF-κB,1,1,-9.1,0.2
Triptonide,A3892,38647-11-9,Others,dCTP Pyrophosphatase,1,1,111.6,0.5
Troglitazone,A3893,97322-87-7,Metabolism,PPAR,Selective PPARγ agonist,CC1=C(C(=C2CCC(OC2=C1C)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C)O,91.5,0.6
Trometamol,B1861,77-86-1,Neuroscience,COX,proton acceptor used to treat acidemia,C(C(CO)(CO)N)O,98.9,11.7
Tropicamide,B1608,1508-75-4,Neuroscience,AChR,Antimuscarinic drug,CCN(CC1=CC=NC=C1)C(=O)C(CO)C2=CC=CC=C2,127.2,19.8
Tropisetron,B2258,105826-92-4,Neuroscience,5-HT Receptor,1,1,107.8,9.8
Trospium chloride,B1616,10405-02-4,Neuroscience,AChR,Antimuscarinic agent,C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],104.3,8.4
Troxerutin,B5988,7085-55-4,Others,Antioxidants,flavonoid,C[C@@](O1)([H])[C@@](O)([H])[C@](O)([H])[C@](O)([H])[C@]1([H])OC[C@]2([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@@](OC(C(C3=C(O)C=C(OCCO)C=C3O4)=O)=C4C5=CC(OCCO)=C(OCCO)C=C5)([H])O2,105.7,0.6
Troxipide,B1862,30751-05-4,Others,Others,Gastric cytoprotective agent,COC1=CC(=CC(=C1OC)OC)C(=O)NC2CCCNC2,100.7,1.1
Tylosin tartrate,B2059,74610-55-2,Microbiology & Virology,Anti-infection,macrolide antibiotic,CCC1C(C=C(C=CC(=O)C(CC(C(C(C(CC(=O)O1)O)C)OC2C(C(C(C(O2)C)OC3CC(C(C(O3)C)O)(C)O)N(C)C)O)CC=O)C)C)COC4C(C(C(C(O4)C)O)OC)OC.C(C(C(=O)O)O)(C(=O)O)O,95.0,15.5
Tyramine,C4159,51-67-2,GPCR/G Protein,TAAR,1,OC1=CC=C(CCN)C=C1,95.3,8.5
Tyrosol,N1496,501-94-0,Natural Products,Others,1,C1=CC(=CC=C1CCO)O,96.7,0.9
"UK 14,304",B3465,59803-98-4,GPCR/G protein,Adenosine Receptor,full α2-adrenergic receptor (α2-AR) agonist,BrC1=C(NC2=NCCN2)C=CC3=C1N=CC=N3,101.3,7.2
Ulipristal,B2134,159811-51-5,Endocrinology and Hormones,Estrogen/progestogen Receptor,progestogen receptor modulator,CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,108.0,5.6
Ulipristal acetate,B1049,126784-99-4,Endocrinology and Hormones,Estrogen/progestogen Receptor,Novel selective progesterone receptor modulator (SPRM),CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C,94.3,3.3
Umbelliferone,N2282,93-35-6,Natural Products,Others,1,1,111.5,16.1
Undecanoic Acid,C5468,112-37-8,Others,Others,1,OC(CCCCCCCCCC)=O,97.1,11.7
Uracil,B1863,66-22-8,Others,Others,antineoplastic agent,C1=CNC(=O)NC1=O,103.1,2.4
Urapidil HCl,B2242,64887-14-5,Neuroscience,5-HT Receptor,α1-adrenoceptor antagonist and 5-HT1A receptor agonist,CN1C(=CC(=O)N(C1=O)C)NCCCN2CCN(CC2)C3=CC=CC=C3OC.Cl,103.5,2.7
Urea,B7781,57-13-6,Others,Reagents,organic compound,O=C(N)N,98.3,4.3
Uridine,B1473,58-96-8,DNA Damage/DNA Repair,DNA Synthesis,DNA/RNA synthesis chemical,C1=CN(C(=O)NC1=O)C2C(C(C(O2)CO)O)O,103.0,5.7
Ursodiol,B2135,128-13-2,Others,Others,Bile acids for PBC treatment,CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C,100.2,1.9
Ursolic acid,N1823,77-52-1,Natural Products,Others,1,1,103.0,2.6
VRT752271,B1106,869886-67-9,MAPK Signaling,ERK,ERK1/ERK2 inhibitor,CC(C)NC1=NC=C(C(=C1)C2=CNC(=C2)C(=O)NC(CO)C3=CC(=CC=C3)Cl)Cl,98.5,1.2
"VX-222 (VCH-222, Lomibuvir)",A4032,1026785-59-0,Proteases,HCV Protease,NNI of HCV RNA polymerase,CC1CCC(CC1)C(=O)N(C2CCC(CC2)O)C3=C(SC(=C3)C#CC(C)(C)C)C(=O)O,90.2,4.2
VX-661,A2664,1152311-62-0,Membrane Transporter/Ion Channel,CFTR,1,1,91.9,14.9
"VX-680 (MK-0457,Tozasertib)",A4111,639089-54-6,Chromatin/Epigenetics,Aurora Kinase,Aurora kinase inhibitor,CC1=CC(=NN1)NC2=NC(=NC(=C2)N3CCN(CC3)C)SC4=CC=C(C=C4)NC(=O)C5CC5,102.2,19.9
VX-745,A8686,209410-46-8,MAPK Signaling,p38,1,1,78.2,36.6
VX-809,A8351,936727-05-8,Membrane Transporter/Ion Channel,CFTR,CFTR corrector,CC1=C(N=C(C=C1)NC(=O)C2(CC2)C3=CC4=C(C=C3)OC(O4)(F)F)C5=CC(=CC=C5)C(=O)O,99.2,2.0
Valaciclovir HCl,B2061,124832-27-5,Microbiology & Virology,Anti-infection,antiviral drug for herpes viruses,CC(C)C(C(=O)OCCOCN1C=NC2=C1NC(=NC2=O)N)N.Cl,104.5,6.8
Valdecoxib,B1459,181695-72-7,Neuroscience,COX,COX-2 inhibitor,CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N,100.8,10.7
Valganciclovir HCl,B1864,175865-59-5,Microbiology & Virology,CMV,prodrug for ganciclovir,CC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N.Cl,98.9,1.3
Valnemulin HCl,B1865,133868-46-9,Microbiology & Virology,Anti-infection,pleuromutilin antibiotic,O[C@H]([C@](C)(C=C)C1)[C@H](C)[C@]2(CCC3=O)[C@@H]3[C@@]([C@@H]1OC(CSC(C)(C)CNC([C@@H](C(C)C)N)=O)=O)(C)[C@H](C)CC2.Cl,105.8,1.8
Valproic acid,B1251,99-66-1,DNA Damage/DNA Repair,HDAC,HDAC1 inhibitor,CCCC(CCC)C(=O)O,103.2,5.9
Valproic acid sodium salt (Sodium valproate),A4099,1069-66-5,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,CCCC(CCC)C(=O)[O-].[Na+],99.9,4.5
Valsartan,B2214,137862-53-4,GPCR/G protein,Adenosine Receptor,Angiotensin II AT1 receptor antagonist,CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)C(C(C)C)C(=O)O,96.2,13.6
Vancomycin hydrochloride,B1223,1404-93-9,Microbiology & Virology,Antibiotic,Narrow-spectrum glycopeptide antibacterial agent,1,97.2,6.7
Vandetanib (ZD6474),A8555,443913-73-3,Tyrosine Kinase,VEGFR,VEGFR2/EGFR antagonist,CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC,90.5,21.3
Vanillic acid,B7917,121-34-6,Others,Others,Used as a precursor in the synthesis of a wide range of bio-based epoxy resins and polyesters,COC1=C(O)C=CC(C(O)=O)=C1,104.2,16.1
Vanillin,B3679,121-33-5,Others,Others,flavorant,OC1=C(C=C(C=O)C=C1)OC,107.3,9.6
Vardenafil,B3343,224785-90-4,Metabolism,PDE,PDE5 inhibitor,CCCC1=NC(=C2N1NC(=NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CC)OCC)C,102.2,6.5
Vardenafil HCl Trihydrate,A4323,330808-88-3,Metabolism,PDE,1,1,103.1,9.6
Varenicline Tartrate,A5391,375815-87-5,Neuroscience,AChR,"Subtype-selective agonist of α4β2 nicotinic receptors,orally active",O=C([C@]([C@@](C(O[H])=O)([H])O[H])([H])O[H])O[H].[H][C@@]12C([H])([H])C(C([H])([H])N([H])C2([H])[H])([H])C3=C([H])C4=NC([H])=C([H])N=C4C([H])=C13,96.7,4.9
Vatalanib (PTK787) 2HCl,A1778,212141-51-0,Tyrosine Kinase,VEGFR,Tyrosine kinase receptor inhibitor,C1=CC=C2C(=C1)C(=NN=C2NC3=CC=C(C=C3)Cl)CC4=CC=NC=C4.Cl.Cl,90.6,9.7
Vecuronium Bromide,A5220,50700-72-6,Neuroscience,AChR,Nonpolarizing neuromuscular relaxant,CC(=O)OC1CC2CCC3C(C2(CC1N4CCCCC4)C)CCC5(C3CC(C5OC(=O)C)[N+]6(CCCCC6)C)C.[Br-],8.9,4.9
"Vemurafenib (PLX4032, RG7204)",A3004,918504-65-1,MAPK Signaling,MEK1/2,BRAF kinase inhibitor,CCCS(=O)(=O)NC1=C(C(=C(C=C1)F)C(=O)C2=CNC3=NC=C(C=C23)C4=CC=C(C=C4)Cl)F,139.0,13.9
Venlafaxine,A5355,99300-78-4,Neuroscience,5-HT Receptor,Dual serotonin/noradrenalin re-uptake inhibitor,CN(C)CC(C1=CC=C(C=C1)OC)C2(CCCCC2)O.Cl,89.4,6.2
Verapamil HCl,B1867,152-11-4,Membrane Transporter/Ion Channel,Calcium Channel,L-type calcium channel blocker,CC(C)C(CCCN(C)CCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC.Cl,114.3,0.6
Verteporfin,A8327,129497-78-5,Others,Others,Photosensitizer used in photodynamic therapy,O=C([C@H]1[C@](/C(N=C2/C=C(C(C)=C/3C=C)\NC3=C/C4=N/C(C(CCC(O)=O)=C4C)=C\5)=C/C6=C(C)C(CCC(OC)=O)=C5N6)(C)C2=CC=C1C(OC)=O)OC,108.9,5.3
Vidarabine,B2062,5536-17-4,Microbiology & Virology,HSV,antiviral drug for herpes viruses,C1=NC2=C(C(=N1)N)N=CN2C3C(C(C(O3)CO)O)O,125.7,44.7
Vidofludimus,B4669,717824-30-1,Metabolism,Dehydrogenase,DHODH inhibitor,FC1=CC(C2=CC=CC(OC)=C2)=CC=C1NC(C3=C(C(O)=O)CCC3)=O,99.4,0.4
Vilanterol trifenatate,B1006,503070-58-4,GPCR/G protein,Adrenergic Receptor,β2-AR agonist,C1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)O.C1=CC(=C(C(=C1)Cl)COCCOCCCCCCNCC(C2=CC(=C(C=C2)O)CO)O)Cl,103.9,4.5
Vilazodone,A3918,163521-12-8,Neuroscience,5-HT Receptor,Combined SSRI and 5-HT1A receptor partial agonist,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N,86.8,2.1
Vilazodone Hydrochloride,A3919,163521-08-2,Neuroscience,5-HT Receptor,Combined SSRI and 5-HT1A receptor partial agonist,C1CN(CCN1CCCCC2=CNC3=C2C=C(C=C3)C#N)C4=CC5=C(C=C4)OC(=C5)C(=O)N.Cl,85.8,3.1
Vildagliptin (LAF-237),A4037,274901-16-5,Proteases,DPP-4,DPP-4 inhibitor,C1CC(N(C1)C(=O)CNC23CC4CC(C2)CC(C4)(C3)O)C#N,75.0,28.6
Vinblastine sulfate,A3920,143-67-9,Ubiquitination/Proteasome,Autophagy,Anti-mitotic agent,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O.OS(=O)(=O)O,112.0,2.7
Vincristine,A1765,2068-78-2,Cell Cycle/Checkpoint,Microtubule/Tubulin,"Microtubule disrupter,antitumor agent",O[C@]1(CC)CN(CC2)C[C@@](C1)([H])C[C@](C(OC)=O)(C3=C(OC)C=C(N(C=O)[C@]4([H])[C@@]56C7[C@](C=CCN7CC6)(CC)C(OC(C)=O)[C@@]4(C(OC)=O)O)C5=C3)C8=C2C9=CC=CC=C9N8.OS(O)(=O)=O,15.9,3.5
Vindoline,N1289,2182-14-1,Natural Products,Microtubule Associated,1,1,98.3,6.7
Vinorelbine,N2250,71486-22-1,Natural Products,Microtubule Associated,1,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC,86.6,13.5
Vinorelbine ditartrate,A3921,125317-39-7,Others,Others,Anti-mitotic chemotherapy drug,CCC1=CC2CC(C3=C(CN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC.C(C(C(=O)O)O)(C(=O)O)O.C(C(C(=O)O)O)(C(=O)O)O,-6.1,11.2
Vinpocetine,B2276,42971-09-5,Metabolism,PDE,PDE inhibitor,O=C(C(N1C2=C(C3=C([H])C([H])=C([H])C([H])=C13)C([H])([H])C4([H])[H])=C([H])[C@@]5(C([H])([H])C([H])([H])[H])[C@]2([H])N4C([H])([H])C([H])([H])C5([H])[H])OC([H])([H])C([H])([H])[H],109.6,9.4
Vitamin A,B8660,68-26-8,Others,Others,Precursor of active retinoids,1,100.5,2.7
Vitamin A Acetate,B1868,127-47-9,Metabolism,Vitamin,Unsaturated nutritional hydrocarbons,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CCOC(=O)C)C)C,83.3,5.4
Vitamin B12,B2063,68-19-9,Metabolism,Vitamin,water soluble vitamin,CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3],98.9,1.9
Vitamin C,B2064,50-81-7,Others,Others,water soluble vitamin,O=C1OC(C(O[H])=C1O[H])([H])C(C([H])([H])O[H])([H])O[H],112.9,3.6
Vitamin D2 (Ergocalciferol),A8543,50-14-6,Others,Others,DNA Polymerase inhibitor,CC(C)C(C)C=CC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,101.6,4.6
Vitamin D3,B2065,67-97-0,Vitamin D Related,VD/VDR,Fat-soluble secosteroids,CC(C)CCCC(C)C1CCC2C1(CCCC2=CC=C3CC(CCC3=C)O)C,88.8,3.4
Vitamin K1,B8631,84-80-0,Metabolism system,Osteocalcin,"Essential vitamin for the synthesis of coagulation factors II, VII, IX, and X in the liver",1,107.9,5.3
Vitexicarpin,N1318,479-91-4,Natural Products,NF-κB,1,1,16.4,1.8
Voglibose,B1870,83480-29-9,Others,Others,α-glucosidases inhibitor,C1C(C(C(C(C1(CO)O)O)O)O)NC(CO)CO,107.9,4.5
Vorapaxar,A8809,618385-01-6,Others,Others,"PAR-1 antagonist,potent and orally active",CCOC(=O)NC1CCC2C(C1)CC3C(C2C=CC4=NC=C(C=C4)C5=CC(=CC=C5)F)C(OC3=O)C,95.7,1.5
Voriconazole,A4320,137234-62-9,Metabolism,CYP3A/CYP450,CYP51 inhibitor,CC(C1=NC=NC=C1F)C(CN2C=NC=N2)(C3=C(C=C(C=C3)F)F)O,107.6,3.8
"Vorinostat (SAHA, MK0683)",A4084,149647-78-9,DNA Damage/DNA Repair,HDAC,HDAC inhibitor,C1=CC=C(C=C1)NC(=O)CCCCCCC(=O)NO,117.7,1.7
Vortioxetine,A3926,508233-74-7,Neuroscience,5-HT Receptor,5-HT receptors antagonist,CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C,21.4,4.9
Vortioxetine (Lu AA21004) HBr,A2547,960203-27-4,Neuroscience,5-HT Receptor,"5-HT receptor modulator, antidepressant and anxiolytic",CC1=CC(=C(C=C1)SC2=CC=CC=C2N3CCNCC3)C.Br,100.5,32.2
Warfarin,B3449,81-81-2,Others,Others,anticoagulant drug,CC(CC(C1=C(O)C2=CC=CC=C2OC1=O)C3=CC=CC=C3)=O,92.6,2.7
Wedelolactone,N2131,524-12-9,Immunology/Inflammation,IκB/IKK,1,COC1=CC(=C2C(=C1)OC(=O)C3=C2OC4=CC(=C(C=C43)O)O)O,85.3,3.0
Xylazine,B3344,7361-61-7,GPCR/G protein,Adrenergic Receptor,1,1,102.7,18.1
Xylazine HCl,B1351,23076-35-9,GPCR/G protein,Adrenergic Receptor,α2 Adrenoceptor agonist,CC1=C(C(=CC=C1)C)NC2=NCCCS2.Cl,103.0,13.3
Xylitol,N1725,87-99-0,Natural Products,Others,1,C(C(C(C(CO)O)O)O)O,103.2,3.2
Xylometazoline HCl,B2066,1218-35-5,GPCR/G protein,Adrenergic Receptor,α1 and α2 adrenergic receptor agonist,CC1=CC(=CC(=C1CC2=NCCN2)C)C(C)(C)C.Cl,102.6,1.6
Xylose,B2067,25990-60-7,Others,Others,monosaccharide of the aldopentose type,C(C(C(C(C=O)O)O)O)O,94.6,0.2
YM155,A4221,781661-94-7,Apoptosis,IAP,"Survivin suppressant,apoptosis inhibitor",CC1=[N+](C2=C(N1CCOC)C(=O)C3=CC=CC=C3C2=O)CC4=NC=CN=C4.[Br-],99.9,2.7
Yohimbine Hydrochloride,N1704,65-19-0,Natural Products,Adrenergic Receptor,1,COC(=O)C1C(CCC2C1CC3C4=C(CCN3C2)C5=CC=CC=C5N4)O.Cl,99.8,1.1
Z-Ligustilide,N1901,4431-01-0,Natural Products,Others,1,1,108.5,6.9
Zafirlukast,B2068,107753-78-6,GPCR/G protein,Leukotriene Receptor,oral leukotriene receptor antagonist,CC1=CC=CC=C1S(=O)(=O)NC(=O)C2=CC(=C(C=C2)CC3=CN(C4=C3C=C(C=C4)NC(=O)OC5CCCC5)C)OC,108.8,5.1
Zalcitabine,B2223,7481-89-2,Microbiology & Virology,Reverse Transcriptase,Reverse transcriptase inhibitor,C1CC(OC1CO)N2C=CC(=NC2=O)N,98.7,3.4
Zaltoprofen,B1460,74711-43-6,Neuroscience,COX,Cyclooxygenase (COX) inhibitor,CC(C1=CC2=C(C=C1)SC3=CC=CC=C3C(=O)C2)C(=O)O,97.5,3.9
Zanamivir,B2136,139110-80-8,Microbiology & Virology,1,Influenza A/B virus neuraminidases inhibitor,CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N,97.5,11.7
Zibotentan (ZD4054),A5489,186497-07-4,GPCR/G protein,Endothelin Receptor,"ETA receptor antagonist,potent and specific",CC1=CN=C(C(=N1)OC)NS(=O)(=O)C2=C(N=CC=C2)C3=CC=C(C=C3)C4=NN=CO4,106.6,4.7
Zidovudine,B2221,30516-87-1,DNA Damage/DNA Repair,Nucleoside Antimetabolite/Analogue,Reverse transcriptase inhibitor,CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)N=[N+]=[N-],104.2,8.0
Zileuton,A5384,111406-87-2,Immunology/Inflammation,5-Lipoxygenase,"5-lipoxygenase (5-LOX) inhibitor, orally active",CC(C1=CC2=CC=CC=C2S1)N(C(=O)N)O,100.9,0.1
Zinc Pyrithione,B2201,13463-41-7,Membrane Transporter/Ion Channel,Proton Pump,Proton pump inhibitor,C1=CC(=S)N(C=C1)[O-].C1=CC(=S)N(C=C1)[O-].[Zn+2],61.0,1.1
Ziprasidone,A3952,146939-27-7,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54,98.4,1.4
Ziprasidone HCl,A5350,122883-93-6,Neuroscience,5-HT Receptor,Serotonin and dopamine receptor antagonist,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.Cl,90.6,1.1
Ziprasidone hydrochloride monohydrate,A3953,138982-67-9,Neuroscience,5-HT Receptor,5-HT (serotonin)/dopamine receptor antagonist,C1CN(CCN1CCC2=C(C=C3C(=C2)CC(=O)N3)Cl)C4=NSC5=CC=CC=C54.O.Cl,114.2,0.3
Zoledronic Acid,A1352,118072-93-8,Cell Cycle/Checkpoint,Rho,Potent nitrogen-containing bisphosphonates,C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O,115.5,5.8
Zolmitriptan,B2261,139264-17-8,Neuroscience,5-HT Receptor,Potent 5-HT1B/1D/1F agonist,CN(C)CCC1=CNC2=C1C=C(C=C2)CC3COC(=O)N3,101.9,1.1
Zonisamide,A5354,68291-97-4,Membrane Transporter/Ion Channel,Calcium Channel,Antiepileptic with anticonvulsant and mechanistic effect,C1=CC=C2C(=C1)C(=NO2)CS(=O)(=O)N,80.6,38.0
Zotarolimus(ABT-578),B4786,221877-54-9,PI3K/Akt/mTOR Signaling,mTOR,anti-proliferative drug used exclusively in coronary drug eluting stent,1,72.2,16.6
Zoxazolamine,B1871,61-80-3,Others,Others,uricosuric and muscle relaxant,C1=CC2=C(C=C1Cl)N=C(O2)N,103.6,8.2
alpha-tocopherol,M1387,59-02-9,Neuroscience,"COX,VEGFR",1,CC(CCC[C@@](CCC[C@@](CCC[C@@]1(CCC2=C(C(O)=C(C(C)=C2O1)C)C)C)([H])C)([H])C)C,96.4,0.6
beta-Alanine,C6114,107-95-9,Others,Others,1,1,99.3,1.5
cis-Anethol,N2095,104-46-1,Natural Products,Others,1,CC=CC1=CC=C(C=C1)OC,70.2,9.5
cis-aconitate,M1226,585-84-2,Others,Others,1,O=C(O)/C([H])=C(C(O)=O)/CC(O)=O,106.5,4.2
delta-Gluconolactone,C6206,90-80-2,Others,Others,1,1,98.2,1.8
glucuronate,M1200,6556-12-3,Others,Others,1,O=C[C@@](O)([H])[C@](O)([H])[C@@](O)([H])[C@@](O)([H])C(O)=O,103.2,2.7
hippurate,M1191,495-69-2,Others,Others,1,O=C(O)CNC(C1=CC=CC=C1)=O,89.1,0.2
histamine,M1375,51-45-6,Neuroscience,Histamine Receptor,1,NCCC1=CN=CN1,98.3,1.4
m-Cresol,C6313,108-39-4,Others,Others,1,1,98.5,2.0
myo-Inositol,B7903,87-89-8,Others,Others,1,OC1C(O)C(O)C(O)C(O)C1O,101.3,0.5
o-Cresol,C6258,95-48-7,Others,Others,1,1,98.9,3.3
o-Toluic acid,C6207,118-90-1,Others,Others,1,1,104.8,4.7
p-Anisaldehyde,C6107,123-11-5,Microbiology & Virology,Anti-infection,1,1,94.9,0.6
p-Cresol,C6320,106-44-5,Others,Others,1,1,97.5,0.2
sn-Glycero-3-phosphocholine,B1157,28319-77-9,Others,Others,Nootropic phospholipid,C[N+](C)(C)CCOP(=O)([O-])OCC(CO)O,102.3,3.3
sodium fluoride,B7846,7681-49-4,Metabolism,phosphatases,1,1,91.4,0.9
sucrose,M1202,57-50-1,Metabolism,Endogenous Metabolite,1,OC[C@]1([H])[C@](O)([H])[C@@](O)([H])[C@](O)([H])[C@](O[C@]2([C@](O)([H])[C@@](O)([H])[C@@](O2)([H])CO)CO)([H])O1,109.9,3.9
tetrahydro-L-Biopterin (hydrochloride),C5419,69056-38-8,Metabolism,Hydroxylase,1,C[C@@H]([C@@H]([C@@]([H])(CN(C(N(C(N)=N1)[H])=C2C1=O)[H])N2[H])O)O.Cl.Cl,103.7,1.2
thiamine,M1376,59-43-8,Others,Others,1,CC([N+](CC(C1=N)=CN=C(N1)C)=CS2)=C2CCO.[Cl-],97.8,4.0
vinblastine,N2256,865-21-4,Natural Products,"Microtubule Associated,AChR",1,CCC1(CC2CC(C3=C(CCN(C2)C1)C4=CC=CC=C4N3)(C5=C(C=C6C(=C5)C78CCN9C7C(C=CC9)(C(C(C8N6C)(C(=O)OC)O)OC(=O)C)CC)OC)C(=O)OC)O,79.7,23.3
α-L-Rhamnose monohydrate,B8359,6155-35-7,Others,Others,"Part of plant cell wall polysaccharides, rhamnogalacturonan I and rhamnogalacturonan",C[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)O1.O,103.2,0.2
